For	O
the	O
ER22	O
/	O
EK23	O
polymorphism	O
,	O
we	O
have	O
used	O
the	O
following	O
primers	O
:	O
5	O
′-	O
GATTCGGAGTTAACTAAAAG	O
-	O
3	O
′	O
and	O
5	O
′-	O
CTACCCTTTACTGGACCCTA	O
-	O
3	O
′,	O
followed	O
by	O
restriction	O
digest	O
using	O
MnI	O
I	O
(	O
New	O
England	O
Biolabs	O
,	O
UK	O
)	O
at	O
37	O
°	O
C	O
for	O
4	O
hours	O
.	O

A	O
study	O
in	O
human	O
subjects	O
involved	O
the	O
administration	O
of	O
100	O
,	O
000	O
IU	O
vitamin	O
D	O
per	O
day	O
(	O
2	O
.	O
5	O
mg	O
/	O
day	O
)	O
throughout	O
pregnancy	O
to	O
hypoparathyroid	O
women	O
to	O
maintain	O
serum	O
calcium	O
with	O
no	O
fatal	O
outcome	O
.	O

Eighty	O
-	O
four	O
cases	O
(	O
85	O
.	O
7	O
%)	O
took	O
Vitamin	O
D	O
supplements	O
with	O
duration	O
of	O
2w	O
-	O
31w	O
,	O
and	O
with	O
average	O
daily	O
intake	O
dose	O
of	O
517	O
.	O
5	O
±	O
113	O
.	O
1	O
IU	O
.	O

After	O
this	O
incubation	O
,	O
three	O
10	O
-	O
minute	O
washes	O
were	O
followed	O
in	O
2xSSC	O
at	O
37	O
°	O
C	O
.	O

A	O
targeted	O
screening	O
strategy	O
to	O
detect	O
and	O
treat	O
women	O
at	O
high	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
is	O
clearly	O
needed	O
in	O
Belgium	O
and	O
in	O
other	O
European	O
countries	O
.	O

According	O
to	O
the	O
longitudinal	O
study	O
design	O
the	O
'	O
AMPK	O
(	O
AMP	O
-	O
dependent	O
activated	O
kinase	O
)	O
signaling	O
'	O
was	O
found	O
to	O
be	O
regulated	O
throughout	O
ontogenesis	O
in	O
AP	O
offspring	O
only	O
.	O

In	O
2011	O
the	O
U	O
.	O
S	O
.	O

Results	O
:	O
The	O
infants	O
were	O
followed	O
up	O
for	O
a	O
mean	O
duration	O
of	O
10	O
.	O
19	O
±	O
2	O
.	O
83	O
months	O
.	O

Other	O
studies	O
did	O
not	O
effectively	O
account	O
for	O
dietary	O
intake	O
and	O
are	O
thus	O
at	O
risk	O
of	O
bias	O
.	O

Improved	O
communication	O
and	O
collaboration	O
among	O
researchers	O
investigating	O
these	O
linked	O
outcomes	O
will	O
provide	O
an	O
opportunity	O
to	O
accelerate	O
the	O
discovery	O
,	O
development	O
and	O
delivery	O
of	O
innovation	O
,	O
especially	O
across	O
disciplines	O
and	O
between	O
laboratory	O
benches	O
and	O
remote	O
and	O
under	O
-	O
resourced	O
hospitals	O
.	O

Then	O
,	O
2	O
weeks	O
before	O
mating	O
(	O
Figure1	O
),	O
animals	O
were	O
weighed	O
(	O
average	O
weight	O
240	O
.	O
7	O
±	O
3	O
.	O
4	O
g	O
)	O
and	O
randomly	O
exposed	O
to	O
an	O
ad	O
libitum	O
access	O
of	O
a	O
standard	O
chow	O
(	O
control	O
group	O
;	O
n	O
=	O
9	O
)	O
or	O
a	O
restricted	O
access	O
of	O
the	O
same	O
standard	O
chow	O
(	O
caloric	O
restriction	O
group	O
;	O
n	O
=	O
15	O
).	O

This	O
is	O
worrisome	O
as	O
suboptimal	O
childhood	O
development	O
is	O
associated	O
with	O
poorer	O
adult	O
health	O
,	O
well	O
-	O
being	O
and	O
productivity	O
–	O
leading	O
to	O
an	O
intergenerational	O
cycle	O
of	O
poverty	O
.	O

Two	O
-	O
way	O
ANOVA	O
showed	O
effects	O
of	O
diet	O
and	O
sex	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
γ	O
in	O
liver	O
and	O
PAT	O
(	O
see	O
TableS4for	O
statistical	O
values	O
).	O

Less	O
than	O
half	O
the	O
participants	O
(	O
42	O
.	O
0	O
%)	O
declared	O
they	O
received	O
advice	O
on	O
diet	O
during	O
pregnancy	O
and	O
83	O
.	O
5	O
%	O
stated	O
they	O
were	O
advised	O
to	O
breastfeed	O
(	O
Table	O
1	O
).	O

The	O
reactions	O
occurred	O
within	O
1	O
to	O
3	O
days	O
postpartum	O
and	O
resolved	O
within	O
1	O
to	O
2	O
days	O
.	O

They	O
included	O
the	O
core	O
research	O
villages	O
of	O
the	O
Keneba	O
,	O
Kanton	O
Kunda	O
and	O
Manduar	O
and	O
9	O
of	O
the	O
villages	O
to	O
the	O
east	O
and	O
west	O
of	O
Keneba	O
.	O

The	O
pain	O
began	O
roughly	O
30	O
minutes	O
prior	O
to	O
her	O
presentation	O
to	O
the	O
ED	O
and	O
occurred	O
as	O
she	O
was	O
getting	O
out	O
of	O
the	O
swimming	O
pool	O
.	O

Increased	O
adiposity	O
,	O
lipid	O
profile	O
,	O
glycemia	O
,	O
and	O
leptinemia	O
in	O
male	O
offspring	O
have	O
been	O
reported	O
after	O
the	O
exposure	O
to	O
a	O
moderate	O
undernutrition	O
at	O
different	O
pregnancy	O
periods	O
(	O
Desai	O
et	O
al	O
.,	O
2007a	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
).	O

Provider	O
Advice	O
on	O
Gestational	O
Weight	O
Gain	O
and	O
Weight	O
Gain	O
Target	O
Women	O
were	O
asked	O
(	O
1	O
)	O
“	O
Has	O
your	O
health	O
professional	O
told	O
you	O
how	O
many	O
pounds	O
(	O
kilos	O
)	O
you	O
should	O
gain	O
during	O
this	O
pregnancy	O
?”	O
(	O
2	O
)	O
“	O
How	O
many	O
pounds	O
(	O
kilos	O
)	O
did	O
your	O
health	O
professional	O
say	O
you	O
should	O
gain	O
from	O
the	O
beginning	O
to	O
the	O
end	O
of	O
this	O
pregnancy	O
?”	O
and	O
(	O
3	O
)	O
“	O
How	O
many	O
pounds	O
(	O
kilos	O
)	O
do	O
you	O
think	O
you	O
should	O
gain	O
from	O
the	O
beginning	O
to	O
the	O
end	O
of	O
this	O
pregnancy	O
?”	O
Responses	O
were	O
compared	O
to	O
the	O
2009	O
IOM	O
recommendations	O
.	O

In	O
LP	O
offspring	O
1	O
,	O
959	O
probe	O
-	O
sets	O
were	O
differently	O
expressed	O
(	O
834	O
188	O
dpn	O
≻	O
28	O
dpn	O
).	O

In	O
the	O
longest	O
follow	O
-	O
up	O
of	O
women	O
who	O
have	O
had	O
GDM	O
36	O
%	O
of	O
women	O
had	O
developed	O
diabetes	O
within	O
22	O
–	O
28	O
years	O
(	O
by	O
WHO	O
criteria	O
).	O
21This	O
was	O
in	O
a	O
predominantly	O
white	O
population	O
in	O
Boston	O
from	O
the	O
1960s	O
.	O

While	O
in	O
a	O
study	O
by	O
Cassidy	O
-	O
Bushrow	O
et	O
al	O
.,	O
in	O
African	O
-	O
American	O
women	O
,	O
an	O
inverse	O
relationship	O
was	O
observed	O
between	O
maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
at	O
the	O
early	O
stages	O
of	O
pregnancy	O
and	O
antenatal	O
depression	O
.	O

Three	O
subjects	O
had	O
cathelicidin	O
concentrations	O
that	O
were	O
more	O
than	O
two	O
times	O
greater	O
than	O
the	O
next	O
lowest	O
concentration	O
.	O

The	O
variations	O
of	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
with	O
seasons	O
reflect	O
the	O
changes	O
in	O
UVB	O
exposure	O
,	O
one	O
of	O
the	O
main	O
determinants	O
of	O
vitamin	O
D	O
status	O
in	O
many	O
European	O
countries	O
.	O

gave	O
2000	O
IU	O
of	O
vitamin	O
D	O
per	O
day	O
to	O
non	O
-	O
pregnant	O
women	O
in	O
form	O
of	O
oral	O
drops	O
for	O
105	O
days	O
.	O

Maternal	O
characteristics	O
,	O
as	O
well	O
as	O
pregnancy	O
,	O
delivery	O
and	O
neonatal	O
outcomes	O
,	O
were	O
compared	O
between	O
groups	O
.	O

In	O
a	O
study	O
by	O
Kazemi	O
et	O
al	O
.,	O
in	O
67	O
mothers	O
with	O
term	O
birth	O
in	O
Zanjan	O
,	O
86	O
%	O
in	O
the	O
winter	O
and	O
46	O
%	O
in	O
the	O
summer	O
had	O
vitamin	O
D	O
levels	O
lower	O
than	O
25	O
ng	O
/.	O

In	O
our	O
study	O
,	O
the	O
definition	O
of	O
psychotic	O
-	O
like	O
symptoms	O
was	O
based	O
on	O
self	O
-	O
reported	O
frequency	O
of	O
psychosis	O
-	O
like	O
experiences	O
.	O

METHODS	O
Our	O
study	O
was	O
a	O
case	O
-	O
control	O
type	O
.	O

Immediately	O
following	O
fertilization	O
the	O
quiescent	O
embryo	O
genome	O
requires	O
protection	O
,	O
hence	O
higher	O
expression	O
of	O
piRNAs	O
and	O
esiRNAs	O
,	O
both	O
of	O
which	O
are	O
involved	O
in	O
maintaining	O
genome	O
stability	O
(	O
Watanabe	O
et	O
al	O
.	O
2006	O
,	O
2008	O
).	O

Moreover	O
,	O
another	O
study	O
,	O
18showed	O
that	O
a	O
single	O
dose	O
of	O
200	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
in	O
the	O
healthy	O
youths	O
was	O
associated	O
with	O
a	O
peak	O
in	O
vitamin	O
D	O
concentration	O
after	O
two	O
weeks	O
of	O
treatment	O
,	O
but	O
lower	O
than	O
that	O
of	O
our	O
study	O
at	O
three	O
months	O
after	O
treatment	O
.	O

Each	O
year	O
,	O
great	O
care	O
is	O
taken	O
to	O
explain	O
the	O
methodology	O
for	O
grade	O
determination	O
and	O
the	O
basis	O
of	O
comparison	O
to	O
other	O
states	O
.	O

3	O
.	O

In	O
this	O
cohort	O
,	O
we	O
have	O
collected	O
detailed	O
information	O
on	O
social	O
and	O
environmental	O
influences	O
on	O
the	O
child	O
'	O
s	O
development	O
and	O
in	O
a	O
number	O
of	O
other	O
publications	O
address	O
this	O
question	B
,	O
including	O
cultural	O
and	O
familial	O
influences	O
.	O

Moderate	O
physical	O
activity	O
should	O
be	O
encouraged	O
.	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

High	O
fat	O
perinatal	O
nutrition	O
advanced	O
the	O
age	O
at	O
puberty	O
to	O
the	O
same	O
degree	O
as	O
did	O
post	O
-	O
weaning	O
high	O
fat	O
nutrition	O
in	O
control	O
offspring	O
,	O
and	O
intriguingly	O
the	O
addition	O
of	O
a	O
high	O
fat	O
postnatal	O
diet	O
following	O
high	O
fat	O
prenatal	O
nutrition	O
had	O
no	O
further	O
effect	O
on	O
pubertal	O
age	O
.	O

Therefore	O
,	O
the	O
infants	O
were	O
then	O
sedated	O
with	O
oral	O
chloral	O
hydrate	O
(	O
50	O
–	O
75	O
mg	O
/	O
kg	O
)	O
and	O
placed	O
in	O
the	O
supine	O
position	O
,	O
with	O
the	O
neck	O
mildly	O
extended	O
.	O

We	O
considered	O
the	O
period	O
from	O
2010	O
to	O
2015	O
and	O
then	O
through	O
2025	O
to	O
allow	O
for	O
a	O
more	O
feasible	O
time	O
frame	O
to	O
scale	O
up	O
care	O
and	O
progress	O
on	O
the	O
prevention	O
agenda	O
.	O

The	O
program	O
addresses	O
a	O
wide	O
range	O
of	O
health	O
topics	O
,	O
as	O
compared	O
to	O
other	O
studies	O
that	O
focused	O
on	O
1	O
or	O
a	O
few	O
closely	O
related	O
health	O
behaviors	O
.	O

Overall	O
,	O
this	O
book	O
will	O
be	O
of	O
benefit	O
to	O
postgraduates	O
in	O
the	O
field	O
of	O
nutrition	O
,	O
nutritionists	O
in	O
hospitals	O
and	O
physicians	O
.	O

AluYb8	O
levels	O
were	O
found	O
to	O
marginally	O
differ	O
by	O
infant	O
sex	O
,	O
which	O
is	O
consistent	O
with	O
the	O
previous	O
literature	O
in	O
that	O
repetitive	O
element	O
methylation	O
markers	O
in	O
blood	O
may	O
vary	O
by	O
sex	O
(	O
Cash	O
et	O
al	O
.	O

To	O
compare	O
pregnancy	O
outcomes	O
following	O
maternal	O
use	O
of	O
SGA	O
monotherapy	O
and	O
polytherapy	O
involving	O
other	O
psychotropic	O
medications	O
.	O

This	O
subtle	O
difference	O
may	O
indicate	O
some	O
alterations	O
in	O
the	O
central	O
rewarding	O
functions	O
of	O
the	O
ECS	O
,	O
as	O
was	O
previously	O
described	O
in	O
animals	O
with	O
reduced	O
preference	O
for	O
highly	O
palatable	O
foods	O
(	O
Brand	O
et	O
al	O
.,	O
2012	O
).	O

We	O
hypothesize	O
that	O
the	O
maternal	O
exposure	O
to	O
a	O
moderate	O
calorie	O
-	O
restricted	O
diet	O
could	O
alter	O
the	O
energy	O
homeostasis	O
regulated	O
by	O
the	O
ECS	O
and	O
could	O
re	O
-	O
program	O
fatty	O
-	O
acid	O
metabolism	O
later	O
in	O
life	O
in	O
a	O
sex	O
-	O
specific	O
manner	O
.	O

Hepatic	O
hydroxylation	O
of	O
previtamin	O
D	O
to	O
25	O
(	O
OH	O
)	O
D	O
is	O
thought	O
not	O
to	O
be	O
regulated	O
and	O
is	O
therefore	O
primarily	O
dependent	O
on	O
availability	O
of	O
the	O
substrate	O
.	O

Prophylaxis	O
iron	O
supplement	O
and	O
food	O
fortification	O
with	O
iron	O
have	O
the	O
prospects	O
of	O
improving	O
maternal	O
and	O
child	O
health	O
,	O
except	O
for	O
the	O
identified	O
constraints	O
.	O

The	O
team	O
analyzed	O
96	O
confirmed	O
cancer	O
cases	O
from	O
the	O
New	O
Mexico	O
Tumor	O
Registry	O
,	O
32	O
lung	O
cancer	O
cases	O
and	O
64	O
cases	O
of	O
other	O
cancers	O
.	O

Methods	O
The	O
methods	O
and	O
primary	O
clinical	O
findings	O
of	O
the	O
LIMIT	O
randomised	O
trial	O
have	O
been	O
published	O
[	O
21	O
–	O
23	O
],	O
with	O
the	O
trial	O
registered	O
on	O
the	O
Australian	O
and	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ACTRN12607000161426	O
).	O

According	O
to	O
the	O
national	O
guidelines	O
,	O
GDM	O
was	O
diagnosed	O
if	O
the	O
OGTT	O
results	O
exceeded	O
cut	O
-	O
offs	O
for	O
one	O
or	O
more	O
values	O
:	O
fasting	O
plasma	O
glucose	O
≥	O
5	O
.	O
3	O
mmol	O
/	O
l	O
,	O
1	O
-	O
h	O
≥	O
10	O
.	O
0	O
mmol	O
/	O
l	O
and	O
2	O
-	O
h	O
≥	O
8	O
.	O
6	O
mmol	O
/	O
l	O
[	O
19	O
].	O

Thus	O
,	O
the	O
World	O
Health	O
Organization	O
has	O
defined	O
anaemia	O
in	O
pregnancy	O
as	O
a	O
haemoglobin	O
value	O
below	O
11	O
g	O
/	O
dL	O
[	O
1	O
,	O
3	O
].	O

The	O
existence	O
of	O
receptors	O
for	O
the	O
active	O
form	O
of	O
vitamin	O
D	O
(	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
)	O
in	O
the	O
brain	O
induces	O
a	O
direct	O
effect	O
.	O

Ovarian	O
function	O
Maternal	O
exposure	O
to	O
either	O
caloric	O
restriction	O
or	O
to	O
high	O
fat	O
nutrition	O
was	O
associated	O
with	O
accelerated	O
puberty	O
in	O
female	O
offspring	O
,	O
but	O
there	O
were	O
distinct	O
differences	O
in	O
mature	O
ovarian	O
function	O
as	O
measured	O
by	O
progesterone	O
concentrations	O
in	O
the	O
proestrous	O
phase	O
.	O

Asibey	O
-	O
Berko	O
et	O
al	O
.	O

This	O
suggests	O
that	O
the	O
interventions	O
(	O
prenatal	O
visits	O
)	O
are	O
productive	O
,	O
and	O
that	O
the	O
Romanian	O
government	O
should	O
seek	O
ways	O
of	O
encouraging	O
less	O
well	O
-	O
educated	O
women	O
to	O
participate	O
.	O

Within	O
developmental	O
period	O
III	O
,	O
AP	O
offspring	O
showed	O
a	O
decreased	O
expression	O
of	O
genes	O
associated	O
with	O
Polo	O
-	O
like	O
kinases	O
,	O
which	O
is	O
in	O
line	O
with	O
the	O
assumption	O
that	O
LP	O
pigs	O
have	O
not	O
terminated	O
their	O
growth	O
at	O
stage	O
188	O
dpn	O
;	O
in	O
particular	O
their	O
liver	O
has	O
not	O
attained	O
a	O
steady	O
-	O
state	O
and	O
that	O
there	O
is	O
persistent	O
functional	O
demand	O
towards	O
cell	O
proliferation	O
potentially	O
to	O
respond	O
to	O
an	O
elevated	O
metabolic	O
burden	O
,	O
including	O
a	O
higher	O
turn	O
over	O
of	O
lipids	O
and	O
ketone	O
bodies	O
.	O

Given	O
that	O
this	O
is	O
the	O
first	O
study	O
to	O
be	O
conducted	O
among	O
pregnant	O
women	O
,	O
and	O
that	O
pre	O
-	O
pregnancy	O
BMI	O
may	O
reasonably	O
be	O
considered	O
a	O
confounder	O
or	O
a	O
covariate	O
along	O
the	O
causal	O
pathway	O
between	O
maternal	O
habitual	O
sleep	O
behaviors	O
and	O
GDM	O
,	O
we	O
were	O
careful	O
to	O
assess	O
the	O
potential	O
independent	O
contributions	O
of	O
the	O
sleep	O
variables	O
(	O
from	O
pre	O
-	O
pregnancy	O
BMI	O
).	O

The	O
slides	O
were	O
then	O
briefly	O
rinsed	O
in	O
DEPC	O
treated	O
H2O	O
and	O
mounted	O
in	O
Vectashield	O
Mounting	O
Medium	O
containing	O
DAPI	O
prior	O
to	O
examining	O
the	O
emitted	O
fluorescent	O
signal	O
under	O
a	O
Zeiss	O
Axiovert	O
200M	O
microscope	O
viewed	O
using	O
the	O
AxioVision	O
software	O
.	O

It	O
may	O
also	O
exert	O
determinant	O
developmental	O
effects	O
,	O
given	O
the	O
observation	O
that	O
the	O
postnatal	O
maturation	O
of	O
BAT	O
appears	O
to	O
relate	O
to	O
the	O
onset	O
of	O
feeding	O
and	O
initiation	O
of	O
hepatic	O
function	O
,	O
as	O
mediated	O
by	O
the	O
release	O
of	O
FGF21	O
(	O
Hondares	O
et	O
al	O
.,	O
2010	O
).	O

110	O
Is	B
Pet	O
Ownership	O
Associated	O
with	O
Higher	O
Vitamin	O
D	O
?	O

Provision	O
of	O
all	O
pregnant	O
and	O
lactating	O
women	O
with	O
the	O
Recommended	O
Daily	O
Allowance	O
of	O
600	O
IU	O
/	O
day	O
is	O
an	O
important	O
public	O
health	O
strategy	O
.	O

Vitamin	O
D2	O
was	O
not	O
detected	O
among	O
participants	O
without	O
Vitamin	O
D	O
supplement	O
use	O
in	O
this	O
study	O
.	O

Skm1	O
mice	O
were	O
visibly	O
leaner	O
than	O
their	O
littermate	O
controls	O
and	O
presented	O
with	O
either	O
an	O
elongated	O
body	O
or	O
a	O
thoracolumbar	O
kyphosis	O
and	O
a	O
kinked	O
tail	O
(	O
Figure	O
1B	O
).	O

Children	O
with	O
S	O
-	O
ECC	O
had	O
significantly	O
lower	O
mean	O
25	O
(	O
OH	O
)	O
D	O
(	O
68	O
.	O
9	O
±	O
28	O
.	O
0	O
nmol	O
/	O
L	O
vs	O
.	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
001	O
),	O
calcium	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
and	O
albumin	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
,	O
and	O
significantly	O
higher	O
parathyroid	O
hormone	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
levels	O
than	O
those	O
caries	O
-	O
free	O
.	O

Of	O
the	O
13	O
term	O
placentas	O
12	O
were	O
in	O
labor	O
(	O
mode	O
of	O
delivery	O
:	O
10	O
caesarean	O
sections	O
[	O
CS	O
],	O
2	O
vaginal	O
deliveries	O
)	O
and	O
1	O
nonlabor	O
/	O
CS	O
tissue	O
.	O

Other	O
studies	O
,	O
however	O
,	O
have	O
found	O
no	O
evidence	O
to	O
support	O
this	O
hypothesis	O
[	O
23	O
],[	O
24	O
],[	O
25	O
],[	O
26	O
],[	O
27	O
],[	O
28	O
],[	O
29	O
],[	O
30	O
].	O

PubMed	O
Central	O
:	O

2011	O
).	O

Detailed	O
information	O
about	O
food	O
preparation	O
and	O
brands	O
is	O
also	O
lacking	O
in	O
this	O
instrument	O
.	O

[	O
43	O
].	O

There	O
are	O
high	O
-	O
impact	O
,	O
cost	O
-	O
effective	O
interventions	O
currently	O
at	O
low	O
coverage	O
[	O
5	O
,	O
6	O
],	O
such	O
as	O
antenatal	O
corticosteroids	O
and	O
KMC	O
,	O
that	O
could	O
significantly	O
accelerate	O
progress	O
,	O
which	O
were	O
not	O
available	O
in	O
the	O
United	O
States	O
and	O
the	O
United	O
Kingdom	O
in	O
the	O
middle	O
of	O
the	O
20th	O
century	O
when	O
the	O
neonatal	O
mortality	O
rate	O
(	O
NMR	O
)	O
was	O
significantly	O
reduced	O
.	O

25	O
(	O
OH	O
)	O
D	O
was	O
similar	O
at	O
baseline	O
between	O
the	O
two	O
groups	O
but	O
significantly	O
higher	O
in	O
the	O
women	O
randomized	O
to	O
cholecalciferol	O
at	O
34	O
weeks	O
of	O
gestation	O
[	O
mean	O
(	O
standard	O
deviation	O
),	O
67	O
.	O
3	O
(	O
20	O
.	O
8	O
)	O
nmol	O
/	O
L	O
]	O
compared	O
with	O
placebo	O
[	O
mean	O
(	O
standard	O
deviation	O
),	O
43	O
.	O
0	O
(	O
22	O
.	O
2	O
)	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

F1	O
-	O
VitD	O
-	O
offspring	O
displayed	O
higher	O
levels	O
of	O
expression	O
of	O
AT1r	O
than	O
F1	O
-	O
SC	O
offspring	O
(	O
P	O
<	O
0	O
.	O
02	O
)	O
There	O
was	O
no	O
difference	O
between	O
F1	O
and	O
F2	O
VitD	O
-	O
offspring	O
or	O
F1	O
and	O
F2	O
SC	O
offspring	O
.	O

In	O
the	O
homozygous	O
group	O
for	O
Tth111	O
I	O
polymorphism	O
,	O
mothers	O
with	O
negative	O
attitudes	O
towards	O
the	O
pregnancy	O
gave	O
birth	O
to	O
infants	O
with	O
significantly	O
lower	O
birth	O
weights	O
compared	O
to	O
women	O
with	O
positive	O
/	O
neutral	O
attitudes	O
.	O

For	O
all	O
animals	O
of	O
the	O
experiment	O
no	O
significant	O
differences	O
in	O
body	O
weight	O
were	O
observed	O
at	O
28	O
and	O
188	O
dpn	O
[	O
15	O
,	O
16	O
].	O

(%)	O
northern	O
countries18	O
060	O
(	O
98	O
)	O
13	O
942	O
(	O
97	O
)	O
744	O
(	O
91	O
)	O
other	O
countries318	O
(	O
2	O
)	O
427	O
(	O
3	O
)	O
68	O
(	O
8	O
)	O
missing33	O
(	O
0	O
.	O
2	O
)	O
26	O
(	O
0	O
.	O
2	O
)	O
5	O
(	O
0	O
.	O
6	O
)	O
Smokers	O
,	O
No	O
.	O

Concerns	O
have	O
been	O
expressed	O
about	O
the	O
use	O
of	O
glargine	O
in	O
pregnancy	O
,	O
because	O
of	O
its	O
potential	O
effect	O
on	O
mitogenesis	O
,	O
mediated	O
by	O
its	O
high	O
affinity	O
to	O
the	O
IGF	O
-	O
1	O
receptor	O
,	O
which	O
is	O
six	O
times	O
that	O
of	O
natural	O
insulin48	O
,	O
49Whilst	O
insulin	O
detemir	O
has	O
a	O
lower	O
binding	O
affinity	O
to	O
the	O
IGF	O
-	O
1	O
receptor	O
than	O
natural	O
insulin	O
,	O
there	O
is	O
even	O
less	O
information	O
regarding	O
its	O
use	O
in	O
pregnancy	O
.	O

The	O
binding	O
of	O
this	O
to	O
vitamin	O
D	O
receptors	O
in	O
turn	O
results	O
in	O
increased	O
intracellular	O
formation	O
of	O
antimicrobial	O
compounds	O
,	O
such	O
as	O
cathelicidins	O
.	O
5The	O
generation	O
of	O
intracellular	O
antimicrobial	O
compounds	O
is	O
impaired	O
in	O
patients	O
who	O
are	O
vitamin	O
D	O
deficient	O
(	O
ie	O
,	O
low	O
serum	O
concentrations	O
of	O
calcifediol	O
).	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

We	O
obtained	O
a	O
CT	O
angiography	O
of	O
the	O
chest	O
due	O
to	O
our	O
high	O
index	O
of	O
suspicion	O
for	O
an	O
acute	O
aortic	O
dissection	O
.	O

The	O
serum	O
25	O
(	O
OH	O
)	O
vitamin	O
D3	O
was	O
measured	O
by	O
ELISA	O
and	O
kit	O
of	O
immunodiagnostic	O
systems	O
Ltd	O
(	O
Nyco	O
card	O
equipment	O
,	O
Nyco	O
corporation	O
,	O
Norway	O
).	O

The	O
latter	O
tend	O
to	O
live	O
and	O
work	O
in	O
a	O
more	O
closed	O
indoor	O
environment	O
and	O
thus	O
suffer	O
greater	O
exposure	O
to	O
indoor	O
pollutants	O
(	O
e	O
.	O
g	O
.,	O
polychlorinated	O
biphenyls	O
,	O
phthalates	O
,	O
phenols	O
,	O
flame	O
retardants	O
)	O
[	O
29	O
].	O

Stata	O
Statistical	O
Software	O
:	O
Release	O
14	O
.	O

Although	O
this	O
is	O
not	O
a	O
large	O
number	O
of	O
total	O
messages	O
,	O
it	O
is	O
worth	O
noting	O
that	O
they	O
reinforce	O
information	O
women	O
are	O
already	O
receiving	O
from	O
other	O
sources	O
regarding	O
avoiding	O
alcohol	O
use	O
.	O

All	O
statistical	O
analyses	O
were	O
conducted	O
using	O
the	O
IBM	O
SPSS	O
program	O
for	O
Windows	O
,	O
version	O
22	O
(	O
IBM	O
,	O
Chicago	O
,	O
IL	O
,	O
USA	O
).	O

While	O
no	O
interaction	O
effect	O
was	O
observed	O
between	O
season	O
and	O
vitamin	O
D	O
with	O
regards	O
to	O
glucose	O
homeostasis	O
,	O
it	O
is	O
well	O
recognised	O
that	O
25OHD	O
declines	O
in	O
winter	O
,	O
and	O
is	O
a	O
modifiable	O
factor	O
.	O

We	O
used	O
the	O
elbow	O
method	O
to	O
determine	O
the	O
optimal	O
number	O
of	O
clusters	O
,	O
which	O
is	O
based	O
on	O
the	O
within	O
-	O
cluster	O
sum	O
of	O
squares	O
.	O

In	O
conclusion	O
,	O
we	O
found	O
that	O
lack	O
of	O
PNV	O
use	O
during	O
pregnancy	O
was	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
early	O
in	O
pregnancy	O
,	O
but	O
not	O
among	O
black	O
women	O
.	O

The	O
dams	O
were	O
housed	O
individually	O
in	O
ventilated	O
plastic	O
transparent	O
cages	O
with	O
bedding	O
in	O
a	O
12	O
:	O
12	O
h	O
light	O
-	O
dark	O
cycle	O
(	O
lights	O
on	O
at	O
0700	O
at	O
22	O
±	O
1	O
°	O
C	O
).	O

Present	O
study	O
showed	O
that	O
the	O
women	O
with	O
prior	O
problematic	O
pregnancies	O
or	O
higher	O
socioeconomic	O
status	O
or	O
education	O
level	O
were	O
more	O
prone	O
to	O
have	O
a	O
healthy	O
dietary	O
pattern	O
.	O

None	O
of	O
the	O
individual	O
phthalate	O
metabolites	O
or	O
BPA	O
were	O
statistically	O
significant	O
at	O
the	O
0	O
.	O
05	O
or	O
0	O
.	O
5	O
level	O
,	O
which	O
may	O
explain	O
why	B
the	O
class	O
as	O
a	O
whole	O
was	O
not	O
significantly	O
different	O
from	O
zero	O
.	O

Surveys	O
were	O
self	O
-	O
administered	O
and	O
baseline	O
surveys	O
were	O
completed	O
usually	O
in	O
clinic	O
,	O
with	O
a	O
small	O
number	O
completed	O
remotely	O
online	O
.	O

Unlike	O
the	O
previously	O
published	O
data	O
on	O
vitamin	O
D	O
in	O
the	O
Auckland	O
cohort	O
[	O
20	O
],	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
measured	O
using	O
the	O
IDS	O
-	O
iSYS	O
chemiluminescent	O
-	O
based	O
assay	O
(	O
Abacus	O
,	O
ALS	O
)	O
as	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

Data	O
on	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
were	O
collected	O
from	O
obstetrics	O
charts	O
based	O
on	O
standardized	O
measures	O
.	O

Although	O
risk	O
estimates	O
varied	O
by	O
study	O
center	O
,	O
combined	O
results	O
suggest	O
that	O
maternal	O
supplementation	O
for	O
two	O
trimesters	O
may	O
decrease	O
risk	O
of	O
brain	O
tumor	O
(	O
odds	O
ratio	O
[	O
OR	O
]	O
0	O
.	O
7	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
0	O
.	O
5	O
-	O
0	O
.	O
9	O
),	O
with	O
a	O
trend	O
of	O
less	O
risk	O
with	O
longer	O
duration	O
of	O
use	O
(	O
p	O
trend	O
=	O
0	O
.	O
0007	O
).	O

Such	O
changes	O
may	O
still	O
prove	O
useful	O
for	O
regulatory	O
purposes	O
and	O
also	O
do	O
not	O
rule	O
out	O
the	O
possibility	O
of	O
later	O
onset	O
effects	O
.	O

However	O
,	O
controversy	O
surrounds	O
the	O
exact	O
mechanisms	O
by	O
which	B
these	O
responses	O
are	O
regulated	O
.	O

Genotyping	O
,	O
which	O
was	O
not	O
practical	O
in	O
our	O
study	O
setting	O
,	O
might	O
have	O
aided	O
the	O
interpretation	O
of	O
our	O
findings	O
,	O
as	O
shown	O
in	O
a	O
vitamin	O
D	O
supplementation	O
trial	O
for	O
tuberculosis	O
.	O
20	O
We	O
accounted	O
for	O
nutritional	O
factors	O
through	O
a	O
diet	O
questionnaire	O
,	O
weight	O
at	O
recruitment	O
,	O
and	O
growth	O
comparison	O
at	O
the	O
end	O
of	O
our	O
study	O
—	O
any	O
nutritional	O
deficiencies	O
would	O
have	O
been	O
equally	O
balanced	O
between	O
the	O
two	O
groups	O
.	O

Consequently	O
,	O
a	O
range	O
of	O
mechanisms	O
for	O
the	O
demethylation	O
of	O
DNA	O
have	O
been	O
proposed	O
(	O
described	O
in	O
relation	O
to	O
mammalian	O
development	O
in	O
Dean2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
,	O
2016	O
).	O

General	O
Practice	O
Physical	O
Activity	O
Questionnaire	O
(	O
GPPAQ	O
)	O
was	O
used	O
to	O
assess	O
the	O
physical	O
activity	O
of	O
participants	O
[	O
22	O
].	O

Acryomns	O
used	O
:	O
ANC	O
=	O
Antenatal	O
care	O
;	O
CPAP	O
=	O
Continuous	O
positive	O
airway	O
pressure	O
;	O
HIV	O
=	O
Human	O
Immunodeficiency	O
Virus	O
;	O
IMCI	O
=	O
Integrated	O
Management	O
of	O
Childhood	O
Illnesses	O
;	O
IPTp	O
=	O
Intermittent	O
presumptive	O
treatment	O
during	O
pregnancy	O
for	O
malaria	O
;	O
pPROM	O
=	O
prelabour	O
premature	O
rupture	O
of	O
membranes	O
;	O
STI	O
=	O
Sexually	O
Transmitted	O
Illness	O
.	O

It	O
has	O
been	O
suggested	O
that	O
vitamin	O
D	O
might	O
be	O
used	O
in	O
the	O
treatment	O
of	O
opportunistic	O
and	O
antibiotic	O
-	O
resistant	O
infections	O
.	O

There	O
are	O
no	O
current	O
studies	O
that	O
can	O
give	O
real	O
good	O
answers	O
to	O
the	O
question	B
if	O
dietary	O
deficiency	O
interacts	O
with	O
genetic	O
vulnerability	O
for	O
schizophrenia	O
.	O

The	O
other	O
seasonal	O
behaviours	O
were	O
not	O
significantly	O
associated	O
with	O
metabolic	O
markers	O
.	O

Averaging	O
parameters	O
were	O
set	O
at	O
70	O
%,	O
therefore	O
for	O
a	O
protein	O
spot	O
to	O
appear	O
in	O
the	O
averaged	O
gel	O
it	O
must	O
be	O
present	O
in	O
70	O
%	O
of	O
all	O
gels	O
within	O
a	O
group	O
.	O

[	O
1819	O
]	O
To	O
attain	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
that	O
exceed	O
250	O
nmol	O
/	O
L	O
(	O
100	O
ng	O
/	O
mL	O
),	O
a	O
daily	O
vitamin	O
D	O
intake	O
well	O
in	O
excess	O
of	O
10	O
,	O
000	O
IU	O
/	O
d	O
(	O
250	O
μg	O
/	O
d	O
)	O
for	O
several	O
months	O
would	O
be	O
required	O
.	O

Data	O
analysis	O
was	O
done	O
using	O
EPI	O
info	O
version	O
3	O
.	O
5	O
.	O
1	O
.	O

Two	O
-	O
way	O
ANOVA	O
showed	O
a	O
main	O
effect	O
of	O
the	O
diet	O
on	O
the	O
gene	O
expression	O
of	O
Cnr1	O
in	O
hypothalamus	O
and	O
liver	O
,	O
Cnr2	O
in	O
hypothalamus	O
and	O
PAT	O
,	O
Napepld	O
,	O
Faah	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
liver	O
and	O
PAT	O
,	O
and	O
Dagl	O
α	O
in	O
PAT	O
(	O
see	O
TableS2for	O
statistical	O
values	O
).	O

Examining	O
predictors	O
of	O
birth	O
weight	O
,	O
the	O
strongest	O
predictor	O
of	O
higher	O
WFA	O
z	O
score	O
was	O
consumption	O
of	O
a	O
greater	O
percentage	O
of	O
calories	O
from	O
sweets	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
19	O
;	O
P	O
=	O
0	O
.	O
004	O
;	O
Table	O
3	O
).	O

During	O
a	O
national	O
survey	O
in	O
2012	O
,	O
approximately	O
40	O
%	O
of	O
the	O
population	O
were	O
reported	O
to	O
have	O
a	O
monotonous	O
diet	O
based	O
mainly	O
on	O
starches	O
[	O
18	O
].	O

It	O
would	O
also	O
be	O
of	O
interest	O
to	O
expand	O
these	O
observations	O
in	O
human	O
myometrium	O
that	O
is	O
a	O
key	O
organ	O
responsible	O
for	O
quiescence	O
and	O
contractility	O
responses	O
and	O
also	O
assess	O
whether	O
changes	O
in	O
GR	O
transcripts	O
are	O
due	O
to	O
labor	O
or	O
nonlabor	O
.	O

In	O
the	O
core	O
region	O
of	O
the	O
nucleus	O
accumbens	O
,	O
neurons	O
have	O
dense	O
spines	O
,	O
which	O
may	O
reflect	O
the	O
degree	O
of	O
synaptic	O
plasticity	O
required	O
for	O
the	O
integrative	O
function	O
of	O
cells	O
in	O
this	O
region	O
[	O
36	O
].	O

The	O
reaction	O
was	O
quenched	O
by	O
adding	O
10	O
mM	O
DTT	O
followed	O
by	O
20	O
mg	O
citric	O
acid	O
to	O
adjust	O
pH	O
to	O
approximately	O
pH	O
6	O
.	O
0	O
.	O

Women	O
who	O
have	O
vitamin	O
D	O
deficiency	O
do	O
not	O
usually	O
feel	O
any	O
different	O
but	O
in	O
some	O
may	O
have	O
muscle	O
weakness	O
and	O
weakened	O
bones	O
.	O

Indeed	O
,	O
a	O
number	O
of	O
polymorphisms	O
have	O
been	O
described	O
in	O
the	O
gene	O
coding	O
for	O
the	O
GR	O
although	O
it	O
is	O
still	O
unclear	O
whether	O
the	O
variability	O
in	O
the	O
glucocorticoid	O
responses	O
observed	O
is	O
due	O
to	O
the	O
polymorphisms	O
or	O
to	O
other	O
factors	O
[	O
10	O
].	O

The	O
average	O
number	O
of	O
visits	O
to	O
the	O
general	O
practitioner	O
was	O
4	O
.	O
8	O
±	O
2	O
.	O
54	O
.	O

Mass	O
fortification	O
programme	O
of	O
common	O
local	O
staple	O
foods	O
with	O
iron	O
and	O
folic	O
acid	O
is	O
a	O
long	O
-	O
term	O
goal	O
,	O
which	O
national	O
governments	O
in	O
developing	O
countries	O
should	O
consider	O
as	O
a	O
strategy	O
aimed	O
at	O
reducing	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
the	O
general	O
population	O
.	O

PSM	O
matched	O
one	O
vaccinated	O
case	O
to	O
one	O
unvaccinated	O
case	O
for	O
the	O
probability	O
of	O
vaccination	O
.	O

For	O
example	O
,	O
epigenetic	O
mechanisms	O
and	O
markers	O
identified	O
within	O
the	O
47	O
studies	O
highlighted	O
in	O
this	O
review	O
could	O
be	O
further	O
examined	O
and	O
potentially	O
validated	O
in	O
existing	O
regulatory	O
studies	O
.	O

No	O
prior	O
studies	O
have	O
specifically	O
examined	O
impacts	O
of	O
maternal	O
intake	O
of	O
sweets	O
or	O
soft	O
drinks	O
in	O
pregnancy	O
on	O
offspring	O
weight	O
parameters	O
.	O

1	O
.	O

The	O
quotient	O
omega	O
-	O
6	O
PUFA	O
/	O
omega	O
-	O
3	O
PUFA	O
was	O
4	O
:	O
1	O
in	O
this	O
study	O
,	O
and	O
this	O
value	O
is	O
comparable	O
to	O
other	O
European	O
cohorts	O
[	O
56	O
,	O
57	O
],	O
but	O
lower	O
than	O
that	O
has	O
been	O
reported	O
for	O
US	O
populations	O
(	O
Food	O
and	O
Nutrition	O
Board	O
.	O

Currently	O
,	O
maternal	O
undernutrition	O
is	O
a	O
problem	O
not	O
exclusive	O
of	O
developing	O
countries	O
.	O

Due	O
to	O
the	O
high	O
prevalence	O
of	O
HIV	O
in	O
the	O
country	O
(	O
36	O
%	O
of	O
women	O
aged	O
30	O
–	O
34	O
years	O
[	O
31	O
]),	O
their	O
inclusion	O
will	O
make	O
generalisation	O
to	O
the	O
wider	O
South	O
African	O
population	O
a	O
possibility	O
.	O

Note	O
that	O
confidence	O
intervals	O
for	O
beta	O
coefficients	O
from	O
LASSO	O
and	O
Elastic	O
Net	O
are	O
not	O
available	O
using	O
standard	O
software	O
,	O
and	O
calculating	O
standard	O
errors	O
for	O
parameter	O
estimates	O
is	O
challenging	O
because	O
the	O
shrinkage	O
estimation	O
produces	O
biased	O
estimates	O
for	O
large	O
coefficients	O
.	O

One	O
possibility	O
that	O
emerges	O
from	O
our	O
data	O
is	O
that	O
male	O
offspring	O
can	O
increase	O
their	O
body	O
weight	O
by	O
either	O
a	O
reduction	O
of	O
energy	O
expenditure	O
or	O
higher	O
metabolism	O
efficiency	O
.	O

Regression	O
analysis	O
confirmed	O
no	O
association	O
between	O
oral	O
glucose	O
tolerance	O
test	O
results	O
and	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
>	O
0	O
.	O
53	O
).	O

She	O
described	O
the	O
pain	O
as	O
continuous	O
,	O
10	O
/	O
10	O
in	O
severity	O
,	O
worsened	O
with	O
movement	O
and	O
breathing	O
,	O
and	O
relieved	O
by	O
nothing	O
.	O

However	O
psychotic	O
-	O
like	O
experiences	O
in	O
the	O
general	O
population	O
might	O
be	O
more	O
equally	O
distributed	O
among	O
women	O
and	O
men	O
[	O
60	O
].	O

The	O
daily	O
dietary	O
calcium	O
intake	O
of	O
both	O
the	O
urban	O
and	O
rural	O
populations	O
was	O
low	O
compared	O
with	O
the	O
recommended	O
dietary	O
allowances	O
issued	O
by	O
the	O
Indian	O
Council	O
of	O
Medical	O
Research	O
.	O

These	O
associations	O
were	O
not	O
confounded	O
by	O
intake	O
of	O
sugar	O
in	O
early	O
childhood	O
,	O
which	O
was	O
unrelated	O
to	O
these	O
outcomes	O
.	O

It	O
is	O
established	O
that	O
diet	O
is	O
an	O
important	O
driver	O
of	O
the	O
gut	O
microbiome	O
.	O

Results	O
showed	O
that	O
at	O
baseline	O
,	O
in	O
72	O
.	O
8	O
%	O
of	O
the	O
participants	O
,	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
were	O
lower	O
than20	O
ng	O
/	O
mL	O
.	O

All	O
data	O
are	O
collected	O
either	O
by	O
health	O
professionals	O
on	O
site	O
or	O
by	O
trained	O
fieldworkers	O
.	O

New	O
Evidence	O
Emerges	O
For	O
nearly	O
30	O
years	O
Philippe	O
Grandjean	O
has	O
led	O
studies	O
on	O
the	O
effects	O
of	O
marine	O
contaminants	O
on	O
the	O
health	O
of	O
adults	O
and	O
children	O
in	O
the	O
Faroe	O
Islands	O
,	O
19an	O
archipelago	O
in	O
the	O
North	O
Atlantic	O
about	O
halfway	O
between	O
Scotland	O
and	O
Iceland	O
.	O

Thus	O
,	O
PPV	O
was	O
61	O
%	O
(	O
75	O
/	O
123	O
)	O
for	O
self	O
-	O
reporting	O
receiving	O
influenza	O
vaccination	O
,	O
and	O
NPV	O
was	O
98	O
%	O
(	O
126	O
/	O
128	O
)	O
for	O
self	O
-	O
reports	O
of	O
being	O
unvaccinated	O
.	O

Concordance	O
of	O
mothers	O
’	O
personal	O
weight	O
gain	O
target	O
with	O
clinical	O
recommendations	O
varied	O
by	O
mothers	O
’	O
pre	O
-	O
pregnancy	O
weight	O
status	O
[	O
χ	O
(	O
4	O
)	O
2	O
=	O
9	O
.	O
781	O
,	O
p	O
=	O
0	O
.	O
044	O
].	O

SPSS	O
16	O
.	O
0	O
(	O
SPSS	O
,	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
was	O
used	O
for	O
all	O
statistical	O
analyses	O
.	O

To	O
validate	O
the	O
nutritional	O
knowledge	O
questionnaire	O
,	O
item	O
analysis	O
was	O
performed	O
to	O
determine	O
item	O
difficulty	O
and	O
item	O
discrimination	O
indices	O
to	O
increase	O
reliability	O
.	O

It	O
was	O
described	O
that	O
long	O
-	O
term	O
undernutrition	O
from	O
early	O
stages	O
lead	O
to	O
higher	O
gene	O
expression	O
of	O
Cnr1	O
in	O
several	O
brain	O
regions	O
of	O
the	O
leptin	O
-	O
deficient	O
obese	O
Zucker	O
rats	O
(	O
Thanos	O
et	O
al	O
.,	O
2008	O
).	O

However	O
,	O
the	O
girl	O
’	O
s	O
height	O
was	O
more	O
strongly	O
correlated	O
with	O
that	O
of	O
the	O
mother	O
than	O
father	O
.	O

The	O
positive	O
association	O
remained	O
,	O
though	O
was	O
attenuated	O
somewhat	O
,	O
after	O
further	O
adjustment	O
for	O
maternal	O
pre	O
-	O
pregnancy	O
BMI	O
(	O
RR	O
=	O
4	O
.	O
18	O
;	O
95	O
%	O
CI	O
0	O
.	O
94	O
-	O
18	O
.	O
60	O
).	O

Ancient	O
Chinese	O
Cancer	O
Secret	O
?	B

Thus	O
,	O
49	O
261	O
returned	O
the	O
questionnaires	O
and	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Fetal	O
demands	O
for	O
iron	O
are	O
maximal	O
during	O
the	O
third	O
trimester	O
and	O
these	O
are	O
estimated	O
at	O
about	O
270	O
mg	O
in	O
a	O
3	O
kg	O
fetus	O
[	O
16	O
].	O

Calbindin	O
is	O
strongly	O
induced	O
by	O
vitamin	O
D	O
[	O
29	O
],	O
and	O
thus	O
it	O
is	O
feasible	O
that	O
the	O
reduction	O
in	O
this	O
protein	O
may	O
be	O
a	O
consequence	O
of	O
the	O
early	O
life	O
reduction	O
in	O
vitamin	O
D	O
.	O
The	O
potential	O
links	O
between	O
vitamin	O
D	O
and	O
neuronal	O
calcium	O
binding	O
proteins	O
has	O
been	O
noted	O
in	O
a	O
recent	O
review	O
article	O
[	O
30	O
]	O
Two	O
members	O
of	O
the	O
dynamin	O
family	O
(	O
dynamin	O
1	O
and	O
dynamin	O
1	O
-	O
like	O
proteins	O
)	O
were	O
also	O
significantly	O
down	O
-	O
regulated	O
.	O

Analyses	O
will	O
be	O
done	O
by	O
the	O
SAMRC	O
by	O
linking	O
data	O
to	O
the	O
most	O
recent	O
food	O
composition	O
database	O
.	O

Humans	O
have	O
seven	O
SIRT	O
isoforms	O
.	O

Although	O
,	O
a	O
56	O
%	O
decreased	O
risk	O
for	O
GDM	O
was	O
observed	O
in	O
those	O
with	O
low	O
-	O
moderate	O
levels	O
of	O
standardised	O
vitamin	O
D	O
when	O
compared	O
to	O
moderate	O
-	O
high	O
levels	O
for	O
women	O
carrying	O
a	O
female	O
fetus	O
(	O
aRR	O
:	O
0	O
.	O
44	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
20	O
,	O
0	O
.	O
97	O
).	O

The	O
risk	O
of	O
autism	O
spectrum	O
disorders	O
was	O
shown	O
to	O
be	O
doubled	O
with	O
maternal	O
use	O
of	O
SSRIs	O
in	O
a	O
recent	O
case	O
controlled	O
study	O
of	O
298	O
children	O
,	O
with	O
prenatal	O
exposure	O
reported	O
for	O
20	O
of	O
those	O
children	O
[	O
36	O
].	O

The	O
OGTTs	O
were	O
carried	O
out	O
at	O
24	O
–	O
28	O
weeks	O
’	O
gestation	O
;	O
thus	O
,	O
summer	O
at	O
the	O
time	O
of	O
OGTT	O
would	O
correspond	O
approximately	O
with	O
winter	O
in	O
early	O
pregnancy	O
in	O
our	O
population	O
.	O

We	O
will	O
provide	O
a	O
specially	O
designed	O
medicine	O
box	O
to	O
each	O
participant	O
to	O
preserve	O
the	O
medicine	O
.	O

The	O
foods	O
that	O
women	O
eat	O
when	O
they	O
are	O
pregnant	O
and	O
nursing	O
are	O
precisely	O
the	O
ones	O
that	O
their	O
infants	O
should	O
prefer	O
because	O
the	O
mothers	O
'	O
eating	O
them	O
teaches	O
the	O
child	O
that	O
these	O
foods	O
are	O
available	O
,	O
safe	O
,	O
and	O
nutritious	O
.	O

The	O
women	O
in	O
the	O
high	O
level	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
were	O
significantly	O
younger	O
,	O
had	O
a	O
higher	O
prevalence	O
of	O
overweight	O
and	O
obesity	O
and	O
were	O
less	O
educated	O
than	O
women	O
with	O
less	O
or	O
no	O
experience	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Data	O
were	O
checked	O
for	O
normality	O
using	O
a	O
Shapiro	O
-	O
Wilks	O
test	O
and	O
differences	O
between	O
women	O
recruited	O
in	O
Adelaide	O
compared	O
to	O
Auckland	O
were	O
tabulated	O
and	O
compared	O
using	O
a	O
Welch	O
’	O
s	O
t	O
-	O
test	O
(	O
continuous	O
variables	O
)	O
or	O
Fisher	O
’	O
s	O
exact	O
test	O
(	O
categorical	O
variables	O
).	O

Associations	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
birth	O
size	O
were	O
inconsistent	O
.	O

An	O
intake	O
of	O
fish	O
may	O
reflect	O
a	O
health	O
conscious	O
diet	O
and	O
thus	O
the	O
positive	O
effects	O
may	O
not	O
be	O
directly	O
attributed	O
to	O
the	O
fish	O
but	O
rather	O
to	O
the	O
diet	O
as	O
a	O
whole	O
.	O

The	O
original	O
article	O
was	O
published	O
in	O
PDF	O
format	O
in	O
the	O
WHO	O
Report	O
"	O
Born	O
Too	O
Soon	O
:	O
the	O
global	O
action	O
report	O
on	O
preterm	O
birth	O
"	O
(	O
ISBN	O
978	O
92	O
4	O
150343	O
30	O
),	O
which	O
involved	O
collaboration	O
from	O
more	O
than	O
50	O
organizations	O
.	O

In	O
a	O
recent	O
mouse	O
study	O
,	O
exposure	O
to	O
smoke	O
in	O
utero	O
induced	O
a	O
higher	O
risk	O
of	O
sensitization	O
against	O
allergens	O
in	O
adult	O
age	O
in	O
the	O
offspring	O
[	O
70	O
].	O

This	O
suggested	O
that	O
FGF21	O
could	O
play	O
a	O
similar	O
role	O
in	O
humans	O
as	O
in	O
rodents	O
in	O
promoting	O
cold	O
-	O
induced	O
metabolic	O
changes	O
(	O
i	O
.	O
e	O
.,	O
lipolysis	O
and	O
cold	O
-	O
induced	O
thermogenesis	O
).	O

Previously	O
,	O
ELISA	O
was	O
used	O
to	O
measure	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
.	O

PubMed	O
Central	O
:	O

However	O
,	O
in	O
developing	O
countries	O
,	O
it	O
is	O
still	O
a	O
common	O
problem	O
in	O
the	O
pediatric	O
population	O
[	O
4	O
,	O
5	O
].	O

There	O
was	O
insufficient	O
case	O
information	O
available	O
to	O
assess	O
any	O
causal	O
association	O
between	O
the	O
allergic	O
reaction	O
and	O
the	O
fetal	O
loss	O
.	O

We	O
studied	O
kidney	O
stereology	O
at	O
birth	O
,	O
10	O
days	O
and	O
6	O
months	O
of	O
age	O
in	O
each	O
generation	O
(	O
n	O
=	O
6	O
for	O
each	O
group	O
).	O

The	O
execution	O
of	O
the	O
study	O
is	O
coordinated	O
by	O
the	O
Centre	O
of	O
Excellence	O
for	O
Nutrition	O
of	O
the	O
North	O
-	O
West	O
University	O
.	O

Antiacids	O
During	O
Pregnancy	O
Recent	O
studies	O
have	O
indicated	O
that	O
acid	O
-	O
suppressing	O
medications	O
can	O
promote	O
sensitization	O
in	O
adults	O
[	O
86	O
,	O
87	O
].	O

Preterm	O
birth	O
is	O
not	O
a	O
single	O
condition	O
,	O
but	O
a	O
single	O
outcome	O
(	O
birth	O
before	O
37	O
completed	O
weeks	O
)	O
due	O
to	O
multiple	O
causes	O
.	O

These	O
findings	O
are	O
compatible	O
with	O
a	O
previous	O
report	O
of	O
early	O
puberty	O
following	O
high	O
fat	O
nutrition	O
during	O
pregnancy	O
[	O
57	O
].	O

High	O
VD	O
serum	O
levels	O
and	O
their	O
derivatives	O
are	O
found	O
in	O
human	O
decidua	O
from	O
the	O
1st	O
trimester	O
of	O
pregnancy	O
,	O
which	O
strongly	O
suggests	O
its	O
contribution	O
in	O
the	O
implantation	O
process	O
and	O
a	O
local	O
immunological	O
preference	O
of	O
the	O
embryo	O
.	O

Potential	O
confounders	O
We	O
selected	O
potential	O
confounding	O
factors	O
which	O
are	O
known	O
(	O
from	O
existing	O
literature	O
)	O
to	O
be	O
associated	O
with	O
one	O
or	O
more	O
of	O
the	O
outcomes	O
of	O
interest	O
[	O
20	O
].	O

All	O
foot	O
and	O
headwear	O
is	O
removed	O
before	O
measurements	O
are	O
taken	O
.	O

The	O
intra	O
-	O
and	O
inter	O
-	O
assay	O
coefficients	O
of	O
variation	O
were	O
4	O
.	O
2	O
%,	O
and	O
9	O
%	O
respectively	O
.	O

C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
has	O
lower	O
affinity	O
for	O
the	O
vitamin	O
D	O
receptor	O
,	O
thus	O
it	O
own	O
lower	O
bio	O
-	O
function	O
than	O
25	O
(	O
OH	O
)	O
D	O
in	O
vivo	O
.	O

It	O
has	O
been	O
suggested	O
that	O
foods	O
containing	O
allergy	O
-	O
provoking	O
proteins	O
such	O
as	O
milk	O
,	O
egg	O
,	O
peanuts	O
,	O
tree	O
nuts	O
,	O
fish	O
,	O
and	O
seafood	O
should	O
not	O
be	O
introduced	O
into	O
the	O
diet	O
of	O
the	O
child	O
before	O
the	O
age	O
of	O
6	O
months	O
to	O
3	O
years	O
[	O
117	O
].	O

Comparing	O
perinatal	O
and	O
juvenile	O
piglets	O
(	O
period	O
II	O
)	O
991	O
probe	O
-	O
sets	O
were	O
regulated	O
in	O
a	O
different	O
manner	O
in	O
AP	O
offspring	O
and	O
in	O
LP	O
offspring	O
.	O

But	O
,	O
adjustment	O
for	O
multivitamin	O
supplement	O
intake	O
,	O
containing	O
vitamin	O
D	O
,	O
did	O
not	O
change	O
the	O
estimates	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
metabolic	O
enzymes	O
regulating	O
de	O
novo	O
lipogenesis	O
(	O
Acaca	O
,	O
Fasn	O
,	O
Scd1	O
)	O
and	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1a	O
,	O
Cpt1b	O
,	O
Acox1	O
),	O
and	O
key	O
regulators	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
(	O
Chrebp	O
,	O
Srebp1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
Hmgcr	O
)	O
and	O
mitochondrial	O
respiration	O
(	O
Ucp1	O
,	O
Cox4i1	O
)	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure5	O
).	O

Ethical	O
approval	O
was	O
granted	O
from	O
the	O
local	O
ethics	O
authority	O
.	O

In	O
line	O
with	O
this	O
,	O
there	O
was	O
no	O
association	O
between	O
maternal	O
intake	O
of	O
foods	O
during	O
pregnancy	O
and	O
the	O
occurrence	O
of	O
asthma	O
,	O
respiratory	O
disease	O
,	O
or	O
allergy	O
in	O
5	O
-	O
year	O
-	O
old	O
children	O
[	O
80	O
].	O

Inflammatory	O
responses	O
also	O
may	O
favor	O
tumor	O
development	O
[	O
93	O
].	O

Researchers	O
were	O
blinded	O
to	O
subject	O
allocation	O
scheme	O
and	O
subjects	O
and	O
field	O
staff	O
knew	O
only	O
the	O
colour	O
-	O
coded	O
allocation	O
groups	O
.	O

Conclusion	O
In	O
conclusion	O
,	O
lower	O
early	O
pregnancy	O
25OHD	O
was	O
associated	O
with	O
pregnancy	O
loss	O
.	O

Mazaki	O
-	O
Tovi	O
analyzed	O
the	O
relationship	O
of	O
increased	O
maternal	O
serum	O
visfatin	O
with	O
gestational	O
diabetes	O
mellitus	O
infection	O
and	O
the	O
birth	O
of	O
LGA	O
infants	O
.	O

Even	O
though	O
some	O
negative	O
outcomes	O
with	O
U	O
-	O
shaped	O
associations	O
were	O
observed	O
,	O
with	O
risks	O
at	O
both	O
low	O
and	O
high	O
levels	O
[	O
66	O
],	O
the	O
recent	O
meta	O
-	O
analysis	O
did	O
not	O
find	O
any	O
association	O
with	O
high	O
VD	O
levels	O
and	O
negative	O
health	O
outcomes	O
[	O
67	O
].	O

Birth	O
weight	O
We	O
will	O
measure	O
birth	O
weight	O
within	O
24	O
h	O
of	O
delivery	O
using	O
standard	O
methods	O
with	O
a	O
portable	O
electronic	O
scale	O
.	O

Differences	O
extend	O
not	O
only	O
to	O
metabolic	O
parameters	O
and	O
gene	O
expression	O
but	O
also	O
to	O
behavioral	O
responses	O
.	O

We	O
assessed	O
nutritional	O
knowledge	O
using	O
a	O
standardized	O
questionnaire	O
divided	O
into	O
three	O
sections	O
:	O
general	O
nutritional	O
recommendations	O
for	O
pregnant	O
women	O
;	O
the	O
roles	O
of	O
nutrients	O
;	O
and	O
sources	O
of	O
nutrients	O
.	O

These	O
findings	O
suggest	O
that	O
proteins	O
involved	O
in	O
SNAP	O
and	O
SNARE	O
mediated	O
vesicle	O
release	O
may	O
be	O
disrupted	O
in	O
the	O
DVD	O
model	O
.	O

However	O
,	O
this	O
information	O
is	O
limited	O
to	O
a	O
single	O
study	O
,	O
which	O
was	O
conducted	O
in	O
a	O
relatively	O
small	O
sample	O
(	O
n	O
=	O
217	O
).	O

MH	O
prepared	O
the	O
manuscript	O
in	O
collaboration	O
with	O
ML	O
.	O

GR	O
β	O
differs	O
from	O
GR	O
α	O
on	O
the	O
C	O
-	O
terminus	O
of	O
the	O
receptor	O
protein	O
.	O

It	O
is	O
a	O
complex	O
condition	O
that	O
lacks	O
an	O
established	O
preventive	O
method	O
,	O
warranting	O
a	O
need	O
for	O
research	O
to	O
identify	O
possible	O
environmental	O
triggers	O
.	O

Also	O
the	O
present	O
diet	O
substances	O
causes	O
complication	O
.	O

The	O
observed	O
rate	O
of	O
PNA	O
signs	O
in	O
the	O
monotherapy	O
group	O
was	O
similar	O
to	O
that	O
reported	O
in	O
the	O
healthy	O
comparison	O
group	O
(	O
4	O
%	O
vs	O
5	O
.	O
2	O
%).	O

The	O
patient	O
had	O
no	O
known	O
risk	O
factors	O
and	O
a	O
negative	O
family	O
history	O
of	O
aortic	O
dissection	O
or	O
connective	O
tissue	O
disease	O
.	O

Nonetheless	O
,	O
folic	O
acid	O
supplementation	O
might	O
address	O
other	O
forms	O
of	O
anaemia	O
,	O
and	O
the	O
advice	O
might	O
also	O
increase	O
the	O
likelihood	O
of	O
folic	O
acid	O
use	O
before	O
and	O
during	O
future	O
pregnancies	O
.	O

The	O
potential	O
for	O
such	O
adaptations	O
is	O
already	O
acknowledged	O
at	O
the	O
OECD	O
,	O
but	O
more	O
applied	O
development	O
of	O
key	O
markers	O
and	O
subsequent	O
validation	O
work	O
is	O
needed	O
to	O
formally	O
incorporate	O
epigenetic	O
endpoints	O
into	O
TGs	O
.	O

However	O
,	O
environmental	O
exposures	O
during	O
critical	O
windows	O
of	O
human	O
development	O
and	O
subsequent	O
non	O
-	O
genotoxic	O
/	O
epigenetic	O
changes	O
that	O
may	O
lead	O
to	O
later	O
life	O
adverse	O
health	O
outcomes	O
(	O
such	O
as	O
obesity	O
,	O
diabetes	O
and	O
cancer	O
)	O
across	O
multiple	O
generations	O
continues	O
to	O
be	O
of	O
high	O
concern	O
for	O
all	O
the	O
Organization	O
for	O
Economic	O
Co	O
-	O
operation	O
and	O
Development	O
(	O
OECD	O
)	O
member	O
countries	O
,	O
the	O
International	O
Agency	O
on	O
Research	O
for	O
Cancer	O
(	O
IARC	O
)	O
and	O
the	O
European	O
Commission	O
(	O
EFSA2013	O
;	O
Greally	O
&	O
Jacobs2013	O
;	O
Herceg	O
et	O
al	O
.	O
2013	O
;	O
OECD2014	O
).	O

“	O
The	O
conventional	O
wisdom	O
has	O
been	O
that	O
mothers	O
’	O
worries	O
about	O
milk	O
supply	O
are	O
due	O
either	O
to	O
their	O
misperception	O
of	O
normal	O
lactation	O
and	O
infant	O
breastfeeding	O
behaviors	O
or	O
to	O
mismanagement	O
of	O
breastfeeding	O
technique	O
,	O
and	O
only	O
on	O
very	O
rare	O
occasions	O
due	O
to	O
an	O
intrinsic	O
inability	O
to	O
make	O
enough	O
milk	O
,”	O
says	O
Laurie	O
Nommsen	O
-	O
Rivers	O
,	O
a	O
perinatal	O
nutrition	O
specialist	O
at	O
the	O
University	O
of	O
Cincinnati	O
College	O
of	O
Allied	O
Health	O
Sciences	O
.	O

These	O
visits	O
will	O
be	O
made	O
between	O
12	O
and	O
14	O
weeks	O
,	O
20	O
–	O
24	O
weeks	O
,	O
28	O
–	O
32	O
weeks	O
,	O
within	O
24	O
h	O
of	O
delivery	O
,	O
7	O
–	O
10	O
days	O
after	O
delivery	O
,	O
38	O
–	O
42	O
days	O
after	O
delivery	O
(	O
Fig	O
.	O

Vertebral	O
malformations	O
that	O
cause	O
kyphosis	O
or	O
scoliosis	O
are	O
an	O
important	O
health	O
problem	O
that	O
can	O
result	O
in	O
disability	O
and	O
suffering	O
attributable	O
to	O
both	O
physical	O
pain	O
and	O
psychological	O
distress	O
from	O
the	O
disfigurement	O
.	O

Methods	O
This	O
article	O
presents	O
an	O
up	O
-	O
to	O
-	O
date	O
review	O
of	O
publications	O
describing	O
the	O
function	O
of	O
cholecalciferol	O
in	O
reproduction	O
and	O
its	O
place	O
in	O
infertility	O
treatment	O
.	O

Questionnaire	O
data	O
were	O
systematically	O
checked	O
for	O
errors	O
during	O
data	O
entry	O
by	O
using	O
legal	O
values	O
and	O
specified	O
ranges	O
in	O
Epi	O
-	O
info	O
.	O

Vitamin	O
D	O
status	O
will	O
be	O
determined	O
by	O
measuring	O
total	O
25	O
-	O
Hydroxyvitamin	O
D	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
concentrations	O
in	O
serum	O
using	O
liquid	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
LCMSMS	O
)	O
[	O
72	O
].	O

It	O
is	O
possible	O
that	O
the	O
increased	O
energy	O
,	O
protein	O
and	O
fat	O
observed	O
in	O
our	O
study	O
during	O
extended	O
summer	O
could	O
be	O
due	O
to	O
changes	O
in	O
dietary	O
habits	O
during	O
the	O
summer	O
holidays	O
.	O

Children	O
of	O
normal	O
weight	O
mothers	O
who	O
were	O
exposed	O
to	O
excessive	O
GWG	O
(	O
n	O
=	O
71	O
)	O
had	O
higher	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
(	O
0	O
.	O
42	O
±	O
0	O
.	O
75	O
versus	O
0	O
.	O
03	O
±	O
0	O
.	O
73	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
GWG	O
,	O
but	O
no	O
significant	O
effects	O
were	O
seen	O
on	O
odds	O
of	O
macrosomia	O
or	O
WFA	O
z	O
score	O
>	O
90th	O
percentile	O
.	O

Statistical	O
analytical	O
methods	O
We	O
compared	O
the	O
frequency	O
distribution	O
of	O
sociodemographic	O
,	O
lifestyle	O
,	O
behavioral	O
and	O
medical	O
history	O
characteristics	O
of	O
participants	O
according	O
to	O
GDM	O
diagnosis	O
status	O
.	O

Between	O
December	O
2003	O
and	O
July	O
2006	O
,	O
1	O
,	O
393	O
(	O
82	O
%)	O
of	O
1	O
,	O
685	O
approached	O
women	O
consented	O
to	O
participate	O
.	O

For	O
categorical	O
analysis	O
of	O
vitamin	O
D	O
levels	O
,	O
we	O
used	O
cutoff	O
values	O
of	O
:	O
sufficient	O
(⩾	O
50	O
nmol	O
l	O
−	O
1	O
)	O
and	O
deficient	O
(<	O
50	O
nmol	O
l	O
−	O
1	O
).	O
28	O
,	O
29	O
,	O
30	O
,	O
31	O
Statistical	O
analysis	O
Distributions	O
of	O
continuous	O
variables	O
were	O
evaluated	O
for	O
normality	O
graphically	O
using	O
histogram	O
and	O
box	O
plots	O
and	O
are	O
described	O
using	O
means	O
and	O
s	O
.	O
d	O
.	O

We	O
acknowledge	O
the	O
following	O
limitations	O
.	O

Similarly	O
in	O
UCB	O
,	O
the	O
adjusted	O
analysis	O
showed	O
no	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
in	O
infants	O
born	O
to	O
women	O
with	O
and	O
without	O
GDM	O
(	O
79	O
.	O
1	O
±	O
2	O
.	O
3	O
vs	O
80	O
.	O
1	O
±	O
0	O
.	O
8	O
nmol	O
/	O
L	O
,	O
P	O
=	O
0	O
.	O
69	O
)	O
(	O
Fig	O
.	O
1	O
).	O

The	O
expression	O
and	O
activity	O
of	O
1	O
-	O
α	O
-	O
hydroxylase	O
(	O
CYP27B1	O
)	O
was	O
evaluated	O
in	O
in	O
vitro	O
experiments	O
on	O
decidua	O
cell	O
cultures	O
collected	O
in	O
the	O
1st	O
and	O
3rd	O
trimesters	O
[	O
15	O
].	O

Excessive	O
gestational	O
weight	O
gain	O
is	O
also	O
associated	O
with	O
risk	O
of	O
GDM	O
.	O

Innovate	O
•	O
Work	O
in	O
partnership	O
to	O
provide	O
universal	O
access	O
to	O
the	O
essential	O
package	O
of	O
interventions	O
,	O
including	O
both	O
prevention	O
and	O
care	O
,	O
and	O
involving	O
task	O
shifting	O
where	O
appropriate	O
.	O

Bodnar	O
et	O
al	O
.	O

The	O
associations	O
for	O
fatty	O
fish	O
or	O
shellfish	O
were	O
J	O
-	O
shaped	O
,	O
with	O
the	O
strongest	O
inverse	O
association	O
for	O
an	O
intermediate	O
dietary	O
intake	O
,	O
whereas	O
a	O
high	O
intake	O
was	O
associated	O
with	O
a	O
higher	O
rate	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
.	O

All	O
procedures	O
were	O
performed	O
with	O
approval	O
from	O
the	O
Queensland	O
University	O
Animal	O
Ethics	O
Committee	O
,	O
under	O
the	O
guidelines	O
of	O
the	O
National	O
Health	O
and	O
Medical	O
Research	O
Council	O
of	O
Australia	O
.	O

Among	O
women	O
with	O
initial	O
25	O
(	O
OH	O
)	O
D	O
<	O
40	O
ng	O
/	O
mL	O
,	O
PTB	O
rates	O
were	O
60	O
%	O
lower	O
for	O
those	O
with	O
≥	O
40	O
vs	O
.	O
<	O
40	O
ng	O
/	O
mL	O
on	O
a	O
follow	O
-	O
up	O
test	O
(	O
p	O
=	O
0	O
.	O
006	O
);	O
38	O
%	O
for	O
whites	O
(	O
p	O
=	O
0	O
.	O
33	O
)	O
and	O
78	O
%	O
for	O
non	O
-	O
whites	O
(	O
p	O
=	O
0	O
.	O
01	O
).	O

There	O
was	O
an	O
overall	O
significant	O
relationship	O
between	O
AluYb8	O
methylation	O
and	O
RPMM	O
class	O
methylation	O
(	O
p	O
=	O
0	O
.	O
01	O
);	O
no	O
association	O
was	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
RPMM	O
class	O
methylation	O
.	O

Our	O
results	O
lie	O
within	O
these	O
ranges	O
,	O
but	O
it	O
is	O
difficult	O
to	O
make	O
a	O
comparison	O
,	O
as	O
the	O
variations	O
are	O
very	O
wide	O
and	O
we	O
recorded	O
the	O
use	O
of	O
folic	O
acid	O
throughout	O
pregnancy	O
without	O
focusing	O
on	O
the	O
first	O
trimester	O
.	O

Infant	O
lung	O
function	O
testing	O
Measurements	O
were	O
taken	O
of	O
healthy	O
infants	O
who	O
had	O
had	O
no	O
respiratory	O
tract	O
infection	O
for	O
at	O
least	O
3	O
weeks	O
.	O

Another	O
limitation	O
is	O
the	O
inability	O
to	O
address	O
confounding	O
by	O
indication	O
and	O
separate	O
the	O
relative	O
effects	O
of	O
maternal	O
mental	O
illness	O
from	O
psychotropic	O
pharmacotherapy	O
on	O
pregnancy	O
outcome	O
.	O

Of	O
course	O
,	O
birth	O
weight	O
is	O
likely	O
a	O
proxy	O
for	O
a	O
complex	O
interplay	O
of	O
underlying	O
etiologic	O
mechanisms	O
and	O
environmental	O
factors	O
that	O
overall	O
contribute	O
to	O
infant	O
health	O
at	O
birth	O
and	O
beyond	O
.	O

During	O
days	O
30	O
–	O
32	O
,	O
we	O
completed	O
3	O
-	O
hour	O
structured	O
observations	O
of	O
106	O
(	O
85	O
%)	O
control	O
and	O
112	O
(	O
90	O
%)	O
intervention	O
participants	O
(	O
Table	O
2	O
).	O

There	O
was	O
no	O
association	O
between	O
the	O
education	O
level	O
of	O
the	O
primary	O
caregiver	O
and	O
the	O
child	O
’	O
s	O
vitamin	O
D	O
status	O
with	O
respect	O
to	O
both	O
the	O
mean	O
levels	O
and	O
the	O
proportion	O
with	O
levels	O
≥	O
75	O
nmol	O
/	O
L	O
(	O
p	O
=	O
0	O
.	O
74	O
and	O
p	O
=	O
0	O
.	O
35	O
,	O
respectively	O
).	O

At	O
some	O
time	O
in	O
their	O
life	O
,	O
these	O
children	O
laid	O
down	O
less	O
cortical	O
bone	O
than	O
normal	O
children	O
,	O
a	O
finding	O
consistent	O
with	O
undetected	O
and	O
untreated	O
childhood	O
or	O
even	O
intrauterine	O
vitamin	O
D	O
deficiency	O
.	O

The	O
effect	O
of	O
high	O
vitamin	O
maternal	O
diets	O
on	O
chronic	O
disease	O
in	O
the	O
offspring	O
can	O
be	O
attributed	O
primarily	O
to	O
epigenetic	O
modulation	O
of	O
gene	O
expression	O
leading	O
to	O
programming	O
of	O
regulatory	O
systems	O
.	O
11Because	O
methyl	O
group	O
vitamins	O
,	O
and	O
specifically	O
folate	O
,	O
have	O
been	O
shown	O
to	O
participate	O
in	O
epigenetic	O
changes	O
through	O
its	O
functions	O
in	O
DNA	O
methylation	O
,	O
12we	O
also	O
fed	O
offspring	O
a	O
high	O
folate	O
(	O
HFol	O
)	O
diet	O
.	O

Exclusion	O
criteria	O
were	O
delivering	O
a	O
stillborn	O
or	O
newborn	O
with	O
congenital	O
or	O
neonatal	O
anomalies	O
,	O
receiving	O
influenza	O
vaccination	O
before	O
May	O
1st	O
,	O
2014	O
-	O
the	O
start	O
date	O
for	O
the	O
national	O
influenza	O
vaccination	O
campaign	O
[	O
32	O
]-	O
or	O
less	O
than	O
14	O
days	O
before	O
delivery	O
,	O
and	O
having	O
a	O
gestational	O
age	O
<	O
28	O
or	O
>	O
42	O
weeks	O
at	O
delivery	O
which	O
are	O
the	O
viability	O
and	O
post	O
-	O
term	O
cut	O
-	O
offs	O
,	O
respectively	O
[	O
35	O
],[	O
36	O
].	O

High	O
meat	O
consumption	O
during	O
pregnancy	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
wheeze	O
in	O
the	O
first	O
year	O
of	O
life	O
,	O
while	O
maternal	O
dairy	O
intake	O
is	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
infantile	O
wheeze	O
[	O
2	O
].	O

Our	O
knowledge	O
is	O
growing	O
of	O
how	B
,	O
beginning	O
very	O
early	O
in	O
life	O
,	O
early	O
sensory	O
experience	O
can	O
shape	O
and	O
modify	O
flavor	O
and	O
food	O
preferences	O
.	O

Fasting	O
blood	O
samples	O
were	O
also	O
obtained	O
on	O
follow	O
ups	O
and	O
were	O
used	O
to	O
prepare	O
serums	O
,	O
which	O
were	O
kept	O
similarly	O
.	O

Any	O
medication	O
and	O
supplementation	O
use	O
is	O
also	O
recorded	O
daily	O
.	O

ENU	O
mutagenesis	O
Male	O
129S1	O
mice	O
received	O
one	O
intraperitoneal	O
injection	O
of	O
ENU	O
at	O
a	O
dose	O
of	O
150	O
mg	O
/	O
kg	O
at	O
age	O
8	O
–	O
12	O
wk	O
.	O

PubMed	O
Central	O
:	O

We	O
also	O
examined	O
pair	O
wise	O
EDC	O
correlation	O
in	O
a	O
heat	O
map	O
(	O
Additional	O
file1	O
:	O
Figure	O
S2	O
).	O

As	O
with	O
asthma	O
,	O
preexisting	O
AR	O
can	O
worsen	O
,	O
improve	O
,	O
or	O
remain	O
unchanged	O
during	O
pregnancy	O
[	O
27	O
].	O

trial	O
cohort	O
[	O
12	O
].	O

Using	O
a	O
robust	O
,	O
validated	O
chemiluminescent	O
-	O
based	O
assay	O
to	O
measure	O
serum	O
25	O
(	O
OH	O
)	O
D	O
[	O
27	O
],	O
we	O
aimed	O
to	O
investigate	O
the	O
differences	O
between	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
in	O
two	O
distinct	O
populations	O
of	O
nulliparous	O
women	O
from	O
Australia	O
and	O
New	O
Zealand	O
.	O

Statistical	O
Analysis	O
Chi	O
-	O
squared	O
tests	O
were	O
used	O
to	O
compare	O
frequency	O
distributions	O
.	O

Dams	O
(	O
and	O
corresponding	O
litters	O
)	O
were	O
placed	O
under	O
control	O
conditions	O
for	O
the	O
remainder	O
of	O
the	O
experiment	O
.	O

Standardised	O
methods	O
of	O
the	O
International	O
Society	O
for	O
the	O
Advancement	O
of	O
Kinanthropometry	O
[	O
45	O
]	O
are	O
used	O
with	O
a	O
calibrated	O
digital	O
scale	O
for	O
weight	O
,	O
a	O
mobile	O
stadiometer	O
for	O
height	O
;	O
and	O
non	O
-	O
stretchable	O
metal	O
measuring	O
tape	O
for	O
MUAC	O
.	O

CONCLUSION	O
In	O
this	O
article	O
,	O
we	O
reviewed	O
several	O
factors	O
(	O
genetic	O
,	O
management	O
,	O
and	O
nutritional	O
factors	O
)	O
affecting	O
IMF	O
deposition	O
in	O
cattle	O
(	O
Table	O
2	O
).	O

Nearly	O
half	O
of	O
the	O
participants	O
(	O
47	O
.	O
8	O
%,	O
451	O
/	O
943	O
)	O
reported	O
having	O
had	O
a	O
prior	O
live	O
birth	O
.	O

Interestingly	O
,	O
recent	O
studies	O
have	O
documented	O
epigenetic	O
modifications	O
or	O
affectation	O
of	O
adrenocortical	O
growth	O
in	O
offspring	O
after	O
maternal	O
dietary	O
restriction	O
around	O
the	O
time	O
of	O
conception	O
(	O
Nicholas	O
et	O
al	O
.,	O
2013	O
;	O
Zhang	O
et	O
al	O
.,	O
2013	O
),	O
pointing	O
out	O
the	O
importance	O
of	O
the	O
periconceptional	O
window	O
in	O
the	O
metabolic	O
programming	O
.	O

Most	O
studies	O
on	O
breastfeeding	O
over	O
the	O
past	O
few	O
decades	O
have	O
focused	O
on	O
the	O
advantages	O
of	O
breastfeeding	O
and	O
how	B
to	O
get	O
more	O
women	O
to	O
breastfeed	O
their	O
babies	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
University	O
of	O
Cincinnati	O
and	O
Cincinnati	O
Children	O
'	O
s	O
Hospital	O
Medical	O
Center	O
Institutional	O
Review	O
Boards	O
.	O

However	O
,	O
maternal	O
adherence	O
to	O
healthy	O
dietary	O
pattern	O
was	O
not	O
related	O
to	O
birth	O
weight	O
of	O
infants	O
in	O
all	O
crude	O
and	O
adjusted	O
models	O
.	O

Artificial	O
insemination	O
and	O
fertility	O
medications	O
,	O
meconium	O
aspiration	O
syndrome	O
,	O
and	O
birth	O
weight	O
have	O
also	O
all	O
been	O
subjects	O
of	O
focus	O
and	O
the	O
respective	O
association	O
with	O
pregnancy	O
and	O
neurodevelopmental	O
complications	O
such	O
as	O
autism	O
.	O

Also	O
,	O
increasing	O
physical	O
activity	O
during	O
pregnancy	O
has	O
been	O
related	O
to	O
lower	O
GWG	O
in	O
some	O
[	O
41	O
]	O
but	O
not	O
all	O
[	O
42	O
]	O
observational	O
studies	O
.	O

We	O
calculated	O
basic	O
descriptive	O
statistics	O
for	O
participant	O
variables	O
(	O
Table1	O
),	O
EDC	O
concentration	O
geometric	O
means	O
and	O
percentiles	O
(	O
Table2	O
).	O

The	O
glycosylated	O
hemoglobin	O
A1C	O
(	O
HBA1C	O
),	O
serum	O
25	O
-	O
OH	O
-	O
D	O
,	O
parathyroid	O
hormone	O
(	O
PTH	O
),	O
serum	O
calcium	O
and	O
phosphorus	O
were	O
measured	O
.	O

Multianalyte	O
profiling	O
was	O
performed	O
on	O
the	O
Luminex	O
Magpix	O
system	O
(	O
Luminex	O
Corporation	O
Austin	O
,	O
USA	O
).	O

We	O
will	O
publish	O
the	O
analysis	O
of	O
the	O
outcomes	O
in	O
the	O
form	O
of	O
internal	O
documents	O
,	O
working	O
papers	O
,	O
and	O
in	O
international	O
peer	O
-	O
reviewed	O
journals	O
.	O

In	O
Korean	O
cattle	O
,	O
Park	O
et	O
al	O
[	O
39	O
]	O
compared	O
marbling	O
degree	O
by	O
sex	O
(	O
bulls	O
,	O
steers	O
,	O
and	O
cows	O
),	O
and	O
steers	O
had	O
the	O
best	O
MS	O
,	O
followed	O
by	O
cows	O
.	O

In	O
Australia	O
and	O
New	O
Zealand	O
,	O
the	O
deficiency	O
cut	O
-	O
offs	O
are	O
based	O
on	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
bone	O
health	O
where	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
at	O
the	O
end	O
of	O
winter	O
is	O
required	O
for	O
optimal	O
musculoskeletal	O
health	O
[	O
1	O
].	O

A	O
recent	O
study	O
provides	O
evidence	O
with	O
reference	O
to	O
the	O
consequences	O
of	O
vitamin	O
D	O
deficiency	O
on	O
the	O
neurodevelopment	O
of	O
the	O
fetus	O
during	O
pregnancy	O
in	O
a	O
rat	O
model	O
.	O

New	O
OB	O
patients	O
were	O
offered	O
a	O
free	O
bottle	O
of	O
Bio	O
-	O
Tech	O
Pharmacal	O
,	O
Inc	O
.	O
(	O
Fayetteville	O
,	O
AR	O
)	O
vitamin	O
D	O
supplements	O
(	O
5000	O
IU	O
per	O
capsule	O
)	O
at	O
their	O
first	O
visit	O
and	O
personalized	O
dosing	O
recommendations	O
were	O
provided	O
based	O
on	O
the	O
result	O
of	O
their	O
initial	O
25	O
(	O
OH	O
)	O
D	O
test	O
using	O
an	O
algorithm	O
of	O
existing	O
dose	O
-	O
response	O
data	O
[	O
11	O
].	O

Many	O
of	O
the	O
findings	O
regarding	O
the	O
relationship	O
between	O
vitamin	O
D	O
deficiency	O
and	O
GDM	O
are	O
based	O
on	O
case	O
-	O
control	O
studies	O
,	O
which	O
may	O
include	O
a	O
potential	O
selection	O
bias	O
.	O

Phosphatase	O
and	O
tensin	O
homolog	O
deleted	O
on	O
chromosome	O
ten	O
(	O
PTEN	O
),	O
a	O
well	O
-	O
known	O
tumor	O
suppressor	O
is	O
a	O
phosphatase	O
that	O
specifically	O
catalyzes	O
the	O
dephosphorylation	O
of	O
phosphatidylinositol	O
-	O
3	O
,	O
4	O
,	O
5	O
-	O
triphosphate	O
(	O
PIP3	O
),	O
in	O
phosphatidylinositol	O
-	O
4	O
,	O
5	O
-	O
diphosphate	O
PIP2	O
(	O
Cantley	O
and	O
Neel	O
,	O
1999	O
).	O

Early	O
life	O
nutrition	O
,	O
the	O
developing	O
immune	O
system	O
and	O
subsequent	O
allergic	O
manifestations	O
Over	O
the	O
last	O
half	O
-	O
century	O
,	O
chronic	O
disease	O
incidence	O
,	O
including	O
allergic	O
manifestations	O
(	O
AM	O
),	O
has	O
increased	O
exponentially	O
in	O
developed	O
nations	O
and	O
amongst	O
the	O
wealthy	O
in	O
developing	O
nations	O
.	O

Urine	O
parameters	O
(	O
Table	O
2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Urine	O
parameters	O
.	O
ParametersF1	O
-	O
SCF1	O
-	O
VitD	O
-	O
F2	O
-	O
SCF2	O
-	O
VitD	O
-	O
WI	O
,	O
g	O
/	O
100	O
g	O
BM	O
/	O
day	O
16	O
.	O
3	O
±	O
1	O
.	O
014	O
.	O
4	O
±	O
1	O
.	O
615	O
.	O
2	O
±	O
1	O
.	O
113	O
.	O
3	O
±	O
1	O
.	O
3	O
Urine	O
output	O
0	O
.	O
05	O
±	O
0	O
.	O
0020	O
.	O
02	O
±	O
0	O
.	O
004	O
†	O
0	O
.	O
04	O
±	O
0	O
.	O
0060	O
.	O
04	O
±	O
0	O
.	O
004	O
Urea	O
,	O
mg	O
/	O
dL	O
36	O
.	O
5	O
±	O
3	O
.	O
8194	O
.	O
7	O
±	O
23	O
.	O
2	O
†	O
45	O
.	O
5	O
±	O
8	O
.	O
158	O
.	O
2	O
±	O
8	O
.	O
5	O
‡	O
Creatinine	O
,	O
mg	O
/	O
dL	O
1	O
.	O
2	O
±	O
0	O
.	O
13	O
.	O
3	O
±	O
0	O
.	O
2	O
†	O
1	O
.	O
0	O
±	O
0	O
.	O
11	O
.	O
4	O
±	O
0	O
.	O
1	O
‡	O
Uric	O
acid	O
,	O
mg	O
/	O
dL	O
0	O
.	O
6	O
±	O
0	O
.	O
21	O
.	O
2	O
±	O
0	O
.	O
60	O
.	O
5	O
±	O
0	O
.	O
10	O
.	O
9	O
±	O
0	O
.	O
3	O
Proteinuria	O
,	O
g	O
/	O
L	O
0	O
.	O
43	O
±	O
0	O
.	O
10	O
.	O
55	O
±	O
0	O
.	O
10	O
.	O
40	O
±	O
0	O
.	O
10	O
.	O
44	O
±	O
0	O
.	O
1	O
Data	O
were	O
kept	O
for	O
six	O
-	O
month	O
-	O
old	O
male	O
offspring	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
.	O

However	O
,	O
according	O
to	O
the	O
recent	O
studies	O
,	O
vitamin	O
D	O
deficiency	O
is	O
also	O
common	O
in	O
these	O
countries10	O
,	O
11	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
how	B
well	O
the	O
recommendations	O
were	O
implemented	O
.	O

Vitamin	O
D	O
Effect	O
on	O
In	O
Vitro	O
Fertilization	O
VD	O
insufficiency	O
has	O
been	O
in	O
the	O
spotlight	O
of	O
in	O
vitro	O
fertilization	O
(	O
IVF	O
)	O
researchers	O
for	O
many	O
years	O
.	O

However	O
,	O
it	O
must	O
be	O
borne	O
in	O
mind	O
that	O
a	O
proportion	O
of	O
children	O
who	O
develop	O
atopic	O
manifestations	O
in	O
the	O
first	O
years	O
of	O
life	O
come	O
from	O
families	O
in	O
which	O
neither	O
parents	O
nor	O
siblings	O
are	O
atopic	O
.	O

However	O
,	O
to	O
determine	O
whether	O
,	O
or	O
not	O
,	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
is	O
a	O
real	O
concern	O
for	O
public	O
health	O
there	O
are	O
a	O
number	O
of	O
important	O
considerations	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
frequency	O
of	O
daily	O
“	O
between	O
-	O
meal	O
”	O
snacking	O
between	O
the	O
groups	O
(	O
93	O
.	O
8	O
%	O
S	O
-	O
ECC	O
vs	O
.	O
96	O
.	O
7	O
%	O
caries	O
-	O
free	O
,	O
p	O
=	O
0	O
.	O
39	O
,	O
Fisher	O
’	O
s	O
Exact	O
Test	O
).	O

PubMed	O
Central	O
:	O

The	O
control	O
group	O
was	O
offspring	O
fed	O
the	O
RV	O
diet	O
and	O
born	O
to	O
dams	O
fed	O
the	O
RV	O
diet	O
.	O

For	O
this	O
reason	O
,	O
preventive	O
interventions	O
may	O
be	O
most	O
effective	O
during	O
pregnancy	O
and	O
postpartum	O
,	O
when	O
women	O
are	O
highly	O
motivated	O
to	O
change	O
for	O
the	O
benefit	O
of	O
their	O
children	O
.	O

Glucose	O
can	O
also	O
be	O
used	O
as	O
a	O
substrate	O
for	O
FA	O
de	O
novo	O
synthesis	O
in	O
ruminants	O
.	O

Furthermore	O
,	O
studies	O
have	O
focussed	O
predominantly	O
on	O
measures	O
of	O
adiposity	O
,	O
and	O
have	O
not	O
reported	O
other	O
clinically	O
relevant	O
infant	O
outcomes	O
[	O
18	O
,	O
20	O
],	O
or	O
specifically	O
reported	O
infant	O
outcomes	O
among	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
[	O
19	O
].	O

The	O
vast	O
majority	O
of	O
mothers	O
reported	O
prenatal	O
vitamin	O
use	O
;	O
only	O
three	O
subjects	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
.	O

The	O
sample	O
was	O
diverse	O
but	O
self	O
-	O
selected	O
and	O
free	O
of	O
diseases	O
that	O
might	O
contraindicate	O
participation	O
in	O
a	O
lifestyle	O
intervention	O
study	O
;	O
thus	O
,	O
findings	O
may	O
not	O
generalize	O
to	O
the	O
population	O
at	O
large	O
.	O

Minority	O
women	O
are	O
at	O
increased	O
risk	O
for	O
excessive	O
GWG	O
,	O
yet	O
are	O
underrepresented	O
in	O
published	O
weight	O
control	O
interventions	O
.	O

Nutritional	O
effects	O
on	O
the	O
fetus	O
and	O
mother	O
may	O
vary	O
with	O
prepregnancy	O
body	O
weight	O
,	O
trimester	O
of	O
exposure	O
during	O
pregnancy	O
,	O
and	O
overall	O
balance	O
of	O
macronutrients	O
[	O
8	O
,	O
38	O
].	O

Furthermore	O
,	O
some	O
studies	O
have	O
found	O
a	O
beneficial	O
effect	O
of	O
influenza	O
vaccination	O
on	O
birth	O
outcomes	O
,	O
specifically	O
a	O
decreased	O
likelihood	O
of	O
delivering	O
a	O
baby	O
preterm	O
or	O
small	O
for	O
gestational	O
age	O
[	O
16	O
],[	O
17	O
],[	O
18	O
],[	O
19	O
],[	O
20	O
],[	O
21	O
],[	O
22	O
].	O

95	O
%	O
CI	O
=	O
95	O
%	O
Confidence	O
Intervals	O
.	O

(	O
2016	O
)	O
stated	O
that	O
maternal	O
fasting	O
glucose	O
or	O
GDM	O
status	O
was	O
not	O
associated	O
with	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
,	O
which	O
in	O
their	O
study	O
was	O
on	O
average	O
93	O
nmol	O
/	O
L	O
[	O
23	O
].	O

In	O
post	O
hoc	O
analysis	O
of	O
two	O
-	O
tail	O
t	O
test	O
,	O
the	O
statistical	O
power	O
could	O
reach	O
0	O
.	O
6	O
(	O
alpha	O
risk	O
,	O
0	O
.	O
05	O
;	O
effect	O
size	O
,	O
0	O
.	O
5	O
).	O

PubMed	O
Central	O
:	O

Of	O
note	O
,	O
one	O
of	O
these	O
children	O
was	O
obese	O
,	O
one	O
had	O
seasonal	O
allergies	O
treated	O
with	O
a	O
long	O
-	O
term	O
steroid	O
nasal	O
spray	O
,	O
and	O
the	O
third	O
had	O
a	O
history	O
of	O
febrile	O
seizures	O
.	O

Both	O
histone	O
modifications	O
and	O
DNA	O
methylation	O
changes	O
can	O
inhibit	O
or	O
promote	O
transcription	O
of	O
mRNAs	O
and	O
ncRNAs	O
.	O

Subjects	O
were	O
asked	O
to	O
notify	O
fieldworkers	O
of	O
suspected	O
pregnancy	O
and	O
following	O
confirmation	O
of	O
pregnancy	O
by	O
study	O
midwives	O
,	O
women	O
were	O
instructed	O
to	O
stop	O
supplementation	O
and	O
no	O
further	O
supplements	O
were	O
issued	O
.	O

In	O
contrast	O
maternal	O
intakes	O
of	O
carbohydrate	O
were	O
negatively	O
associated	O
with	O
infant	O
length	O
and	O
abdominal	O
circumference	O
[	O
26	O
].	O

Changes	O
in	O
height	O
with	O
age	O
This	O
was	O
carried	O
out	O
separately	O
for	O
boys	O
and	O
girls	O
.	O

No	O
difference	O
in	O
serum	O
25OHD	O
was	O
noted	O
between	O
groups	O
.	O

Measuring	O
dietary	O
intake	O
in	O
cohort	O
studies	O
is	O
problematic	O
due	O
to	O
the	O
difficulty	O
in	O
obtaining	O
detailed	O
information	O
without	O
causing	O
significant	O
subject	O
burden	O
.	O

Differentiated	O
thyroid	O
cancer	O
(	O
DTC	O
)	O
in	O
young	O
people	O
generally	O
has	O
an	O
excellent	O
prognosis	O
,	O
and	O
disease	O
-	O
free	O
survival	O
among	O
women	O
with	O
DTC	O
diagnosed	O
during	O
pregnancy	O
may	O
not	O
differ	O
from	O
that	O
in	O
age	O
-	O
matched	O
non	O
-	O
pregnant	O
women	O
with	O
similar	O
disease	O
.	O

Acetate	O
or	O
glucose	O
is	O
used	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
[	O
85	O
].	O

Nutritional	O
knowledge	O
was	O
significantly	O
associated	O
with	O
the	O
intake	O
of	O
these	O
supplements	O
,	O
regardless	O
of	O
the	O
frequency	O
of	O
prenatal	O
visits	O
or	O
socio	O
-	O
demographic	O
characteristics	O
.	O

Previous	O
studies	O
have	O
demonstrated	O
that	O
those	O
born	O
with	O
low	O
or	O
high	O
birth	O
weight	O
have	O
impairment	O
of	O
the	O
arterial	O
vascular	O
system	O
with	O
modifications	O
in	O
both	O
functional	O
(	O
e	O
.	O
g	O
.,	O
endothelium	O
dysfunction	O
,	O
reduction	O
in	O
nitric	O
oxide	O
production	O
)	O
and	O
structural	O
/	O
mechanical	O
(	O
e	O
.	O
g	O
.,	O
higher	O
arterial	O
intima	O
-	O
media	O
thickness	O
,	O
elastin	O
synthesis	O
deficiency	O
,	O
increased	O
arterial	O
stiffness	O
)	O
properties	O
[	O
8	O
,	O
9	O
,	O
11	O
–	O
14	O
].	O

A	O
report	O
of	O
the	O
Young	O
Finns	O
Study	O
followed	O
offspring	O
in	O
relation	O
to	O
parental	O
BMI	O
from	O
3	O
to	O
18	O
years	O
and	O
later	O
again	O
when	O
children	O
were	O
24	O
–	O
39	O
years	O
old	O
.	O

The	O
amplification	O
was	O
conducted	O
in	O
duplicate	O
according	O
to	O
manufacturer	O
'	O
s	O
instructions	O
using	O
10	O
μM	O
of	O
each	O
primer	O
.	O

PubMed	O
Central	O
:	O

In	O
contrast	O
,	O
in	O
the	O
previous	O
studies	O
2000	O
IU	O
vitamin	O
D	O
supplementation	O
was	O
more	O
sufficient	O
to	O
increase	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
up	O
to	O
the	O
adequate	O
amount	O
(≥	O
32	O
ng	O
/	O
mL	O
)	O
[	O
18	O
,	O
57	O
,	O
58	O
].	O

Health	O
outcomes	O
must	O
be	O
included	O
in	O
the	O
educational	O
agenda	O
and	O
become	O
part	O
of	O
school	O
accountability	O
to	O
obtain	O
support	O
and	O
funding	O
for	O
health	O
-	O
based	O
policies	O
and	O
interventions	O
,	O
such	O
as	O
physical	O
education	O
,	O
comprehensive	O
health	O
education	O
,	O
or	O
BMI	O
monitoring	O
.	O

3	O
.	O
4	O
.	O

Vitamin	O
D	O
Vitamin	O
D	O
also	O
inhibits	O
adipogenesis	O
in	O
vitro	O
.	O

It	O
assists	O
in	O
identifying	O
the	O
normal	O
ranges	O
of	O
circulating	O
cathelicidin	O
concentrations	O
found	O
in	O
healthy	O
children	O
.	O

For	O
ease	O
of	O
administration	O
in	O
the	O
field	O
,	O
randomisation	O
was	O
to	O
one	O
of	O
four	O
colour	O
-	O
coded	O
groups	O
(	O
2	O
for	O
intervention	O
;	O
2	O
for	O
placebo	O
),	O
stratified	O
by	O
age	O
.	O

Nulliparous	O
and	O
multiparous	O
mothers	O
were	O
considered	O
as	O
the	O
strata	O
.	O

Few	O
herb	O
users	O
discussed	O
use	O
with	O
their	O
providers	O
,	O
and	O
there	O
was	O
no	O
documentation	O
in	O
the	O
medical	O
record	O
.	O

Laboratory	O
Measurements	O
After	O
an	O
overnight	O
fasting	O
,	O
samples	O
of	O
6	O
ml	O
peripheral	O
blood	O
were	O
taken	O
from	O
all	O
of	O
the	O
patients	O
at	O
most	O
10	O
days	O
after	O
the	O
delivery	O
,	O
and	O
were	O
used	O
to	O
determine	O
plasma	O
glycosylated	O
hemoglobin	O
A1C	O
(	O
HBA1C	O
)	O
test	O
by	O
immunoassay	O
method	O
.	O

The	O
biological	O
underpinnings	O
of	O
EAH	O
and	O
other	O
appetite	O
-	O
related	O
behaviors	O
are	O
not	O
well	O
understood	O
.	O

Therefore	O
,	O
the	O
transcriptional	O
control	O
of	O
cyclins	O
provides	O
an	O
additional	O
level	O
of	O
growth	O
regulation	O
.	O

Evaluating	O
Provider	O
Advice	O
and	O
Women	O
’	O
s	O
Beliefs	O
on	O
Total	O
Weight	O
Gain	O
During	O
Pregnancy	O
Abstract	O
Excessive	O
gestational	O
weight	O
gain	O
(	O
GWG	O
)	O
is	O
associated	O
with	O
complications	O
for	O
both	O
mother	O
and	O
child	O
.	O

Thyroid	O
hormone	O
deficiency	O
may	O
cause	O
severe	O
neurologic	O
disorders	O
,	O
resulting	O
from	O
defects	O
in	O
neuronal	O
cell	O
differentiation	O
and	O
migration	O
,	O
axonal	O
and	O
dendritic	O
outgrowth	O
,	O
myelin	O
formation	O
and	O
synaptogenesis7913	O
.	O

Among	O
the	O
71	O
infants	O
,	O
36	O
were	O
boys	O
.	O

However	O
,	O
an	O
accelerated	O
reproductive	O
tempo	O
may	O
not	O
be	O
maintained	O
in	O
the	O
face	O
of	O
later	O
nutritional	O
constraints	O
.	O

Visfatin	O
,	O
a	O
new	O
52KDa	O
adipokine	O
(	O
2	O
),	O
was	O
renamed	O
to	O
nicotinamide	O
phosphoribosyl	O
transferase	O
(	O
Nampt	O
)	O
in	O
2002	O
after	O
it	O
was	O
shown	O
that	O
it	O
encodes	O
an	O
enzyme	O
called	O
Nampt	O
,	O
which	O
is	O
involved	O
in	O
the	O
conversion	O
of	O
nicotinamide	O
into	O
nicotinamide	O
adenine	O
dinucleotide	O
(	O
NAD	O
)(	O
3	O
).	O

The	O
country	O
is	O
undergoing	O
a	O
rapid	O
nutrition	O
transition	O
characterised	O
by	O
changes	O
in	O
dietary	O
patterns	O
and	O
nutrient	O
intake	O
alongside	O
urbanisation	O
[	O
19	O
,	O
20	O
],	O
which	O
has	O
resulted	O
in	O
a	O
growing	O
double	O
-	O
burden	O
of	O
under	O
-	O
and	O
over	O
-	O
nutrition	O
[	O
20	O
,	O
21	O
].	O

This	O
was	O
more	O
pronounced	O
in	O
women	O
who	O
received	O
best	O
-	O
practice	O
care	O
(	O
25	O
.	O
0	O
%	O
(	O
yes	O
)	O
vs	O
.	O
27	O
.	O
2	O
%	O
(	O
no	O
)).	O

As	O
I	O
discussed	O
in	O
my	O
original	O
paper	O
,	O
this	O
has	O
been	O
known	O
since	O
the	O
early	O
1980s	O
but	O
was	O
dismissed	O
as	O
being	O
because	O
of	O
ascertainment	O
bias	O
.	O

These	O
offspring	O
also	O
had	O
higher	O
rates	O
of	O
physiological	O
changes	O
,	O
including	O
atypical	O
sperm	O
formation	O
.	O
38And	O
a	O
mouse	O
study	O
produced	O
evidence	O
that	O
uranium	O
in	O
drinking	O
water	O
caused	O
estrogenic	O
activity	O
even	O
at	O
levels	O
below	O
the	O
EPA	O
safe	O
drinking	O
water	O
level	O
of	O
30	O
µg	O
/	O
L	O
.	O
39	O
To	O
look	O
more	O
closely	O
at	O
the	O
effects	O
of	O
uranium	O
exposure	O
on	O
human	O
reproduction	O
and	O
development	O
,	O
Lewis	O
has	O
recently	O
begun	O
recruiting	O
up	O
to	O
1	O
,	O
500	O
pregnant	O
women	O
to	O
participate	O
in	O
the	O
Navajo	O
Birth	O
Cohort	O
Study	O
.	O
40Besides	O
tracking	O
birth	O
outcomes	O
and	O
infant	O
development	O
,	O
pharmacologist	O
Laurie	O
Hudson	O
of	O
the	O
University	O
of	O
New	O
Mexico	O
is	O
looking	O
at	O
molecular	O
changes	O
that	O
may	O
be	O
induced	O
by	O
exposure	O
to	O
uranium	O
waste	O
.	O

In	O
particular	O
,	O
a	O
7	O
.	O
5	O
-	O
fold	O
OR	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
3	O
–	O
44	O
.	O
9	O
)	O
for	O
low	O
grade	O
astrocytoma	O
has	O
been	O
observed	O
for	O
neonatal	O
urinary	O
tract	O
infections	O
[	O
141	O
].	O

Complex	O
evaluation	O
of	O
vitamin	O
D	O
activity	O
mechanism	O
on	O
fertility	O
requires	O
further	O
studies	O
.	O

Animal	O
studies	O
suggest	O
that	O
excess	O
iron	O
can	O
also	O
trigger	O
formation	O
of	O
free	O
radicals	O
in	O
the	O
intestinal	O
mucosa	O
and	O
other	O
tissues	O
,	O
and	O
that	O
both	O
iron	O
deficiency	O
and	O
iron	O
overload	O
can	O
damage	O
nuclear	O
DNA	O
and	O
mitochondrial	O
DNA	O
.	O

School	O
programs	O
intended	O
to	O
alleviate	O
the	O
obesity	O
crisis	O
need	O
funding	O
,	O
partnerships	O
,	O
and	O
evaluation	O
.	O

Thus	O
,	O
during	O
the	O
late	O
fattening	O
stage	O
of	O
beef	O
cattle	O
,	O
marbling	O
adipocytes	O
may	O
grow	O
continuously	O
even	O
though	O
development	O
of	O
abdominal	O
,	O
intermuscular	O
,	O
and	O
subcutaneous	O
fat	O
may	O
slow	O
or	O
cease	O
.	O

Notably	O
,	O
investigators	O
have	O
reported	O
that	O
short	O
sleep	O
duration	O
and	O
other	O
parameters	O
of	O
sleep	O
disturbance	O
during	O
mid	O
and	O
late	O
pregnancy	O
are	O
associated	O
with	O
increased	O
systematic	O
inflammation	O
and	O
higher	O
stimulated	O
levels	O
of	O
IL	O
-	O
6	O
[	O
49	O
,	O
50	O
];	O
and	O
we	O
have	O
previously	O
reported	O
that	O
early	O
pregnancy	O
CRP	O
concentrations	O
are	O
predictive	O
of	O
incident	O
GDM	O
[	O
51	O
].	O

One	O
such	O
study	O
,	O
led	O
by	O
Maria	O
Limson	O
-	O
Zamora	O
,	O
head	O
of	O
Health	O
Canada	O
’	O
s	O
Bioassay	O
Section	O
,	O
compared	O
biomarkers	O
of	O
kidney	O
function	O
in	O
the	O
urine	O
of	O
Canadians	O
chronically	O
exposed	O
to	O
high	O
(	O
2	O
–	O
780	O
µg	O
/	O
L	O
)	O
or	O
low	O
(	O
0	O
.	O
02	O
µg	O
/	O
L	O
)	O
levels	O
of	O
uranium	O
in	O
their	O
drinking	O
water	O
.	O

These	O
results	O
will	O
supply	O
context	O
to	O
intervention	O
studies	O
with	O
the	O
aim	O
to	O
improve	O
maternal	O
as	O
well	O
as	O
offspring	O
health	O
in	O
South	O
Africa	O
.	O

Estimation	O
of	O
foetal	O
crown	O
rump	O
length	O
and	O
/	O
or	O
biparietal	O
diameter	O
or	O
femur	O
length	O
between	O
6	O
and	O
18	O
weeks	O
’	O
gestation	O
indicates	O
an	O
accuracy	O
within	O
5	O
–	O
7	O
days	O
[	O
54	O
].	O

The	O
participants	O
were	O
selected	O
from	O
one	O
prenatal	O
clinic	O
.	O

All	O
analyses	O
were	O
performed	O
in	O
R	O
software	O
(	O
R	O
version	O
3	O
.	O
2	O
.	O
2	O
).	O

None	O
of	O
the	O
mothers	O
reported	O
taking	O
additional	O
vitamin	O
D	O
supplements	O
separate	O
from	O
their	O
prenatal	O
vitamins	O
.	O

[	O
13	O
]	O
Kruavit	O
et	O
al	O
.	O

They	O
were	O
also	O
asked	O
to	O
attend	O
weekly	O
supplementation	O
clinics	O
held	O
in	O
their	O
own	O
villages	O
when	O
they	O
were	O
re	O
-	O
supplied	O
with	O
supplements	O
.	O

In	O
contrast	O
for	O
white	O
women	O
,	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
significantly	O
higher	O
seasonally	O
-	O
adjusted	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
early	O
(	O
OR	O
3	O
.	O
5	O
,	O
95	O
%	O
CI	O
2	O
.	O
1	O
,	O
5	O
.	O
8	O
)	O
(	O
Interaction	O
P	O
value	O
0	O
.	O
01	O
).	O

Identifying	O
and	O
understanding	O
environmentally	O
induced	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
may	O
lead	O
to	O
adverse	O
outcomes	O
is	O
vital	O
for	O
protecting	O
public	O
health	O
.	O

Women	O
enrolled	O
at	O
a	O
median	O
(	O
interquartile	O
range	O
)	O
gestational	O
age	O
of	O
9	O
.	O
6	O
weeks	O
(	O
8	O
.	O
4	O
–	O
11	O
.	O
4	O
).	O

Nutritional	O
education	O
is	O
considered	O
an	O
important	O
tool	O
for	O
promoting	O
a	O
healthy	O
lifestyle	O
,	O
but	O
has	O
not	O
been	O
studied	O
as	O
a	O
determinant	O
for	O
maternal	O
use	O
of	O
supplements	O
during	O
pregnancy	O
,	O
especially	O
in	O
Romania	O
,	O
where	O
evidence	O
about	O
pregnancy	O
and	O
nutrition	O
is	O
scarce	O
.	O

Otherwise	O
,	O
we	O
found	O
no	O
clear	O
published	O
evidence	O
for	O
times	O
at	O
which	O
maternal	O
or	O
other	O
caregiver	O
handwashing	O
may	O
prevent	O
pathogen	O
transfer	O
to	O
/	O
from	O
hands	O
in	O
low	O
-	O
income	O
settings	O
.	O

)—	O
Low	O
Frequency	O
in	O
Normalized	O
Units	O
;	O
HF	O
(	O
n	O
.	O
u	O
.	O

Mean	O
cost	O
per	O
beneficiary	O
were	O
calculated	O
as	O
USD1	O
.	O
95	O
(	O
vitamin	O
A	O
),	O
USD3	O
.	O
64	O
(	O
iodine	O
),	O
USD0	O
.	O
52	O
(	O
zinc	O
–	O
only	O
1	O
program	O
),	O
but	O
was	O
not	O
calculated	O
for	O
iron	O
.	O

BMC	O
=	O
bone	O
mineral	O
content	O
BMD	O
=	O
bone	O
mineral	O
density	O
PTH	O
=	O
serum	O
parathyroid	O
hormone	O
25	O
(	O
OH	O
)	O
D	O
=	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
(	O
conversion	O
to	O
nmol	O
/	O
L	O
is	O
by	O
multiplying	O
values	O
shown	O
by	O
2	O
.	O
5	O
)	O
For	O
entire	O
49	O
subjects	O
enrolled	O
:	O
Values	O
for	O
cord	O
25	O
(	O
OH	O
)	O
D	O
,	O
Non	O
-	O
Hispanic	O
Caucasian	O
(	O
n	O
=	O
22	O
),	O
22	O
.	O
3	O
±	O
9	O
.	O
4	O
ng	O
/	O
mL	O
and	O
Hispanic	O
(	O
n	O
=	O
27	O
),	O
16	O
.	O
4	O
±	O
6	O
.	O
5	O
ng	O
/	O
mL	O
,	O
p	O
=	O
0	O
.	O
01	O
.	O

PubMed	O
Central	O
:	O

The	O
degree	O
of	O
risk	O
seems	O
to	O
be	O
directly	O
related	O
to	O
the	O
family	O
history	O
of	O
allergy	O
and	O
especially	O
to	O
maternal	O
atopy	O
,[	O
53	O
]	O
particularly	O
when	O
the	O
mother	O
has	O
diagnosed	O
atopic	O
eczema	O
and	O
has	O
elevated	O
IgE	O
levels	O
.	O

We	O
combined	O
EPA	O
,	O
DHA	O
and	O
DPA	O
to	O
estimate	O
the	O
total	O
intake	O
of	O
marine	O
fatty	O
acids	O
.	O

We	O
will	O
present	O
the	O
intermediate	O
and	O
immediate	O
results	O
,	O
which	O
support	O
the	O
hypotheses	O
generated	O
from	O
the	O
trial	O
,	O
at	O
national	O
and	O
international	O
conferences	O
and	O
publish	O
them	O
in	O
conference	O
proceedings	O
.	O

After	O
PSM	O
,	O
we	O
evaluated	O
these	O
variables	O
for	O
significant	O
differences	O
between	O
the	O
vaccination	O
status	O
groups	O
in	O
order	O
to	O
know	O
how	O
well	O
matching	O
occurred	O
.	O

Bonferrroni	O
analysis	O
indicated	O
that	O
CC	O
and	O
RC	O
adult	O
females	O
displayed	O
higher	O
chocolate	O
preference	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adult	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
).	O

A	O
number	O
of	O
lessons	O
can	O
be	O
drawn	O
from	O
this	O
historical	O
data	O
:	O
Basic	O
care	O
and	O
infection	O
case	O
management	O
interventions	O
have	O
an	O
effect	O
on	O
neonatal	O
deaths	O
and	O
on	O
deaths	O
amongst	O
moderate	O
and	O
late	O
preterm	O
births	O
,	O
which	O
account	O
for	O
over	O
80	O
%	O
of	O
preterm	O
births	O
.	O

AMH	O
is	O
produced	O
by	O
ovary	O
granulosa	O
cells	O
irrespective	O
of	O
stimulation	O
with	O
gonadotropins	O
,	O
but	O
,	O
as	O
stated	O
above	O
,	O
it	O
may	O
be	O
triggered	O
by	O
VD	O
supplementation	O
.	O

A	O
recent	O
systematic	O
review	O
concluded	O
that	O
antenatal	O
vitamin	O
D	O
supplementation	O
is	O
effective	O
in	O
improving	O
the	O
vitamin	O
D	O
status	O
of	O
Asian	O
and	O
white	O
women	O
,	O
improves	O
growth	O
in	O
the	O
first	O
year	O
of	O
life	O
in	O
South	O
Asian	O
babies	O
and	O
therefore	O
may	O
contribute	O
to	O
reducing	O
the	O
incidence	O
of	O
rickets	O
in	O
this	O
latter	O
group	O
,	O
without	O
evidence	O
of	O
harm	O
.	O

Briefly	O
,	O
at	O
insemination	O
German	O
Landrace	O
primiparous	O
sows	O
(	O
n	O
=	O
42	O
)	O
were	O
randomly	O
assigned	O
to	O
either	O
a	O
low	O
protein	O
diet	O
(	O
LP	O
)	O
with	O
6	O
%	O
(	O
w	O
/	O
w	O
)	O
crude	O
protein	O
or	O
an	O
adequate	O
protein	O
diet	O
(	O
AP	O
)	O
containing	O
12	O
%	O
crude	O
protein	O
.	O

One	O
southern	O
U	O
.	O
S	O
.	O
state	O
,	O
with	O
the	O
second	O
highest	O
preterm	O
birth	O
rate	O
in	O
the	O
country	O
,	O
has	O
received	O
an	O
"	O
F	O
"	O
on	O
its	O
Report	O
Card	O
every	O
year	O
since	O
2008	O
.	O

Six	O
children	O
in	O
the	O
vitamin	O
D	O
and	O
four	O
in	O
the	O
placebo	O
group	O
died	O
of	O
septicaemia	O
or	O
pneumonia	O
.	O

The	O
intervention	O
period	O
was	O
only	O
3	O
-	O
months	O
,	O
compared	O
with	O
12	O
-	O
months	O
in	O
the	O
present	O
study	O
,	O
and	O
there	O
was	O
a	O
high	O
dropout	O
rate	O
.	O

The	O
dose	O
-	O
response	O
effects	O
observed	O
here	O
suggest	O
the	O
need	O
to	O
study	O
methods	O
to	O
evaluate	O
exposure	O
and	O
achieve	O
optimal	O
dosage	O
effects	O
in	O
future	O
research	O
.	O

This	O
multiplex	O
immune	O
-	O
assay	O
also	O
includes	O
the	O
acute	O
phase	O
proteins	O
C	O
-	O
reactive	O
protein	O
(	O
CRP	O
)	O
and	O
alpha1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
),	O
as	O
well	O
as	O
the	O
malaria	O
marker	O
HRP2	O
and	O
thyroglobulin	O
,	O
which	O
is	O
a	O
marker	O
of	O
iodine	O
status	O
.	O

Among	O
the	O
factors	O
evaluated	O
in	O
our	O
study	O
,	O
area	O
of	O
residence	O
,	O
level	O
of	O
education	O
and	O
marital	O
status	O
were	O
associated	O
with	O
the	O
intake	O
of	O
folic	O
acid	O
during	O
pregnancy	O
,	O
independently	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

They	O
opined	O
that	O
sufficient	O
attention	O
should	O
be	O
paid	O
to	O
adolescent	O
girls	O
and	O
women	O
of	O
reproductive	O
age	O
long	O
before	O
pregnancy	O
and	O
suggested	O
intermittent	O
low	O
-	O
dose	O
iron	O
supplements	O
and	O
in	O
some	O
cases	O
,	O
combined	O
with	O
necessary	O
micronutrients	O
[	O
36	O
,	O
37	O
].	O

It	O
synchronizes	O
growth	O
and	O
fertility	O
with	O
periods	O
of	O
either	O
adequate	O
or	O
inadequate	O
food	O
availability	O
[	O
45	O
];	O
post	O
-	O
weaning	O
treatment	O
with	O
leptin	O
accelerates	O
puberty	O
in	O
rodents	O
[	O
46	O
],[	O
47	O
],	O
and	O
leptin	O
in	O
the	O
rat	O
neonate	O
affects	O
hypothalamic	O
maturation	O
[	O
48	O
].	O

Associations	O
between	O
SNPs	O
and	O
change	O
in	O
25	O
(	O
OH	O
)	O
D	O
from	O
14	O
to	O
34	O
weeks	O
of	O
gestation	O
following	O
supplementation	O
with	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
.	O

(	O
2016	O
),	O
could	O
impair	O
the	O
sympathetic	O
neurotransmission	O
and	O
hormones	O
involved	O
in	O
energy	O
metabolism	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
;	O
Keimpema	O
et	O
al	O
.,	O
2013	O
,	O
2014	O
;	O
Cristino	O
et	O
al	O
.,	O
2014	O
).	O

The	O
association	O
between	O
polytherapy	O
exposure	O
and	O
higher	O
rates	O
of	O
malformations	O
should	O
be	O
considered	O
in	O
the	O
context	O
of	O
the	O
small	O
sample	O
size	O
,	O
severity	O
of	O
the	O
baseline	O
disorder	O
that	O
required	O
polytherapy	O
,	O
associated	O
comorbidities	O
,	O
as	O
well	O
as	O
any	O
other	O
unknown	O
environmental	O
factors	O
that	O
were	O
not	O
assessed	O
in	O
this	O
study	O
.	O

Indeed	O
,	O
not	O
all	O
environmentally	O
induced	O
epigenetic	O
changes	O
have	O
proved	O
detrimental	O
.	O

cups	O
,	O
bowls	O
and	O
glasses	O
)	O
as	O
well	O
as	O
two	O
-	O
and	O
three	O
-	O
dimensional	O
food	O
models	O
are	O
being	O
used	O
to	O
assist	O
in	O
quantifying	O
portion	O
sizes	O
.	O

The	O
putative	O
connection	O
between	O
handedness	O
,	O
season	O
of	O
birth	O
,	O
and	O
glioma	O
risk	O
remains	O
difficult	O
to	O
interpret	O
.	O

Although	O
SSRIs	O
are	O
not	O
contraindicated	O
for	O
use	O
during	O
pregnancy	O
,	O
the	O
effects	O
should	O
be	O
examined	O
more	O
carefully	O
[	O
66	O
].	O

Preeclampsia	O
occurred	O
less	O
frequently	O
in	O
the	O
intervention	O
group	O
(	O
12	O
%	O
vs	O
18	O
%,	O
adjusted	O
risk	O
reduction	O
0	O
.	O
7	O
,	O
p	O
=	O
0	O
.	O
02	O
).	O

Studies	O
have	O
found	O
a	O
significant	O
association	O
between	O
maternal	O
prepregnancy	O
overweight	O
or	O
obesity	O
and	O
overweight	O
in	O
children	O
.	O

It	O
also	O
sought	O
to	O
establish	O
reasons	O
that	O
determined	O
these	O
women	O
'	O
s	O
choice	O
of	O
ANC	O
site	O
as	O
well	O
as	O
explore	O
the	O
geographic	O
distribution	O
of	O
the	O
women	O
with	O
respect	O
to	O
their	O
residence	O
and	O
their	O
attending	O
health	O
centre	O
.	O

Interestingly	O
,	O
similar	O
results	O
were	O
obtained	O
by	O
adipose	O
tissue	O
-	O
specific	O
overexpression	O
of	O
PR	O
-	O
domain	O
-	O
containing	O
16	O
(	O
PRDM16	O
)	O
or	O
BMP4	O
in	O
mice	O
.	O

Such	O
effects	O
should	O
be	O
evaluated	O
because	O
podocin	O
serves	O
in	O
the	O
structural	O
organization	O
of	O
the	O
slit	O
diaphragm	O
and	O
the	O
regulation	O
of	O
its	O
filtration	O
function	O
[	O
35	O
].	O

The	O
α	O
isoform	O
was	O
shown	O
to	O
regulate	O
adaptive	O
thermogenesis	O
,	O
whereas	O
the	O
β	O
isoform	O
appears	O
to	O
modulate	O
UCP1	O
expression	O
,	O
without	O
increasing	O
thermogenesis	O
(	O
Ribeiro	O
et	O
al	O
.,	O
2001	O
).	O

The	O
location	O
of	O
the	O
mutation	O
is	O
indicated	O
by	O
shading	O
.	O

*	O
p	O
<	O
0	O
.	O
05	O
,	O
and	O
**	O
p	O
<	O
0	O
.	O
01	O
comparing	O
“	O
High	O
cord	O
25	O
(	O
OH	O
)	O
D	O
”	O
group	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Demographic	O
data	O
,	O
family	O
and	O
environmental	O
data	O
,	O
outcomes	O
,	O
and	O
infant	O
lung	O
function	O
in	O
groups	O
with	O
different	O
25	O
(	O
OH	O
)	O
D	O
status	O
of	O
maternal	O
serum	O
.	O
Low	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
36	O
)	O
High	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
(	O
n	O
=	O
35	O
)	O
Demographic	O
data	O
Gestational	O
age	O
(	O
weeks	O
)	O
38	O
.	O
4	O
±	O
1	O
.	O
238	O
.	O
8	O
±	O
1	O
.	O
3Male	O
(%)	O
5049Nature	O
delivery	O
(%)	O
6662Birth	O
BW	O
(	O
kg	O
)	O
3	O
.	O
1	O
±	O
0	O
.	O
33	O
.	O
2	O
±	O
0	O
.	O
4Birth	O
BL	O
(	O
cm	O
)	O
50	O
.	O
6	O
±	O
2	O
.	O
150	O
.	O
4	O
±	O
2	O
.	O
5BW	O
(	O
kg	O
)	O
8	O
.	O
3	O
±	O
1	O
.	O
18	O
.	O
1	O
±	O
1	O
.	O
0BL	O
(	O
cm	O
)	O
69	O
.	O
0	O
±	O
2	O
.	O
868	O
.	O
6	O
±	O
3	O
.	O
3	O
%	O
of	O
fall	O
/	O
winter	O
birth38	O
.	O
951	O
.	O
4	O
Family	O
and	O
environmental	O
data	O
Asthma	O
,	O
mother2	O
.	O
88	O
.	O
6Asthma	O
,	O
father2	O
.	O
80AR	O
mother22	O
.	O
231	O
.	O
4AR	O
,	O
father30	O
.	O
631	O
.	O
4AD	O
,	O
mother13	O
.	O
98	O
.	O
6AD	O
,	O
father02	O
.	O
8Daycare	O
attendance	O
(%)	O
11	O
.	O
114	O
.	O
3Maternal	O
smoke	O
in	O
pregnancy	O
(%)	O
8	O
.	O
32	O
.	O
8Postnatal	O
smoke	O
Exposure	O
(%)	O
41	O
.	O
637	O
.	O
1	O
Outcomes	O
NP	O
colonization	O
rate	O
(%)	O
69	O
.	O
766	O
.	O
7Ever	O
RTI	O
till	O
6	O
months	O
(%)	O
25	O
.	O
022	O
.	O
8Eczema	O
at	O
6	O
months	O
(%)	O
1720Ever	O
wheeze	O
at	O
6	O
months	O
(%)	O
2523	O
Infant	O
lung	O
function	O
%	O
of	O
Tpef	O
/	O
Te	O
<	O
0	O
.	O
2259Z	O
score	O
of	O
Rrs	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
33	O
-	O
0	O
.	O
04	O
±	O
0	O
.	O
39Z	O
score	O
of	O
Crs	O
-	O
0	O
.	O
03	O
±	O
1	O
.	O
13	O
-	O
0	O
.	O
39	O
±	O
1	O
.	O
08Z	O
score	O
of	O
VmaxFRC0	O
.	O
07	O
±	O
1	O
.	O
01	O
-	O
0	O
.	O
24	O
±	O
1	O
.	O
09	O
BW	O
,	O
body	O
weight	O
;	O
BL	O
,	O
body	O
length	O
;	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
AD	O
,	O
atopic	O
dermatitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
;	O
RTI	O
,	O
respiratory	O
tract	O
infection	O
,	O
Tpef	O
/	O
Te	O
,	O
ratio	O
of	O
time	O
to	O
peak	O
expiratory	O
flow	O
to	O
total	O
expiratory	O
time	O
;	O
Rrs	O
,	O
resistance	O
of	O
respiratory	O
system	O
;	O
Crs	O
,	O
compliance	O
of	O
respiratory	O
system	O
;	O
VmaxFRC	O
,	O
maximal	O
expiratory	O
flow	O
at	O
functional	O
residual	O
capacity	O
.	O

We	O
identified	O
147	O
rodent	O
studies	O
within	O
PubMed	O
(	O
up	O
to	O
7	O
March	O
2016	O
)	O
demonstrating	O
both	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
reduced	O
fertility	O
,	O
reproductive	O
,	O
developmental	O
or	O
other	O
organ	O
-	O
specific	O
abnormalities	O
,	O
or	O
adult	O
onset	O
diseases	O
(	O
cancer	O
,	O
diabetes	O
,	O
obesity	O
or	O
immune	O
disorders	O
))	O
and	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
histone	O
modification	O
,	O
DNA	O
methylation	O
,	O
epigenetic	O
machinery	O
or	O
miRNAs	O
)	O
following	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
chemicals	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
,	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
lactation	O
,	O
childhood	O
,	O
adolescence	O
and	O
adulthood	O
).	O

Other	O
studies	O
,	O
however	O
,	O
found	O
no	O
link	O
between	O
feeding	O
restriction	O
and	O
EAH	O
(	O
54	O
).	O

Methods	O
This	O
work	O
studied	O
the	O
first	O
two	O
generations	O
of	O
offspring	O
(	O
F1	O
and	O
F2	O
)	O
of	O
Swiss	O
mice	O
from	O
mothers	O
fed	O
one	O
of	O
two	O
diets	O
:	O
SC	O
(	O
standard	O
chow	O
)	O
or	O
VitD	O
-	O
(	O
vitamin	O
D	O
-	O
deficient	O
).	O

The	O
castration	O
rate	O
of	O
bulls	O
has	O
been	O
increasing	O
in	O
Korea	O
in	O
the	O
21st	O
century	O
,	O
and	O
it	O
was	O
about	O
95	O
%	O
in	O
2013	O
[	O
59	O
].	O

Our	O
data	O
do	O
have	O
limitations	O
,	O
as	O
they	O
are	O
based	O
on	O
a	O
relatively	O
small	O
-	O
scale	O
cohort	O
with	O
differential	O
response	O
rates	O
at	O
each	O
sweep	O
and	O
the	O
numbers	O
of	O
measured	O
children	O
at	O
age	O
9	O
was	O
considerably	O
lower	O
than	O
in	O
the	O
previous	O
sweeps	O
.	O

We	O
then	O
highlight	O
evidence	O
-	O
based	O
interventions	O
for	O
preterm	O
birth	O
in	O
the	O
context	O
of	O
the	O
wider	O
health	O
system	O
drawing	O
on	O
the	O
other	O
papers	O
in	O
this	O
supplement	O
,	O
and	O
here	O
we	O
focus	O
on	O
the	O
implications	O
for	O
integrating	O
and	O
scaling	O
up	O
those	O
available	O
interventions	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
where	O
the	O
coverage	O
of	O
care	O
is	O
lowest	O
and	O
the	O
potential	O
lives	O
saved	O
as	O
a	O
result	O
.	O

Additionally	O
,	O
using	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
is	O
a	O
better	O
indicator	O
of	O
vitamin	O
D	O
status	O
and	O
statistically	O
more	O
powerful	O
than	O
using	O
reported	O
intake	O
because	O
it	O
accounts	O
for	O
all	O
vitamin	O
D	O
input	O
sources	O
(	O
sun	O
exposure	O
,	O
food	O
,	O
and	O
supplements	O
)	O
and	O
makes	O
provision	O
for	O
inter	O
-	O
individual	O
variability	O
in	O
vitamin	O
D	O
dose	O
response	O
.	O

The	O
purpose	O
of	O
the	O
phase	O
7	O
data	O
collection	O
point	O
specifically	O
is	O
to	O
assess	O
measles	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
as	O
marker	O
of	O
response	O
to	O
immunisation	O
at	O
6	O
months	O
and	O
immune	O
function	O
.	O

Introduction	O
Although	O
,	O
overnutrition	O
is	O
an	O
important	O
life	O
style	O
factor	O
for	O
the	O
development	O
of	O
metabolic	O
syndrome	O
,	O
obesity	O
,	O
cardiovascular	O
disease	O
and	O
diabetes	O
mellitus	O
(	O
Alberti	O
et	O
al	O
.,	O
2009	O
),	O
maternal	O
undernutrition	O
resulting	O
in	O
early	O
life	O
nutritional	O
unbalance	O
can	O
be	O
also	O
related	O
to	O
the	O
onset	O
of	O
long	O
-	O
term	O
metabolic	O
alterations	O
observed	O
later	O
in	O
life	O
.	O

This	O
may	O
decrease	O
digestibility	O
of	O
feed	O
,	O
increase	O
animal	O
feed	O
waste	O
,	O
and	O
eventually	O
raise	O
issues	O
of	O
animal	O
industry	O
sustainability	O
.	O

Materials	O
and	O
Methods	O
Program	O
implementation	O
,	O
compliance	O
and	O
impact	O
assessment	O
In	O
May	O
2006	O
the	O
National	O
Institute	O
of	O
Malariology	O
,	O
Parasitology	O
and	O
Entomology	O
(	O
NIMPE	O
)	O
and	O
partners	O
introduced	O
a	O
pilot	O
program	O
consisting	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
periodic	O
de	O
-	O
worming	O
for	O
women	O
of	O
reproductive	O
age	O
in	O
Yen	O
Bai	O
province	O
.	O

Although	O
we	O
report	O
that	O
the	O
combination	O
of	O
prenatal	O
caloric	O
restriction	O
and	O
postnatal	O
high	O
fat	O
nutrition	O
also	O
advanced	O
the	O
age	O
at	O
puberty	O
,	O
this	O
was	O
not	O
directly	O
linked	O
to	O
body	O
weight	O
at	O
puberty	O
.	O

Risk	O
factors	O
that	O
may	O
exhibit	O
seasonal	O
epidemicity	O
include	O
exposure	O
to	O
infectious	O
agents	O
,	O
allergens	O
,	O
pesticides	O
,	O
indoor	O
environmental	O
tobacco	O
smoke	O
,	O
and	O
other	O
sources	O
of	O
polycyclic	O
aromatic	O
hydrocarbons	O
(	O
e	O
.	O
g	O
.,	O
soot	O
from	O
fires	O
for	O
home	O
heating	O
),	O
and	O
use	O
of	O
antihistamines	O
.	O

[	O
14	O
]	O
assessed	O
vitamin	O
D	O
status	O
in	O
healthy	O
Thai	O
elderly	O
women	O
and	O
found	O
that	O
two	O
-	O
thirds	O
had	O
vitamin	O
D	O
insufficiency	O
and	O
one	O
-	O
third	O
had	O
vitamin	O
D	O
deficiency	O
.	O

The	O
MAS5	O
algorithm	O
was	O
used	O
to	O
skip	O
those	O
transcripts	O
which	O
were	O
expressed	O
in	O
less	O
than	O
50	O
%	O
of	O
the	O
animals	O
within	O
one	O
dietary	O
group	O
per	O
stage	O
.	O

Spearman	O
correlations	O
(	O
ρ	O
)	O
were	O
used	O
to	O
assess	O
the	O
association	O
between	O
each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
the	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
obtained	O
at	O
various	O
time	O
points	O
:	O
(	O
1	O
)	O
at	O
the	O
corresponding	O
follow	O
-	O
up	O
visit	O
;	O
(	O
2	O
)	O
at	O
delivery	O
;	O
(	O
3	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
(	O
using	O
the	O
area	O
under	O
the	O
curve	O
from	O
visit	O
3	O
to	O
visit	O
7	O
);	O
and	O
(	O
4	O
)	O
maternal	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
within	O
one	O
month	O
of	O
delivery	O
.	O

BAT	O
consists	O
in	O
brown	O
adipocytes	O
,	O
characterized	O
by	O
multiple	O
,	O
small	O
,	O
multilocular	O
lipid	O
droplets	O
with	O
a	O
central	O
nucleus	O
and	O
a	O
high	O
number	O
of	O
mitochondria	O
.	O

The	O
study	O
was	O
conducted	O
with	O
steer	O
of	O
three	O
genotypes	O
(	O
Angus	O
,	O
Hereford	O
and	O
Wagyu	O
×	O
Angus	O
):	O
Angus	O
was	O
targeting	O
high	O
IMF	O
and	O
high	O
subcutaneous	O
fat	O
,	O
Hereford	O
was	O
targeting	O
low	O
IMF	O
and	O
high	O
subcutaneous	O
fat	O
,	O
and	O
Wagyu	O
sires	O
Angus	O
dams	O
were	O
targeting	O
high	O
IMF	O
and	O
lower	O
subcutaneous	O
fat	O
.	O

Authors	O
’	O
contributions	O
RS	O
:	O
Conception	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
,	O
drafting	O
of	O
article	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

Multivariate	O
linear	O
regression	O
was	O
then	O
used	O
to	O
adjust	O
for	O
relevant	O
confounders	O
.	O

Unadjusted	O
odds	O
ratios	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
were	O
also	O
calculated	O
.	O

We	O
also	O
found	O
that	O
lower	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
related	O
to	O
pregnancy	O
loss	O
.	O

Previous	O
interventions	O
to	O
promote	O
reproductive	O
health	O
care	O
utilization	O
among	O
low	O
-	O
and	O
middle	O
-	O
income	O
women	O
suggested	O
an	O
approximate	O
12	O
%	O
effect	O
(	O
intervention	O
vs	O
control	O
)	O
of	O
such	O
programs	O
after	O
a	O
12	O
-	O
month	O
time	O
period	O
[	O
38	O
].	O

We	O
will	O
also	O
collect	O
information	O
on	O
exposure	O
to	O
household	O
air	O
pollution	O
and	O
out	O
of	O
pocket	O
expenses	O
for	O
any	O
antenatal	O
and	O
postnatal	O
care	O
seeking	O
(	O
Table1	O
).	O

Several	O
studies	O
have	O
revealed	O
that	O
vitamin	O
D	O
supplementation	O
can	O
raise	O
vitamin	O
D	O
reserves	O
gradually	O
,	O
according	O
to	O
baseline	O
concentration	O
of	O
vitamin	O
D	O
,	O
dose	O
and	O
duration	O
of	O
consumption	O
[	O
16	O
–	O
18	O
].	O

The	O
patients	O
’	O
weights	O
were	O
measured	O
by	O
Seca	O
scale	O
with	O
0	O
.	O
1	O
kg	O
accuracy	O
.	O

Some	O
epidemiological	O
evidence	O
suggests	O
that	O
children	O
who	O
are	O
breastfed	O
exclusively	O
during	O
the	O
first	O
several	O
months	O
tend	O
to	O
have	O
higher	O
IQs	O
than	O
those	O
fed	O
formula	O
or	O
a	O
combination	O
of	O
formula	O
and	O
breast	O
milk	O
.	O
39However	O
,	O
there	O
is	O
some	O
debate	O
as	O
to	O
whether	O
breastfeeding	O
actually	O
makes	O
children	O
more	O
intelligent	O
or	O
whether	O
associations	O
between	O
breastfeeding	O
and	O
IQ	O
could	O
be	O
due	O
largely	O
to	O
parents	O
’	O
intelligence	O
.	O
40Some	O
studies	O
also	O
suggest	O
that	O
breastfed	O
babies	O
have	O
a	O
lower	O
risk	O
of	O
obesity	O
,	O
asthma	O
,	O
and	O
other	O
allergies	O
.	O
41	O
But	O
despite	O
the	O
body	O
of	O
evidence	O
in	O
humans	O
and	O
animals	O
suggesting	O
that	O
ubiquitous	O
environmental	O
exposures	O
may	O
interfere	O
with	O
this	O
highly	O
beneficial	O
process	O
,	O
opportunities	O
to	O
further	O
probe	O
these	O
associations	O
remain	O
spotty	O
at	O
best	O
,	O
say	O
many	O
of	O
the	O
researchers	O
interviewed	O
for	O
this	O
article	O
.	O

However	O
an	O
analysis	O
of	O
the	O
effects	O
of	O
supplementation	O
on	O
broader	O
micronutrient	O
status	O
in	O
this	O
population	O
would	O
have	O
been	O
of	O
interest	O
and	O
is	O
a	O
specified	O
outcome	O
in	O
the	O
main	O
trial	O
,	O
which	O
will	O
be	O
reported	O
elsewhere	O
.	O

However	O
,	O
it	O
will	O
be	O
increasingly	O
important	O
to	O
examine	O
,	O
in	O
larger	O
studies	O
,	O
how	B
additional	O
specific	O
exposures	O
,	O
such	O
as	O
lead	O
as	O
has	O
been	O
done	O
by	O
previous	O
researchers	O
(	O
Pilsner	O
et	O
al	O
.	O

Dietary	O
data	O
was	O
collected	O
using	O
a	O
validated	O
semiquantitative	O
food	O
frequency	O
questionnaire	O
.	O

Caregivers	O
completed	O
a	O
questionnaire	O
administered	O
by	O
staff	O
which	O
collected	O
information	O
about	O
the	O
child	O
and	O
caregiver	O
,	O
dietary	O
intakes	O
,	O
use	O
of	O
supplements	O
,	O
sun	O
exposure	O
and	O
skin	O
pigmentation	O
,	O
oral	O
hygiene	O
behaviours	O
,	O
and	O
socioeconomic	O
factors	O
including	O
household	O
income	O
,	O
parental	O
education	O
level	O
,	O
and	O
receipt	O
of	O
government	O
assistance	O
[	O
12	O
].	O

Conclusion	O
Black	O
obese	O
mothers	O
on	O
Medicaid	O
without	O
prenatal	O
vitamin	O
use	O
were	O
at	O
the	O
highest	O
risk	O
of	O
delivering	O
neonates	O
with	O
vitamin	O
D	O
deficiency	O
.	O

Limitations	O
of	O
this	O
study	O
include	O
the	O
cohort	O
size	O
and	O
an	O
unequal	O
distribution	O
of	O
subjects	O
within	O
age	O
groups	O
.	O

The	O
means	O
at	O
each	O
time	O
point	O
and	O
for	O
hypothalamic	O
gene	O
expression	O
,	O
folate	O
status	O
and	O
glucose	O
response	O
were	O
compared	O
by	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
using	O
the	O
PROC	O
GLM	O
followed	O
by	O
a	O
Tukey	O
’	O
s	O
post	O
-	O
hoc	O
test	O
.	O

[	O
2	O
].	O

Under	O
this	O
condition	O
,	O
FGF21	O
expression	O
was	O
indeed	O
decreased	O
in	O
the	O
liver	O
,	O
but	O
enhanced	O
in	O
BAT	O
,	O
as	O
well	O
as	O
in	O
WAT	O
,	O
where	O
it	O
acted	O
to	O
markedly	O
increase	O
UCP1	O
expression	O
and	O
the	O
“	O
browning	O
”	O
of	O
subcutaneous	O
tissue	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

CMH	O
was	O
responsible	O
for	O
the	O
questions	O
on	O
positive	O
psychotic	O
-	O
like	O
symptom	O
,	O
funding	O
and	O
the	O
initial	O
idea	O
in	O
collaboration	O
with	O
MH	O
.	O

Conclusions	O
Iron	O
deficiency	O
remains	O
the	O
most	O
important	O
cause	O
of	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

This	O
study	O
is	O
registered	O
withClinicalTrials	O
.	O
gov	O
,	O
numberNCT00548379	O
.	O

The	O
lower	O
SEI	O
of	O
the	O
Adelaide	O
women	O
could	O
therefore	O
make	O
them	O
more	O
susceptible	O
to	O
lower	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
because	O
of	O
factors	O
relating	O
to	O
disadvantage	O
.	O

Therefore	O
,	O
it	O
is	O
justifiable	O
that	O
in	O
our	O
study	O
,	O
vitamin	O
D	O
group	O
had	O
lower	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
compared	O
to	O
those	O
were	O
in	O
the	O
study	O
by	O
Taheri	O
et	O
al	O
.	O

purports	O
that	O
labor	O
duration	O
of	O
less	O
than	O
1	O
hour	O
carries	O
an	O
increased	O
risk	O
of	O
developing	O
ASD	O
[	O
8	O
].	O

Reducing	O
anaemia	O
rates	O
by	O
18	O
.	O
2	O
%	O
for	O
women	O
of	O
reproductive	O
age	O
therefore	O
constitutes	O
a	O
6	O
.	O
7	O
%	O
reduction	O
in	O
anaemia	O
on	O
average	O
in	O
the	O
labour	O
force	O
(	O
using	O
the	O
proportion	O
of	O
women	O
of	O
reproductive	O
age	O
in	O
the	O
overall	O
labour	O
force	O
in	O
Vietnam	O
:	O
women	O
'	O
s	O
labour	O
force	O
participation	O
rate	O
is	O
similar	O
to	O
men	O
'	O
s	O
).	O

In	O
an	O
uncontrolled	O
trial	O
,	O
supplementation	O
with	O
a	O
multivitamin	O
/	O
mineral	O
supplement	O
and	O
halibut	O
liver	O
oil	O
(	O
containing	O
900	O
IU	O
/	O
d	O
vitamin	O
D	O
)	O
provided	O
at	O
20	O
wk	O
gestation	O
reduced	O
the	O
odds	O
of	O
preeclampsia	O
by	O
32	O
%	O
(	O
95	O
%	O
CI	O
,	O
11	O
-	O
47	O
%).	O

Furthermore	O
,	O
there	O
are	O
new	O
therapeutic	O
approaches	O
under	O
validation	O
for	O
advanced	O
or	O
recurrent	O
disease46	O
-	O
48	O
.	O

The	O
MiG	O
Study	O
randomized	O
751	O
women	O
with	O
GDM	O
to	O
treatment	O
with	O
insulin	O
or	O
metformin	O
.	O
72The	O
women	O
in	O
the	O
metformin	O
arm	O
were	O
treated	O
with	O
supplemental	O
insulin	O
if	O
the	O
maximal	O
dose	O
of	O
metformin	O
,	O
2500	O
mg	O
daily	O
,	O
failed	O
to	O
meet	O
the	O
glucose	O
targets	O
.	O

However	O
,	O
no	O
differences	O
were	O
found	O
in	O
the	O
incidence	O
of	O
wheeze	O
and	O
eczema	O
or	O
the	O
rate	O
of	O
nasopharyngeal	O
bacterial	O
colonization	O
between	O
the	O
groups	O
with	O
high	O
and	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
of	O
mother	O
—	O
cord	O
serum	O
pairs	O
.	O

PubMed	O
Central	O
:	O

To	O
get	O
access	O
to	O
the	O
workers	O
,	O
the	O
researchers	O
had	O
to	O
strike	O
a	O
Faustian	O
bargain	O
with	O
the	O
mining	O
companies	O
:	O
They	O
could	O
not	O
inform	O
the	O
miners	O
of	O
the	O
potential	O
health	O
hazards	O
of	O
their	O
work	O
.	O
2Seeing	O
it	O
as	O
the	O
only	O
way	O
to	O
convince	O
government	O
regulators	O
to	O
improve	O
safety	O
in	O
the	O
mines	O
,	O
the	O
researchers	O
accepted	O
.	O
16By	O
1965	O
,	O
the	O
investigators	O
reported	O
an	O
association	O
between	O
cumulative	O
exposure	O
to	O
uranium	O
and	O
lung	O
cancer	O
among	O
white	O
miners	O
and	O
had	O
definitively	O
identified	O
the	O
cause	O
as	O
radiation	O
exposure	O
.	O
17	O
In	O
1984	O
another	O
team	O
published	O
results	O
of	O
a	O
case	O
–	O
control	O
study	O
that	O
further	O
implicated	O
uranium	O
mining	O
as	O
a	O
cause	O
of	O
lung	O
cancer	O
in	O
Navajo	O
men	O
.	O

Oka	O
[	O
134	O
]	O
recommended	O
that	O
vitamin	O
A	O
-	O
deficient	O
levels	O
not	O
fall	O
below	O
30	O
IU	O
/	O
dL	O
to	O
enhance	O
MS	O
and	O
maintain	O
health	O
.	O

Homes	O
with	O
high	O
pet	O
activities	O
have	O
been	O
shown	O
to	O
have	O
greater	O
levels	O
of	O
pesticide	O
residues	O
in	O
sampled	O
carpet	O
dust	O
than	O
homes	O
with	O
low	O
pet	O
activities	O
[	O
31	O
,	O
32	O
].	O

However	O
,	O
literature	O
has	O
presented	O
different	O
views	O
on	O
iron	O
requirements	O
during	O
pregnancy	O
ranging	O
from	O
450	O
to	O
1	O
,	O
150	O
mg	O
with	O
a	O
median	O
of	O
790	O
mg	O
[	O
14	O
,	O
19	O
–	O
21	O
].	O

The	O
study	O
was	O
approved	O
by	O
the	O
Institutional	O
Review	O
Boards	O
at	O
the	O
Miriam	O
Hospital	O
,	O
in	O
Providence	O
,	O
RI	O
.,	O
Women	O
and	O
Infants	O
Hospital	O
of	O
Rhode	O
Island	O
Providence	O
,	O
RI	O
and	O
California	O
Polytechnic	O
State	O
University	O
,	O
in	O
San	O
Luis	O
Obispo	O
,	O
Calif	O
.	O
2	O
.	O
2	O
.	O

A	O
plot	O
of	O
gestational	O
age	O
at	O
birth	O
as	O
a	O
function	O
of	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
with	O
the	O
fitted	O
LOESS	O
curve	O
for	O
women	O
with	O
a	O
history	O
of	O
PTB	O
is	O
shown	O
inFig	O
3	O
.	O

Also	O
,	O
future	O
adequately	O
powered	O
randomized	O
clinical	O
trials	O
are	O
needed	O
to	O
determine	O
whether	O
modifying	O
maternal	O
prenatal	O
behaviors	O
and	O
GWG	O
can	O
prevent	O
offspring	O
obesity	O
.	O

One	O
earlier	O
study	O
,	O
from	O
Denmark	O
,	O
found	O
that	O
lower	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
associated	O
with	O
pregnancy	O
loss	O
in	O
the	O
first	O
trimester	O
[	O
24	O
].	O

One	O
trial	O
in	O
schoolchildren28	O
(	O
measuring	O
influenza	O
A	O
antigen	O
from	O
swabs	O
)	O
found	O
a	O
statistically	O
significant	O
reduced	O
incidence	O
in	O
the	O
intervention	O
group	O
(	O
RR	O
0	O
·	O
58	O
,	O
95	O
%	O
CI	O
0	O
·	O
34	O
–	O
0	O
·	O
99	O
).	O

Experiments	O
with	O
animals	O
models	O
have	O
succeeded	O
in	O
simulate	O
metabolic	O
alterations	O
of	O
undernutrition	O
during	O
gestational	O
periods	O
in	O
humans	O
,	O
particularly	O
by	O
the	O
implementation	O
of	O
a	O
moderate	O
or	O
severe	O
calorie	O
restricted	O
diets	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
García	O
et	O
al	O
.,	O
2010	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

,	O
39who	O
found	O
that	O
lack	O
of	O
prenatal	O
vitamin	O
use	O
was	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
in	O
white	O
but	O
not	O
black	O
women	O
.	O

Materials	O
and	O
methods	O
The	O
planned	O
implementation	O
consisted	O
of	O
a	O
9	O
-	O
month	O
pre	O
(	O
usual	O
care	O
)/	O
post	O
(	O
new	O
model	O
of	O
care	O
)	O
design	O
with	O
a	O
month	O
for	O
‘	O
integration	O
’	O
across	O
2012	O
-	O
2013	O
.	O

Currently	O
,	O
researchers	O
are	O
attempting	O
to	O
reveal	O
the	O
non	O
-	O
classical	O
influence	O
of	O
cholecalciferol	O
on	O
health	O
.	O

It	O
was	O
concluded	O
that	O
although	O
autism	O
is	O
unlikely	O
to	O
be	O
caused	O
by	O
a	O
single	O
obstetric	O
factor	O
,	O
there	O
was	O
an	O
increased	O
prevalence	O
of	O
obstetric	O
complications	O
among	O
autism	O
cases	O
that	O
is	O
most	O
likely	O
due	O
to	O
underlying	O
genetic	O
factors	O
and	O
an	O
interaction	O
of	O
these	O
factors	O
with	O
the	O
environment	O
[	O
8	O
].	O

There	O
is	O
also	O
evidence	O
that	O
PFOA	O
can	O
alter	O
the	O
expression	O
of	O
milk	O
protein	O
genes	O
,	O
which	O
are	O
important	O
for	O
the	O
production	O
of	O
milk	O
.	O
26Fenton	O
further	O
notes	O
that	O
PFASs	O
are	O
only	O
one	O
class	O
of	O
environmental	O
chemicals	O
that	O
may	O
cause	O
concern	O
for	O
lactation	O
.	O
28	O
Poor	O
maternal	O
metabolic	O
health	O
may	O
be	O
another	O
factor	O
that	O
hampers	O
lactation	O
.	O

But	O
neither	O
body	O
weight	O
at	O
weaning	O
nor	O
body	O
weight	O
at	O
188	O
dpn	O
differed	O
significantly	O
among	O
offspring	O
of	O
the	O
LP	O
and	O
the	O
AP	O
group	O
,	O
whereas	O
visceral	O
and	O
subcutaneous	O
fat	O
content	O
remained	O
higher	O
in	O
LP	O
than	O
in	O
AP	O
during	O
postnatal	O
life	O
[	O
15	O
-	O
17	O
].	O

In	O
pooled	O
data	O
of	O
different	O
sexes	O
(	O
cows	O
,	O
bulls	O
,	O
and	O
steers	O
)	O
of	O
Korean	O
cattle	O
,	O
MS	O
and	O
LM	O
area	O
increased	O
with	O
increasing	O
carcass	O
weight	O
from	O
143	O
to	O
536	O
kg	O
[	O
39	O
].	O

Delivery	O
and	O
neonatal	O
outcomes	O
All	O
instrumental	O
deliveries	O
were	O
performed	O
in	O
the	O
polytherapy	O
-	O
exposed	O
group	O
(	O
12	O
.	O
3	O
%	O
vs	O
0	O
%).	O

For	O
missing	O
data	O
and	O
attrition	O
of	O
participants	O
,	O
a	O
t	O
test	O
was	O
used	O
to	O
compare	O
covariates	O
,	O
including	O
sociodemographic	O
and	O
other	O
variables	O
used	O
in	O
the	O
regressions	O
,	O
between	O
cases	O
with	O
and	O
without	O
missing	O
data	O
to	O
verify	O
whether	O
or	O
not	O
data	O
were	O
missing	O
completely	O
at	O
random	O
.	O

Maternal	O
attitudes	O
were	O
related	O
to	O
self	O
-	O
reported	O
stress	O
status	O
ranging	O
from	O
low	O
and	O
medium	O
(	O
low	O
stress	O
response	O
)	O
to	O
high	O
and	O
very	O
high	O
(	O
high	O
stress	O
response	O
).	O

Therefore	O
,	O
we	O
hypothesized	O
that	O
the	O
effects	O
of	O
HV	O
gestational	O
diets	O
on	O
obesogenic	O
phenotype	O
in	O
the	O
offspring	O
arise	O
as	O
a	O
consequence	O
of	O
altered	O
hypothalamic	O
control	O
of	O
feeding	O
behavior	O
and	O
these	O
effects	O
could	O
be	O
prevented	O
by	O
feeding	O
them	O
HV	O
or	O
HFol	O
diets	O
.	O

All	O
participants	O
’	O
records	O
and	O
clinical	O
information	O
were	O
anonymized	O
and	O
deidentified	O
before	O
analysis	O
.	O

Once	O
again	O
some	O
of	O
the	O
most	O
active	O
TEs	O
also	O
escape	O
this	O
second	O
phase	O
of	O
epigenetic	O
re	O
-	O
programing	O
,	O
thereby	O
maintaining	O
genome	O
stability	O
.	O

2007	O
).	O

In	O
calorie	O
restricted	O
offspring	O
(	O
UNP	O
,	O
UNL	O
,	O
UNPL	O
),	O
a	O
post	O
-	O
weaning	O
HF	O
diet	O
further	O
advanced	O
the	O
age	O
at	O
puberty	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
Figure	O
2B	O
,	O
C	O
,	O
D	O
;	O
Table	O
1	O
)	O
compared	O
to	O
those	O
offspring	O
who	O
were	O
normally	O
nourished	O
in	O
utero	O
and	O
fed	O
a	O
HF	O
diet	O
post	O
-	O
weaning	O
(	O
Table	O
1	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Percentage	O
of	O
offspring	O
entering	O
puberty	O
over	O
time	O
in	O
animals	O
whose	O
dams	O
received	O
50	O
%	O
of	O
normal	O
nutrition	O
.	O

Mitotic	O
roles	O
of	O
PLK	O
,	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
,	O
G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulation	O
).	O

When	O
a	O
simple	O
increase	O
in	O
serum	O
Htg	O
levels	O
is	O
observed	O
,	O
further	O
therapy	O
is	O
not	O
necessary	O
.	O

Mean	O
early	O
pregnancy	O
25OHD	O
versus	O
month	O
of	O
first	O
antenatal	O
visit	O
is	O
displayed	O
in	O
Additional	O
file1	O
:	O
Fig	O
.	O

Sensible	O
sun	O
exposure	O
and	O
education	O
of	O
the	O
public	O
about	O
the	O
beneficial	O
effects	O
of	O
some	O
limited	O
sun	O
exposure	O
to	O
satisfy	O
their	O
body	O
'	O
s	O
vitamin	O
D	O
requirements	O
should	O
be	O
implemented	O
.	O

There	O
was	O
a	O
65	O
%	O
lower	O
risk	O
of	O
PTB	O
among	O
white	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
<	O
20	O
ng	O
/	O
mL	O
(	O
OR	O
=	O
0	O
.	O
35	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
13	O
–	O
0	O
.	O
92	O
,	O
p	O
=	O
0	O
.	O
03	O
;	O
AAR	O
=	O
13	O
.	O
8	O
%;	O
NNT	O
=	O
7	O
)	O
and	O
a	O
68	O
%	O
lower	O
risk	O
among	O
non	O
-	O
white	O
women	O
(	O
OR	O
=	O
0	O
.	O
32	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
14	O
–	O
0	O
.	O
74	O
,	O
p	O
=	O
0	O
.	O
008	O
;	O
AAR	O
=	O
11	O
.	O
7	O
%;	O
NNT	O
=	O
9	O
).	O

However	O
,	O
it	O
may	O
not	O
be	O
the	O
absolute	O
content	O
but	O
the	O
ratio	O
of	O
n	O
-	O
6	O
to	O
n	O
-	O
3	O
PUFAs	O
that	O
may	O
influence	O
the	O
development	O
of	O
either	O
tolerance	O
or	O
sensitization	O
to	O
food	O
,	O
as	O
a	O
high	O
ratio	O
of	O
9	O
of	O
n	O
-	O
6	O
/	O
n	O
-	O
3	O
in	O
the	O
diet	O
of	O
the	O
mother	O
prevented	O
the	O
induction	O
of	O
oral	O
tolerance	O
to	O
ovalbumin	O
in	O
the	O
offspring	O
in	O
a	O
rat	O
study	O
[	O
81	O
].	O

Inform	O
•	O
Use	O
and	O
strengthen	O
existing	O
tracking	O
systems	O
for	O
commodities	O
and	O
devices	O
to	O
improve	O
supply	O
chain	O
logistics	O
.	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
any	O
of	O
the	O
baseline	O
characteristics	O
between	O
the	O
groups	O
(	O
table	O
1	O
),	O
including	O
reported	O
sun	O
exposure	O
.	O

Maternal	O
pregnancy	O
-	O
specific	O
stress	O
may	O
be	O
a	O
more	O
powerful	O
contributor	O
to	O
birth	O
outcomes	O
than	O
general	O
stress	O
[	O
1	O
].	O

In	O
preliminary	O
analyses	O
of	O
all	O
infants	O
,	O
delivery	O
mode	O
,	O
feeding	O
method	O
,	O
as	O
previously	O
shown	O
in	O
our	O
cohort	O
[	O
24	O
],	O
and	O
parity	O
were	O
significantly	O
related	O
to	O
infant	O
stool	O
microbial	O
community	O
composition	O
at	O
6	O
weeks	O
of	O
age	O
.	O

The	O
intake	O
of	O
fatty	O
acids	O
and	O
vitamin	O
D	O
was	O
categorized	O
into	O
quartiles	O
,	O
with	O
the	O
lowest	O
quartile	O
as	O
the	O
reference	O
category	O
for	O
comparison	O
.	O

There	O
was	O
no	O
effect	O
of	O
the	O
gestational	O
or	O
pup	O
diets	O
on	O
hypothalamic	O
expression	O
of	O
other	O
genes	O
.	O

The	O
diagnosis	O
and	O
treatment	O
of	O
drug	O
allergy	O
are	O
the	O
same	O
in	O
pregnant	O
as	O
in	O
nonpregnant	O
patients	O
.	O

A	O
significant	O
interaction	O
was	O
detected	O
between	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
genotype	O
and	O
vitamin	O
A	O
supplementation	O
for	O
IMF	O
content	O
in	O
the	O
LM	O
.	O

The	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
of	O
the	O
71	O
infants	O
who	O
successfully	O
underwent	O
later	O
infant	O
lung	O
function	O
testing	O
was	O
13	O
.	O
8	O
±	O
6	O
.	O
3	O
ng	O
/	O
ml	O
,	O
and	O
that	O
of	O
their	O
mothers	O
was	O
15	O
.	O
0	O
±	O
6	O
.	O
1	O
ng	O
/	O
ml	O
,	O
which	O
were	O
also	O
significantly	O
correlated	O
(	O
r2	O
=	O
0	O
.	O
468	O
,	O
p	O
<	O
0	O
.	O
0001	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0173268	O
.	O
g002	O
Caption	O
(	O
FIG	O
):	O
FIG	O
2	O
Correlation	O
between	O
maternal	O
and	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

The	O
criteria	O
described	O
by	O
Vickers	O
were	O
adopted	O
to	O
refer	O
to	O
different	O
stages	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
).	O

Height	O
and	O
weight	O
were	O
collected	O
in	O
participants	O
either	O
through	O
self	O
-	O
report	O
or	O
measurement	O
at	O
various	O
sweeps	O
(	O
seetable	O
1	O
).	O

Of	O
current	O
concern	O
in	O
developed	O
countries	O
are	O
the	O
rising	O
rates	O
of	O
obesity	O
[	O
30	O
]	O
and	O
gestational	O
diabetes	O
,	O
both	O
of	O
which	O
produce	O
offspring	O
who	O
develop	O
obesity	O
[	O
31	O
]–[	O
35	O
].	O

Recent	O
studies	O
of	O
the	O
text4baby	O
program	O
have	O
found	O
that	O
it	O
changes	O
attitudes	O
and	O
beliefs	O
,	O
but	O
effects	O
on	O
behavior	O
have	O
not	O
previously	O
been	O
established	O
[	O
23	O
,	O
26	O
].	O

Purebred	O
Japanese	O
Black	O
cattle	O
show	O
a	O
linear	O
increase	O
in	O
IMF	O
content	O
with	O
increasing	O
slaughter	O
age	O
from	O
16	O
.	O
7	O
months	O
(	O
500	O
d	O
)	O
to	O
over	O
33	O
.	O
3	O
months	O
(	O
1	O
,	O
000	O
d	O
)	O
[	O
66	O
].	O

Renin	O
expression	O
was	O
significantly	O
higher	O
at	O
6	O
months	O
of	O
age	O
than	O
at	O
weaning	O
in	O
both	O
the	O
F1	O
and	O
F2	O
VitD	O
-	O
offspring	O
(	O
P	O
=	O
0	O
.	O
0003	O
,	O
Fig	O
.	O

Abbreviations	O
CI	O
:	O
Confidence	O
intervals	O
;	O
dmft	O
:	O
decayed	O
,	O
missing	O
,	O
filled	O
teeth	O
;	O
ECC	O
:	O
Early	O
childhood	O
caries	O
;	O
GA	O
:	O
General	O
anesthesia	O
;	O
HSC	O
:	O
Health	O
sciences	O
centre	O
;	O
IOM	O
:	O
Institute	O
of	O
medicine	O
;	O
MHC	O
:	O
Misericordia	O
health	O
centre	O
;	O
OR	O
:	O
Odds	O
ratio	O
;	O
PTH	O
:	O
Parathyroid	O
hormone	O
;	O
SD	O
:	O
Standard	O
deviation	O
;	O
S	O
-	O
ECC	O
:	O
Severe	O
early	O
childhood	O
caries	O
.	O

Neither	O
trial	O
utilised	O
a	O
placebo	O
-	O
controlled	O
design	O
,	O
limiting	O
the	O
interpretation	O
of	O
the	O
study	O
results	O
.	O

The	O
large	O
number	O
of	O
23	O
PCBs	O
examined	O
in	O
this	O
study	O
meant	O
that	O
the	O
BHLM	O
performed	O
more	O
aggressive	O
shrinkage	O
on	O
the	O
model	O
regression	O
coefficients	O
for	O
this	O
class	O
.	O

Our	O
findings	O
report	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
impact	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
for	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
on	O
early	O
infant	O
neurodevelopment	O
.	O

There	O
was	O
a	O
further	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
reduction	O
in	O
birth	O
weight	O
of	O
female	O
offspring	O
born	O
to	O
PLHF	O
dams	O
compared	O
to	O
MHF	O
and	O
Cont	O
offspring	O
.	O

Similarly	O
,	O
as	O
the	O
percentage	O
of	O
calories	O
from	O
fat	O
and	O
carbohydrates	O
was	O
highly	O
correlated	O
(	O
r	O
=	O
−.	O
90	O
;	O
P	O
=	O
.	O
0001	O
),	O
only	O
the	O
percentage	O
of	O
calories	O
from	O
fat	O
was	O
used	O
in	O
initial	O
modeling	O
.	O

Traditionally	O
,	O
and	O
in	O
may	O
regions	O
of	O
the	O
world	O
today	O
,	O
seasonal	O
availability	O
of	O
food	O
determines	O
dietary	O
intakes	O
.	O

This	O
data	O
-	O
driven	O
clustering	O
allowed	O
us	O
to	O
define	O
stable	O
classes	O
of	O
CpG	O
loci	O
demonstrating	O
similar	O
patterns	O
of	O
methylation	O
,	O
which	O
we	O
used	O
to	O
examine	O
associations	O
between	O
methylation	O
of	O
these	O
classes	O
of	O
CpGs	O
and	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
.	O

It	O
is	O
noteworthy	O
that	O
there	O
are	O
few	O
studies	O
assessing	O
the	O
birth	O
anthropometric	O
measurements	O
along	O
the	O
maternal	O
dietary	O
patterns	O
[	O
16	O
].	O

This	O
statistical	O
pooling	O
of	O
several	O
studies	O
,	O
taking	O
into	O
account	O
the	O
size	O
of	O
individual	O
studies	O
,	O
confers	O
more	O
power	O
to	O
detect	O
a	O
potential	O
association	O
,	O
and	O
quantitative	O
meta	O
-	O
analyses	O
are	O
often	O
put	O
at	O
the	O
top	O
of	O
evidence	O
hierarchies	O
.	O

Conclusion	O
:	O
Maternal	O
serum	O
visfatin	O
level	O
shows	O
a	O
relationship	O
with	O
fetal	O
and	O
infant	O
anthropometric	O
indicators	O
,	O
with	O
different	O
effects	O
in	O
the	O
two	O
groups	O
,	O
suggesting	O
visfatin	O
dysfunction	O
in	O
the	O
overweight	O
group	O
before	O
pregnancy	O
.	O

The	O
mean	O
GD	O
was	O
7	O
%	O
smaller	O
(	O
81	O
.	O
0	O
±	O
0	O
.	O
6	O
µm	O
)	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1	O
-	O
SC	O
mice	O
(	O
87	O
.	O
2	O
±	O
0	O
.	O
6	O
µm	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

Data	O
are	O
collected	O
on	O
dual	O
core	O
electronic	O
archives	O
with	O
automatic	O
backup	O
.	O

We	O
are	O
therefore	O
grateful	O
for	O
Prasad	O
’	O
s	O
insights	O
.	O

The	O
cost	O
per	O
woman	O
treated	O
(	O
defined	O
as	O
consuming	O
at	O
least	O
75	O
%	O
of	O
the	O
recommended	O
intake	O
)	O
was	O
USD0	O
.	O
76	O
per	O
annum	O
.	O

In	O
contrast	O
to	O
the	O
above	O
-	O
mentioned	O
studies	O
,	O
our	O
results	O
show	O
that	O
the	O
combination	O
of	O
black	O
race	O
and	O
vitamin	O
D	O
deficiency	O
was	O
associated	O
with	O
increased	O
odds	O
of	O
SGA	O
,	O
but	O
this	O
relationship	O
was	O
not	O
preserved	O
for	O
white	O
infants	O
.	O

Red	O
and	O
processed	O
meat	O
intake	O
is	O
considered	O
less	O
healthful	O
,	O
and	O
consumption	O
below	O
the	O
median	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

There	O
may	O
be	O
a	O
postnatal	O
override	O
such	O
that	O
if	O
energetics	O
remain	O
poor	O
during	O
postnatal	O
life	O
,	O
reproductive	O
maturation	O
may	O
be	O
delayed	O
until	O
the	O
nutritional	O
environment	O
is	O
improved	O
sufficiently	O
to	O
support	O
a	O
first	O
pregnancy	O
.	O

Pups	O
were	O
sexed	O
by	O
measuring	O
the	O
anogenital	O
distance	O
,	O
which	O
is	O
sexually	O
dimorphic	O
in	O
mice	O
(	O
the	O
male	O
'	O
s	O
anogenital	O
distance	O
is	O
approximately	O
twice	O
as	O
long	O
as	O
the	O
female	O
'	O
s	O
)[	O
15	O
].	O

In	O
another	O
study	O
,	O
Graugnard	O
et	O
al	O
[	O
56	O
]	O
reported	O
that	O
a	O
high	O
-	O
starch	O
diet	O
induced	O
precocious	O
upregulation	O
of	O
the	O
adipogenic	O
gene	O
network	O
in	O
the	O
longissimus	O
lumborum	O
of	O
early	O
-	O
weaned	O
(	O
average	O
155	O
d	O
)	O
Angus	O
cattle	O
.	O

However	O
,	O
in	O
that	O
study	O
neurodevelopment	O
was	O
assessed	O
when	O
the	O
infant	O
was	O
only	O
three	O
days	O
old	O
.	O

However	O
,	O
the	O
potential	O
side	O
effects	O
of	O
any	O
drug	O
must	O
be	O
balanced	O
against	O
the	O
risks	O
of	O
the	O
mother	O
or	O
the	O
infant	O
having	O
inadequately	O
treated	O
disease	O
.	O

Based	O
on	O
maternal	O
colostrum	O
visfatin	O
levels	O
,	O
the	O
aurors	O
were	O
able	O
to	O
predict	O
neonatal	O
weight	O
loss	O
in	O
the	O
first	O
three	O
days	O
of	O
birth	O
(	O
25	O
,	O
26	O
).	O

Based	O
on	O
1000	O
simulations	O
when	O
requirement	O
one	O
-	O
to	O
-	O
two	O
vaccinated	O
-	O
to	O
-	O
unvaccinated	O
proportion	O
for	O
good	O
propensity	O
score	O
matching	O
was	O
not	O
met	O
;	O
point	O
estimate	O
and	O
lower	O
and	O
upper	O
confidence	O
interval	O
represent	O
50th	O
,	O
25th	O
and	O
97	O
.	O
5th	O
percentiles	O
of	O
point	O
estimates	O
(	O
n	O
=	O
1000	O
),	O
respectively	O
.	O

Associations	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
We	O
separately	O
assessed	O
the	O
relation	O
of	O
maternal	O
diet	O
with	O
the	O
infant	O
gut	O
microbiome	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
n	O
=	O
48	O
).	O

Linear	O
models	O
indicated	O
a	O
positive	O
association	O
of	O
maternal	O
dairy	O
intake	O
with	O
OTUs	O
classified	O
to	O
the	O
family	O
Enterobacteriaceae	O
and	O
the	O
species	O
Escherichia	O
coli	O
and	O
negative	O
association	O
with	O
the	O
OTUs	O
that	O
belong	O
to	O
the	O
genera	O
Bifidobacterium	O
,	O
Pseudomonas	O
,	O
and	O
Bacteroides	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S5b	O
).	O

Environmental	O
factors	O
and	O
epigenetic	O
perturbation	O
Epigenetic	O
processes	O
are	O
susceptible	O
to	O
perturbation	O
throughout	O
an	O
individual	O
’	O
s	O
life	O
(	O
Figure	O
1	O
).	O

We	O
were	O
unable	O
to	O
assess	O
associations	O
with	O
maternal	O
sugar	O
intake	O
in	O
early	O
pregnancy	O
;	O
however	O
,	O
intakes	O
in	O
early	O
and	O
late	O
pregnancy	O
are	O
likely	O
to	O
be	O
highly	O
correlated	O
.	O

A	O
study	O
examined	O
the	O
incidence	O
of	O
autism	O
in	O
the	O
neonatal	O
intensive	O
care	O
unit	O
and	O
risk	O
factors	O
connected	O
with	O
autistic	O
development	O
.	O

Infections	O
in	O
the	O
newborn	O
period	O
typically	O
include	O
pneumonia	O
,	O
sepsis	O
,	O
and	O
those	O
of	O
the	O
umbilical	O
cord	O
[	O
1	O
].	O

DEP	O
,	O
one	O
OPP	O
,	O
was	O
associated	O
with	O
a	O
16	O
g	O
birth	O
weight	O
increase	O
using	O
LASSO	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
)	O
and	O
DMP	O
,	O
the	O
other	O
OPP	O
,	O
was	O
associated	O
with	O
a	O
48	O
g	O
decrease	O
(	O
Additional	O
file1	O
:	O
Figure	O
S3	O
).	O

The	O
mRNA	O
expression	O
level	O
of	O
genes	O
associated	O
with	O
cell	O
cycle	O
,	O
mitosis	O
,	O
and	O
metabolism	O
of	O
purines	O
and	O
pyrimidines	O
was	O
increased	O
in	O
LP	O
offspring	O
.	O

All	O
participants	O
received	O
standard	O
antenatal	O
care	O
and	O
could	O
continue	O
self	O
-	O
administration	O
of	O
dietary	O
supplements	O
containing	O
up	O
to	O
400	O
IU	O
/	O
d	O
vitamin	O
D	O
.	O
Maternal	O
assessments	O
during	O
pregnancy	O
Prior	O
to	O
commencing	O
the	O
study	O
medication	O
and	O
again	O
at	O
34	O
weeks	O
of	O
gestation	O
,	O
the	O
women	O
attended	O
the	O
research	O
center	O
for	O
a	O
detailed	O
assessment	O
of	O
diet	O
(	O
including	O
supplement	O
use	O
),	O
lifestyle	O
(	O
smoking	O
,	O
physical	O
activity	O
participation	O
,	O
employment	O
),	O
and	O
health	O
(	O
medical	O
history	O
,	O
current	O
medication	O
use	O
)	O
using	O
interviewer	O
-	O
led	O
questionnaires	O
.	O

Overall	O
,	O
we	O
did	O
not	O
observe	O
statistically	O
significant	O
associations	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
after	O
adjusting	O
for	O
risk	O
factors	O
,	O
with	O
either	O
MLR	O
or	O
PSM	O
.	O

Statistical	O
Analyses	O
The	O
statistical	O
analyses	O
were	O
carried	O
out	O
using	O
STATA	O
10	O
.	O
1	O
(	O
StataCorp	O
,	O
Texas	O
,	O
USA	O
).	O

The	O
tendency	O
to	O
lower	O
chocolate	O
preference	O
suggests	O
an	O
increased	O
threshold	O
of	O
the	O
palatability	O
.	O

Trial	O
registration	O
ISRCTN	O
registry	O
,	O
ISRCTN54392969	O
,	O
date	O
of	O
registration	O
:	O
22	O
/	O
04	O
/	O
2009	O
,	O
retrospectively	O
registered	O
.	O

Fetal	O
programming	O
of	O
nutritional	O
restriction	O
with	O
pasture	O
-	O
based	O
systems	O
retarded	O
offspring	O
growth	O
performance	O
(	O
body	O
weight	O
,	O
feed	O
intake	O
,	O
carcass	O
weight	O
)	O
and	O
production	O
parameters	O
including	O
muscle	O
weight	O
,	O
meat	O
yield	O
,	O
and	O
fat	O
and	O
bone	O
weight	O
at	O
any	O
given	O
age	O
.	O

Discussion	O
3	O
.	O
1	O
.	O

2	O
.	O
2	O
.	O

Dose	O
and	O
Follow	O
-	O
Up	O
The	O
administered	O
vitamin	O
D	O
was	O
vitamin	O
D3	O
,	O
which	O
were	O
kept	O
from	O
light	O
,	O
frozen	O
,	O
and	O
stored	O
at	O
15	O
to	O
30oC	O
during	O
the	O
study	O
.	O

The	O
number	O
of	O
children	O
lost	O
to	O
follow	O
-	O
up	O
was	O
low	O
and	O
many	O
children	O
lost	O
at	O
one	O
time	O
because	O
of	O
travel	O
rejoined	O
the	O
study	O
later	O
with	O
rates	O
being	O
similar	O
between	O
the	O
two	O
groups	O
(	O
figure	O
1	O
).	O

Additionally	O
,	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
0	O
and	O
24	O
,	O
median	O
9	O
.	O
50	O
,	O
and	O
mode	O
13	O
were	O
observed	O
.	O

As	O
such	O
,	O
confirmation	O
of	O
these	O
findings	O
in	O
severely	O
vitamin	O
D	O
–	O
deficient	O
women	O
is	O
needed	O
as	O
it	O
is	O
possible	O
that	O
women	O
with	O
specific	O
genotypes	O
were	O
selectively	O
excluded	O
by	O
this	O
inclusion	O
criterion	O
.	O

Lab	O
and	O
questionnaire	O
data	O
were	O
entered	O
into	O
an	O
Excel	O
(	O
Microsoft	O
Office	O
)	O
spreadsheet	O
and	O
analyzed	O
using	O
Number	O
Cruncher	O
Statistical	O
Software	O
(	O
NCSS	O
)	O
version	O
7	O
.	O
0	O
(	O
Kaysville	O
,	O
Utah	O
).	O

Tobacco	O
use	O
and	O
vitamin	O
D	O
supplement	O
use	O
were	O
also	O
investigated	O
as	O
potential	O
confounders	O
but	O
did	O
not	O
show	O
any	O
confounding	O
effect	O
and	O
were	O
thus	O
not	O
included	O
in	O
the	O
final	O
models	O
.	O

We	O
also	O
assumed	O
one	O
fecal	O
contact	O
event	O
to	O
be	O
detected	O
per	O
3	O
-	O
hour	O
structured	O
observation	O
.	O

Decreasing	O
slaughter	O
age	O
may	O
be	O
better	O
for	O
reducing	O
production	O
costs	O
when	O
feed	O
prices	O
are	O
high	O
.	O

Those	O
presently	O
taking	O
vitamin	O
D	O
drops	O
also	O
had	O
higher	O
25	O
(	O
OH	O
)	O
D	O
levels	O
(	O
92	O
.	O
2	O
±	O
34	O
.	O
6	O
nmol	O
/	O
L	O
vs	O
.	O
72	O
.	O
2	O
±	O
28	O
.	O
2	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
main	O
groups	O
of	O
PUFA	O
are	O
omega	O
-	O
6	O
and	O
omega	O
-	O
3	O
fatty	O
acids	O
,	O
of	O
which	O
some	O
need	O
to	O
be	O
supplied	O
through	O
the	O
diet	O
.	O

Materials	O
and	O
Methods	O
2	O
.	O
1	O
.	O

These	O
findings	O
preserved	O
even	O
after	O
adjusting	O
for	O
prematurity	O
,	O
gender	O
,	O
age	O
,	O
BMI	O
,	O
physical	O
activity	O
index	O
and	O
SBP	O
levels	O
.	O

Birth	O
weight	O
percentile	O
was	O
calculated	O
using	O
the	O
Fenton	O
growth	O
chart	O
from	O
gestational	O
age	O
and	O
birth	O
weight	O
in	O
grams	O
(	O
Fenton	O
2003	O
),	O
allowing	O
us	O
to	O
account	O
for	O
gestational	O
age	O
in	O
our	O
birth	O
weight	O
metric	O
and	O
to	O
create	O
a	O
normalized	O
distribution	O
for	O
birth	O
weight	O
through	O
birth	O
weight	O
percentile	O
.	O

This	O
study	O
was	O
conducted	O
to	O
evaluate	O
early	O
life	O
bone	O
mineral	O
content	O
(	O
BMC	O
)	O
and	O
the	O
effects	O
of	O
three	O
months	O
of	O
vitamin	O
D	O
supplementation	O
in	O
breast	O
-	O
fed	O
Hispanic	O
and	O
non	O
-	O
Hispanic	O
Caucasian	O
(	O
henceforth	O
,	O
"	O
Caucasian	O
")	O
infants	O
on	O
vitamin	O
D	O
levels	O
.	O

We	O
did	O
not	O
have	O
data	O
on	O
whether	B
women	O
were	O
taking	O
separate	O
calcium	O
or	O
vitamin	O
D	O
supplements	O
beyond	O
what	O
is	O
contained	O
in	O
PNVs	O
.	O

In	O
the	O
same	O
period	O
881	O
probe	O
-	O
sets	O
exhibited	O
ontogenetic	O
regulation	O
that	O
was	O
specific	O
to	O
LP	O
offspring	O
.	O

In	O
total	O
,	O
28	O
individual	O
liver	O
mRNA	O
samples	O
were	O
analyzed	O
in	O
duplicate	O
per	O
stage	O
.	O

Vitamin	O
D	O
activity	O
pathways	O
in	O
patients	O
with	O
PCOS	O
remain	O
unknown	O
,	O
but	O
cholecalciferol	O
supplementation	O
improves	O
their	O
insulin	O
resistance	O
and	O
the	O
effects	O
of	O
infertility	O
treatment	O
.	O

(	O
2010	O
)¶/*/†	O
Lifestyle	O
factors	O
Alcohol	O
(	O
ethanol	O
)	O
Mouse	O
RatOral	O
(	O
water	O
)	O
(	O
10	O
g	O
/	O
kg	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
5	O
.	O
25	O
g	O
/	O
kg	O
/	O
d	O
or	O
56	O
%	O
(	O
v	O
/	O
v	O
)/	O
d	O
)	O
Injection	O
(	O
ip	O
)	O
(	O
2	O
.	O
9	O
g	O
/	O
kg	O
+	O
1	O
.	O
45	O
g	O
/	O
kg	O
2	O
h	O
later	O
In	O
utero	O
Neonatal	O
Adolescence	O
/	O
early	O
adulthood	O
In	O
utero	O
Neonatal	O
Childhood	O
Adolescence	O
Adulthood	O
F0	O
-	O
F1generationsNeurological	O
,	O
behavioral	O
,	O
cardiac	O
and	O
mesenchymal	O
stem	O
cell	O
abnormalitiesHistone	O
modification	O
miRNAsIgnacio	O
et	O
al	O
.	O

Methods	O
This	O
cross	O
-	O
sectional	O
study	O
included	O
723	O
mother	O
-	O
child	O
pairs	O
.	O

It	O
is	O
possible	O
to	O
implement	O
some	O
evidence	O
-	O
based	O
interventions	O
for	O
the	O
care	O
of	O
premature	O
babies	O
at	O
the	O
community	O
level	O
through	O
behaviour	O
change	O
initiatives	O
and	O
women	O
'	O
s	O
groups	O
[	O
16	O
],	O
as	O
well	O
as	O
home	O
-	O
visit	O
packages	O
with	O
extra	O
care	O
for	O
premature	O
babies	O
,	O
particularly	O
breastfeeding	O
support	O
and	O
awareness	O
of	O
the	O
importance	O
of	O
seeking	O
care	O
when	O
danger	O
signs	O
occur	O
[	O
17	O
].	O

Lifestyle	O
measures	O
can	O
provide	O
adequate	O
control	O
in	O
the	O
majority	O
of	O
cases	O
.	O

1b	O
Operational	O
taxonomic	O
units	O
in	O
the	O
infant	O
gut	O
and	O
maternal	O
dietary	O
factors	O
To	O
investigate	O
the	O
microbial	O
taxa	O
that	O
may	O
drive	O
differences	O
observed	O
above	O
,	O
we	O
measured	O
associations	O
between	O
each	O
maternal	O
dietary	O
factor	O
and	O
the	O
relative	O
abundance	O
of	O
individual	O
infant	O
stool	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
with	O
linear	O
models	O
adjusted	O
for	O
feeding	O
method	O
,	O
maternal	O
BMI	O
,	O
parity	O
,	O
and	O
batch	O
.	O

However	O
,	O
only	O
four	O
out	O
of	O
nineteen	O
participants	O
with	O
supplement	O
use	O
who	O
was	O
also	O
positive	O
for	O
Vitamin	O
D2	O
received	O
Vitamin	O
D2	O
-	O
containing	O
supplements	O
.	O

The	O
primary	O
objective	O
of	O
a	O
quantitative	O
meta	O
-	O
analysis	O
is	O
to	O
combine	O
the	O
results	O
of	O
previous	O
studies	O
examining	O
a	O
specific	O
research	O
question	O
to	O
arrive	O
at	O
a	O
summary	O
conclusion	O
about	O
a	O
body	O
of	O
research	O
.	O

Obviously	O
,	O
at	O
least	O
a	O
part	O
of	O
the	O
innate	O
immune	O
system	O
is	O
impaired	O
when	O
LP	O
offspring	O
is	O
faced	O
with	O
a	O
pre	O
-	O
biotical	O
stress	O
like	O
weaning	O
.	O

Lower	O
levels	O
of	O
PUFA	O
have	O
been	O
found	O
in	O
brain	O
content	O
,	O
red	O
blood	O
cells	O
and	O
skin	O
fibroblast	O
among	O
patients	O
with	O
schizophrenia	O
,	O
compared	O
with	O
a	O
healthy	O
population	O
[	O
13	O
,	O
16	O
].	O

Zeybel	O
et	O
al	O
.	O

folate	O
,	O
vitamin	O
B6	O
and	O
B12	O
)	O
is	O
closely	O
linked	O
.	O
36	O
A	O
significant	O
weakness	O
of	O
the	O
study	O
arises	O
from	O
the	O
lack	O
of	O
measurement	O
of	O
gene	O
expression	O
at	O
different	O
stages	O
of	O
maturity	O
.	O

The	O
infant	O
received	O
2	O
boluses	O
of	O
10	O
%	O
Dextrose	O
for	O
hypoglycemia	O
and	O
was	O
then	O
placed	O
on	O
Dextrose	O
10	O
%	O
in	O
water	O
at	O
6	O
mL	O
/	O
hour	O
with	O
normal	O
saline	O
at	O
1	O
mL	O
/	O
hour	O
via	O
umbilical	O
vein	O
.	O

Indoor	O
exposures	O
to	O
these	O
agents	O
frequently	O
occur	O
[	O
29	O
,	O
30	O
].	O

[	O
30	O
],	O
we	O
used	O
the	O
Zymo	O
DNA	O
extraction	O
kit	O
(	O
Zymo	O
Research	O
)	O
to	O
extract	O
microbial	O
DNA	O
from	O
thawed	O
samples	O
and	O
quantified	O
the	O
DNA	O
using	O
OD260	O
/	O
280	O
nanodrop	O
.	O

Reduction	O
of	O
energy	O
intake	O
induced	O
SIRT1	O
in	O
brain	O
(	O
21	O
).	O

Consequently	O
,	O
the	O
recommendations	O
for	O
primary	O
and	O
secondary	O
preventive	O
measures	O
are	O
also	O
very	O
limited	O
in	O
number	O
and	O
verification	O
.	O

However	O
,	O
there	O
were	O
elements	O
of	O
dissatisfaction	O
with	O
health	O
centre	O
services	O
,	O
poor	O
sitting	O
facilities	O
,	O
amenities	O
,	O
few	O
health	O
education	O
talks	O
and	O
poor	O
nursing	O
skills	O
.	O

The	O
use	O
of	O
opium	O
,	O
bread	O
and	O
tea	O
could	O
not	O
be	O
assessed	O
in	O
the	O
retrospective	O
framework	O
.	O

VD	O
serum	O
levels	O
are	O
inversely	O
proportional	O
to	O
blood	O
pressure	O
,	O
lipid	O
levels	O
,	O
insulin	O
resistance	O
and	O
metabolic	O
syndrome	O
symptoms	O
in	O
PCOS	O
patients	O
[	O
27	O
,	O
28	O
,	O
29	O
,	O
30	O
].	O
Figure	O
2shows	O
how	O
VD	O
deficiency	O
,	O
together	O
with	O
obesity	O
,	O
may	O
increase	O
insulin	O
resistance	O
and	O
deplete	O
glucose	O
transport	O
through	O
cellular	O
walls	O
—	O
VD	O
stimulates	O
insulin	O
receptor	O
expression	O
and	O
insulin	O
secretion	O
[	O
31	O
].	O

Thus	O
,	O
to	O
formulate	O
the	O
10	O
-	O
fold	O
HFol	O
diet	O
,	O
we	O
added	O
18	O
mg	O
of	O
folate	O
to	O
make	O
a	O
total	O
of	O
20	O
mg	O
/	O
kg	O
.	O

Subgroup	O
analyses	O
were	O
also	O
conducted	O
.	O

It	O
is	O
worth	O
mentioning	O
that	O
their	O
tools	O
for	O
determining	O
depression	O
were	O
different	O
than	O
ours	O
.	O

These	O
changes	O
occur	O
according	O
to	O
the	O
needs	O
for	O
the	O
mineralization	O
of	O
the	O
fetus	O
bones	O
as	O
well	O
as	O
adequate	O
secretion	O
of	O
vitamin	O
D	O
in	O
mother	O
’	O
s	O
milk	O
.	O
1	O
Due	O
to	O
rapid	O
fetal	O
development	O
,	O
particularly	O
bone	O
calcification	O
at	O
the	O
terminal	O
stages	O
of	O
pregnancy	O
,	O
there	O
is	O
a	O
possibility	O
of	O
vitamin	O
D	O
deficiency	O
to	O
occur	O
in	O
mothers	O
.	O

Dose	O
-	O
Response	O
Effects	O
of	O
the	O
Text4baby	O
Mobile	O
Health	O
Program	O
:	O
Randomized	O
Controlled	O
Trial	O
Abstract	O
Background	O
Mobile	O
health	O
(	O
mHealth	O
)	O
is	O
growing	O
rapidly	O
,	O
but	O
more	O
studies	O
are	O
needed	O
on	O
how	B
to	O
optimize	O
programs	O
,	O
including	O
optimal	O
timing	O
of	O
messaging	O
,	O
dose	O
of	O
exposure	O
,	O
and	O
value	O
of	O
interactive	O
features	O
.	O

Some	O
of	O
the	O
respondents	O
(	O
25	O
.	O
6	O
%)	O
were	O
recommended	O
an	O
ANC	O
site	O
.	O

It	O
represents	O
one	O
of	O
the	O
largest	O
mHealth	O
text	O
-	O
based	O
programs	O
developed	O
to	O
date	O
.	O

Although	O
the	O
exact	O
mechanisms	O
underlying	O
these	O
associations	O
have	O
yet	O
to	O
be	O
fully	O
elucidated	O
,	O
evidence	O
from	O
experimental	O
studies	O
suggest	O
that	O
insufficient	O
sleep	O
and	O
sleep	O
fragmentation	O
result	O
in	O
metabolic	O
and	O
neuroendocrine	O
alterations	O
,	O
particularly	O
alterations	O
in	O
the	O
hypothalamic	O
-	O
pituitary	O
adrenal	O
(	O
HPA	O
)	O
axis	O
,	O
that	O
may	O
contribute	O
to	O
the	O
development	O
of	O
impaired	O
glucose	O
tolerance	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
mellitus	O
[	O
16	O
-	O
20	O
].	O

Calcitonin	O
is	O
the	O
most	O
clinically	O
useful	O
biochemical	O
marker	O
for	O
these	O
tumours	O
,	O
and	O
C	O
cell	O
hyperplasia	O
represents	O
a	O
pre	O
-	O
cancerous	O
stage	O
.	O

In	O
particular	O
,	O
mHealth	O
programs	O
have	O
proven	O
effective	O
in	O
drug	O
adherence	O
,	O
as	O
patient	O
reminder	O
systems	O
,	O
and	O
in	O
some	O
areas	O
of	O
areas	O
of	O
chronic	O
disease	O
management	O
,	O
prevention	O
,	O
and	O
control	O
[	O
5	O
,	O
6	O
].	O

For	O
1307	O
women	O
a	O
general	O
questionnaire	O
was	O
available	O
.	O

Since	O
1991	O
/	O
1992	O
,	O
688	O
women	O
were	O
deceased	O
,	O
and	O
491	O
women	O
had	O
emigrated	O
.	O

No	O
studies	O
reported	O
adjusting	O
results	O
from	O
the	O
FFQ	O
for	O
energy	O
intake	O
,	O
a	O
recommendation	O
made	O
by	O
Freedman	O
et	O
al	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
the	O
distributions	O
of	O
the	O
demographic	O
characteristics	O
of	O
this	O
subsample	O
and	O
the	O
larger	O
population	O
examined	O
for	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
extent	O
(	O
data	O
not	O
shown	O
).	O

Interestingly	O
,	O
the	O
findings	O
for	O
atopy	O
became	O
stronger	O
when	O
we	O
examined	O
the	O
association	O
with	O
multiple	O
sensitisation	O
.	O

In	O
addition	O
,	O
concurrent	O
in	O
vivo	O
and	O
in	O
vitro	O
studies	O
have	O
improved	O
our	O
knowledge	O
of	O
the	O
mechanisms	O
involved	O
in	O
the	O
mammalian	O
life	O
cycle	O
,	O
including	O
recent	O
insights	O
into	O
early	O
human	O
development	O
(	O
Laird2013	O
;	O
Slieker	O
et	O
al	O
.	O
2015	O
;	O
Surani2015	O
;	O
Williams	O
et	O
al	O
.	O
2015	O
),	O
and	O
epigenetic	O
inheritance	O
in	O
simpler	O
model	O
systems	O
such	O
as	O
Caenorhabditis	O
elegans	O
,	O
Drosophilamelanogaster	O
and	O
Daniorerio	O
(	O
zebrafish	O
)	O
(	O
Padilla	O
et	O
al	O
.	O
2014	O
;	O
Somer	O
&	O
Thummel2014	O
;	O
Williams	O
et	O
al	O
.	O
2014	O
).	O

Women	O
were	O
recruited	O
between	O
13	O
and	O
19	O
weeks	O
of	O
pregnancy	O
from	O
prenatal	O
clinics	O
between	O
2003	O
and	O
2006	O
.	O

Since	O
PTB	O
is	O
the	O
leading	O
cause	O
of	O
neonatal	O
death	O
and	O
multiple	O
short	O
and	O
long	O
term	O
health	O
problems	O
[	O
3	O
],	O
it	O
is	O
critical	O
to	O
identify	O
modifiable	O
maternal	O
risk	O
factors	O
that	O
could	O
significantly	O
reduce	O
PTB	O
risk	O
at	O
the	O
population	O
level	O
.	O

Lack	O
of	O
engagement	O
may	O
be	O
a	O
consequence	O
of	O
insufficient	O
involvement	O
of	O
policy	O
makers	O
,	O
issues	O
regarding	O
distribution	O
and	O
costs	O
and	O
difficulties	O
in	O
training	O
the	O
educators	O
,	O
or	O
the	O
beliefs	O
and	O
cultural	O
practices	O
of	O
the	O
target	O
population	O
and	O
the	O
characteristics	O
and	O
side	O
effects	O
of	O
supplements	O
[	O
11	O
,	O
14	O
].	O

MUSC	O
is	O
a	O
comprehensive	O
,	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
(~	O
3000	O
deliveries	O
/	O
year	O
).	O

The	O
Chang	O
Gung	O
Ethics	O
Committee	O
approved	O
the	O
study	O
,	O
and	O
written	O
informed	O
consent	O
was	O
obtained	O
from	O
the	O
parents	O
or	O
legal	O
guardians	O
of	O
the	O
neonates	O
.	O

Usually	O
,	O
patients	O
are	O
recommended	O
to	O
postpone	O
pregnancy	O
to	O
6	O
-	O
12	O
months	O
after	O
radioiodine	O
(	O
I	O
-	O
131	O
)	O
treatment	O
to	O
avoid	O
a	O
potentially	O
higher	O
risk	O
of	O
miscarriage	O
in	O
the	O
first	O
few	O
months	O
after	O
radioiodine	O
therapy	O
and	O
to	O
allow	O
time	O
enough	O
to	O
exclude	O
residual	O
disease	O
requiring	O
further	O
treatment41438	O
.	O

PcG	O
targets	O
are	O
a	O
family	O
of	O
developmentally	O
related	O
genes	O
that	O
can	O
remodel	O
chromatin	O
and	O
are	O
responsible	O
for	O
silencing	O
HOX	O
genes	O
,	O
which	O
are	O
critical	O
in	O
embryonic	O
development	O
as	O
well	O
as	O
potentially	O
hundreds	O
of	O
other	O
genes	O
involved	O
in	O
cellular	O
differentiation	O
(	O
Kirmizis	O
et	O
al	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

When	O
adjusting	O
for	O
the	O
other	O
variables	O
in	O
the	O
models	O
,	O
no	O
significant	O
relationship	O
between	O
any	O
of	O
the	O
25	O
(	O
OH	O
)	O
D	O
measurements	O
and	O
cathelicidin	O
was	O
found	O
.	O

The	O
meagre	O
body	O
of	O
literature	O
regarding	O
pregnancy	O
outcomes	O
following	O
the	O
maternal	O
use	O
of	O
SGAs	O
has	O
produced	O
conflicting	O
findings	O
,	O
which	O
may	O
be	O
attributed	O
to	O
the	O
different	O
methodologies	O
and	O
inadequate	O
control	O
for	O
confounding	O
variables	O
.	O
15A	O
number	O
of	O
studies	O
have	O
found	O
that	O
exposure	O
to	O
SGAs	O
is	O
associated	O
with	O
a	O
significantly	O
increased	O
risk	O
of	O
low	O
birth	O
weight16	O
–	O
18and	O
small	O
for	O
gestational	O
age	O
infants	O
,	O
in	O
comparison	O
to	O
healthy	O
controls	O
.	O
17Conversely	O
,	O
Lin	O
et	O
al	O
17found	O
that	O
the	O
risk	O
of	O
low	O
birth	O
weight	O
,	O
preterm	O
births	O
and	O
small	O
/	O
large	O
for	O
gestational	O
age	O
(	O
LGA	O
)	O
infants	O
did	O
not	O
differ	O
between	O
women	O
with	O
schizophrenia	O
receiving	O
SGAs	O
and	O
those	O
with	O
the	O
disorder	O
who	O
did	O
not	O
use	O
an	O
antipsychotic	O
drug	O
.	O

In	O
contradistinction	O
,	O
metformin	O
reduces	O
insulin	O
resistance	O
and	O
hepatic	O
gluconeogenesis	O
,	O
which	O
theoretically	O
would	O
be	O
beneficial	O
for	O
the	O
preservation	O
of	O
β	O
-	O
cell	O
function	O
.	O

Mice	O
with	O
a	O
mutation	O
in	O
Npr3	O
,	O
or	O
Npr3	O
knockout	O
mice	O
,	O
all	O
exhibit	O
the	O
same	O
skeletal	O
-	O
overgrowth	O
phenotype	O
,	O
resulting	O
in	O
an	O
elongated	O
body	O
and	O
thoracic	O
kyphosis	O
(	O
Jaubert	O
et	O
al	O
.	O

The	O
factors	O
were	O
rotated	O
by	O
varimax	O
rotation	O
function	O
.	O

We	O
hypothesized	O
that	O
25	O
(	O
OH	O
)	O
D	O
would	O
be	O
lower	O
in	O
Hispanic	O
than	O
Caucasian	O
newborns	O
but	O
that	O
these	O
differences	O
would	O
not	O
be	O
substantial	O
enough	O
to	O
be	O
related	O
closely	O
to	O
BMC	O
and	O
bone	O
mineral	O
density	O
(	O
BMD	O
)	O
or	O
their	O
changes	O
during	O
the	O
first	O
three	O
months	O
of	O
life	O
.	O

What	O
we	O
can	O
do	O
is	O
modulate	O
children	O
'	O
s	O
flavor	O
preferences	O
by	O
providing	O
early	O
exposure	O
,	O
starting	O
in	O
utero	O
and	O
early	O
infancy	O
,	O
to	O
a	O
variety	O
of	O
healthy	O
flavors	O
.	O

There	O
are	O
no	O
representative	O
country	O
data	O
available	O
on	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
in	O
Europe	O
.	O

While	O
the	O
intervention	O
increased	O
the	O
frequency	O
of	O
handwashing	O
,	O
mothers	O
and	O
others	O
washed	O
hands	O
with	O
soap	O
at	O
less	O
than	O
10	O
%	O
of	O
the	O
times	O
we	O
recommended	O
for	O
handwashing	O
.	O

Furthermore	O
,	O
in	O
Thailand	O
dairy	O
products	O
are	O
not	O
fortified	O
with	O
vitamin	O
D	O
and	O
very	O
few	O
vitamin	O
D	O
-	O
rich	O
foods	O
are	O
part	O
of	O
the	O
Thai	O
diet	O
.	O

The	O
study	O
controlled	O
for	O
environmental	O
factors	O
such	O
as	O
socioeconomic	O
status	O
,	O
maternal	O
health	O
,	O
pregnancy	O
-	O
related	O
events	O
and	O
conditions	O
,	O
and	O
birth	O
year	O
.	O

Thus	O
,	O
even	O
though	O
there	O
is	O
no	O
consensus	O
on	O
recommending	O
the	O
use	O
of	O
multivitamins	O
during	O
pregnancy	O
,	O
they	O
are	O
used	O
more	O
often	O
by	O
those	O
women	O
with	O
a	O
better	O
socio	O
-	O
economic	O
status	O
,	O
with	O
a	O
higher	O
level	O
of	O
education	O
and	O
who	O
attended	O
more	O
prenatal	O
consultations	O
.	O

“	O
Unfortunately	O
,	O
we	O
don	O
’	O
t	O
have	O
a	O
good	O
understanding	O
of	O
what	B
could	O
be	O
going	O
on	O
‘	O
under	O
the	O
hood	O
’—	O
what	B
biological	O
mechanisms	O
could	O
be	O
driving	O
these	O
associations	O
,”	O
she	O
says	O
.	O

The	O
assertion	O
that	O
autism	O
patients	O
engage	O
in	O
repetitive	O
,	O
behavioral	O
patterns	O
has	O
arguably	O
become	O
stereotyped	O
.	O

Diet	O
significantly	O
affected	O
KM	O
(	O
P	O
=	O
0	O
.	O
006	O
),	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

Pubertal	O
onset	O
and	O
adult	O
ovarian	O
function	O
is	O
dependent	O
on	O
maternal	O
nutritional	O
background	O
Pubertal	O
onset	O
in	O
control	O
offspring	O
Pubertal	O
age	O
of	O
offspring	O
born	O
to	O
control	O
dams	O
was	O
similar	O
to	O
that	O
reported	O
previously	O
[	O
38	O
].	O

Lower	O
vitamin	O
D	O
levels	O
have	O
been	O
found	O
in	O
many	O
autoimmune	O
diseases	O
,	O
such	O
as	O
rheumatoid	O
arthritis	O
,	O
systemic	O
lupus	O
erythematosus	O
,	O
systemic	O
sclerosis	O
,	O
type	O
1	O
diabetes	O
mellitus	O
,	O
multiple	O
sclerosis	O
,	O
inflammatory	O
bowel	O
diseases	O
,	O
autoimmune	O
thyroid	O
diseases	O
[	O
6	O
,	O
7	O
].	O

For	O
this	O
reason	O
,	O
in	O
addition	O
to	O
calcitonin	O
-	O
gene	O
products	O
,	O
such	O
as	O
calcitonin	O
CGRP	O
(	O
calcitonin	O
-	O
generelated	O
-	O
peptide	O
)	O
and	O
C	O
-	O
CAP	O
(	O
katacalcin	O
),	O
MTC	O
cells	O
express	O
several	O
other	O
biochemical	O
markers	O
that	O
reflect	O
the	O
features	O
of	O
diffuse	O
neuroendocrine	O
system	O
,	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
the	O
symptoms	O
(	O
flushing	O
,	O
diarrhoea	O
,	O
carcinoid	O
syndrome	O
or	O
Cushing	O
'	O
s	O
syndrome	O
)	O
that	O
may	O
occur	O
in	O
patients	O
with	O
advanced	O
disease	O
.	O

Since	O
there	O
were	O
few	O
cases	O
of	O
SGA	O
based	O
on	O
birth	O
weight	O
alone	O
,	O
the	O
definition	O
of	O
SGA	O
used	O
in	O
this	O
study	O
was	O
based	O
on	O
birth	O
weight	O
and	O
/	O
or	O
length	O
.	O

Similarly	O
,	O
indoor	O
-	O
outdoor	O
pets	O
are	O
efficient	O
carriers	O
of	O
agents	O
into	O
the	O
home	O
,	O
and	O
also	O
pose	O
an	O
exposure	O
source	O
for	O
pesticides	O
from	O
anti	O
flea	O
/	O
tick	O
collars	O
,	O
sprays	O
,	O
and	O
shampoos	O
.	O

The	O
data	O
were	O
analyzed	O
using	O
the	O
SPSS	O
statistical	O
software	O
(	O
v	O
.	O
16	O
).	O

So	O
in	O
this	O
survey	O
,	O
we	O
investigated	O
the	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
MS	O
patients	O
and	O
compared	O
it	O
with	O
controls	O
in	O
central	O
region	O
of	O
Iran	O
,	O
an	O
area	O
with	O
medium	O
to	O
high	O
risk	O
for	O
MS	O
disease	O
,	O
in	O
spite	O
of	O
high	O
sun	O
exposure	O
.	O

35	O
±	O
26	O
.	O
13	O
nmol	O
/	O
L	O
and	O
60	O
.	O
45	O
±	O
23	O
.	O
63	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
and	O
the	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
intervention	O
group	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

These	O
results	O
informed	O
the	O
next	O
stage	O
of	O
analyses	O
that	O
examined	O
race	O
and	O
vitamin	O
D	O
levels	O
with	O
the	O
outcome	O
of	O
SGA	O
by	O
assessing	O
potential	O
confounders	O
:	O
race	O
,	O
smoking	O
,	O
pre	O
-	O
eclampsia	O
,	O
maternal	O
age	O
,	O
Medicaid	O
status	O
and	O
BMI	O
at	O
delivery	O
.	O

The	O
exact	O
biologic	O
mechanisms	O
underlying	O
a	O
protective	O
effect	O
are	O
not	O
clearly	O
understood	O
.	O

Results	O
Sample	O
Demographics	O
The	O
mean	O
age	O
of	O
respondents	O
(	O
N	O
=	O
123	O
)	O
was	O
26	O
.	O
3	O
years	O
(	O
SD	O
5	O
.	O
9	O
).	O

Discussion	O
In	O
this	O
study	O
,	O
we	O
have	O
identified	O
significant	O
associations	O
between	O
infant	O
growth	O
,	O
in	O
utero	O
exposures	O
,	O
and	O
repetitive	O
element	O
methylation	O
in	O
placental	O
tissue	O
.	O

25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
assessed	O
by	O
chemiluminescence	O
immunoassay	O
(	O
Liaison	O
automated	O
platform	O
;	O
Diasorin	O
,	O
Dartford	O
,	O
UK	O
).	O

2003	O
;	O
Spanò	O
et	O
al	O
.	O

There	O
were	O
no	O
correlations	O
between	O
BMI	O
of	O
the	O
child	O
of	O
either	O
sex	O
at	O
ages	O
0	O
and	O
5	O
with	O
maternal	O
or	O
PGFs	O
,	O
so	O
this	O
evidence	O
suggests	O
that	O
transmission	O
of	O
BMI	O
is	O
not	O
primarily	O
genetic	O
.	O

The	O
feedback	O
loop	O
in	O
which	O
low	O
self	O
-	O
esteem	O
increases	O
the	O
risk	O
of	O
overweight	O
and	O
overweight	O
contributes	O
to	O
low	O
self	O
-	O
esteem	O
could	O
be	O
a	O
critical	O
point	O
of	O
intervention	O
.	O

Although	O
14	O
.	O
3	O
%	O
of	O
exposed	O
mothers	O
were	O
also	O
taking	O
an	O
antiepileptic	O
drug	O
,	O
primarily	O
lamotrigine	O
,	O
the	O
reported	O
malformations	O
were	O
not	O
found	O
among	O
those	O
infants	O
exposed	O
to	O
anticonvulsants	O
.	O

Pregnancy	O
termination	O
was	O
mostly	O
due	O
to	O
fetal	O
malformations	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
6	O
Well	O
-	O
preforming	O
countries	O
for	O
preterm	O
-	O
specific	O
neonatal	O
mortality	O
reduction	O
by	O
region	O
.	O

PubMed	O
Central	O
:	O

When	O
compared	O
with	O
the	O
neonates	O
exposed	O
to	O
monotherapy	O
,	O
a	O
larger	O
proportion	O
of	O
neonates	O
in	O
the	O
polytherapy	O
group	O
were	O
admitted	O
to	O
the	O
NICU	O
(	O
28	O
.	O
8	O
%	O
vs	O
16	O
%)	O
and	O
presented	O
with	O
PNA	O
signs	O
(	O
21	O
.	O
2	O
%	O
vs	O
4	O
%).	O

All	O
participants	O
provided	O
written	O
informed	O
consent	O
to	O
participate	O
.	O

Their	O
liver	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
,	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
,	O
the	O
de	O
novo	O
lipogenic	O
enzymes	O
Acaca	O
and	O
Fasn	O
,	O
and	O
the	O
liver	O
-	O
specific	O
cholesterol	O
biosynthesis	O
regulators	O
Insig1	O
and	O
Hmgcr	O
.	O

One	O
case	O
of	O
anaphylaxis	O
and	O
3	O
cases	O
of	O
serious	O
allergic	O
reaction	O
involved	O
women	O
taking	O
prenatal	O
supplements	O
,	O
two	O
of	O
which	O
reported	O
spontaneous	O
abortion	O
.	O

In	O
order	O
to	O
survey	O
expression	O
of	O
the	O
liver	O
tissue	O
samples	O
,	O
total	O
transcript	O
levels	O
of	O
selected	O
target	O
and	O
reference	O
genes	O
(	O
Table5	O
)	O
were	O
quantified	O
by	O
real	O
-	O
time	O
quantitative	O
PCR	O
(	O
qPCR	O
)	O
performed	O
on	O
a	O
LightCycler	O
®	O
480	O
system	O
using	O
the	O
LightCycler	O
480	O
SYBR	O
Green	O
I	O
Master	O
(	O
Roche	O
,	O
Mannheim	O
,	O
Germany	O
).	O

Methods	O
To	O
investigate	O
potential	O
relationships	O
between	O
household	O
pet	O
exposure	O
and	O
cord	O
blood	O
vitamin	O
D	O
concentrations	O
,	O
we	O
analyzed	O
information	O
from	O
a	O
large	O
,	O
geographically	O
-	O
based	O
,	O
general	O
risk	O
birth	O
cohort	O
.	O

Conclusion	O
We	O
observed	O
a	O
high	O
prevalence	O
of	O
risk	O
factors	O
for	O
GDM	O
in	O
this	O
sample	O
.	O

Similar	O
analyses	O
were	O
conducted	O
using	O
logistic	O
regression	O
to	O
examine	O
impact	O
on	O
odds	O
of	O
macrosomia	O
.	O

End	O
Note	O
Research	O
for	O
this	O
article	O
was	O
supported	O
by	O
Hertha	O
Firnberg	O
stipend	O
T283	O
-	O
B13	O
and	O
SFB	O
F1808	O
-	O
B13	O
from	O
the	O
Austrian	O
Science	O
Fund	O
(	O
FWF	O
).	O

Unexpectedly	O
,	O
the	O
intake	O
of	O
fatty	O
fish	O
(	O
salmon	O
,	O
herring	O
and	O
mackerel	O
)	O
or	O
shellfish	O
more	O
than	O
twice	O
a	O
week	O
increased	O
the	O
risk	O
of	O
being	O
in	O
the	O
group	O
with	O
the	O
highest	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Synthetic	O
folic	O
acid	O
does	O
not	O
occur	O
naturally	O
and	O
is	O
distinct	O
from	O
naturally	O
occurring	O
folic	O
acid	O
[	O
1	O
,	O
4	O
,	O
5	O
].	O

2	O
.	O

Totally	O
45	O
participants	O
were	O
randomly	O
divided	O
into	O
intervention	O
group	O
(	O
IG	O
)	O
and	O
control	O
group	O
(	O
CG	O
).	O

No	O
increase	O
in	O
pregnancy	O
complications	O
have	O
been	O
found	O
in	O
observational	O
studies	O
where	O
lispro	O
was	O
used	O
,	O
in	O
either	O
women	O
with	O
GDM38	O
,	O
43or	O
pre	O
-	O
existing	O
diabetes	O
.	O
38	O
–	O
43There	O
are	O
few	O
reports	O
regarding	O
the	O
use	O
of	O
aspart	O
in	O
pregnancy	O
.	O

Pregnant	O
women	O
were	O
recruited	O
from	O
gestational	O
week	O
4	O
during	O
fall	O
2013	O
and	O
spring	O
2014	O
,	O
when	O
registering	O
at	O
one	O
of	O
the	O
participating	O
antenatal	O
care	O
units	O
.	O

Mothers	O
with	O
GDM	O
were	O
older	O
(	O
P	O
=	O
0	O
.	O
018	O
),	O
heavier	O
and	O
had	O
higher	O
prepregnancy	O
BMI	O
(	O
P	O
for	O
both	O
<	O
0	O
.	O
001	O
),	O
and	O
their	O
educational	O
level	O
was	O
at	O
borderline	O
of	O
significance	O
(	O
P	O
=	O
0	O
.	O
051	O
)	O
lower	O
compared	O
with	O
mothers	O
without	O
GDM	O
.	O

As	O
a	O
result	O
,	O
GRs	O
cannot	O
bind	O
to	O
their	O
DNA	O
GRE	O
and	O
subsequently	O
their	O
function	O
is	O
compromised	O
[	O
8	O
].	O

The	O
mean	O
25	O
(	O
OH	O
)	O
D	O
level	O
in	O
our	O
sample	O
was	O
adequate	O
,	O
mirroring	O
our	O
pilot	O
study	O
findings	O
[	O
14	O
]	O
and	O
those	O
of	O
the	O
Canadian	O
Health	O
Measures	O
Survey	O
[	O
32	O
].	O

While	O
the	O
exact	O
mechanism	O
by	O
which	O
PFAS	O
impact	O
birth	O
weight	O
is	O
unknown	O
,	O
several	O
theories	O
have	O
been	O
proposed	O
.	O

The	O
cross	O
-	O
sectional	O
design	O
did	O
not	O
allow	O
us	O
to	O
distinguish	O
between	O
cause	O
and	O
effect	O
.	O

Rodent	O
models	O
The	O
deleterious	O
effects	O
of	O
exposures	O
to	O
environmental	O
factors	O
in	O
human	O
cohorts	O
have	O
stimulated	O
investigations	O
of	O
environmentally	O
induced	O
toxicity	O
in	O
rodent	O
models	O
.	O

Therefore	O
,	O
in	O
considering	O
early	O
vitamin	O
D	O
supplementation	O
,	O
the	O
question	B
becomes	O
whether	B
there	O
is	O
physiological	O
benefit	O
to	O
rapid	O
replenishment	O
with	O
vitamin	O
D	O
(	O
e	O
.	O
g	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
better	O
elucidate	O
the	O
role	O
of	O
dietary	O
factors	O
and	O
specific	O
nutrients	O
in	O
the	O
risk	O
for	O
this	O
disease	O
.	O

There	O
are	O
concerns	O
about	O
possible	O
detrimental	O
interactions	O
between	O
micronutrients	O
combined	O
within	O
a	O
single	O
supplement	O
but	O
experimental	O
data	O
are	O
sparse	O
and	O
the	O
potential	O
synergistic	O
and	O
positive	O
effects	O
of	O
particular	O
combinations	O
should	O
not	O
be	O
ignored	O
(	O
Sandstrom	O
2001	O
).	O

Even	O
after	O
controlling	O
for	O
seasonal	O
influence	O
on	O
endogenous	O
synthesis	O
,	O
low	O
household	O
income	O
,	O
and	O
infrequent	O
consumption	O
of	O
vitamin	O
D	O
drops	O
and	O
milk	O
,	O
the	O
significant	O
association	O
remained	O
.	O

Brandenburg	O
et	O
al	O
.	O

Our	O
study	O
compared	O
women	O
who	O
had	O
been	O
in	O
the	O
US	O
for	O
fewer	O
or	O
more	O
than	O
5	O
years	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
244X	O
/	O
10	O
/	O
38	O
/	O
prepub	O
Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Additional	O
file	O
1	O
Appendix	O
1	O
.	O

The	O
major	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
glomerular	O
development	O
and	O
renal	O
structure	O
at	O
birth	O
,	O
10	O
days	O
and	O
adulthood	O
in	O
mice	O
born	O
to	O
mothers	O
fed	O
a	O
diet	O
restricted	O
in	O
vitamin	O
D	O
.	O
Although	O
,	O
we	O
examined	O
other	O
variables	O
,	O
such	O
as	O
body	O
mass	O
and	O
24	O
h	O
urine	O
,	O
the	O
present	O
study	O
was	O
not	O
designed	O
to	O
investigate	O
renal	O
functional	O
and	O
metabolic	O
consequences	O
but	O
rather	O
was	O
designed	O
to	O
answer	O
the	O
question	B
of	O
whether	O
there	O
were	O
structural	O
,	O
glomerular	O
alterations	O
or	O
transgenerational	O
effects	O
.	O

Women	O
who	O
have	O
a	O
weight	O
gain	O
target	O
that	O
is	O
concordant	O
with	O
IOM	O
recommendation	O
are	O
less	O
likely	O
to	O
have	O
excessive	O
weight	O
gain	O
[	O
4	O
].	O

Intrauterine	O
transmission	O
must	O
be	O
considered	O
important	O
as	O
the	O
maternal	O
relationship	O
is	O
consistent	O
at	O
all	O
time	O
points	O
and	O
between	O
each	O
mother	O
–	O
child	O
pair	O
,	O
for	O
example	O
,	O
the	O
mother	O
and	O
her	O
children	O
,	O
the	O
mother	O
and	O
her	O
own	O
mother	O
and	O
the	O
father	O
and	O
his	O
mother	O
.	O

In	O
populations	O
with	O
similar	O
characteristics	O
,	O
quarterly	O
population	O
level	O
supplementation	O
of	O
vitamin	O
D	O
to	O
infants	O
and	O
young	O
children	O
is	O
not	O
a	O
policy	O
option	O
for	O
reducing	O
the	O
burden	O
of	O
pneumonia	O
in	O
children	O
.	O

Such	O
overviews	O
are	O
,	O
however	O
,	O
rarely	O
included	O
in	O
the	O
relevant	O
literature	O
associated	O
with	O
extended	O
lifetime	O
studies	O
.	O

In	O
90	O
%	O
of	O
the	O
genes	O
that	O
we	O
validated	O
by	O
qRT	O
-	O
PCR	O
,	O
significant	O
expression	O
differences	O
in	O
mRNA	O
levels	O
between	O
the	O
treatment	O
groups	O
were	O
identified	O
by	O
both	O
qRT	O
-	O
PCR	O
and	O
microarray	O
analysis	O
(	O
Table4	O
).	O

Maternal	O
high	O
fat	O
exposure	O
We	O
found	O
that	O
exposure	O
to	O
a	O
high	O
fat	O
diet	O
either	O
throughout	O
the	O
lifetime	O
of	O
the	O
mother	O
or	O
restricted	O
to	O
pregnancy	O
and	O
/	O
or	O
lactation	O
led	O
to	O
early	O
pubertal	O
onset	O
.	O

In	O
such	O
instances	O
,	O
the	O
avoidance	O
of	O
peanuts	O
,	O
nuts	O
,	O
fish	O
,	O
eggs	O
,	O
and	O
sesame	O
during	O
the	O
last	O
3	O
months	O
of	O
pregnancy	O
may	O
have	O
a	O
protective	O
effect	O
[	O
106	O
].	O

Our	O
findings	O
suggest	O
that	O
an	O
adequate	O
maternal	O
vitamin	O
status	O
have	O
been	O
achieved	O
in	O
Finland	O
.	O

Examinations	O
of	O
infant	O
lung	O
function	O
were	O
successfully	O
performed	O
for	O
71	O
infants	O
at	O
6	O
months	O
of	O
age	O
.	O

Of	O
all	O
women	O
,	O
74	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
71	O
.	O
8	O
–	O
76	O
.	O
5	O
%)	O
were	O
vitamin	O
D	O
insufficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
30	O
ng	O
/	O
ml	O
)	O
and	O
44	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
=	O
41	O
.	O
9	O
–	O
47	O
.	O
3	O
%)	O
of	O
the	O
pregnant	O
women	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
20	O
ng	O
/	O
ml	O
),	O
while	O
12	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
10	O
.	O
3	O
–	O
13	O
.	O
8	O
%)	O
of	O
the	O
women	O
were	O
severely	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
<	O
10	O
ng	O
/	O
ml	O
).	O

Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaeous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
and	O
stratified	O
by	O
fetal	O
sex	O
.	O

To	O
investigate	O
the	O
role	O
of	O
visfatin	O
in	O
the	O
growth	O
of	O
the	O
fetus	O
and	O
up	O
to	O
a	O
year	O
after	O
birth	O
,	O
we	O
measured	O
serum	O
visfatin	O
levels	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
weeks	O
of	O
gestation	O
in	O
an	O
Iranian	O
population	O
.	O

Furthermore	O
,	O
the	O
divergence	O
of	O
results	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
reported	O
throughout	O
this	O
work	O
suggests	O
that	O
these	O
repetitive	O
element	O
methylation	O
markers	O
are	O
distinct	O
measures	O
and	O
may	O
not	O
represent	O
true	O
,	O
and	O
potentially	O
interchangeable	O
,	O
surrogates	O
of	O
“	O
global	O
”	O
methylation	O
.	O

In	O
obese	O
mothers	O
,	O
lower	O
protein	O
intake	O
early	O
in	O
pregnancy	O
and	O
increased	O
protein	O
intakes	O
over	O
the	O
course	O
of	O
the	O
pregnancy	O
were	O
independently	O
related	O
to	O
higher	O
offspring	O
weight	O
at	O
6	O
months	O
.	O

Simple	O
linear	O
regression	O
was	O
used	O
to	O
determine	O
the	O
univariate	O
associations	O
between	O
metabolic	O
markers	O
,	O
25OHD	O
,	O
and	O
early	O
-	O
pregnancy	O
season	O
.	O

Combining	O
a	O
multilevel	O
approach	O
with	O
a	O
developmental	O
perspective	O
can	O
inform	O
more	O
effective	O
and	O
sustainable	O
strategies	O
for	O
obesity	O
prevention	O
.	O

The	O
FFQ	O
lacked	O
quantitative	O
information	O
on	O
soft	O
drink	O
consumption	O
and	O
this	O
will	O
have	O
led	O
to	O
underestimation	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
.	O

Vitamin	O
D	O
status	O
is	O
a	O
key	O
modifiable	O
maternal	O
risk	O
factor	O
for	O
the	O
prevention	O
of	O
PTB	O
.	O

Evidence	O
in	O
some	O
studies	O
pointed	O
out	O
that	O
hyperphagia	O
could	O
be	O
a	O
transitory	O
effect	O
that	O
disappears	O
when	O
the	O
underweighted	O
animals	O
after	O
maternal	O
undernutrition	O
were	O
able	O
to	O
reach	O
the	O
weight	O
as	O
controls	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

Researchers	O
have	O
persistently	O
reported	O
noncompliance	O
with	O
this	O
recommendation	O
at	O
a	O
given	O
antenatal	O
visit	O
.	O

All	O
reported	O
p	O
-	O
values	O
are	O
two	O
-	O
tailed	O
.	O

These	O
data	O
point	O
towards	O
an	O
interaction	O
between	O
stress	O
and	O
genetics	O
,	O
since	O
only	O
in	O
the	O
CC	O
polymorphic	O
GR	O
group	O
did	O
negative	O
maternal	O
attitude	O
predict	O
fetal	O
weight	O
reduction	O
,	O
but	O
not	O
in	O
the	O
CT	O
group	O
,	O
independent	O
of	O
confounders	O
.	O

Participants	O
were	O
classified	O
into	O
three	O
predefined	O
levels	O
:	O
low	O
,	O
middle	O
and	O
high	O
frequency	O
of	O
symptoms	O
.	O

Results	O
18	O
411	O
women	O
were	O
classified	O
as	O
having	O
a	O
low	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
,	O
14	O
395	O
as	O
middle	O
and	O
817	O
as	O
having	O
a	O
high	O
level	O
.	O

Confidentiality	O
of	O
the	O
respondents	O
was	O
observed	O
by	O
coding	O
questionnaires	O
and	O
the	O
database	O
was	O
password	O
-	O
protected	O
.	O

Therefore	O
,	O
rampant	O
caries	O
can	O
influence	O
nutritional	O
health	O
.	O

Specifically	O
,	O
we	O
disconfirmed	O
our	O
first	O
hypothesis	O
that	O
there	O
was	O
no	O
direct	O
treatment	O
effect	O
of	O
text4baby	O
.	O

The	O
patients	O
were	O
randomly	O
assigned	O
into	O
intervention	O
group	O
(	O
IG	O
)	O
and	O
control	O
group	O
(	O
CG	O
).	O

He	O
believes	O
there	O
is	O
far	O
more	O
research	O
that	O
needs	O
to	O
be	O
done	O
to	O
understand	O
the	O
barriers	O
to	O
breastfeeding	O
and	O
why	B
some	O
women	O
have	O
difficulties	O
with	O
lactation	O
.	O

There	O
were	O
no	O
differences	O
in	O
neonatal	O
outcomes	O
.	O

Risk	O
Factors	O
Related	O
To	O
Season	O
of	O
Birth	O
The	O
underlying	O
rationale	O
for	O
the	O
occurrence	O
of	O
a	O
glioma	O
decades	O
after	O
a	O
seasonal	O
exposure	O
remains	O
elusive	O
.	O

Notably	O
,	O
at	O
stage	O
1	O
dpn	O
no	O
regulation	O
of	O
a	O
distinct	O
pathway	O
was	O
found	O
in	O
LP	O
offspring	O
.	O

Discussion	O
Ensuring	O
adequate	O
nutrition	O
during	O
pregnancy	O
is	O
one	O
of	O
the	O
key	O
actions	O
endorsed	O
by	O
the	O
South	O
African	O
Government	O
to	O
promote	O
optimal	O
early	O
childhood	O
development	O
in	O
an	O
effort	O
to	O
eradicate	O
poverty	O
.	O

This	O
was	O
to	O
ascertain	O
calcifediol	O
serum	O
concentrations	O
1	O
week	O
after	O
giving	O
the	O
first	O
dose	O
in	O
the	O
placebo	O
group	O
(	O
a	O
baseline	O
value	O
for	O
the	O
whole	O
population	O
)	O
as	O
well	O
as	O
early	O
concentrations	O
after	O
the	O
first	O
vitamin	O
D	O
supplementation	O
in	O
the	O
intervention	O
group	O
(	O
70	O
in	O
placebo	O
and	O
69	O
in	O
intervention	O
groups	O
).	O

In	O
addition	O
,	O
microarray	O
analyses	O
demonstrated	O
that	O
many	O
transcripts	O
were	O
differentially	O
expressed	O
between	O
JEG	O
-	O
3	O
and	O
BeWo	O
cells	O
[	O
25	O
].	O

Male	O
Infertility	O
Factor	O
Should	B
males	O
visiting	O
infertility	O
clinics	O
be	O
treated	O
with	O
VD	O
preparations	O
?	B

(	O
2010	O
)¶/†	O
Melkamu	O
et	O
al	O
.	O

Due	O
to	O
the	O
lack	O
of	O
conclusive	O
evidence	O
,	O
we	O
cannot	O
recommend	O
the	O
ubiquitous	O
use	O
of	O
prenatal	O
vitamins	O
,	O
in	O
particular	O
folate	O
,	O
in	O
men	O
attempting	O
to	O
plan	O
a	O
pregnancy	O
with	O
their	O
female	O
partner	O
at	O
this	O
time	O
.	O

Data	O
are	O
mean	O
±	O
SD	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
pregnancy	O
outcome	O
Of	O
the	O
2800	O
women	O
present	O
in	O
this	O
study	O
,	O
1217	O
(	O
43	O
%)	O
women	O
went	O
on	O
to	O
develop	O
a	O
pregnancy	O
complication	O
and	O
included	O
5	O
.	O
8	O
%	O
(	O
n	O
=	O
161	O
)	O
who	O
developed	O
PE	O
,	O
7	O
.	O
6	O
%	O
(	O
n	O
=	O
213	O
)	O
who	O
developed	O
GH	O
,	O
3	O
.	O
3	O
%	O
(	O
n	O
=	O
92	O
)	O
who	O
developed	O
GDM	O
,	O
5	O
%	O
(	O
n	O
=	O
139	O
)	O
who	O
spontaneously	O
delivered	O
preterm	O
and	O
10	O
.	O
6	O
%	O
(	O
n	O
=	O
298	O
)	O
who	O
delivered	O
an	O
SGA	O
infant	O
.	O

There	O
was	O
a	O
low	O
prevalence	O
of	O
malaria	O
parasitaemia	O
in	O
the	O
current	O
study	O
,	O
which	O
is	O
likely	O
to	O
have	O
been	O
a	O
consequence	O
of	O
cross	O
-	O
sectional	O
sampling	O
of	O
partially	O
immune	O
adults	O
early	O
in	O
the	O
wet	O
season	O
,	O
in	O
an	O
area	O
of	O
highly	O
seasonal	O
endemicity	O
.	O

Because	O
it	O
is	O
possible	O
to	O
consume	O
fish	O
and	O
seafood	O
safely	O
during	O
pregnancy	O
,	O
through	O
following	O
recommendations	O
to	O
limit	O
high	O
mercury	O
species	O
,	O
it	O
is	O
prudent	O
to	O
recommend	O
that	O
pregnant	O
women	O
consume	O
these	O
foods	O
,	O
rather	O
than	O
rely	O
on	O
supplementation	O
,	O
in	O
order	O
to	O
maximise	O
infant	O
neurodevelopment	O
outcomes	O
.	O

Hence	O
,	O
there	O
will	O
not	O
be	O
a	O
single	O
solution	O
,	O
but	O
rather	O
an	O
array	O
of	O
solutions	O
that	O
address	O
the	O
various	O
biological	O
,	O
clinical	O
,	O
behavioural	O
and	O
social	O
risk	O
factors	O
that	O
result	O
in	O
preterm	O
birth	O
.	O

Genetics	O
and	O
breed	O
,	O
management	O
,	O
and	O
nutrition	O
affect	O
IMF	O
deposition	O
.	O

DNA	O
methylation	O
analysis	O
.	O

All	O
other	O
offspring	O
from	O
dams	O
fed	O
the	O
HV	O
diet	O
were	O
weaned	O
to	O
RV	O
,	O
HV	O
or	O
HFol	O
diets	O
.	O

As	O
mentioned	O
earlier	O
,	O
there	O
are	O
a	O
number	O
of	O
loci	O
within	O
PGCs	O
that	O
escape	O
the	O
two	O
global	O
DNA	O
demethylation	O
re	O
-	O
programing	O
events	O
.	O

In	O
addition	O
,	O
we	O
analysed	O
13	O
infants	O
treated	O
by	O
our	O
department	O
for	O
idiopathic	O
infantile	O
hypercalcaemia	O
(	O
IIH	O
)	O
from	O
2011	O
-	O
2013	O
.	O

Some	O
studies	O
have	O
also	O
noticed	O
that	O
the	O
metabolic	O
profile	O
exhibited	O
by	O
offspring	O
depends	O
on	O
the	O
sex	O
(	O
Desai	O
et	O
al	O
.,	O
2007a	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
).	O

In	O
the	O
February	O
2008	O
issue	O
of	O
Food	O
and	O
Chemical	O
Toxicology	O
,	O
researchers	O
from	O
India	O
report	O
that	O
aqueous	O
garlic	O
extract	O
(	O
AGE	O
)	O
fed	O
to	O
at	O
-	O
risk	O
individuals	O
may	O
reduce	O
the	O
toxic	O
effects	O
of	O
arsenic	O
.	O

These	O
results	O
were	O
in	O
line	O
with	O
Northstone	O
et	O
al	O
.	O

This	O
study	O
demonstrated	O
that	O
as	O
children	O
age	O
,	O
the	O
concentration	O
of	O
cathelicidin	O
increases	O
.	O

PubMed	O
Central	O
:	O

Far	O
fewer	O
studies	O
have	O
examined	O
the	O
relationship	O
between	O
cord	O
blood	O
vitamin	O
D	O
levels	O
,	O
which	O
may	O
more	O
accurately	O
reflect	O
fetal	O
levels	O
of	O
vitamin	O
D	O
,	O
and	O
neonatal	O
outcomes	O
.	O
14	O
,	O
24Given	O
the	O
racial	O
disparities	O
seen	O
in	O
both	O
vitamin	O
D	O
deficiency	O
and	O
perinatal	O
outcomes	O
,	O
vitamin	O
D	O
has	O
been	O
proposed	O
as	O
part	O
of	O
the	O
explanation	O
for	O
this	O
disparity	O
,	O
particularly	O
with	O
regard	O
to	O
fetal	O
growth	O
and	O
SGA	O
.	O
8	O
Increased	O
awareness	O
of	O
the	O
growing	O
prevalence	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
has	O
led	O
to	O
an	O
urgent	O
need	O
for	O
consideration	O
of	O
supplementation	O
during	O
pregnancy	O
.	O

There	O
is	O
no	O
dietary	O
recommended	O
intake	O
(	O
DRI	O
)	O
for	O
vitamin	O
D	O
.	O
What	O
is	O
known	O
today	O
is	O
that	O
for	O
a	O
pregnant	O
woman	O
,	O
the	O
adequate	O
intake	O
for	O
vitamin	O
D	O
is	O
200	O
IU	O
per	O
day	O
.	O

MTCs	O
,	O
like	O
other	O
neuroendocrine	O
tumours	O
,	O
can	O
express	O
somatostatin	O
receptors	O
.	O

Vitamin	O
D	O
deficiency	O
was	O
not	O
significantly	O
associated	O
with	O
SGA	O
in	O
white	O
infants	O
.	O

A	O
comparison	O
of	O
the	O
maternal	O
characteristics	O
between	O
those	O
included	O
(	O
n	O
=	O
334	O
)	O
and	O
excluded	O
from	O
the	O
original	O
ROLO	O
study	O
is	O
included	O
in	O
Additional	O
file1	O
:	O
Table	O
S1	O
.	O

Proteins	O
were	O
extracted	O
in	O
homogenizing	O
buffer	O
with	O
protease	O
inhibitors	O
.	O

On	O
the	O
other	O
hand	O
,	O
multiple	O
regression	O
analysis	O
revealed	O
a	O
significant	O
interaction	O
of	O
the	O
three	O
independent	O
variables	O
birth	O
weight	O
,	O
age	O
and	O
BMI	O
in	O
predicting	O
PNN50	O
(	O
Table	O
2	O
).	O

At	O
initial	O
recruitment	O
within	O
the	O
main	O
study	O
baseline	O
stool	O
samples	O
had	O
not	O
been	O
collected	O
.	O

Fatty	O
acids	O
in	O
red	O
blood	O
cell	O
total	O
phospholipids	O
are	O
determined	O
using	O
gas	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
GCMSMS	O
)	O
[	O
73	O
].	O

From	O
three	O
to	O
six	O
months	O
,	O
all	O
animals	O
had	O
systolic	O
blood	O
pressure	O
(	O
BP	O
)	O
measured	O
weekly	O
with	O
a	O
non	O
-	O
invasive	O
tail	O
-	O
cuff	O
plethysmography	O
(	O
Letica	O
LE	O
5100	O
,	O
Panlab	O
,	O
Barcelona	O
,	O
Spain	O
).	O

There	O
was	O
also	O
a	O
larger	O
,	O
statistically	O
significant	O
percentage	O
who	O
reported	O
consuming	O
3	O
or	O
more	O
vegetables	O
per	O
day	O
in	O
the	O
control	O
vs	O
treatment	O
group	O
:	O
37	O
.	O
8	O
%	O
(	O
95	O
%	O
CI	O
33	O
.	O
44	O
-	O
42	O
.	O
19	O
)	O
in	O
control	O
vs	O
30	O
.	O
0	O
%	O
(	O
95	O
%	O
CI	O
25	O
.	O
81	O
-	O
34	O
.	O
15	O
,	O
P	O
=.	O
046	O
)	O
in	O
the	O
treatment	O
group	O
,	O
respectively	O
.	O

Since	O
GR	O
is	O
present	O
as	O
different	O
isoforms	O
,	O
multiple	O
bands	O
were	O
observed	O
and	O
there	O
was	O
an	O
expected	O
interpatient	O
variation	O
in	O
the	O
protein	O
expression	O
.	O

It	O
has	O
been	O
estimated	O
that	O
up	O
to	O
one	O
third	O
of	O
women	O
with	O
diabetes	O
,	O
had	O
a	O
GDM	O
pregnancy	O
earlier	O
in	O
their	O
life	O
,	O
2though	O
this	O
was	O
not	O
evident	O
in	O
a	O
recent	O
survey	O
of	O
women	O
with	O
type	O
2	O
diabetes	O
.	O
23	O
This	O
review	O
will	O
focus	O
on	O
the	O
medical	O
management	O
of	O
GDM	O
,	O
in	O
particular	O
self	O
monitoring	O
of	O
blood	O
glucose	O
and	O
diabetes	O
education	O
,	O
dietary	O
therapy	O
and	O
physical	O
activity	O
,	O
pharmacotherapy	O
,	O
and	O
post	O
-	O
partum	O
management	O
.	O

Conversely	O
,	O
a	O
multigenerational	O
change	O
represents	O
an	O
epigenetic	O
effect	O
that	O
affects	O
multiple	O
generations	O
,	O
all	O
of	O
which	O
were	O
exposed	O
to	O
the	O
original	O
stimulus	O
,	O
either	O
directly	O
as	O
the	O
exposed	O
mother	O
or	O
child	O
/	O
adult	O
or	O
indirectly	O
as	O
an	O
embryo	O
or	O
PGC	O
within	O
the	O
exposed	O
generation	O
.	O

Whenever	O
possible	O
,	O
surgery	O
should	O
be	O
carried	O
out	O
during	O
the	O
second	O
trimester	O
or	O
after	O
delivery	O
,	O
as	O
for	O
newly	O
diagnosed	O
thyroid	O
cancer	O
.	O

Furthermore	O
,	O
studies	O
have	O
shown	O
that	O
vitamin	O
D	O
supports	O
early	O
placental	O
development	O
[	O
44	O
,	O
45	O
]	O
in	O
which	O
,	O
abnormal	O
placentation	O
can	O
be	O
a	O
characteristic	O
of	O
a	O
number	O
of	O
pregnancy	O
complications	O
including	O
GDM	O
,	O
PE	O
,	O
sPTB	O
and	O
SGA	O
[	O
46	O
].	O

Sampling	O
frame	O
and	O
sample	O
size	O
To	O
detect	O
a	O
25	O
%	O
reduction	O
in	O
neonatal	O
mortality	O
(	O
33	O
neonatal	O
deaths	O
/	O
1000	O
live	O
births	O
in	O
control	O
to	O
24	O
.	O
8	O
neonatal	O
deaths	O
/	O
1000	O
live	O
births	O
in	O
the	O
intervention	O
group	O
),	O
with	O
90	O
%	O
power	O
,	O
5	O
%	O
two	O
-	O
sided	O
alpha	O
,	O
1	O
:	O
1	O
ratio	O
of	O
treatment	O
allocation	O
and	O
intra	O
-	O
cluster	O
correlation	O
coefficient	O
(	O
ICC	O
)	O
of	O
0	O
.	O
0245	O
,	O
we	O
require	O
100	O
clusters	O
(	O
each	O
covering	O
an	O
average	O
of	O
4000	O
households	O
),	O
or	O
50	O
clusters	O
per	O
treatment	O
group	O
,	O
with	O
a	O
total	O
of	O
30	O
,	O
000	O
live	O
births	O
over	O
one	O
year	O
.	O

Common	O
risk	O
factors	O
for	O
developing	O
aortic	O
dissection	O
include	O
hypertension	O
,	O
collagen	O
disorders	O
including	O
Marfan	O
/	O
Ehlers	O
-	O
Danlos	O
syndromes	O
,	O
bicuspid	O
aortic	O
valve	O
,	O
positive	O
family	O
history	O
,	O
trauma	O
,	O
and	O
cocaine	O
use	O
[	O
3	O
–	O
7	O
].	O

We	O
then	O
controlled	O
for	O
potential	O
confounders	O
that	O
changed	O
multivariable	O
RRs	O
by	O
more	O
than	O
10	O
%	O
relative	O
to	O
the	O
unadjusted	O
RR	O
[	O
31	O
].	O

Many	O
women	O
who	O
gestate	O
through	O
a	O
typical	O
winter	O
in	O
the	O
northern	O
hemisphere	O
are	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
[	O
4	O
,	O
5	O
].	O

Negative	O
maternal	O
energy	O
status	O
at	O
mid	O
-	O
gestation	O
(	O
80	O
%	O
of	O
the	O
energy	O
requirements	O
for	O
maintenance	O
of	O
body	O
weight	O
)	O
did	O
not	O
affect	O
MS	O
,	O
intramuscular	O
fat	O
percentage	O
,	O
and	O
HCW	O
,	O
but	O
increased	O
the	O
ratio	O
of	O
MS	O
to	O
12th	O
rib	O
fat	O
thickness	O
and	O
the	O
ratio	O
of	O
percent	O
intramuscular	O
fat	O
to	O
12th	O
rib	O
fat	O
thickness	O
in	O
offspring	O
compared	O
with	O
positive	O
energy	O
status	O
[	O
154	O
].	O

1	O
Map	O
of	O
study	O
area	O
,	O
Shonjibon	O
Trial	O
(	O
created	O
by	O
the	O
authors	O
)	O
Cluster	O
selection	O
We	O
will	O
define	O
a	O
cluster	O
as	O
a	O
BRAC	O
PO	O
area	O
,	O
which	O
will	O
consist	O
of	O
a	O
pair	O
of	O
BRAC	O
village	O
field	O
workers	O
(	O
called	O
Shasthya	O
Kormi	O
or	O
SK	O
)	O
and	O
their	O
20	O
BRAC	O
village	O
volunteers	O
(	O
referred	O
to	O
as	O
Shasthya	O
Shebika	O
or	O
SS	O
)	O
who	O
are	O
supervised	O
by	O
a	O
single	O
BRAC	O
PO	O
.	O

The	O
analysis	O
showed	O
that	O
high	O
cord	O
25	O
(	O
OH	O
)	O
D	O
was	O
the	O
strongest	O
predictor	O
of	O
good	O
lung	O
function	O
performance	O
(	O
Table	O
3	O
),	O
and	O
vice	O
versa	O
,	O
low	O
cord	O
level	O
predicted	O
poor	O
lung	O
function	O
outcome	O
.	O

PCBs	O
,	O
PBDEs	O
,	O
OCPs	O
and	O
OPPs	O
were	O
lipid	O
-	O
normalized	O
in	O
units	O
of	O
ng	O
/	O
g	O
serum	O
lipid	O
.	O

[	O
20	O
]	O
reported	O
that	O
only	O
1	O
.	O
7	O
%	O
of	O
women	O
consumed	O
fish	O
oil	O
supplements	O
not	O
affecting	O
outcomes	O
,	O
however	O
,	O
this	O
study	O
did	O
not	O
consider	O
supplements	O
other	O
than	O
fish	O
oil	O
.	O

Multiple	O
linear	O
and	O
logistic	O
regression	O
models	O
were	O
constructed	O
to	O
investigate	O
significant	O
predictors	O
of	O
the	O
outcomes	O
of	O
interest	O
.	O

Earlier	O
studies	O
have	O
mostly	O
examined	O
the	O
effects	O
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
[	O
13	O
]	O
and	O
few	O
data	O
are	O
available	O
linking	O
habitual	O
diet	O
to	O
neonatal	O
anthropometric	O
measurements	O
.	O

5	O
.	O

Severe	O
or	O
poorly	O
controlled	O
asthma	O
may	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
fetal	O
death	O
,	O
low	O
birth	O
weight	O
,	O
congenital	O
malformations	O
,[	O
18	O
]	O
and	O
parental	O
complications	O
[	O
14	O
].	O

that	O
late	O
but	O
not	O
early	O
pregnancy	O
25OHD	O
was	O
related	O
to	O
gestational	O
length	O
and	O
neonatal	O
birth	O
size	O
[	O
8	O
].	O

P	O
is	O
for	O
trend	O
by	O
linear	O
regression	O
with	O
adjustment	O
for	O
confounders	O
.	O

However	O
,	O
it	O
appears	O
that	O
,	O
at	O
least	O
in	O
a	O
southern	O
US	O
setting	O
,	O
400	O
IU	O
/	O
day	O
is	O
adequate	O
for	O
infants	O
regardless	O
of	O
vitamin	O
D	O
status	O
at	O
birth	O
.	O

The	O
health	O
care	O
education	O
topics	O
were	O
similar	O
among	O
the	O
studies	O
reviewed	O
though	O
there	O
were	O
some	O
disparities	O
in	O
the	O
frequency	O
.	O

None	O
of	O
the	O
women	O
in	O
this	O
study	O
reported	O
the	O
use	O
of	O
dietary	O
supplements	O
containing	O
fish	O
oil	O
or	O
PUFA	O
at	O
baseline	O
.	O

Because	O
the	O
hypothalamus	O
is	O
an	O
important	O
regulator	O
of	O
food	O
intake	O
and	O
appetite	O
control	O
,	O
6it	O
can	O
be	O
hypothesized	O
that	O
the	O
HV	O
diet	O
alters	O
development	O
of	O
feeding	O
neurocircuitry	O
in	O
the	O
offspring	O
resulting	O
in	O
an	O
obesogenic	O
phenotype	O
.	O

The	O
structured	O
observation	O
was	O
conducted	O
on	O
days	O
30	O
–	O
32	O
postpartum	O
and	O
lasted	O
3	O
hours	O
.	O

Improving	O
the	O
vitamin	O
D	O
status	O
of	O
women	O
with	O
underlying	O
conditions	O
may	O
avert	O
the	O
need	O
for	O
a	O
medically	O
indicated	O
preterm	O
delivery	O
.	O

Gestational	O
age	O
at	O
enrollment	O
or	O
interview	O
was	O
not	O
a	O
confounder	O
in	O
this	O
study	O
.	O

More	O
than	O
20	O
%	O
of	O
the	O
women	O
in	O
the	O
sample	O
were	O
from	O
non	O
-	O
Caucasian	O
origin	O
.	O

The	O
fractionator	O
method	O
was	O
used	O
to	O
estimate	O
the	O
number	O
of	O
glomeruli	O
in	O
a	O
slice	O
(	O
starting	O
with	O
a	O
random	O
number	O
for	O
each	O
10th	O
section	O
).	O

While	O
fruit	O
is	O
considered	O
healthful	O
and	O
red	O
and	O
processed	O
meat	O
consumption	O
is	O
recommended	O
to	O
be	O
limited	O
,	O
OTUs	O
in	O
the	O
genus	O
Bifidobacterium	O
,	O
generally	O
recognized	O
as	O
a	O
beneficial	O
microbe	O
,	O
were	O
decreased	O
with	O
increasing	O
maternal	O
fruit	O
consumption	O
in	O
vaginally	O
born	O
infants	O
yet	O
increased	O
with	O
higher	O
maternal	O
red	O
and	O
processed	O
meat	O
consumption	O
in	O
those	O
born	O
by	O
Cesarean	O
section	O
.	O

†	O
t	O
-	O
test	O
,	O
*	O
chi	O
-	O
square	O
,	O
aFisher	O
’	O
s	O
Exact	O
Test	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
.	O

Of	O
the	O
SGA	O
deliveries	O
,	O
37	O
were	O
SGA	O
by	O
weight	O
and	O
56	O
by	O
length	O
.	O

This	O
study	O
points	O
towards	O
a	O
potential	O
gene	O
-	O
environment	O
interaction	O
that	O
could	O
be	O
of	O
predictive	O
value	O
for	O
fetal	O
weight	O
.	O

Methylation	O
at	O
CGIs	O
is	O
generally	O
associated	O
with	O
transcriptional	O
repression	O
,	O
although	O
the	O
local	O
CpG	O
density	O
within	O
a	O
specific	O
promoter	O
can	O
contribute	O
to	O
the	O
actual	O
transcriptional	O
effect	O
(	O
Hackett	O
&	O
Surani2013	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
).	O

At	O
the	O
verge	O
of	O
the	O
21st	O
century	O
,	O
rickets	O
was	O
sporadically	O
observed	O
in	O
Europe	O
.	O

A	O
cohort	O
study	O
on	O
the	O
Isle	O
of	O
Wight	O
,	O
United	O
Kingdom	O
,	O
found	O
adverse	O
reactions	O
to	O
food	O
in	O
approximately	O
20	O
%	O
of	O
969	O
pregnant	O
women	O
[	O
38	O
].	O

Based	O
on	O
our	O
current	O
information	O
,	O
insulin	O
is	O
still	O
the	O
best	O
option	O
,	O
with	O
the	O
least	O
potential	O
for	O
long	O
-	O
term	O
risk	O
to	O
the	O
mother	O
and	O
child	O
.	O

Inclusion	O
of	O
such	O
endpoints	O
as	O
non	O
-	O
compulsory	O
measurements	O
would	O
(	O
1	O
)	O
encourage	O
better	O
use	O
of	O
existing	O
studies	O
by	O
adding	O
a	O
valuable	O
non	O
-	O
genotoxic	O
/	O
epigenetic	O
component	O
that	O
is	O
not	O
currently	O
included	O
,	O
(	O
2	O
)	O
provide	O
an	O
extensive	O
sample	O
resource	O
and	O
(	O
3	O
)	O
initiate	O
the	O
collection	O
of	O
epigenetic	O
data	O
in	O
a	O
regulatory	O
context	O
.	O

Here	O
,	O
the	O
perception	O
of	O
the	O
past	O
users	O
is	O
the	O
only	O
driving	O
tool	O
to	O
refer	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Associations	O
between	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
and	O
number	O
of	O
prenatal	O
visits	O
,	O
among	O
categories	O
of	O
formal	O
educationFormal	O
education	O
(	O
years	O
)	O
Number	O
of	O
prenatal	O
visitsp	O
<	O
44	O
-	O
10	O
>	O
10	O
Folic	O
acid	O
use	O
(%)≤	O
8	O
2	O
.	O
114	O
.	O
630	O
.	O
8	O
.	O
007	O
9	O
-	O
12	O
4	O
.	O
344	O
.	O
372	O
.	O
5	O
<.	O
001	O
>	O
12	O
069	O
.	O
474	O
.	O
7	O
.	O
21	O
Iron	O
use	O
(%)≤	O
8	O
16	O
.	O
756	O
.	O
176	O
.	O
9	O
<.	O
001	O
9	O
-	O
12	O
21	O
.	O
751	O
.	O
466	O
.	O
7	O
<.	O
001	O
>	O
12	O
10077	O
.	O
862	O
.	O
6	O
.	O
19	O
Multivitamins	O
use	O
(%)≤	O
8	O
22	O
.	O
953	O
.	O
776	O
.	O
9	O
<.	O
001	O
9	O
-	O
12	O
26	O
.	O
17079	O
.	O
7	O
<.	O
001	O
>	O
12	O
10088	O
.	O
987	O
.	O
5	O
.	O
88	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Associations	O
between	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
and	O
the	O
interaction	O
between	O
the	O
number	O
of	O
prenatal	O
visits	O
and	O
formal	O
education	O
level	O
Folic	O
acidIronVitamins	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
Education	O
*	O
Prenatal	O
care	O
interaction	O
PC1	O
*	O
E1110	O
.	O
63	O
(	O
14	O
.	O
94	O
-	O
818	O
.	O
97	O
)	O
63	O
.	O
86	O
(	O
8	O
.	O
47	O
-	O
481	O
.	O
41	O
)	O
10	O
.	O
35	O
(	O
4	O
.	O
60	O
-	O
23	O
.	O
27	O
)	O
7	O
.	O
95	O
(	O
3	O
.	O
36	O
-	O
18	O
.	O
83	O
)	O
18	O
.	O
20	O
(	O
8	O
.	O
46	O
-	O
39	O
.	O
16	O
)	O
11	O
.	O
25	O
(	O
4	O
.	O
96	O
-	O
25	O
.	O
49	O
)	O
PC1	O
*	O
E251	O
.	O
78	O
(	O
6	O
.	O
83	O
-	O
392	O
.	O
29	O
)	O
32	O
.	O
281	O
(	O
4	O
.	O
97	O
-	O
294	O
.	O
63	O
)	O
7	O
.	O
45	O
(	O
2	O
.	O
66	O
-	O
20	O
.	O
88	O
)	O
6	O
.	O
20	O
(	O
2	O
.	O
17	O
-	O
17	O
.	O
73	O
)	O
15	O
.	O
33	O
(	O
5	O
.	O
64	O
-	O
41	O
.	O
68	O
)	O
11	O
.	O
71	O
(	O
4	O
.	O
17	O
-	O
32	O
.	O
87	O
)	O
PC2	O
*	O
E113	O
.	O
73	O
(	O
5	O
.	O
50	O
-	O
34	O
.	O
22	O
)	O
10	O
.	O
941	O
(	O
4	O
.	O
30	O
-	O
27	O
.	O
78	O
)	O
1	O
.	O
62	O
(	O
0	O
.	O
82	O
-	O
3	O
.	O
19	O
)	O
1	O
.	O
38	O
(	O
0	O
.	O
68	O
-	O
2	O
.	O
79	O
)	O
4	O
.	O
67	O
(	O
2	O
.	O
28	O
-	O
9	O
.	O
55	O
)	O
3	O
.	O
65	O
(	O
1	O
.	O
72	O
-	O
7	O
.	O
71	O
)	O
PC2	O
*	O
E22	O
.	O
96	O
(	O
1	O
.	O
70	O
-	O
5	O
.	O
15	O
)	O
2	O
.	O
51	O
(	O
1	O
.	O
41	O
-	O
4	O
.	O
49	O
)	O
1	O
.	O
95	O
(	O
1	O
.	O
13	O
-	O
3	O
.	O
38	O
)	O
1	O
.	O
73	O
(	O
1	O
.	O
10	O
-	O
3	O
.	O
03	O
)	O
2	O
.	O
31	O
(	O
1	O
.	O
23	O
-	O
4	O
.	O
34	O
)	O
2	O
.	O
03	O
(	O
1	O
.	O
05	O
-	O
3	O
.	O
91	O
)	O
Nutritional	O
knowledge	O
score	O
Low111111	O
Medium6	O
.	O
67	O
(	O
2	O
.	O
62	O
-	O
17	O
.	O
01	O
)	O
1	O
.	O
47	O
(	O
0	O
.	O
74	O
-	O
2	O
.	O
89	O
)	O
1	O
.	O
80	O
(	O
0	O
.	O
99	O
-	O
3	O
.	O
27	O
)	O
1	O
.	O
65	O
(	O
0	O
.	O
86	O
-	O
3	O
.	O
15	O
)	O
3	O
.	O
58	O
(	O
1	O
.	O
88	O
-	O
6	O
.	O
80	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
52	O
-	O
2	O
.	O
50	O
)	O
High8	O
.	O
30	O
(	O
2	O
.	O
99	O
-	O
23	O
.	O
4	O
)	O
7	O
.	O
13	O
(	O
2	O
.	O
33	O
-	O
21	O
.	O
80	O
)	O
2	O
.	O
41	O
(	O
1	O
.	O
14	O
-	O
5	O
.	O
14	O
)	O
2	O
.	O
37	O
(	O
1	O
.	O
50	O
-	O
5	O
.	O
65	O
)	O
3	O
.	O
48	O
(	O
1	O
.	O
50	O
-	O
8	O
.	O
10	O
)	O
3	O
.	O
62	O
(	O
1	O
.	O
38	O
-	O
9	O
.	O
51	O
)	O
PC1	O
–	O
prenatal	O
care	O
:≥	O
10	O
visits	O
;	O
PC2	O
-	O
prenatal	O
care	O
:	O
4	O
–	O
9	O
visits	O
;	O
reference	O
category	O
-	O
<	O
4	O
visits	O
.	O

Indeed	O
,	O
Nishihara	O
et	O
al	O
.	O

There	O
are	O
few	O
data	O
from	O
India	O
about	O
the	O
prevalence	O
of	O
hypovitaminosis	O
D	O
in	O
pregnancy	O
and	O
in	O
the	O
newborn	O
.	O

The	O
calculation	O
was	O
based	O
on	O
a	O
small	O
effect	O
size	O
F2of	O
0	O
.	O
05	O
;	O
probability	O
of	O
error	O
(	O
alpha	O
)	O
of	O
5	O
%;	O
a	O
power	O
of	O
80	O
%	O
and	O
ten	O
predictors	O
on	O
the	O
birth	O
outcome	O
“	O
low	O
birth	O
weight	O
”.	O

Furthermore	O
,	O
there	O
are	O
data	O
supporting	O
that	O
breast	O
-	O
feeding	O
should	O
not	O
be	O
continued	O
beyond	O
9	O
months	O
of	O
age	O
because	O
doing	O
so	O
seems	O
to	O
increase	O
the	O
child	O
'	O
s	O
risk	O
for	O
atopic	O
diseases	O
,	O
such	O
as	O
atopic	O
dermatitis	O
and	O
food	O
hypersensitivity	O
[	O
116	O
].	O

The	O
answer	O
,	O
as	O
it	O
turned	O
out	O
,	O
wasn	O
’	O
t	O
uranium	O
itself	O
but	O
its	O
decay	O
products	O
,	O
including	O
radium	O
,	O
10thorium	O
,	O
11and	O
radon	O
.	O
12	O
Radon	O
is	O
a	O
gas	O
,	O
but	O
with	O
a	O
half	O
-	O
life	O
of	O
four	O
days	O
,	O
it	O
rapidly	O
decays	O
into	O
solid	O
products	O
,	O
explains	O
Doug	O
Brugge	O
,	O
a	O
professor	O
of	O
public	O
health	O
at	O
Tufts	O
University	O
.	O
13	O
“	O
Being	O
solids	O
,	O
these	O
are	O
going	O
to	O
want	O
to	O
stick	O
to	O
things	O
like	O
your	O
lungs	O
,”	O
Brugge	O
says	O
.	O

Therefore	O
,	O
a	O
better	O
method	O
to	O
achieve	O
high	O
digestibility	O
of	O
starch	O
in	O
the	O
small	O
intestine	O
is	O
required	O
to	O
provide	O
high	O
post	O
-	O
absorptive	O
glucose	O
to	O
the	O
host	O
animal	O
.	O

Our	O
study	O
did	O
not	O
find	O
a	O
difference	O
in	O
self	O
-	O
reported	O
physical	O
activity	O
across	O
the	O
seasons	O
.	O

This	O
can	O
improve	O
after	O
dental	O
surgery	O
under	O
GA	O
[	O
3	O
,	O
9	O
].	O

Prospective	O
studies	O
are	O
needed	O
to	O
minimize	O
these	O
biases	O
.	O

The	O
Avy	O
model	O
in	O
particular	O
has	O
been	O
put	O
forward	O
as	O
a	O
potential	O
epigenetic	O
toxicological	O
tool	O
(	O
Dolinoy2008	O
;	O
Rosenfeld2010	O
;	O
Faulk	O
et	O
al	O
.	O
2013	O
).	O

Therefore	O
,	O
examining	O
childhood	O
nutrition	O
and	O
obesity	O
from	O
a	O
developmental	O
perspective	O
is	O
warranted	O
.	O

Hypervitaminosis	O
D	O
is	O
thought	O
to	O
be	O
associated	O
with	O
a	O
rare	O
infant	O
disease	O
with	O
supravalvular	O
aortic	O
stenosis	O
,	O
elfin	O
facies	O
and	O
mental	O
retardation	O
.	O

Surely	O
,	O
it	O
is	O
better	O
for	O
both	O
society	O
and	O
public	O
health	O
to	O
fully	O
assess	O
the	O
potential	O
epigenetic	O
effects	O
of	O
environmental	O
exposures	O
and	O
introduce	O
regulations	O
and	O
TGs	O
based	O
on	O
relevant	O
data	O
and	O
proven	O
mechanisms	O
of	O
toxicity	O
.	O

Interestingly	O
,	O
the	O
CB2	O
receptor	O
activation	O
was	O
associated	O
with	O
anti	O
-	O
obesity	O
effects	O
(	O
Verty	O
et	O
al	O
.,	O
2015	O
)	O
and	O
a	O
decreased	O
risk	O
for	O
cardiovascular	O
diseases	O
.	O

Therefore	O
,	O
an	O
average	O
daily	O
dose	O
of	O
4	O
–	O
6	O
mg	O
of	O
iron	O
is	O
required	O
in	O
the	O
second	O
and	O
third	O
trimesters	O
of	O
pregnancy	O
[	O
14	O
].	O

The	O
intervention	O
resulted	O
in	O
greater	O
maintenance	O
of	O
handwashing	O
materials	O
in	O
locations	O
where	O
mothers	O
are	O
cocooned	O
with	O
neonate	O
.	O

Epigenetic	O
modifications	O
have	O
been	O
suggested	O
to	O
occur	O
during	O
development	O
(	O
fetal	O
programming	O
),	O
growth	O
,	O
and	O
fat	O
deposition	O
in	O
cattle	O
[	O
13	O
,	O
18	O
,	O
159	O
].	O

We	O
analysed	O
free	O
sugar	O
intake	O
in	O
quintiles	O
:	O
1	O
)	O
as	O
a	O
categorical	O
variable	O
using	O
the	O
lowest	O
quintile	O
as	O
reference	O
to	O
allow	O
for	O
a	O
nonlinear	O
pattern	O
of	O
association	O
and	O
2	O
)	O
as	O
a	O
continuous	O
variable	O
to	O
test	O
for	O
linear	O
trend	O
(	O
i	O
.	O
e	O
.	O

But	O
she	O
will	O
need	O
to	O
consume	O
much	O
more	O
to	O
obtain	O
this	O
daily	O
requirement	O
(	O
i	O
.	O
e	O
.,	O
between	O
20	O
and	O
48	O
mg	O
of	O
dietary	O
iron	O
)	O
[	O
18	O
].	O

What	B
Might	O
Delay	O
Lactogenesis	O
?	B

As	O
such	O
a	O
dose	O
is	O
far	O
higher	O
than	O
the	O
daily	O
dietary	O
allowance	O
recommended	O
for	O
lactating	O
mothers	O
its	O
safety	O
over	O
prolonged	O
periods	O
is	O
not	O
known	O
and	O
should	O
be	O
examined	O
.	O

The	O
remaining	O
four	O
studies	O
did	O
not	O
correct	O
for	O
either	O
paternal	O
IQ	O
or	O
home	O
environment	O
.	O

Supplementing	O
rumen	O
-	O
protected	O
vitamin	O
C	O
in	O
a	O
high	O
sulfur	O
diet	O
increased	O
the	O
MS	O
and	O
the	O
percentage	O
of	O
Choice	O
grade	O
beef	O
in	O
Angus	O
cross	O
steers	O
[	O
151	O
].	O

Infant	O
sex	O
and	O
maternal	O
ethnicity	O
were	O
also	O
significant	O
predictors	O
of	O
birth	O
weight	O
percentile	O
(	O
Table	O
1	O
);	O
all	O
other	O
covariates	O
were	O
not	O
significant	O
.	O

Marbling	O
adipocytes	O
are	O
also	O
found	O
within	O
muscle	O
bundles	O
in	O
the	O
longissimus	O
dorsi	O
muscle	O
(	O
LM	O
)	O
of	O
high	O
-	O
quality	O
grade	O
Japanese	O
Black	O
cattle	O
[	O
5	O
].	O

Despite	O
these	O
,	O
our	O
study	O
was	O
able	O
to	O
replicate	O
findings	O
reported	O
in	O
individuals	O
from	O
developed	O
countries	O
.	O

Additionally	O
,	O
16	O
(	O
6	O
.	O
1	O
%)	O
had	O
deficient	O
vitamin	O
D	O
concentrations	O
(<	O
35	O
nmol	O
/	O
L	O
).	O

Glucose	O
intolerance	O
and	O
gestational	O
diabetes	O
risk	O
in	O
relation	O
to	O
sleep	O
duration	O
and	O
snoring	O
during	O
pregnancy	O
:	O
a	O
pilot	O
study	O
Abstract	O
Background	O
Insufficient	O
sleep	O
and	O
poor	O
sleep	O
quality	O
,	O
considered	O
endemic	O
in	O
modern	O
society	O
,	O
are	O
associated	O
with	O
obesity	O
,	O
impaired	O
glucose	O
tolerance	O
and	O
diabetes	O
.	O

Children	O
'	O
s	O
patterns	O
of	O
weight	O
gain	O
vary	O
by	O
sex	O
and	O
age	O
(	O
85	O
),	O
and	O
during	O
stages	O
of	O
rapid	O
growth	O
,	O
caloric	O
requirements	O
increase	O
.	O

Throughout	O
the	O
manuscript	O
,	O
we	O
have	O
provided	O
values	O
for	O
25	O
(	O
OH	O
)	O
D	O
as	O
ng	O
/	O
mL	O
,	O
these	O
may	O
be	O
multiplied	O
by	O
2	O
.	O
5	O
to	O
obtain	O
results	O
in	O
nmol	O
/	O
L	O
.	O

For	O
example	O
,	O
serum	O
ferritin	O
level	O
,	O
being	O
an	O
acute	O
-	O
phase	O
protein	O
,	O
is	O
raised	O
in	O
associated	O
underlying	O
infections	O
and	O
long	O
-	O
term	O
diseases	O
;	O
it	O
can	O
therefore	O
give	O
a	O
false	O
normal	O
or	O
high	O
level	O
in	O
a	O
state	O
of	O
iron	O
deficiency	O
.	O

The	O
effects	O
of	O
several	O
management	O
factors	O
,	O
including	O
weaning	O
age	O
,	O
castration	O
,	O
slaughter	O
weight	O
and	O
age	O
,	O
and	O
environmental	O
conditions	O
on	O
IMF	O
deposition	O
are	O
also	O
reviewed	O
.	O

Although	O
the	O
FFQ	O
that	O
we	O
used	O
had	O
not	O
been	O
formally	O
calibrated	O
against	O
other	O
instruments	O
such	O
as	O
diet	O
diaries	O
,	O
it	O
was	O
based	O
on	O
the	O
one	O
used	O
by	O
Yarnell	O
et	O
al	O
.	O

All	O
participants	O
gave	O
informed	O
consent	O
to	O
participate	O
in	O
the	O
study	O
and	O
ethical	O
approval	O
was	O
granted	O
by	O
the	O
local	O
ethics	O
committee	O
of	O
the	O
hospital	O
.	O

However	O
and	O
despite	O
these	O
limitations	O
,	O
there	O
is	O
a	O
wealth	O
of	O
literature	O
using	O
those	O
two	O
cell	O
lines	O
as	O
experimental	O
models	O
to	O
study	O
placental	O
function	O
.	O

We	O
acknowledge	O
the	O
limitation	O
that	O
the	O
scale	O
have	O
not	O
been	O
used	O
earlier	O
in	O
Sweden	O
and	O
validated	O
in	O
the	O
Swedish	O
population	O
.	O

There	O
are	O
two	O
major	O
forms	O
of	O
active	O
Vitamin	O
D	O
,	O
Vitamin	O
D2	O
(	O
ergocalciferol	O
)	O
and	O
Vitamin	O
D3	O
(	O
cholecalciferol	O
).	O

Varying	O
observations	O
,	O
however	O
,	O
have	O
been	O
made	O
when	O
determining	O
whether	O
a	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
concentrations	O
exists	O
.	O

There	O
were	O
no	O
differences	O
in	O
NAL	O
throughout	O
the	O
study	O
.	O

In	O
total	O
,	O
18	O
of	O
the	O
40	O
studies	O
shown	O
inTable	O
2validated	O
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	O
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
;	O
thereby	O
demonstrating	O
a	O
definitive	O
causal	O
link	O
between	O
exposure	O
(	O
largely	O
high	O
dose	O
)	O
to	O
BPA	O
,	O
formaldehyde	O
,	O
cadmium	O
,	O
methylmercury	O
,	O
2	O
,	O
3	O
,	O
7	O
,	O
8	O
-	O
tetra	O
-	O
chloro	O
-	O
dibenzo	O
-	O
p	O
-	O
dioxin	O
(	O
TCDD	O
),	O
urethane	O
,	O
vinyl	O
carbamate	O
,	O
alcohol	O
,	O
caffeine	O
,	O
overnutrition	O
,	O
cigarette	O
smoke	O
,	O
nicotine	O
or	O
4	O
-(	O
methyl	O
-	O
nitrosamino	O
)-	O
1	O
-(	O
3	O
-	O
pyridyl	O
)-	O
1	O
-	O
butanone	O
(	O
NNK	O
),	O
epigenetic	O
changes	O
and	O
adverse	O
phenotypes	O
.	O

Non	O
-	O
persistent	O
chemicals	O
exhibit	O
larger	O
degrees	O
of	O
measurement	O
error	O
.	O

Inter	O
-	O
and	O
intra	O
-	O
assay	O
coefficients	O
of	O
variation	O
for	O
the	O
hip	O
and	O
spine	O
phantoms	O
were	O
1	O
%	O
or	O
less	O
.	O

An	O
unquantified	O
food	O
frequency	O
questionnaire	O
for	O
the	O
infant	O
is	O
administered	O
at	O
phases	O
6	O
and	O
8	O
for	O
qualitative	O
assessment	O
(	O
types	O
and	O
frequency	O
)	O
of	O
milk	O
and	O
complementary	O
feeding	O
at	O
6	O
and	O
12	O
months	O
postnatally	O
.	O

Prior	O
to	O
analysis	O
,	O
collinearity	O
between	O
the	O
two	O
predictor	O
variables	O
was	O
measured	O
using	O
Spearman	O
’	O
s	O
rho	O
to	O
ensure	O
they	O
were	O
independent	O
;	O
relatively	O
low	O
correlation	O
was	O
observed	O
between	O
the	O
variables	O
(	O
r	O
=	O
0	O
.	O
24	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Low	O
adherence	O
with	O
advice	O
about	O
supplements	O
was	O
associated	O
with	O
unwanted	O
pregnancy	O
,	O
low	O
maternal	O
age	O
and	O
low	O
economic	O
status	O
in	O
the	O
United	O
Kingdom	O
[	O
36	O
],	O
unplanned	O
pregnancy	O
and	O
lack	O
of	O
education	O
regarding	O
the	O
role	O
of	O
folic	O
acid	O
in	O
South	O
Korea	O
[	O
37	O
].	O

Initiating	O
these	O
changes	O
can	O
start	O
to	O
move	O
countries	O
toward	O
their	O
goal	O
of	O
preterm	O
mortality	O
reduction	O
while	O
also	O
preventing	O
death	O
due	O
to	O
other	O
causes	O
of	O
newborn	O
death	O
,	O
as	O
well	O
as	O
maternal	O
deaths	O
and	O
stillbirths	O
,	O
through	O
shared	O
interventions	O
such	O
as	O
skilled	O
care	O
at	O
birth	O
.	O

The	O
intervention	O
was	O
implemented	O
in	O
two	O
districts	O
targeting	O
all	O
50	O
,	O
000	O
women	O
of	O
reproductive	O
age	O
,	O
and	O
a	O
cost	O
analysis	O
was	O
undertaken	O
.	O

Higher	O
vaccination	O
among	O
pregnant	O
women	O
with	O
high	O
-	O
risk	O
pregnancies	O
could	O
have	O
caused	O
a	O
selection	O
bias	O
as	O
those	O
vaccinated	O
women	O
would	O
have	O
been	O
at	O
higher	O
risk	O
for	O
adverse	O
pregnancy	O
outcomes	O
compared	O
to	O
unvaccinated	O
women	O
.	O

In	O
another	O
study	O
of	O
Massachusetts	O
women	O
,	O
black	O
women	O
reported	O
taking	O
periconceptional	O
multivitamins	O
half	O
as	O
often	O
as	O
white	O
women	O
.	O
19Additionally	O
,	O
our	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
is	O
similar	O
to	O
that	O
reported	O
in	O
NHANES24and	O
in	O
another	O
Boston	O
cohort	O
,	O
Project	O
Viva	O
.	O
13	O
,	O
25Others	O
have	O
analyzed	O
the	O
association	O
between	O
PNV	O
use	O
and	O
vitamin	O
D	O
status	O
.	O

Regular	O
milk	O
drinkers	O
had	O
better	O
vitamin	O
D	O
concentrations	O
,	O
a	O
finding	O
supported	O
by	O
a	O
large	O
-	O
scale	O
clinical	O
study	O
observing	O
an	O
association	O
between	O
frequent	O
milk	O
consumption	O
and	O
increased	O
25	O
(	O
OH	O
)	O
D	O
[	O
33	O
].	O

For	O
these	O
reasons	O
,	O
total	O
thyroidectomy	O
appears	O
to	O
be	O
the	O
appropriate	O
approach	O
to	O
MTC	O
.	O

Vitamin	O
D	O
deficiency	O
is	O
prevalent	O
in	O
India	O
,	O
a	O
finding	O
that	O
is	O
unexpected	O
in	O
a	O
tropical	O
country	O
with	O
abundant	O
sunshine	O
.	O

There	O
may	O
be	O
additional	O
financial	O
benefits	O
associated	O
with	O
reductions	O
in	O
other	O
health	O
care	O
costs	O
such	O
as	O
those	O
associated	O
with	O
reduced	O
maternal	O
and	O
infant	O
mortality	O
,	O
and	O
a	O
reduction	O
in	O
neural	O
tube	O
defects	O
which	O
cannot	O
readily	O
be	O
quantified	O
.	O

A	O
PET	O
/	O
CT	O
study	O
revealed	O
the	O
presence	O
of	O
BAT	O
depots	O
in	O
the	O
lower	O
neck	O
,	O
suprascapular	O
,	O
mediastinal	O
,	O
and	O
thoracic	O
paravertebral	O
regions	O
.	O

Podolian	O
bulls	O
fed	O
grazing	O
pasture	O
and	O
fed	O
a	O
high	O
protein	O
(	O
15	O
%	O
CP	O
,	O
DM	O
basis	O
)	O
supplement	O
had	O
higher	O
IMF	O
content	O
in	O
the	O
LM	O
than	O
did	O
animals	O
grazing	O
pasture	O
and	O
fed	O
a	O
low	O
protein	O
(	O
12	O
%	O
CP	O
)	O
supplement	O
[	O
126	O
].	O

Waist	O
circumference	O
(	O
WC	O
)	O
was	O
recorded	O
at	O
a	O
level	O
midway	O
between	O
the	O
lower	O
rib	O
margin	O
and	O
the	O
iliac	O
crest	O
at	O
the	O
end	O
of	O
normal	O
expiration	O
.	O

Mothers	O
are	O
instructed	O
on	O
how	O
to	O
complete	O
the	O
calendar	O
and	O
to	O
return	O
completed	O
calendars	O
at	O
each	O
visit	O
.	O

This	O
index	O
is	O
not	O
recorded	O
in	O
Romania	O
;	O
instead	O
,	O
we	O
evaluated	O
engagement	O
in	O
prenatal	O
care	O
according	O
to	O
Ministry	O
of	O
Health	O
recommendations	O
,	O
which	O
refer	O
to	O
the	O
total	O
number	O
of	O
prenatal	O
consultations	O
and	O
time	O
of	O
initiation	O
of	O
care	O
.	O

We	O
observed	O
a	O
negative	O
association	O
between	O
fruit	O
intake	O
and	O
OTUs	O
of	O
the	O
genus	O
Bifidobacterium	O
and	O
a	O
positive	O
association	O
with	O
OTUs	O
in	O
the	O
Clostridiaceae	O
family	O
in	O
the	O
infant	O
gut	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S2d	O
).	O

The	O
NAD	O
+	O
dependent	O
deacetylase	O
SIRT1	O
is	O
implicated	O
in	O
energy	O
balance	O
regulation	O
by	O
its	O
effect	O
on	O
pro	O
-	O
opiomelanocortin	O
and	O
agouti	O
-	O
related	O
peptide	O
(	O
AgRP	O
)	O
neurons	O
in	O
the	O
arcuate	O
nucleus	O
of	O
the	O
hypothalamusthis	O
(	O
20	O
).	O

Prior	O
to	O
proper	O
analysis	O
,	O
the	O
frequencies	O
and	O
ranges	O
of	O
every	O
variable	O
were	O
verified	O
for	O
consistency	O
with	O
the	O
study	O
population	O
.	O

Visfatin	O
is	O
expressed	O
in	O
bovine	O
mammary	O
epithelial	O
cells	O
,	O
lactating	O
mammary	O
gland	O
,	O
and	O
milk	O
,	O
which	O
is	O
regulated	O
by	O
the	O
cAMP	O
pathway	O
(	O
24	O
).	O

It	O
can	O
be	O
observed	O
that	O
a	O
slight	O
increase	O
in	O
fT4	O
and	O
a	O
reduction	O
in	O
TSH	O
occur	O
between	O
the	O
9thand	O
12thweeks	O
of	O
gestation	O
;	O
subsequently	O
,	O
HCG	O
levels	O
decrease	O
and	O
TSH	O
reaches	O
normal	O
non	O
-	O
pregnant	O
levels	O
.	O

If	O
a	O
child	O
was	O
not	O
seen	O
for	O
more	O
than	O
45	O
days	O
,	O
at	O
the	O
two	O
weekly	O
visits	O
,	O
or	O
at	O
the	O
hospital	O
,	O
they	O
were	O
censored	O
for	O
that	O
period	O
of	O
our	O
study	O
.	O

Conversely	O
,	O
vitamin	O
D	O
deficiency	O
results	O
in	O
proximal	O
muscle	O
weakness	O
and	O
decreased	O
lower	O
extremity	O
muscle	O
function	O
perhaps	O
contributing	O
to	O
the	O
risk	O
for	O
cesarean	O
section	O
.	O

While	O
this	O
large	O
body	O
of	O
work	O
also	O
provides	O
some	O
comprehensive	O
evidence	O
for	O
,	O
and	O
specific	O
mechanisms	O
of	O
,	O
epigenetic	O
toxicity	O
,	O
it	O
was	O
considered	O
outside	O
the	O
scope	O
of	O
this	O
review	O
.	O

Therefore	O
,	O
the	O
current	O
study	O
includes	O
133	O
women	O
who	O
received	O
SGA	O
medications	O
during	O
pregnancy	O
and	O
133	O
matched	O
healthy	O
women	O
(	O
N	O
=	O
266	O
).	O

Similarly	O
,	O
maternal	O
prenatal	O
behaviors	O
may	O
differentially	O
impact	O
birth	O
and	O
6	O
months	O
offspring	O
weights	O
(	O
e	O
.	O
g	O
.,	O
protein	O
impacting	O
6	O
month	O
but	O
not	O
birth	O
weight	O
in	O
the	O
current	O
study	O
).	O

Statistical	O
analysis	O
Concentrations	O
of	O
25OHD	O
at	O
T1	O
and	O
T3	O
were	O
used	O
as	O
categorical	O
variables	O
,	O
grouped	O
into	O
25OHD	O
<	O
30	O
(	O
used	O
as	O
reference	O
category	O
),	O
30	O
–	O
49	O
.	O
9	O
,	O
50	O
–	O
74	O
.	O
9	O
,	O
75	O
–	O
99	O
.	O
9	O
and	O
≥	O
100	O
nmol	O
/	O
L	O
.	O

Children	O
were	O
classified	O
as	O
overweight	O
(+	O
1	O
SDS	O
)	O
or	O
obese	O
(+	O
2	O
SDS	O
)	O
according	O
to	O
BMI	O
-	O
for	O
-	O
age	O
following	O
the	O
cut	O
-	O
off	O
parameters	O
of	O
the	O
WHO	O
growth	O
standards	O
[	O
23	O
].	O

S	O
-	O
ECC	O
,	O
infrequent	O
milk	O
intake	O
,	O
and	O
winter	O
season	O
were	O
associated	O
with	O
lower	O
25	O
(	O
OH	O
)	O
D	O
levels	O
,	O
but	O
not	O
household	O
income	O
or	O
vitamin	O
D	O
drop	O
use	O
.	O

Statistical	O
significance	O
was	O
set	O
at	O
p	O
<	O
0	O
.	O
05	O
(	O
two	O
-	O
sided	O
)	O
with	O
no	O
adjustment	O
for	O
multiple	O
comparisons	O
,	O
and	O
all	O
analyses	O
followed	O
a	O
pre	O
-	O
specified	O
plan	O
.	O

Although	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
black	O
mothers	O
and	O
neonates	O
is	O
well	O
known	O
,	O
debate	O
exists	O
as	O
to	O
the	O
relationship	O
between	O
race	O
,	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
.	O
12	O
,	O
14	O
,	O
15	O
,	O
17	O
,	O
18We	O
examined	O
this	O
relationship	O
in	O
conjunction	O
with	O
additional	O
maternal	O
characteristics	O
in	O
order	O
to	O
identify	O
groups	O
of	O
pregnant	O
women	O
who	O
could	O
benefit	O
most	O
from	O
vitamin	O
D	O
supplementation	O
.	O

Results	O
:	O
Black	O
race	O
,	O
Medicaid	O
status	O
,	O
mean	O
body	O
mass	O
index	O
at	O
delivery	O
and	O
lack	O
of	O
prenatal	O
vitamin	O
use	O
were	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
.	O

Nevertheless	O
,	O
the	O
statistically	O
significant	O
effect	O
and	O
the	O
size	O
of	O
differences	O
observed	O
between	O
mothers	O
with	O
negative	O
versus	O
positive	O
and	O
neutral	O
attitudes	O
in	O
the	O
Tht111	O
I	O
CC	O
polymorphism	O
group	O
suggest	O
that	O
this	O
effect	O
may	O
be	O
robust	O
.	O

Thus	O
,	O
correlation	O
estimates	O
obtained	O
are	O
comparable	O
across	O
cohorts	O
and	O
age	O
groups	O
.	O

These	O
results	O
were	O
consistent	O
when	O
infants	O
delivered	O
prematurely	O
were	O
not	O
included	O
in	O
the	O
analyses	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S9	O
,	O
Figure	O
S6a	O
).	O

Skm1	O
mice	O
were	O
thin	O
and	O
exhibited	O
a	O
marked	O
thoracolumbar	O
kyphosis	O
(	O
Figure	O
4	O
,	O
C	O
and	O
D	O
)	O
compared	O
to	O
wild	O
-	O
type	O
littermates	O
(	O
Figure	O
4	O
,	O
A	O
and	O
B	O
).	O

It	O
would	O
have	O
been	O
worthwhile	O
to	O
include	O
some	O
more	O
topics	O
such	O
as	O
management	O
of	O
severely	O
acute	O
malnutrition	O
,	O
examples	O
of	O
high	O
,	O
low	O
and	O
moderate	O
glycaemic	O
index	O
foods	O
,	O
how	O
to	O
read	O
food	O
labels	O
(	O
with	O
examples	O
),	O
etc	O
and	O
also	O
additional	O
references	O
for	O
further	O
reading	O
would	O
have	O
been	O
beneficial	O
as	O
the	O
chapters	O
are	O
a	O
quick	O
guide	O
to	O
appraise	O
the	O
topic	O
.	O

In	O
light	O
of	O
two	O
recent	O
meta	O
-	O
analyses	O
/	O
systematic	O
reviews	O
concluding	O
that	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
during	O
pregnancy	O
are	O
associated	O
with	O
several	O
morbidities	O
in	O
pregnancy15	O
,	O
16	O
,	O
optimizing	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
may	O
be	O
important	O
.	O

Examination	O
for	O
concentration	O
of	O
VD2and	O
glucose	O
of	O
follicular	O
fluid	O
in	O
101	O
patients	O
treated	O
with	O
IVF	O
-	O
ICSI	O
method	O
reported	O
poorer	O
quality	O
of	O
embryos	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
a	O
lower	O
rate	O
of	O
clinical	O
pregnancies	O
(	O
14	O
.	O
5	O
%)	O
in	O
patients	O
with	O
VD	O
levels	O
exceeding	O
75	O
nmol	O
/	O
L	O
.	O

A	O
significant	O
percent	O
of	O
infants	O
with	O
a	O
history	O
of	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
bronchiolitis	O
infection	O
,	O
which	O
peaks	O
during	O
the	O
winter	O
season	O
,	O
develop	O
asthma	O
[	O
64	O
].	O

We	O
found	O
that	O
exposure	O
to	O
phthalates	O
and	O
BPA	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
or	O
OCPs	O
had	O
null	O
or	O
small	O
associations	O
with	O
birth	O
weight	O
.	O

The	O
second	O
re	O
-	O
programing	O
and	O
programing	O
event	O
involves	O
PGCs	O
only	O
.	O

This	O
also	O
reduces	O
the	O
Type	O
I	O
error	O
(	O
false	O
positive	O
)	O
rate	O
because	O
the	O
shrunken	O
beta	O
coefficients	O
are	O
closer	O
to	O
zero	O
[	O
33	O
].	O

Effects	O
of	O
dietary	O
energy	O
(	O
TDN	O
:	O
70	O
%,	O
80	O
%;	O
DM	O
basis	O
)	O
and	O
protein	O
levels	O
(	O
crude	O
protein	O
[	O
CP	O
]:	O
11	O
.	O
9	O
%,	O
14	O
.	O
3	O
%;	O
DM	O
basis	O
)	O
on	O
growth	O
performance	O
,	O
carcass	O
characteristics	O
and	O
meat	O
quality	O
were	O
examined	O
in	O
F1	O
Angus	O
×	O
Chinese	O
Xiangxi	O
yellow	O
cattle	O
[	O
125	O
].	O

A	O
separate	O
study	O
from	O
Western	O
Australia	O
concluded	O
that	O
autistic	O
children	O
generally	O
had	O
parents	O
who	O
were	O
older	O
and	O
had	O
greater	O
frequencies	O
of	O
threatened	O
abortions	O
,	O
epidural	O
anesthesia	O
,	O
labor	O
induction	O
,	O
and	O
labor	O
duration	O
of	O
less	O
than	O
1	O
hour	O
.	O

Although	O
they	O
did	O
not	O
start	O
early	O
,	O
these	O
figures	O
indicate	O
there	O
is	O
a	O
substantial	O
opportunity	O
to	O
improve	O
IFA	O
supplements	O
distribution	O
in	O
rural	O
Bangladesh	O
.	O

Furthermore	O
,	O
IMF	O
has	O
a	O
higher	O
expression	O
of	O
glucose	O
transporter	O
4	O
,	O
which	O
is	O
responsible	O
for	O
uptake	O
of	O
glucose	O
in	O
adipose	O
tissues	O
,	O
compared	O
to	O
subcutaneous	O
fat	O
(	O
reviewed	O
in	O
[	O
90	O
]).	O

Results	O
We	O
report	O
that	O
in	O
the	O
female	O
rat	O
,	O
pubertal	O
timing	O
and	O
subsequent	O
ovarian	O
function	O
is	O
influenced	O
by	O
the	O
animal	O
'	O
s	O
nutritional	O
status	O
in	O
utero	O
,	O
with	O
both	O
maternal	O
caloric	O
restriction	O
and	O
maternal	O
high	O
fat	O
nutrition	O
resulting	O
in	O
early	O
pubertal	O
onset	O
.	O

Although	O
a	O
few	O
other	O
studies	O
have	O
correlated	O
array	O
-	O
based	O
methylation	O
levels	O
with	O
repetitive	O
element	O
methylation	O
markers	O
(	O
Fryer	O
et	O
al	O
.	O

Several	O
studies	O
have	O
suggested	O
the	O
association	O
between	O
perinatal	O
factors	O
and	O
the	O
onset	O
of	O
autism	O
.	O

Interestingly	O
,	O
maternal	O
prenatal	O
stress	O
could	O
have	O
negative	O
effects	O
on	O
fetal	O
ANS	O
[	O
46	O
].	O

Parenteral	O
iron	O
sucrose	O
complex	O
is	O
known	O
to	O
have	O
several	O
advantages	O
because	O
of	O
its	O
low	O
-	O
allergenic	O
properties	O
and	O
consequently	O
,	O
an	O
extremely	O
low	O
incidence	O
of	O
severe	O
side	O
effects	O
such	O
as	O
anaphylactic	O
reactions	O
[	O
47	O
,	O
48	O
];	O
however	O
,	O
its	O
use	O
requires	O
caution	O
as	O
it	O
may	O
not	O
be	O
completely	O
devoid	O
of	O
side	O
effect	O
.	O

Based	O
on	O
the	O
distribution	O
of	O
messages	O
,	O
investigators	O
examined	O
estimated	O
dosage	O
levels	O
,	O
dichotomized	O
on	O
whether	O
a	O
participant	O
received	O
lower	O
or	O
higher	O
than	O
median	O
message	O
exposure	O
to	O
messaging	O
.	O

In	O
our	O
study	O
,	O
maternal	O
vitamin	O
D	O
concentrations	O
were	O
similar	O
in	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
,	O
and	O
there	O
was	O
no	O
linear	O
association	O
between	O
vitamin	O
D	O
concentrations	O
and	O
OGTT	O
results	O
.	O

Animal	O
studies	O
have	O
found	O
that	O
vitamin	O
D	O
deficiency	O
can	O
cause	O
deficits	O
in	O
lung	O
function	O
,	O
which	O
can	O
be	O
explained	O
by	O
a	O
change	O
in	O
lung	O
development	O
[	O
32	O
].	O

This	O
is	O
an	O
exciting	O
area	O
of	O
study	O
;	O
especially	O
as	O
antibiotic	O
resistance	O
becomes	O
an	O
increasing	O
problem	O
.	O

We	O
analysed	O
the	O
repeat	O
episodes	O
accounting	O
for	O
clustering	O
within	O
individuals	O
.	O

Assuming	O
a	O
20	O
%	O
loss	O
to	O
follow	O
-	O
up	O
and	O
allowing	O
for	O
protocol	O
violations	O
we	O
intended	O
to	O
recruit	O
3050	O
children	O
for	O
18	O
months	O
follow	O
-	O
up	O
.	O

However	O
,	O
in	O
primary	O
human	O
adipose	O
stem	O
cells	O
,	O
both	O
BMP4	O
and	O
BMP7	O
induced	O
a	O
white	O
-	O
to	O
-	O
brown	O
adipocyte	O
transdifferentiation	O
(	O
Elsen	O
et	O
al	O
.,	O
2014b	O
),	O
pointing	O
to	O
the	O
occurrence	O
of	O
different	O
effects	O
,	O
depending	O
on	O
the	O
model	O
used	O
for	O
investigation	O
.	O

The	O
level	O
of	O
significance	O
was	O
designated	O
at	O
P	O
Results	O
Characteristics	O
of	O
respondents	O
A	O
total	O
of	O
385	O
participants	O
were	O
recruited	O
into	O
the	O
study	O
out	O
of	O
399	O
women	O
who	O
were	O
approached	O
for	O
informed	O
consent	O
.	O

This	O
agenda	O
is	O
ambitious	O
,	O
yet	O
it	O
can	O
and	O
must	O
be	O
accomplished	O
if	O
the	O
actions	O
are	O
to	O
be	O
given	O
the	O
visibility	O
,	O
funding	O
and	O
attention	O
they	O
deserve	O
.	O

The	O
next	O
follow	O
-	O
up	O
of	O
infants	O
was	O
performed	O
between	O
six	O
months	O
and	O
one	O
year	O
after	O
childbirth	O
(	O
both	O
cesarean	O
and	O
vaginal	O
)	O
through	O
telephone	O
contact	O
with	O
the	O
mothers	O
,	O
during	O
which	O
they	O
were	O
asked	O
to	O
attend	O
their	O
local	O
health	O
centers	O
for	O
the	O
assessment	O
of	O
anthropometric	O
indicators	O
(	O
growth	O
monitoring	O
curve	O
,	O
height	O
,	O
weight	O
,	O
and	O
head	O
circumference	O
)	O
and	O
also	O
neonatal	O
diseases	O
.	O

A	O
molecular	O
study	O
revealed	O
that	O
early	O
weaning	O
and	O
a	O
high	O
-	O
starch	O
diet	O
activated	O
precocious	O
pre	O
-	O
adipocyte	O
differentiation	O
and	O
fat	O
accumulation	O
by	O
activating	O
adipogenic	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
-	O
gamma	O
(	O
PPARG	O
)	O
and	O
CCAAT	O
/	O
enhancer	O
-	O
binding	O
protein	O
α	O
pathways	O
.	O

Measures	O
of	O
cardiorespiratory	O
fitness	O
however	O
,	O
improved	O
.	O

Results	O
Descriptive	O
statistics	O
are	O
displayed	O
intable	O
2for	O
children	O
at	O
each	O
age	O
point	O
and	O
for	O
each	O
of	O
the	O
adult	O
lineage	O
groups	O
.	O

Sunlight	O
exposure	O
time	O
has	O
an	O
important	O
impact	O
on	O
Vitamin	O
D3	O
level	O
.	O

In	O
-	O
house	O
precision	O
testing	O
yielded	O
intra	O
-	O
assay	O
coefficients	O
of	O
variation	O
(	O
CVs	O
)	O
of	O
3	O
.	O
7	O
%	O
and	O
3	O
.	O
4	O
%	O
at	O
15	O
and	O
32	O
ng	O
/	O
mL	O
,	O
respectively	O
,	O
and	O
inter	O
-	O
assay	O
CVs	O
of	O
7	O
.	O
9	O
%	O
and	O
5	O
.	O
4	O
%	O
at	O
17	O
and	O
33	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

In	O
previous	O
publications	O
,	O
we	O
have	O
reported	O
on	O
the	O
representativeness	O
of	O
the	O
participating	O
mothers	O
and	O
children	O
and	O
find	O
,	O
as	O
with	O
many	O
cohorts	O
,	O
that	O
less	O
affluent	O
and	O
younger	O
mothers	O
were	O
less	O
likely	O
to	O
continue	O
to	O
participate	O
,	O
but	O
the	O
baseline	O
maternal	O
BMI	O
does	O
not	O
differ	O
between	O
responders	O
and	O
non	O
-	O
responders	O
.	O
22Also	O
,	O
we	O
only	O
report	O
statistically	O
significant	O
findings	O
which	O
by	O
definition	O
are	O
sufficiently	O
powered	O
when	O
the	O
child	O
is	O
aged	O
9	O
.	O

Gestational	O
age	O
was	O
calculated	O
based	O
on	O
the	O
first	O
day	O
of	O
the	O
last	O
menstruation	O
(	O
LMP	O
),	O
or	O
the	O
first	O
trimester	O
ultrasound	O
(	O
if	O
uncertain	O
about	O
LMP	O
).	O

In	O
the	O
neonatal	O
period	O
,	O
we	O
observed	O
soap	O
and	O
water	O
at	O
handwashing	O
places	O
and	O
,	O
at	O
the	O
end	O
of	O
the	O
neonatal	O
period	O
,	O
we	O
estimated	O
impact	O
on	O
maternal	O
handwashing	O
by	O
structured	O
observation	O
.	O

to	O
expand	O
the	O
delivery	O
of	O
services	O
in	O
selected	O
districts	O
of	O
some	O
of	O
the	O
states	O
of	O
the	O
country	O
)	O
(	O
1	O
).	O

In	O
our	O
clinical	O
samples	O
,	O
GR	O
γ	O
is	O
present	O
at	O
much	O
lower	O
levels	O
than	O
the	O
GR	O
α	O
isoform	O
in	O
the	O
placentas	O
studied	O
.	O

We	O
identified	O
76	O
human	O
cohort	O
studies	O
within	O
PubMed	O
that	O
associated	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
birth	O
outcomes	O
,	O
organ	O
-	O
specific	O
abnormalities	O
/	O
disorders	O
,	O
cancer	O
or	O
mortality	O
)	O
with	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
mainly	O
DNA	O
methylation	O
to	O
-	O
date	O
,	O
but	O
also	O
histone	O
modification	O
,	O
epigenetic	O
machinery	O
and	O
miRNAs	O
)	O
and	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
air	O
pollution	O
,	O
chemicals	O
,	O
fibers	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
childhood	O
,	O
adolescence	O
,	O
adulthood	O
and	O
lifetime	O
).	O

No	O
matter	O
which	O
angle	O
we	O
choose	O
to	O
look	O
at	O
for	O
endometriosis	O
,	O
it	O
is	O
a	O
disease	O
caused	O
by	O
metabolic	O
and	O
biochemical	O
imbalance	O
.	O

Results	O
Altered	O
maternal	O
nutrition	O
modifies	O
offspring	O
growth	O
Birth	O
weights	O
of	O
offspring	O
born	O
to	O
rat	O
dams	O
that	O
were	O
undernourished	O
during	O
pregnancy	O
were	O
significantly	O
reduced	O
compared	O
to	O
those	O
of	O
control	O
pregnancies	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
Figure	O
1A	O
).	O

Survival	O
and	O
disease	O
-	O
free	O
intervals	O
identical	O
in	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
The	O
effects	O
of	O
management	O
modalities	O
on	O
pregnancy	O
outcome	O
:	O
No	O
I	O
-	O
131	O
,	O
tailored	O
therapy	O
.	O

Rodents	O
are	O
commonly	O
used	O
to	O
investigate	O
the	O
mechanisms	O
underlying	O
long	O
-	O
term	O
programming	O
of	O
energy	O
balance	O
in	O
the	O
offspring	O
.	O

These	O
findings	O
suggest	O
that	O
improvements	O
in	O
vitamin	O
D	O
status	O
may	O
decrease	O
the	O
disparity	O
in	O
PTB	O
rates	O
between	O
race	O
/	O
ethnic	O
groups	O
.	O

The	O
following	O
search	O
terms	O
were	O
used	O
:	O
prevalence	O
,	O
burden	O
,	O
iron	O
deficiency	O
,	O
anaemia	O
in	O
pregnancy	O
,	O
preventive	O
treatments	O
,	O
and	O
developing	O
countries	O
.	O

Women	O
at	O
their	O
first	O
pregnancy	O
and	O
those	O
with	O
a	O
high	O
level	O
of	O
education	O
were	O
more	O
likely	O
to	O
be	O
unsatisfied	O
with	O
the	O
ANC	O
services	O
they	O
received	O
at	O
their	O
attending	O
health	O
centres	O
.	O

Previous	O
findings	O
from	O
the	O
GraviD	O
study	O
show	O
lower	O
odds	O
of	O
preeclampsia	O
among	O
women	O
with	O
a	O
large	O
increase	O
(≥	O
30	O
nmol	O
/	O
L	O
)	O
in	O
25OHD	O
[	O
3	O
].	O

It	O
has	O
been	O
suggested	O
that	O
intrauterine	O
growth	O
patterns	O
improved	O
prediction	O
of	O
childhood	O
anthropometry	O
,	O
above	O
and	O
beyond	O
birth	O
weight	O
alone	O
.	O

Castration	O
is	O
also	O
known	O
to	O
increase	O
tenderness	O
in	O
several	O
cattle	O
breeds	O
,	O
including	O
Korean	O
cattle	O
[	O
62	O
],	O
Angus	O
and	O
Angus	O
–	O
Hereford	O
cross	O
breeds	O
[	O
63	O
],	O
and	O
Brahman	O
and	O
Charolais	O
cross	O
breeds	O
[	O
64	O
].	O

Once	O
in	O
the	O
circulatory	O
system	O
,	O
compounds	O
enter	O
the	O
brain	O
of	O
the	O
infant	O
relatively	O
quickly	O
as	O
the	O
blood	O
-	O
brain	O
barrier	O
is	O
not	O
fully	O
operational	O
until	O
at	O
least	O
6	O
months	O
of	O
age	O
[	O
10	O
].	O

Approximately	O
two	O
to	O
three	O
times	O
as	O
many	O
women	O
in	O
the	O
exposed	O
group	O
suffered	O
from	O
hypertension	O
,	O
gestational	O
diabetes	O
and	O
hypothyroidism	O
.	O

Even	O
during	O
pregnancy	O
,	O
US	O
guided	O
fine	O
-	O
needle	O
aspiration	O
biopsy	O
(	O
FNA	O
)	O
is	O
the	O
investigation	O
of	O
choice	O
,	O
thanks	O
to	O
its	O
reliability	O
and	O
safety1926	O
.	O

The	O
nutritional	O
and	O
physiological	O
condition	O
of	O
the	O
fetus	O
and	O
the	O
early	O
postnatal	O
stage	O
affects	O
the	O
number	O
of	O
adipocytes	O
in	O
adipose	O
tissues	O
of	O
animals	O
[	O
16	O
].	O

Average	O
level	O
of	O
influenza	O
activity	O
corresponds	O
to	O
years	O
2011	O
–	O
2013	O
(	O
Nicaragua	O
,	O
national	O
influenza	O
surveillance	O
data	O
,	O
Severe	O
Acute	O
Respiratory	O
Infections	O
network	O
,	O
SARInet	O
,	O
PAHO	O
).	O

Average	O
values	O
were	O
measured	O
and	O
equal	O
protein	O
loading	O
was	O
confirmed	O
by	O
probing	O
blots	O
with	O
beta	O
-	O
actin	O
antibody	O
and	O
is	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
SC	O
counterpart	O
.	O

Infant	O
Neurodevelopment	O
:	O
The	O
infant	O
’	O
s	O
primary	O
caregiver	O
was	O
asked	O
to	O
complete	O
a	O
structured	O
Ages	O
and	O
Stages	O
Questionnaire	O
(	O
ASQ	O
)	O
[	O
31	O
],	O
reporting	O
five	O
domains	O
of	O
development	O
(	O
communication	O
,	O
gross	O
motor	O
,	O
fine	O
motor	O
,	O
problem	O
solving	O
,	O
and	O
personal	O
-	O
social	O
skills	O
).	O

Therefore	O
,	O
a	O
multiple	O
imputation	O
model	O
was	O
constructed	O
to	O
account	O
for	O
missing	O
race	O
and	O
marital	O
status	O
through	O
use	O
of	O
a	O
logit	O
function	O
with	O
parity	O
,	O
age	O
,	O
and	O
treatment	O
status	O
as	O
predictors	O
of	O
both	O
race	O
and	O
marital	O
status	O
.	O

The	O
range	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
level	O
was	O
0	O
–	O
24	O
.	O
71	O
nmol	O
/	O
L	O
,	O
with	O
the	O
detection	O
rate	O
of	O
19	O
.	O
4	O
%	O
(	O
19	O
/	O
98	O
).	O

Ninety	O
-	O
three	O
per	O
cent	O
of	O
the	O
exposed	O
neonates	O
that	O
presented	O
with	O
PNA	O
symptoms	O
were	O
born	O
to	O
mothers	O
receiving	O
psychotropic	O
polytherapy	O
,	O
and	O
53	O
%	O
of	O
these	O
neonates	O
were	O
prenatally	O
exposed	O
to	O
a	O
selective	O
serotonin	O
reuptake	O
inhibitor	O
(	O
SSRI	O
).	O

Another	O
study	O
found	O
that	O
smoking	O
during	O
the	O
12	O
months	O
before	O
birth	O
of	O
a	O
child	O
was	O
associated	O
with	O
adolescent	O
overweight	O
(	O
21	O
).	O

We	O
documented	O
2	O
(	O
2	O
%)	O
stillbirths	O
and	O
4	O
(	O
3	O
%)	O
neonatal	O
deaths	O
in	O
the	O
intervention	O
arm	O
and	O
6	O
(	O
5	O
%)	O
stillbirths	O
and	O
2	O
(	O
6	O
%)	O
neonatal	O
deaths	O
in	O
the	O
control	O
arm	O
.	O

From	O
October	O
2009	O
to	O
August	O
2011	O
,	O
otherwise	O
-	O
healthy	O
children	O
with	O
S	O
-	O
ECC	O
were	O
recruited	O
from	O
the	O
MHC	O
in	O
Winnipeg	O
,	O
Canada	O
(	O
49	O
°	O
53	O
′	O
North	O
)	O
on	O
the	O
day	O
of	O
their	O
dental	O
surgery	O
.	O

PubMed	O
Central	O
:	O

In	O
vivo	O
testing	O
should	O
generally	O
be	O
postponed	O
until	O
after	O
pregnancy	O
,	O
unless	O
diagnosis	O
for	O
therapeutic	O
intervention	O
is	O
urgently	O
needed	O
.	O

¶	O
Fisher	O
'	O
s	O
exact	O
test	O
.	O

Adaptive	O
versus	O
adverse	O
epigenetic	O
change	O
Epigenetic	O
change	O
offers	O
a	O
much	O
more	O
versatile	O
,	O
reversible	O
and	O
rapid	O
way	O
for	O
adapting	O
to	O
changes	O
in	O
our	O
environment	O
compared	O
with	O
genetic	O
mutation	O
.	O

Nutritional	O
programming	O
during	O
the	O
fetal	O
and	O
neonatal	O
periods	O
has	O
been	O
suggested	O
as	O
a	O
promising	O
method	O
to	O
manipulate	O
IMF	O
deposition	O
.	O

Of	O
the	O
139	O
PTBs	O
,	O
approximately	O
half	O
were	O
spontaneous	O
(	O
47	O
%)	O
and	O
half	O
were	O
indicated	O
(	O
53	O
%),	O
of	O
the	O
latter	O
,	O
66	O
%	O
were	O
indicated	O
for	O
maternal	O
hypertensive	O
disorders	O
.	O

The	O
impact	O
of	O
these	O
2	O
factors	O
for	O
sensitization	O
to	O
other	O
allergens	O
,	O
such	O
as	O
aeroallergens	O
,	O
has	O
not	O
been	O
investigated	O
.	O

Tertiary	O
prevention	O
is	O
directed	O
at	O
patients	O
with	O
a	O
chronic	O
disease	O
to	O
prevent	O
additional	O
problems	O
related	O
to	O
the	O
disease	O
.	O

Infant	O
stool	O
samples	O
were	O
collected	O
from	O
145	O
infants	O
,	O
and	O
maternal	O
prenatal	O
diet	O
was	O
assessed	O
using	O
a	O
food	O
frequency	O
questionnaire	O
.	O

We	O
stored	O
the	O
serum	O
samples	O
at	O
−	O
20	O
°	O
C	O
and	O
analysed	O
them	O
at	O
the	O
end	O
of	O
our	O
study	O
with	O
IDS	O
-	O
iSYS	O
Multi	O
-	O
Discipline	O
Automated	O
Chemiluminescent	O
assay	O
(	O
Immunodiagnostic	O
Systems	O
Ltd	O
,	O
Tyne	O
and	O
Wear	O
,	O
UK	O
)	O
at	O
the	O
Manchester	O
Royal	O
Infirmary	O
,	O
Manchester	O
,	O
UK	O
(	O
Supra	O
-	O
Regional	O
Vitamin	O
D	O
Reference	O
Laboratories	O
accredited	O
to	O
ISO9001	O
:	O
2000	O
and	O
ISO13485	O
:	O
2003	O
and	O
participating	O
in	O
the	O
Vitamin	O
D	O
Quality	O
Assurance	O
Scheme	O
).	O

Findings	O
1524	O
children	O
were	O
assigned	O
to	O
receive	O
vitamin	O
D3and	O
1522	O
placebo	O
.	O

Immature	O
glomeruli	O
normally	O
begin	O
to	O
disappear	O
at	O
this	O
age	O
,	O
but	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
had	O
150	O
%	O
more	O
immature	O
glomeruli	O
and	O
25	O
%	O
more	O
mature	O
glomeruli	O
than	O
the	O
F1	O
-	O
SC	O
mice	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

The	O
mean	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
for	O
the	O
entire	O
sample	O
was	O
75	O
.	O
4	O
±	O
30	O
.	O
2	O
nmol	O
/	O
L	O
.	O

We	O
monitored	O
the	O
control	O
group	O
to	O
ensure	O
that	O
none	O
of	O
these	O
participants	O
separately	O
enrolled	O
for	O
text4baby	O
(	O
none	O
did	O
).	O

In	O
the	O
same	O
region	O
,	O
Mullany	O
and	O
colleagues	O
found	O
that	O
reported	O
caregiver	O
handwashing	O
was	O
associated	O
with	O
a	O
24	O
%	O
lower	O
risk	O
of	O
umbilical	O
cord	O
infection	O
[	O
3	O
].	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
similar	O
between	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
.	O

UVB	O
in	O
the	O
290	O
-	O
315	O
nm	O
range	O
photolysis	O
7	O
-	O
dehydrocholesterol	O
in	O
the	O
skin	O
to	O
form	O
previtamin	O
D3	O
,	O
which	O
then	O
isomerizes	O
to	O
colecalciferol	O
.	O
6Colecalciferol	O
(	O
and	O
ergocalciferol	O
[	O
vitamin	O
D2	O
])	O
is	O
also	O
available	O
from	O
fortified	O
foods	O
(	O
e	O
.	O
g	O
.,	O
milk	O
,	O
cereal	O
,	O
and	O
some	O
orange	O
juice	O
and	O
cheeses	O
),	O
dark	O
fish	O
(	O
e	O
.	O
g	O
.,	O
salmon	O
and	O
tuna	O
),	O
and	O
vitamin	O
supplements	O
(	O
colecalciferol	O
).	O

These	O
models	O
demonstrate	O
that	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
9	O
.	O
7	O
(	O
95	O
%	O
CI	O
:	O
2	O
.	O
9	O
,	O
16	O
.	O
6	O
),	O
and	O
with	O
a	O
10	O
%	O
increase	O
in	O
AluYb8	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
14	O
.	O
5	O
(	O
95	O
%	O
CI	O
:	O
4	O
.	O
9	O
,	O
24	O
.	O
0	O
)	O
(	O
Table	O
1	O
).	O

While	O
vitamin	O
A	O
restriction	O
improves	O
marbling	O
,	O
but	O
vitamin	O
D	O
restriction	O
did	O
not	O
significantly	O
affect	O
marbling	O
in	O
Angus	O
crossbred	O
steers	O
[	O
133	O
].	O

C	O
-	O
postnatal	O
chow	O
diet	O
;	O
HF	O
–	O
postnatal	O
high	O
fat	O
diet	O
.	O

Darwin	O
’	O
s	O
‘	O
On	O
the	O
Origin	O
of	O
the	O
Species	O
’	O
highlighted	O
the	O
role	O
of	O
the	O
environment	O
in	O
the	O
process	O
of	O
evolution	O
,	O
the	O
natural	O
selection	O
of	O
advantageous	O
genetic	O
mutations	O
through	O
environmental	O
pressures	O
(	O
Darwin1859	O
).	O

Maternal	O
vitamin	O
D	O
status	O
,	O
gestational	O
diabetes	O
and	O
infant	O
birth	O
size	O
Abstract	O
Background	O
Maternal	O
vitamin	O
D	O
status	O
has	O
been	O
associated	O
with	O
both	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
and	O
fetal	O
growth	O
restriction	O
,	O
however	O
,	O
the	O
evidence	O
is	O
inconsistent	O
.	O

Our	O
study	O
was	O
advantageous	O
for	O
the	O
presence	O
of	O
a	O
control	O
group	O
in	O
which	O
all	O
measurements	O
were	O
made	O
similar	O
to	O
those	O
of	O
the	O
IG	O
.	O

Other	O
allergic	O
diseases	O
that	O
may	O
complicate	O
pregnancy	O
include	O
conjunctivitis	O
,	O
acute	O
urticaria	O
,	O
anaphylaxis	O
,	O
food	O
allergy	O
,	O
and	O
drug	O
allergy	O
.	O

and	O
Peet	O
&	O
Horrobin	O
suggest	O
that	O
there	O
might	O
be	O
such	O
a	O
therapeutic	O
window	O
for	O
DHA	O
and	O
EPA	O
regarding	O
their	O
protective	O
role	O
for	O
schizophrenia	O
or	O
depression	O
[	O
39	O
-	O
41	O
].	O

GWAS	O
has	O
been	O
used	O
to	O
identify	O
SNPs	O
associated	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
status	O
(	O
8	O
,	O
22	O
).	O

Feeding	O
low	O
-	O
protein	O
diets	O
to	O
pregnant	O
rats	O
produces	O
a	O
broad	O
spectrum	O
of	O
disorders	O
in	O
their	O
offspring	O
(	O
7	O
):	O
hypertension	O
and	O
vascular	O
defects	O
(	O
8	O
,	O
9	O
),	O
altered	O
fetal	O
pancreatic	O
development	O
and	O
structure	O
(	O
10	O
),	O
altered	O
glucose	O
tolerance	O
(	O
11	O
),	O
altered	O
liver	O
structure	O
and	O
function	O
(	O
12	O
),	O
altered	O
gene	O
expression	O
(	O
13	O
),	O
and	O
possibly	O
type	O
2	O
diabetes	O
mellitus	O
(	O
10	O
).	O

Investigations	O
revealed	O
normal	O
hemoglobin	O
,	O
total	O
and	O
differential	O
counts	O
and	O
normal	O
c	O
-	O
reactive	O
protein	O
.	O

Thirteen	O
of	O
14	O
cases	O
had	O
no	O
documented	O
recurrence	O
.	O

An	O
increase	O
in	O
serum	O
retinol	O
and	O
improved	O
anthropometric	O
status	O
(	O
weight	O
,	O
height	O
,	O
BMI	O
)	O
in	O
supplemented	O
girls	O
was	O
also	O
recorded	O
(	O
Hyder	O
et	O
al	O
2007	O
),	O
indicating	O
the	O
potential	O
benefits	O
of	O
MMN	O
supplementation	O
for	O
a	O
risk	O
group	O
attempting	O
to	O
satisfy	O
increased	O
nutritional	O
requirements	O
for	O
pubertal	O
growth	O
while	O
commonly	O
manifesting	O
a	O
substantial	O
degree	O
of	O
undernutrition	O
.	O

We	O
need	O
facilities	O
equipped	O
with	O
life	O
-	O
saving	O
commodities	O
,	O
and	O
girls	O
,	O
and	O
women	O
who	O
are	O
educated	O
,	O
and	O
enabled	O
,	O
can	O
protect	O
their	O
own	O
health	O
,	O
and	O
that	O
of	O
their	O
babies	O
.	O

ACHOIS	O
has	O
shown	O
that	O
it	O
is	O
acceptable	O
to	O
the	O
majority	O
of	O
women	O
.	O

However	O
,	O
the	O
adult	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
Cnr1	O
and	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
in	O
liver	O
as	O
well	O
as	O
the	O
NAEs	O
-	O
synthesizing	O
enzyme	O
Napepld	O
in	O
PAT	O
.	O

Gut	O
microbiome	O
profiling	O
will	O
be	O
done	O
by	O
isolating	O
microbial	O
DNA	O
from	O
the	O
collected	O
rectal	O
swabs	O
using	O
Qiagen	O
Stool	O
minikit	O
and	O
analysing	O
the	O
16S	O
rRNA	O
genes	O
DNA	O
sequences	O
on	O
the	O
Ion	O
Torrent	O
16S	O
metagenomics	O
solution	O
offered	O
by	O
ThermoFisher	O
Scientific	O
.	O

Sensitivity	O
analysis	O
As	O
the	O
women	O
were	O
allowed	O
to	O
continue	O
taking	O
vitamin	O
D	O
supplements	O
containing	O
up	O
to	O
400	O
IU	O
/	O
d	O
,	O
in	O
sensitivity	O
analyses	O
,	O
we	O
included	O
only	O
women	O
who	O
were	O
not	O
taking	O
additional	O
vitamin	O
D	O
–	O
containing	O
supplements	O
at	O
34	O
weeks	O
of	O
gestation	O
(	O
n	O
=	O
224	O
,	O
67	O
.	O
7	O
%).	O

Procedures	O
We	O
chose	O
a	O
quarterly	O
supplementation	O
regimen	O
because	O
in	O
routine	O
programme	O
conditions	O
a	O
quarterly	O
regimen	O
is	O
likely	O
to	O
have	O
better	O
adherence	O
than	O
a	O
daily	O
regimen	O
,	O
13	O
,	O
14and	O
has	O
been	O
shown	O
to	O
be	O
effective	O
at	O
maintaining	O
the	O
serum	O
vitamin	O
D	O
concentration	O
within	O
normal	O
ranges	O
for	O
2	O
–	O
3	O
months	O
in	O
a	O
French	O
high	O
-	O
risk	O
infant	O
population	O
.	O
16The	O
syringes	O
containing	O
vitamin	O
D	O
or	O
placebo	O
were	O
stored	O
in	O
conditions	O
recommended	O
by	O
the	O
manufacturer	O
—	O
a	O
dry	O
cool	O
environment	O
—	O
between	O
2	O
and	O
24	O
weeks	O
before	O
administration	O
.	O

This	O
disparity	O
may	O
reflect	O
tissue	O
-	O
specific	O
differences	O
in	O
these	O
relationships	O
,	O
as	O
well	O
as	O
the	O
larger	O
and	O
therefore	O
more	O
precise	O
nature	O
of	O
our	O
examination	O
.	O

All	O
sows	O
were	O
fed	O
AP	O
lactation	O
diets	O
.	O

Gestational	O
exposure	O
to	O
endocrine	O
disrupting	O
chemicals	O
in	O
relation	O
to	O
infant	O
birth	O
weight	O
:	O
a	O
Bayesian	O
analysis	O
of	O
the	O
HOME	O
Study	O
Abstract	O
Background	O
Pregnant	O
women	O
are	O
exposed	O
to	O
a	O
mixture	O
of	O
endocrine	O
disrupting	O
chemicals	O
(	O
EDCs	O
).	O

Conclusions	O
The	O
transcriptomic	O
modulations	O
point	O
to	O
persistent	O
functional	O
demand	O
on	O
the	O
liver	O
towards	O
cell	O
proliferation	O
in	O
the	O
LP	O
group	O
but	O
not	O
in	O
the	O
AP	O
group	O
at	O
identical	O
nutritional	O
conditions	O
during	O
postnatal	O
life	O
due	O
to	O
divergent	O
'	O
programming	O
'	O
of	O
the	O
genome	O
.	O

If	O
these	O
measures	O
are	O
unsuccessful	O
,	O
then	O
prescription	O
of	O
antiacid	O
drugs	O
should	O
be	O
considered	O
,	O
for	O
example	O
,	O
in	O
the	O
form	O
of	O
a	O
step	O
-	O
up	O
program	O
beginning	O
with	O
antacids	O
,	O
and	O
in	O
case	O
of	O
failure	O
with	O
histamine	O
-	O
2	O
receptor	O
antagonists	O
,	O
whereas	O
proton	O
pump	O
inhibitors	O
should	O
only	O
be	O
used	O
in	O
women	O
with	O
intractable	O
symptoms	O
or	O
complicated	O
reflux	O
disease	O
[	O
111	O
,	O
112	O
].	O

There	O
are	O
no	O
studies	O
using	O
glitazones	O
in	O
pregnancy	O
.	O

We	O
did	O
not	O
have	O
PTH	O
values	O
on	O
the	O
cord	O
blood	O
but	O
PTH	O
values	O
at	O
three	O
months	O
of	O
age	O
were	O
not	O
correlated	O
significantly	O
with	O
25	O
(	O
OH	O
)	O
D	O
values	O
at	O
birth	O
or	O
three	O
months	O
or	O
with	O
bone	O
mineral	O
outcomes	O
.	O

3	O
.	O

The	O
final	O
adjusted	O
model	O
was	O
:	O
Y	O
=	O
β0	O
+	O
βx1X1	O
....	O
βxpXp	O
+	O
βc1C1	O
+....+	O
βckCk	O
+	O
spline	O
(	O
GA	O
)+	O
error	O
,	O
where	O
Y	O
is	O
the	O
outcome	O
birth	O
weight	O
,	O
β0is	O
the	O
y	O
-	O
intercept	O
,	O
βx1	O
...	O
βxpare	O
the	O
exposure	O
variable	O
regression	O
coefficients	O
,	O
X1	O
...	O
Xpare	O
the	O
exposure	O
variables	O
,	O
spline	O
(	O
GA	O
)	O
is	O
the	O
non	O
-	O
parametric	O
spline	O
for	O
GA	O
,	O
and	O
C1	O
…	O
Ckare	O
the	O
9	O
covariates	O
.	O

After	O
eliminating	O
some	O
of	O
the	O
mothers	O
who	O
scored	O
>	O
13	O
,	O
153	O
women	O
continued	O
their	O
participation	O
in	O
the	O
study	O
.	O

Children	O
were	O
asked	O
to	O
avoid	O
physical	O
activity	O
and	O
to	O
consume	O
liquids	O
2	O
hours	O
before	O
evaluation	O
to	O
prevent	O
errors	O
in	O
measurement	O
due	O
to	O
fluid	O
imbalances	O
.	O

First	O
and	O
second	O
trimester	O
visfatin	O
levels	O
were	O
significant	O
independent	O
predictors	O
of	O
infant	O
’	O
s	O
weight	O
in	O
group	O
B	O
and	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
.	O

Furthermore	O
,	O
follow	O
-	O
up	O
of	O
280	O
infants	O
(	O
35	O
%	O
of	O
the	O
randomised	O
cohort	O
)	O
at	O
6	O
-	O
months	O
of	O
age	O
demonstrated	O
no	O
evidence	O
of	O
an	O
effect	O
of	O
the	O
intervention	O
on	O
early	O
infant	O
measures	O
of	O
growth	O
or	O
adiposity	O
[	O
19	O
].	O

She	O
was	O
only	O
on	O
prenatal	O
vitamins	O
,	O
and	O
her	O
prenatal	O
follow	O
-	O
up	O
was	O
unremarkable	O
.	O

Following	O
weaning	O
,	O
steers	O
were	O
grown	O
with	O
a	O
forage	O
-	O
only	O
system	O
and	O
forage	O
with	O
high	O
-	O
energy	O
supplemented	O
system	O
to	O
test	O
effects	O
of	O
a	O
high	O
-	O
energy	O
grain	O
-	O
based	O
substitution	O
on	O
fat	O
deposition	O
with	O
5	O
times	O
serial	O
slaughter	O
.	O

A	O
smaller	O
sample	O
size	O
of	O
570	O
women	O
/	O
arm	O
or	O
40	O
pregnant	O
women	O
from	O
28	O
clusters	O
is	O
needed	O
to	O
detect	O
a	O
30	O
%	O
reduction	O
in	O
LBW	O
with	O
the	O
same	O
assumptions	O
.	O

(	O
2010	O
)	O
*	O
Ostrow	O
et	O
al	O
.	O

Laboratory	O
studies	O
revealed	O
a	O
serum	O
sodium	O
of	O
171	O
mEq	O
/	O
L	O
,	O
potassium	O
4	O
.	O
1	O
mEq	O
/	O
L	O
,	O
chloride	O
138	O
mEq	O
/	O
L	O
,	O
bicarbonate	O
21	O
mEq	O
/	O
L	O
,	O
glucose	O
197	O
mg	O
/	O
dL	O
,	O
BUN	O
49	O
mg	O
/	O
dL	O
,	O
creatinine	O
3	O
.	O
2	O
mg	O
/	O
dL	O
,	O
calcium	O
7	O
.	O
8	O
mEq	O
/	O
L	O
,	O
total	O
protein	O
5	O
.	O
4	O
gm	O
/	O
dL	O
,	O
albumin	O
1	O
.	O
6	O
gm	O
/	O
dL	O
,	O
alkaline	O
phosphatase	O
576	O
units	O
/	O
L	O
,	O
AST	O
391	O
units	O
/	O
L	O
,	O
and	O
ALT	O
443	O
units	O
/	O
L	O
.	O

The	O
clinical	O
relevance	O
of	O
this	O
finding	O
remains	O
unsolved	O
and	O
needs	O
to	O
be	O
considered	O
in	O
future	O
studies	O
.	O

Similarly	O
,	O
infants	O
of	O
black	O
mothers	O
with	O
history	O
of	O
PIH	O
were	O
associated	O
with	O
2	O
.	O
3	O
greater	O
odds	O
of	O
SGA	O
after	O
adjustment	O
for	O
confounding	O
variables	O
.	O

Setting	O
Community	O
-	O
based	O
study	O
with	O
linkage	O
to	O
health	O
records	O
in	O
the	O
Republic	O
of	O
Ireland	O
.	O

However	O
,	O
in	O
developed	O
countries	O
,	O
seasonal	O
availablity	O
of	O
food	O
has	O
a	O
limited	O
impact	O
on	O
diet	O
,	O
although	O
seasonal	O
differences	O
in	O
dietary	O
intakes	O
among	O
pregnant	O
women	O
have	O
been	O
observed	O
[	O
29	O
].	O

We	O
also	O
defined	O
a	O
reference	O
group	O
to	O
estimate	O
the	O
sample	O
size	O
.	O

Protein	O
expression	O
was	O
detected	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
using	O
an	O
ECL	O
(	O
enhanced	O
chemiluminescence	O
)	O
detection	O
system	O
(	O
Amersham	O
Biosciences	O
).	O

General	O
health	O
,	O
health	O
service	O
utilisation	O
,	O
and	O
quality	O
of	O
life	O
:	O
as	O
assessed	O
by	O
questionnaire	O
[	O
34	O
]	O
completed	O
by	O
the	O
infant	O
’	O
s	O
primary	O
caregiver	O
.	O

Considering	O
the	O
factors	O
affecting	O
vitamin	O
D	O
production	O
such	O
as	O
clothing	O
type	O
,	O
skin	O
color	O
and	O
the	O
time	O
of	O
day	O
being	O
exposed	O
to	O
the	O
sun	O
[	O
48	O
–	O
50	O
],	O
these	O
results	O
are	O
justifiable	O
.	O

The	O
results	O
of	O
this	O
study	O
to	O
address	O
these	O
hypotheses	O
are	O
presented	O
here	O
.	O

Due	O
to	O
heterogeneity	O
in	O
methodology	O
and	O
measured	O
outcomes	O
,	O
a	O
qualitative	O
comparison	O
of	O
study	O
findings	O
was	O
conducted	O
.	O

Also	O
note	O
that	O
,	O
as	O
in	O
that	O
analysis	O
,	O
5we	O
found	O
no	O
difference	O
in	O
BMI	O
heritability	O
estimates	O
between	O
men	O
and	O
women	O
.	O

PubMed	O
Central	O
:	O

Caption	O
(	O
BOXED	O
-	O
TEXT	O
)	O
Strengths	O
and	O
limitations	O
of	O
this	O
study	O
This	O
is	O
one	O
of	O
the	O
few	O
studies	O
to	O
examine	O
association	O
between	O
grandparents	O
’	O
characteristics	O
and	O
grandchildren	O
'	O
s	O
growth	O
across	O
seven	O
lineages	O
and	O
at	O
three	O
time	O
points	O
.	O

There	O
is	O
no	O
significant	O
association	O
between	O
dose	O
of	O
Vitamin	O
D	O
supplement	O
intake	O
,	O
time	O
and	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
.	O

However	O
,	O
a	O
randomized	O
trial	O
revealed	O
quite	O
contrary	O
that	O
promoted	O
and	O
prolonged	O
(	O
exclusive	O
)	O
breast	O
-	O
feeding	O
is	O
not	O
able	O
to	O
prevent	O
development	O
of	O
allergy	O
or	O
asthma	O
in	O
children	O
at	O
the	O
age	O
of	O
about	O
6	O
years	O
[	O
88	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Between	O
groups	O
comparisons	O
of	O
depression	O
scores	O
and	O
25	O
(	O
OH	O
)	O
D	O
concentrationsVariablesmean	O
±	O
sdDepression	O
score	O
,	O
N	O
(%)	O
Vitamin	O
D	O
groupControl	O
group	O
P	O
-	O
valueVitamin	O
D	O
groupControl	O
group	O
<	O
99	O
–	O
13	O
>	O
13	O
<	O
99	O
–	O
13	O
>	O
13	O
P	O
-	O
value	O
*	O
Depression	O
score	O
at	O
baseline8	O
.	O
44	O
±	O
3	O
.	O
898	O
.	O
64	O
±	O
3	O
.	O
810	O
.	O
74737	O
(	O
49	O
.	O
3	O
)	O
38	O
(	O
50	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
33	O
(	O
42	O
.	O
3	O
)	O
45	O
(	O
57	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
383Depression	O
score	O
at	O
38	O
–	O
40w	O
gestation6	O
.	O
17	O
±	O
3	O
.	O
477	O
.	O
77	O
±	O
3	O
.	O
920	O
.	O
0149	O
(	O
72	O
.	O
1	O
)	O
18	O
(	O
26	O
.	O
5	O
)	O
1	O
(	O
1	O
.	O
5	O
)	O
37	O
(	O
50	O
.	O
7	O
)	O
30	O
(	O
41	O
.	O
1	O
)	O
6	O
(	O
8	O
.	O
2	O
)	O
0	O
.	O
024Depression	O
score	O
at	O
post	O
partum	O
(	O
4w	O
)	O
4	O
.	O
59	O
±	O
3	O
.	O
297	O
.	O
36	O
±	O
4	O
.	O
27	O
<	O
0	O
.	O
00158	O
(	O
90	O
.	O
6	O
)	O
6	O
(	O
9	O
.	O
4	O
)	O
0	O
(	O
0	O
)	O
43	O
(	O
59	O
.	O
7	O
)	O
23	O
(	O
31	O
.	O
9	O
)	O
6	O
(	O
8	O
.	O
3	O
)<	O
0	O
.	O
001Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
19	O
±	O
3	O
.	O
767	O
.	O
18	O
±	O
3	O
.	O
99	O
<	O
0	O
.	O
00157	O
(	O
89	O
.	O
1	O
)	O
7	O
(	O
10	O
.	O
9	O
)	O
0	O
(	O
0	O
)	O
46	O
(	O
63	O
.	O
9	O
)	O
22	O
(	O
30	O
.	O
6	O
)	O
4	O
(	O
5	O
.	O
6	O
)	O
0	O
.	O
001Categorized	O
25	O
(	O
OH	O
)	O
D	O
,	O
N	O
(%)<	O
2020	O
–	O
29	O
≥	O
30	O
<	O
2020	O
–	O
29	O
≥	O
30	O
P	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
12	O
.	O
84	O
±	O
7	O
.	O
9111	O
.	O
89	O
±	O
6	O
.	O
400	O
.	O
63a65	O
(	O
86	O
.	O
7	O
)	O
7	O
(	O
9	O
.	O
3	O
)	O
3	O
(	O
4	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
8	O
(	O
10	O
.	O
3	O
)	O
1	O
(	O
1	O
.	O
3	O
)	O
0	O
.	O
6125	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
17	O
.	O
46	O
±	O
10	O
.	O
0912	O
.	O
07	O
±	O
5	O
.	O
980	O
.	O
001a41	O
(	O
66	O
.	O
1	O
)	O
15	O
(	O
24	O
.	O
2	O
)	O
6	O
(	O
9	O
.	O
7	O
)	O
58	O
(	O
85	O
.	O
3	O
)	O
10	O
(	O
14	O
.	O
7	O
)	O
0	O
(	O
0	O
)	O
0	O
.	O
006	O
*	O
Fisher	O
’	O
s	O
Exact	O
Test	O
aMann	O
-	O
Whitney	O
U	O
test	O
The	O
mean	O
depression	O
score	O
of	O
184	O
participants	O
was	O
9	O
.	O
20	O
±	O
4	O
.	O
44	O
at	O
baseline	O
.	O

Mothers	O
also	O
reported	O
duration	O
of	O
breastfeeding	O
on	O
postpartum	O
questionnaires	O
.	O

Headliners	O
:	O
Maternal	O
Nutrition	O
and	O
Child	O
Cancer	O
:	O
Mother	O
’	O
s	O
Pre	O
-	O
pregnancy	O
Diet	O
May	O
Influence	O
Child	O
Cancer	O
Risk	O
Jensen	O
CD	O
,	O
Block	O
G	O
,	O
Buffler	O
P	O
,	O
Ma	O
X	O
,	O
Selvin	O
S	O
,	O
Month	O
S	O
.	O
2004	O
.	O

Results	O
Among	O
the	O
1311	O
pregnant	O
women	O
participating	O
in	O
the	O
survey	O
,	O
there	O
were	O
271	O
from	O
Brussels	O
,	O
597	O
from	O
Flanders	O
and	O
437	O
from	O
Wallonia	O
(	O
Figure	O
1	O
;	O
Table	O
1	O
).	O

The	O
initial	O
reduction	O
has	O
been	O
explained	O
to	O
result	O
from	O
increased	O
red	O
cell	O
mass	O
and	O
demands	O
of	O
the	O
fetus	O
which	O
exceeds	O
iron	O
intake	O
with	O
consequent	O
reduction	O
in	O
iron	O
stores	O
of	O
the	O
woman	O
'	O
s	O
body	O
[	O
2	O
].	O

Many	O
series	O
have	O
reported	O
reduced	O
rates	O
of	O
tumour	O
recurrence	O
both	O
in	O
PTC	O
and	O
in	O
FTC	O
.	O

Conclusions	O
and	O
public	O
health	O
implications	O
We	O
conclude	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
.	O

Briefly	O
,	O
we	O
conducted	O
a	O
multicentre	O
randomised	O
trial	O
involving	O
women	O
with	O
a	O
singleton	O
pregnancy	O
,	O
between	O
10	O
+	O
0and	O
20	O
+	O
0weeks	O
’	O
gestation	O
,	O
and	O
body	O
mass	O
index	O
≥	O
25	O
.	O
0	O
kg	O
/	O
m2	O
,	O
who	O
were	O
randomised	O
to	O
either	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
(	O
Lifestyle	O
Advice	O
Group	O
)	O
or	O
standard	O
antenatal	O
care	O
(	O
Standard	O
Care	O
Group	O
)	O
[	O
22	O
].	O

In	O
summary	O
,	O
despite	O
a	O
location	O
near	O
the	O
equator	O
where	O
sunlight	O
is	O
available	O
year	O
round	O
,	O
Thai	O
people	O
are	O
at	O
risk	O
for	O
vitamin	O
D	O
insufficiency	O
due	O
to	O
environmental	O
,	O
cultural	O
,	O
lifestyle	O
and	O
dietary	O
factors	O
.	O

They	O
drink	O
more	O
water	O
and	O
eat	O
more	O
foods	O
per	O
unit	O
of	O
body	O
weight	O
than	O
adults	O
and	O
will	O
therefore	O
ingest	O
more	O
toxins	O
from	O
well	O
water	O
and	O
agriculturally	O
treated	O
foods	O
[	O
33	O
,	O
34	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Experimental	O
design	O
.	O

In	O
the	O
literature	O
,	O
recent	O
studies	O
across	O
a	O
wide	O
range	O
of	O
populations	O
have	O
demonstrated	O
a	O
positive	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
[	O
8	O
–	O
11	O
,	O
15	O
,	O
16	O
,	O
18	O
,	O
19	O
].	O

Using	O
the	O
results	O
from	O
analyses	O
of	O
the	O
three	O
future	O
scenarios	O
(	O
Figure8	O
),	O
a	O
target	O
for	O
mortality	O
reduction	O
of	O
preterm	O
births	O
was	O
set	O
and	O
agreed	O
by	O
the	O
technical	O
experts	O
(	O
Figure7	O
).	O

Additionally	O
,	O
there	O
are	O
some	O
data	O
that	O
suggest	O
an	O
increase	O
in	O
fetal	O
malformation	O
and	O
perinatal	O
mortality	O
.	O
7	O
,	O
12	O
–	O
15The	O
above	O
risks	O
can	O
be	O
minimized	O
with	O
good	O
glycemic	O
control	O
and	O
judicious	O
obstetric	O
care	O
.	O

Mothers	O
'	O
eating	O
behaviors	O
during	O
pregnancy	O
,	O
especially	O
intake	O
of	O
sweets	O
in	O
OW	O
/	O
OB	O
mothers	O
,	O
may	O
have	O
a	O
lasting	O
effect	O
on	O
child	O
weight	O
.	O

Mid	O
-	O
upper	O
arm	O
circumference	O
(	O
MUAC	O
)	O
was	O
measured	O
at	O
the	O
mid	O
-	O
point	O
of	O
the	O
left	O
arm	O
using	O
standard	O
tapes	O
(	O
TALC	O
,	O
UK	O
).	O

The	O
restriction	O
enzyme	O
Tsp509I	O
(	O
10	O
U	O
)	O
was	O
used	O
to	O
digest	O
the	O
PCR	O
products	O
at	O
65	O
°	O
C	O
for	O
4	O
hours	O
.	O

Control	O
animals	O
were	O
kept	O
under	O
similar	O
conditions	O
except	O
they	O
received	O
a	O
vitamin	O
D	O
replete	O
diet	O
(	O
Dyets	O
,	O
PA	O
,	O
USA	O
and	O
Specialty	O
Foods	O
,	O
WA	O
,	O
Australia	O
)	O
and	O
were	O
housed	O
under	O
standard	O
lighting	O
conditions	O
.	O

All	O
participants	O
sat	O
still	O
for	O
at	O
least	O
5	O
minutes	O
to	O
assess	O
blood	O
pressure	O
and	O
heart	O
rate	O
at	O
rest	O
.	O

Multiple	O
linear	O
regression	O
models	O
were	O
created	O
using	O
a	O
forced	O
-	O
enter	O
approach	O
and	O
were	O
adjusted	O
for	O
confounders	O
.	O

Between	O
31	O
March	O
2011	O
when	O
the	O
first	O
potential	O
subject	O
with	O
the	O
opportunity	O
to	O
collect	O
a	O
6	O
-	O
week	O
infant	O
stool	O
sample	O
from	O
was	O
screened	O
for	O
eligibility	O
and	O
30	O
June	O
2015	O
when	O
the	O
data	O
were	O
frozen	O
for	O
this	O
analysis	O
,	O
6569	O
women	O
were	O
screened	O
for	O
eligibility	O
and	O
1334	O
were	O
eligible	O
.	O

In	O
attention	O
to	O
exclusion	O
criteria	O
(	O
not	O
to	O
give	O
blood	O
sample	O
or	O
usage	O
of	O
vitamin	O
D	O
supplement	O
during	O
the	O
study	O
period	O
)	O
none	O
of	O
the	O
case	O
and	O
control	O
populations	O
were	O
not	O
excluded	O
from	O
our	O
research	O
.	O

A	O
high	O
index	O
of	O
suspicion	O
of	O
gestational	O
diabetes	O
insipidus	O
is	O
required	O
in	O
a	O
correct	O
clinical	O
setting	O
especially	O
in	O
the	O
presence	O
of	O
other	O
risk	O
factors	O
such	O
as	O
preeclampsia	O
,	O
HELLP	O
syndrome	O
,	O
and	O
twin	O
pregnancies	O
.	O

Therefore	O
,	O
cell	O
division	O
is	O
synchronous	O
with	O
cell	O
growth	O
[	O
19	O
,	O
20	O
].	O

Trafficking	O
of	O
cells	O
could	O
therefore	O
be	O
responsible	O
for	O
the	O
passing	O
of	O
allergy	O
risk	O
from	O
mother	O
to	O
fetus	O
.	O

(	O
11	O
)	O
(	O
15	O
to	O
18	O
nmol	O
/	O
L	O
)	O
than	O
our	O
cohort	O
(	O
9	O
to	O
10	O
nmol	O
/	O
L	O
),	O
but	O
this	O
could	O
reflect	O
the	O
higher	O
cholecalciferol	O
doses	O
used	O
in	O
those	O
studies	O
and	O
/	O
or	O
alterations	O
in	O
vitamin	O
D	O
metabolism	O
and	O
volume	O
of	O
distribution	O
in	O
pregnancy	O
.	O

In	O
Iran	O
,	O
iron	O
and	O
folic	O
acid	O
supplements	O
are	O
routinely	O
given	O
to	O
all	O
pregnant	O
mothers	O
and	O
some	O
mothers	O
based	O
on	O
doctors	O
’	O
order	O
may	O
consume	O
multivitamins	O
or	O
calcium	O
.	O

The	O
fold	O
changes	O
were	O
uniformly	O
small	O
,	O
with	O
the	O
largest	O
FC	O
being	O
−	O
1	O
.	O
67	O
(	O
MEPD	O
).	O

Our	O
objective	O
was	O
to	O
compare	O
maternal	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
concentrations	O
[	O
25	O
(	O
OH	O
)	O
D	O
]	O
between	O
mothers	O
with	O
and	O
without	O
GDM	O
,	O
and	O
to	O
investigate	O
if	O
an	O
association	O
existed	O
between	O
maternal	O
vitamin	O
D	O
concentration	O
and	O
infant	O
birth	O
size	O
.	O

#	O
Beta	O
(	O
s	O
.	O
e	O
.	O

Prenatal	O
data	O
collection	O
time	O
points	O
are	O
at	O
<	O
18	O
weeks	O
’	O
gestation	O
(	O
phase	O
1	O
);	O
±	O
22	O
weeks	O
’	O
gestation	O
(	O
phase	O
2	O
);	O
±	O
36	O
weeks	O
’	O
gestation	O
(	O
phase	O
3	O
)	O
and	O
at	O
birth	O
(	O
phase	O
4	O
).	O

In	O
the	O
present	O
study	O
,	O
offspring	O
of	O
nutritionally	O
challenged	O
dams	O
develop	O
obesity	O
;	O
thus	O
a	O
perpetuation	O
and	O
possibly	O
a	O
compounding	O
of	O
accelerated	O
pubertal	O
onset	O
may	O
ensue	O
in	O
the	O
next	O
generation	O
as	O
these	O
offspring	O
will	O
themselves	O
be	O
fatter	O
at	O
an	O
earlier	O
reproductive	O
age	O
.	O

Discussion	O
It	O
is	O
known	O
that	O
the	O
ANS	O
development	O
begins	O
in	O
fetal	O
life	O
and	O
persists	O
after	O
birth	O
[	O
30	O
,	O
31	O
].	O

Finally	O
,	O
136	O
participants	O
completed	O
the	O
EPDS	O
at	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

Methods	O
:	O
We	O
conducted	O
a	O
retrospective	O
cohort	O
study	O
to	O
evaluate	O
associations	O
between	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
.	O

Born	O
Too	O
Soon	O
:	O
Accelerating	O
actions	O
for	O
prevention	O
and	O
care	O
of	O
15	O
million	O
newborns	O
born	O
too	O
soon	O
Abstract	O
Preterm	O
birth	O
complication	O
is	O
the	O
leading	O
cause	O
of	O
neonatal	O
death	O
resulting	O
in	O
over	O
one	O
million	O
deaths	O
each	O
year	O
of	O
the	O
15	O
million	O
babies	O
born	O
preterm	O
.	O

Thus	O
,	O
environmental	O
exposures	O
to	O
those	O
oocytes	O
and	O
spermatozoa	O
that	O
go	O
onto	O
produce	O
an	O
embryo	O
(	O
pre	O
-	O
conception	O
exposures	O
)	O
are	O
also	O
an	O
important	O
consideration	O
.	O

Linear	O
regression	O
analysis	O
revealed	O
that	O
the	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
(	O
Table	O
3	O
).	O

This	O
variable	O
was	O
calculated	O
in	O
stages	O
,	O
first	O
by	O
dividing	O
the	O
number	O
of	O
positive	O
influenza	O
samples	O
by	O
the	O
total	O
number	O
of	O
samples	O
tested	O
per	O
week	O
from	O
the	O
surveillance	O
data	O
and	O
then	O
assigning	O
the	O
cumulative	O
sum	O
of	O
the	O
influenza	O
positive	O
proportions	O
per	O
week	O
to	O
the	O
weeks	O
that	O
women	O
were	O
pregnant	O
;	O
we	O
dichotomized	O
this	O
variable	O
by	O
high	O
or	O
low	O
exposure	O
using	O
the	O
median	O
cumulative	O
influenza	O
exposure	O
as	O
a	O
cutoff	O
.	O

This	O
included	O
evaluating	O
possible	O
effect	O
measure	O
modifications	O
according	O
to	O
fetal	O
sex	O
.	O

In	O
male	O
offspring	O
at	O
six	O
months	O
of	O
age	O
,	O
no	O
differences	O
were	O
found	O
after	O
the	O
24	O
h	O
observation	O
of	O
water	O
intake	O
.	O

One	O
likely	O
reason	O
for	O
the	O
difference	O
is	O
convenience	O
.	O

Additionally	O
,	O
we	O
investigated	O
whether	O
a	O
lifetime	O
of	O
high	O
fat	O
consumption	O
by	O
the	O
dam	O
has	O
differing	O
effects	O
compared	O
to	O
high	O
fat	O
consumption	O
that	O
is	O
restricted	O
to	O
pregnancy	O
and	O
lactation	O
.	O

Although	O
a	O
recent	O
pilot	O
randomized	O
trial	O
[	O
39	O
]	O
found	O
no	O
significant	O
impact	O
of	O
a	O
low	O
glycemic	O
index	O
diet	O
on	O
the	O
offspring	O
weight	O
of	O
overweight	O
/	O
obese	O
mothers	O
,	O
future	O
,	O
larger	O
randomized	O
trials	O
and	O
research	O
with	O
more	O
frequent	O
assessments	O
of	O
diet	O
in	O
pregnancy	O
are	O
needed	O
to	O
untangle	O
the	O
relationship	O
between	O
weight	O
status	O
,	O
time	O
in	O
pregnancy	O
of	O
nutrient	O
exposures	O
,	O
and	O
offspring	O
weight	O
outcomes	O
.	O

Data	O
collection	O
At	O
the	O
first	O
antenatal	O
consultation	O
,	O
participants	O
were	O
weighed	O
in	O
light	O
clothing	O
using	O
a	O
SECA	O
weighing	O
scales	O
(	O
SECA	O
GmbH	O
&	O
Co	O
.	O
Kg	O
.	O

Park	O
et	O
al	O
[	O
15	O
]	O
studied	O
Korean	O
infants	O
at	O
2	O
to	O
5	O
months	O
of	O
age	O
and	O
found	O
no	O
relationship	O
between	O
25	O
(	O
OH	O
)	O
D	O
level	O
and	O
BMC	O
assessed	O
by	O
DXA	O
even	O
though	O
many	O
of	O
the	O
infants	O
had	O
very	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

However	O
,	O
adequate	O
maternal	O
intakes	O
of	O
zinc	O
and	O
vitamin	O
A	O
may	O
also	O
be	O
important	O
for	O
optimal	O
pregnancy	O
outcomes	O
,	O
as	O
well	O
as	O
for	O
maternal	O
and	O
offspring	O
health	O
[	O
11	O
–	O
13	O
].	O

The	O
origins	O
of	O
many	O
childhood	O
and	O
adult	O
malignancies	O
are	O
believed	O
to	O
be	O
determined	O
during	O
a	O
finite	O
perinatal	O
window	O
.	O

However	O
,	O
we	O
could	O
not	O
do	O
it	O
,	O
which	O
is	O
a	O
limitation	O
of	O
our	O
study	O
.	O

This	O
study	O
was	O
approved	O
by	O
the	O
University	O
of	O
Manitoba	O
’	O
s	O
Health	O
Research	O
Ethics	O
Board	O
,	O
the	O
Misericordia	O
Health	O
Centre	O
(	O
MHC	O
),	O
and	O
the	O
Health	O
Sciences	O
Centre	O
(	O
HSC	O
),	O
Winnipeg	O
,	O
Canada	O
.	O

We	O
randomized	O
126	O
(	O
49	O
.	O
8	O
%)	O
participants	O
to	O
the	O
intervention	O
arm	O
and	O
127	O
(	O
50	O
.	O
2	O
%)	O
to	O
the	O
control	O
arm	O
.	O

Maternal	O
health	O
and	O
nutrition	O
gained	O
heightened	O
attention	O
three	O
decades	O
ago	O
with	O
the	O
publication	O
of	O
the	O
developmental	O
origins	O
of	O
health	O
and	O
disease	O
(	O
DOHaD	O
)	O
hypothesis	O
.	O

Luckily	O
,	O
for	O
the	O
time	O
being	O
the	O
in	O
vitro	O
experiments	O
did	O
not	O
prove	O
cross	O
-	O
reaction	O
of	O
specific	O
immunoglobulin	O
with	O
VDBP	O
[	O
50	O
].	O

All	O
dietary	O
variables	O
were	O
modeled	O
as	O
continuous	O
variables	O
.	O

SNPs	O
at	O
rs12785878	O
(	O
DHCR7	O
),	O
rs10741657	O
(	O
CYP2R1	O
),	O
rs6013897	O
(	O
CYP24A1	O
),	O
and	O
rs2282679	O
(	O
GC	O
)	O
were	O
genotyped	O
.	O

Recent	O
surveys	O
in	O
Bangladesh	O
indicate	O
that	O
only	O
52	O
%	O
of	O
rural	O
women	O
reported	O
any	O
use	O
of	O
IFA	O
supplements	O
in	O
their	O
last	O
pregnancy	O
,	O
but	O
this	O
falls	O
to	O
39	O
%	O
for	O
the	O
poorest	O
households	O
,	O
and	O
to	O
34	O
%	O
for	O
women	O
with	O
no	O
education	O
[	O
5	O
].	O

Responses	O
were	O
as	O
follows	O
:	O
(	O
i	O
)	O
all	O
of	O
the	O
time	O
,	O
(	O
ii	O
)	O
most	O
of	O
the	O
time	O
,	O
(	O
iii	O
)	O
some	O
of	O
the	O
time	O
,	O
(	O
iv	O
)	O
a	O
little	O
of	O
the	O
time	O
,	O
and	O
(	O
v	O
)	O
none	O
of	O
the	O
time	O
.	O

Conclusions	O
Folic	O
acid	O
allergy	O
appears	O
to	O
be	O
rare	O
and	O
would	O
not	O
be	O
expected	O
to	O
be	O
well	O
known	O
among	O
health	O
providers	O
or	O
consumers	O
.	O

Multiple	O
regression	O
analysis	O
revealed	O
that	O
S	O
-	O
ECC	O
,	O
infrequent	O
milk	O
consumption	O
,	O
and	O
winter	O
season	O
were	O
significantly	O
associated	O
with	O
lower	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
.	O

It	O
is	O
also	O
possible	O
that	O
as	O
a	O
result	O
of	O
vascular	O
changes	O
in	O
pregnancy	O
the	O
maternal	O
cerebral	O
environment	O
is	O
more	O
vulnerable	O
to	O
inflammation	O
perhaps	O
,	O
explaining	O
in	O
part	O
the	O
link	O
between	O
vitamin	O
D	O
and	O
depression	O
in	O
pregnancy	O
.	O

Moreover	O
,	O
when	O
we	O
performed	O
RNA	O
FISH	O
,	O
the	O
GAS5	O
transcript	O
was	O
localized	O
almost	O
exclusively	O
in	O
the	O
syncytiotrophoblast	O
layer	O
of	O
the	O
human	O
placenta	O
and	O
colocalizes	O
GR	O
α	O
.	O

Trial	O
registration	O
Iranian	O
Registry	O
of	O
Clinical	O
Trials	O
IRCT2015020310327N11	O
.	O

75	O
%	O
of	O
black	O
and	O
19	O
%	O
of	O
white	O
women	O
were	O
vitamin	O
D	O
deficient	O
in	O
the	O
first	O
trimester	O
.	O

A	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
association	O
between	O
autism	O
and	O
developmental	O
abnormalities	O
in	O
children	O
with	O
perinatal	O
cocaine	O
exposure	O
.	O

The	O
results	O
of	O
the	O
LiST	O
analysis	O
found	O
that	O
84	O
%	O
of	O
premature	O
babies	O
(	O
more	O
than	O
921	O
,	O
000	O
lives	O
)	O
could	O
be	O
saved	O
in	O
2025	O
if	O
these	O
interventions	O
were	O
made	O
universally	O
available	O
(	O
95	O
%).	O

Studies	O
in	O
which	O
BMI	O
of	O
children	O
is	O
documented	O
at	O
repeated	O
times	O
show	O
strong	O
tracking	O
patterns	O
with	O
age	O
,	O
6	O
–	O
9but	O
this	O
has	O
not	O
been	O
reported	O
in	O
relation	O
to	O
family	O
lineages	O
including	O
grandparents	O
.	O

If	O
serum	O
concentration	O
exceeded	O
70	O
.	O
3	O
nmol	O
/	O
L	O
(	O
75	O
percentile	O
),	O
the	O
chance	O
of	O
endometriosis	O
development	O
was	O
much	O
higher	O
,	O
with	O
OR	O
=	O
4	O
.	O
8	O
(	O
1	O
.	O
7	O
–	O
13	O
.	O
5	O
)	O
[	O
39	O
].	O

Two	O
mothers	O
(	O
1	O
Hispanic	O
,	O
1	O
Caucasian	O
)	O
reported	O
covering	O
their	O
face	O
and	O
body	O
due	O
to	O
their	O
religious	O
beliefs	O
.	O

A	O
meta	O
-	O
analysis	O
which	O
included	O
the	O
above	O
studies	O
as	O
well	O
as	O
others	O
examining	O
women	O
with	O
pre	O
-	O
existing	O
diabetes	O
,	O
with	O
745	O
glyburide	O
exposed	O
pregnancies	O
and	O
637	O
treated	O
with	O
insulin	O
,	O
has	O
been	O
performed	O
.	O
65This	O
study	O
found	O
that	O
glyburide	O
did	O
not	O
increase	O
the	O
risk	O
of	O
macrosomia	O
,	O
large	O
for	O
gestational	O
age	O
,	O
or	O
neonatal	O
hypoglycemia	O
,	O
but	O
did	O
not	O
examine	O
more	O
serious	O
consequences	O
such	O
as	O
perinatal	O
mortality	O
or	O
congenital	O
anomalies	O
.	O

While	O
vitamin	O
D	O
supplementation	O
in	O
pregnancy	O
has	O
previously	O
been	O
associated	O
with	O
reduced	O
risk	O
of	O
wheezing	O
and	O
type	O
1	O
diabetes	O
.	O

In	O
all	O
dietary	O
patterns	O
,	O
the	O
most	O
of	O
energy	O
and	O
nutrients	O
intake	O
were	O
different	O
in	O
all	O
levels	O
of	O
dietary	O
patterns	O
adherence	O
.	O

However	O
,	O
recently	O
it	O
has	O
become	O
clear	O
that	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
has	O
potent	O
anti	O
-	O
proliferative	O
and	O
immunomodulatory	O
actions	O
that	O
are	O
not	O
immediately	O
linked	O
to	O
its	O
role	O
as	O
a	O
skeletal	O
regulator	O
.	O

Also	O
women	O
are	O
encouraged	O
to	O
continue	O
to	O
take	O
vitamin	O
D	O
supplements	O
after	O
pregnancy	O
to	O
help	O
protect	O
against	O
health	O
problems	O
such	O
as	O
osteoporosis	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
relationship	O
between	O
prenatal	O
visfatin	O
level	O
and	O
infant	O
’	O
s	O
anthropometric	O
indicators	O
in	O
the	O
two	O
years	O
following	O
childbirth	O
was	O
assessed	O
.	O

Furthermore	O
,	O
associations	O
between	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
loss	O
were	O
studied	O
.	O

There	O
is	O
now	O
a	O
small	O
but	O
growing	O
body	O
of	O
data	O
supporting	O
the	O
efficacy	O
of	O
prenatal	O
multi	O
-	O
micronutrients	O
in	O
improving	O
selected	O
perinatal	O
outcomes	O
of	O
women	O
and	O
babies	O
in	O
resource	O
-	O
poor	O
settings	O
.	O

NUTRITIONAL	O
FACTORS	O
Several	O
nutritional	O
factors	O
including	O
fat	O
metabolism	O
,	O
fat	O
digestion	O
and	O
absorption	O
,	O
glucose	O
/	O
starch	O
availability	O
,	O
roughage	O
vs	O
.	O
concentrate	O
ratio	O
,	O
dietary	O
energy	O
and	O
protein	O
levels	O
,	O
vitamins	O
A	O
,	O
D	O
,	O
and	O
C	O
levels	O
,	O
fetal	O
nutritional	O
programming	O
,	O
and	O
stage	O
-	O
specific	O
feeding	O
systems	O
can	O
affect	O
IMF	O
deposition	O
.	O

The	O
same	O
authors	O
suggested	O
that	O
total	O
IMF	O
within	O
the	O
LM	O
in	O
the	O
high	O
-	O
concentrate	O
group	O
might	O
be	O
greater	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
by	O
stimulating	O
intramuscular	O
preadipocyte	O
differentiation	O
.	O

The	O
validity	O
of	O
PUFA	O
estimated	O
by	O
means	O
of	O
the	O
FFQ	O
was	O
r	O
=	O
0	O
.	O
5	O
in	O
comparison	O
to	O
adipose	O
tissue	O
composition	O
[	O
26	O
].	O

The	O
brief	O
,	O
text	O
-	O
based	O
intervention	O
format	O
of	O
text4baby	O
is	O
consistent	O
with	O
other	O
brief	O
prenatal	O
alcohol	O
interventions	O
found	O
to	O
be	O
effective	O
in	O
recent	O
studies	O
[	O
42	O
].	O

Conclusion	O
Children	O
with	O
S	O
-	O
ECC	O
appear	O
to	O
have	O
relatively	O
poor	O
nutritional	O
health	O
compared	O
to	O
caries	O
-	O
free	O
controls	O
,	O
and	O
were	O
significantly	O
more	O
likely	O
to	O
have	O
low	O
vitamin	O
D	O
,	O
calcium	O
,	O
and	O
albumin	O
concentrations	O
and	O
elevated	O
PTH	O
levels	O
.	O

To	O
evaluate	O
miRNA	O
expression	O
,	O
U6	O
small	O
nuclear	O
RNA	O
(	O
U6	O
snRNA	O
)	O
was	O
used	O
as	O
a	O
reference	O
gene	O
to	O
normalize	O
the	O
expression	O
of	O
miRNAs	O
.	O

It	O
was	O
hypothesized	O
that	O
(	O
1	O
)	O
total	O
current	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
would	O
be	O
positively	O
correlated	O
with	O
cathelicidin	O
in	O
children	O
;	O
(	O
2	O
)	O
children	O
with	O
higher	O
plasma	O
cathelicidin	O
concentrations	O
would	O
have	O
had	O
fewer	O
infections	O
than	O
children	O
with	O
lower	O
cathelicidin	O
concentrations	O
;	O
and	O
(	O
3	O
)	O
cathelicidin	O
concentration	O
would	O
increase	O
with	O
advancing	O
age	O
.	O

Similarly	O
,	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
the	O
two	O
groups	O
with	O
regards	O
to	O
the	O
individual	O
components	O
of	O
the	O
Ages	O
and	O
Stages	O
score	O
(	O
Table	O
3	O
).	O

GAS5	O
was	O
significantly	O
lower	O
in	O
expression	O
in	O
JEG	O
-	O
3	O
cells	O
when	O
compared	O
to	O
BeWo	O
under	O
basal	O
conditions	O
(	O
Figure	O
3	O
(	O
a	O
)).	O

In	O
the	O
group	O
of	O
children	O
with	O
a	O
total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
≥	O
20	O
ng	O
/	O
mL	O
,	O
cathelicidin	O
concentration	O
was	O
significantly	O
positively	O
associated	O
with	O
age	O
(	O
ρ	O
=	O
0	O
.	O
373	O
,	O
p	O
=	O
0	O
.	O
0002	O
).	O

Concerning	O
hyperphagia	O
,	O
several	O
studies	O
have	O
reported	O
this	O
feeding	O
alteration	O
after	O
the	O
exposure	O
to	O
undernutrition	O
in	O
critical	O
windows	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
),	O
so	O
it	O
has	O
been	O
proposed	O
as	O
an	O
important	O
contributor	O
of	O
the	O
excessive	O
body	O
weight	O
.	O

Overall	O
,	O
snoring	O
was	O
associated	O
with	O
a	O
1	O
.	O
86	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
RR	O
=	O
1	O
.	O
86	O
;	O
95	O
%	O
CI	O
0	O
.	O
88	O
-	O
3	O
.	O
94	O
).	O

It	O
would	O
not	O
be	O
possible	O
however	O
to	O
relate	O
such	O
levels	O
to	O
prenatal	O
exposure	O
.	O

[	O
27	O
]	O
found	O
a	O
statistically	O
significant	O
inverse	O
association	O
between	O
PBDE	O
exposure	O
and	O
birth	O
weight	O
.	O

In	O
a	O
Nigerian	O
study	O
by	O
Fawoleet	O
al	O
[	O
7	O
]	O
and	O
in	O
Entebe	O
,	O
a	O
semi	O
-	O
urban	O
district	O
in	O
Uganda	O
[	O
28	O
]	O
a	O
proportionately	O
similar	O
profile	O
of	O
ANC	O
services	O
were	O
offered	O
as	O
in	O
our	O
area	O
of	O
study	O
.	O

Though	O
,	O
the	O
interpretation	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
may	O
be	O
complicated	O
by	O
the	O
presence	O
of	O
C3	O
-	O
epimer	O
of	O
25	O
(	O
OH	O
)	O
D	O
[	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
],	O
a	O
vitamin	O
metabolite	O
that	O
may	O
be	O
erroneously	O
included	O
as	O
25	O
(	O
OH	O
)	O
D	O
by	O
LC	O
-	O
MS	O
and	O
immunoassay	O
methods	O
[	O
43	O
].	O

However	O
,	O
conflicting	O
evidence	O
exists	O
[	O
27	O
,	O
28	O
].	O

In	O
vitro	O
diagnostic	O
tools	O
such	O
as	O
serological	O
testing	O
,	O
for	O
example	O
,	O
radioallergosorbent	O
test	O
for	O
type	O
I	O
allergy	O
or	O
the	O
lymphocyte	O
transformation	O
test	O
for	O
type	O
IV	O
allergy	O
[	O
49	O
]	O
are	O
preferred	O
to	O
in	O
vivo	O
testing	O
.	O

The	O
"	O
low	O
level	O
symptoms	O
group	O
"	O
included	O
women	O
with	O
no	O
or	O
few	O
experiences	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(≤	O
3	O
"	O
sometimes	O
"	O
and	O
no	O
"	O
almost	O
always	O
"	O
and	O
"	O
often	O
"	O
answers	O
to	O
any	O
of	O
the	O
questions	O
).	O

Methods	O
Dietary	O
intake	O
was	O
estimated	O
using	O
a	O
food	O
frequency	O
questionnaire	O
among	O
33	O
623	O
women	O
aged	O
30	O
-	O
49	O
years	O
at	O
enrolment	O
(	O
1991	O
/	O
92	O
).	O

DNA	O
methylation	O
and	O
infant	O
growth	O
.	O

The	O
strength	O
of	O
this	O
study	O
lies	O
in	O
its	O
comprehensive	O
sample	O
and	O
size	O
but	O
did	O
not	O
measure	O
some	O
other	O
maternal	O
factors	O
such	O
as	O
substance	O
abuse	O
and	O
nutritional	O
influence	O
[	O
47	O
].	O

A	O
similar	O
pattern	O
was	O
demonstrated	O
in	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
.	O

Although	O
qualitative	O
results	O
(	O
i	O
.	O
e	O
.,	O
normal	O
/	O
abnormal	O
blood	O
glucose	O
concentrations	O
)	O
for	O
the	O
diagnostic	O
test	O
were	O
available	O
for	O
all	O
251	O
subjects	O
,	O
specific	O
glucose	O
concentrations	O
for	O
each	O
time	O
point	O
(	O
i	O
.	O
e	O
.,	O
fasting	O
;	O
1	O
-	O
hour	O
;	O
2	O
-	O
hour	O
;	O
and	O
3	O
-	O
hour	O
post	O
glucose	O
load	O
)	O
were	O
unavailable	O
for	O
approximately	O
44	O
%	O
of	O
subjects	O
.	O

We	O
recruited	O
385	O
consenting	O
pregnant	O
women	O
for	O
the	O
study	O
.	O

The	O
composition	O
of	O
UNIMMAP	O
is	O
shown	O
inTable	O
1	O
(	O
UNICEF	O
/	O
WHO	O
/	O
UNU	O
1999	O
).	O

However	O
,	O
studies	O
in	O
women	O
from	O
Australia	O
and	O
New	O
Zealand	O
are	O
less	O
consistent	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
mean	O
AluYb8	O
levels	O
differed	O
significantly	O
by	O
maternal	O
tobacco	O
use	O
during	O
pregnancy	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
whereas	O
mean	O
LINE	O
-	O
1	O
levels	O
significantly	O
differed	O
only	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
(	O
p	O
=	O
0	O
.	O
02	O
;	O
Table	O
2	O
).	O

Abstract	O
:	O
SHORT	O
Higher	O
maternal	O
intake	O
of	O
sugar	O
in	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
allergy	O
and	O
allergic	O
asthma	O
in	O
the	O
offspring	O
http	O
://	O
ow	O
.	O
ly	O
/	O
zehc30bFswP	O
Introduction	O
There	O
has	O
been	O
considerable	O
interest	O
in	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
in	O
the	O
aetiology	O
of	O
childhood	O
asthma	O
and	O
atopy	O
[	O
1	O
].	O

As	O
a	O
result	O
the	O
calculated	O
cost	O
per	O
woman	O
treated	O
is	O
USD	O
0	O
.	O
76	O
per	O
year	O
(	O
USD133900	O
/	O
175581	O
).	O

Strong	O
homogeneous	O
staining	O
mainly	O
in	O
the	O
cytoplasm	O
is	O
detected	O
in	O
the	O
syncytiotrophoblast	O
cells	O
on	O
the	O
outermost	O
layer	O
of	O
the	O
placental	O
villi	O
,	O
with	O
some	O
scattered	O
expression	O
in	O
cytotrophoblast	O
cells	O
(	O
Figure	O
2	O
(	O
a	O
)).	O

Criteria	O
for	O
admission	O
and	O
hospital	O
management	O
of	O
the	O
pregnant	O
woman	O
with	O
acute	O
asthma	O
should	O
be	O
more	O
lenient	O
than	O
for	O
nonpregnant	O
patients	O
.	O

This	O
overcomes	O
the	O
bias	O
of	O
subject	O
selection	O
and	O
allowed	O
a	O
large	O
sample	O
that	O
was	O
more	O
representative	O
of	O
the	O
larger	O
obstetrical	O
population	O
since	O
it	O
included	O
a	O
diversity	O
of	O
socioeconomic	O
backgrounds	O
,	O
race	O
/	O
ethnic	O
groups	O
,	O
pregnancy	O
-	O
related	O
conditions	O
,	O
and	O
medical	O
histories	O
.	O

Regarding	O
the	O
birth	O
size	O
,	O
mothers	O
with	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(≥	O
80	O
nmol	O
/	O
L	O
)	O
had	O
heavier	O
newborns	O
than	O
those	O
with	O
suboptimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(	O
P	O
=	O
0	O
.	O
010	O
).	O

Birth	O
Weight	O
Many	O
studies	O
have	O
evaluated	O
the	O
association	O
between	O
birth	O
weight	O
and	O
the	O
development	O
of	O
autism	O
.	O

(	O
2012b	O
)*	O
Li	O
et	O
al	O
.	O

Inclusion	O
Criteria	O
Studies	O
were	O
included	O
only	O
if	O
the	O
target	O
population	O
,	O
outcome	O
and	O
exposures	O
of	O
interest	O
were	O
clearly	O
defined	O
and	O
results	O
were	O
based	O
on	O
valid	O
statistical	O
methodology	O
with	O
evaluation	O
of	O
errors	O
and	O
discussion	O
of	O
study	O
bias	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
combined	O
or	O
system	O
-	O
specific	O
morbidity	O
profiles	O
between	O
study	O
groups	O
(	O
data	O
not	O
shown	O
).	O

In	O
addition	O
,	O
there	O
were	O
no	O
apparent	O
changes	O
in	O
protein	O
expression	O
of	O
GR	O
α	O
/	O
β	O
in	O
BeWo	O
cells	O
treated	O
with	O
10	O
–	O
1000	O
nM	O
of	O
cortisol	O
,	O
corroborating	O
the	O
qPCR	O
studies	O
(	O
data	O
not	O
shown	O
).	O

Written	O
informed	O
consent	O
was	O
obtained	O
from	O
the	O
parents	O
/	O
guardians	O
on	O
behalf	O
of	O
the	O
children	O
enrolled	O
in	O
this	O
study	O
.	O

A	O
stool	O
sample	O
was	O
requested	O
and	O
sterile	O
universal	O
containers	O
provided	O
at	O
the	O
study	O
visit	O
following	O
the	O
trial	O
.	O

The	O
observed	O
difference	O
in	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
between	O
the	O
homozygous	O
gene	O
variants	O
was	O
higher	O
in	O
the	O
studies	O
by	O
Sollid	O
et	O
al	O
.	O

;	O
P	O
=	O
0	O
.	O
0001	O
)	O
and	O
at	O
>	O
90th	O
percentile	O
at	O
birth	O
(	O
19	O
.	O
6	O
%	O
versus	O
7	O
.	O
1	O
%;	O
P	O
=	O
.	O
001	O
;	O
Table	O
1	O
).	O

This	O
increment	O
may	O
be	O
brought	O
about	O
largely	O
by	O
thyroid	O
stimulation	O
induced	O
by	O
human	O
chorionic	O
gonadotropin	O
(	O
HCG	O
)	O
through	O
its	O
structural	O
affinity	O
with	O
thyrotropin	O
(	O
TSH	O
).	O

Maternal	O
anthropometric	O
measurements	O
Maternal	O
weight	O
and	O
mid	O
-	O
upperarm	O
circumference	O
(	O
MUAC	O
)	O
are	O
obtained	O
at	O
each	O
phase	O
(	O
1	O
to	O
8	O
),	O
and	O
height	O
only	O
at	O
phase	O
1	O
and	O
5	O
.	O

Multiple	O
regression	O
analyses	O
were	O
then	O
conducted	O
to	O
determine	O
the	O
most	O
robust	O
set	O
of	O
predictors	O
of	O
offspring	O
weight	O
parameters	O
after	O
adjustment	O
for	O
treatment	O
group	O
,	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
(	O
in	O
6	O
-	O
month	O
analyses	O
).	O

Epigenetics	O
and	O
the	O
mammalian	O
life	O
cycle	O
.	O

-	O
not	O
regulated	O
Discussion	O
We	O
applied	O
whole	O
-	O
genome	O
microarrays	O
to	O
evaluate	O
hepatic	O
gene	O
expression	O
profiles	O
of	O
offspring	O
from	O
sows	O
fed	O
either	O
an	O
isocaloric	O
maternal	O
low	O
protein	O
or	O
adequate	O
protein	O
diet	O
throughout	O
their	O
pregnancy	O
.	O

Body	O
mass	O
index	O
is	O
associated	O
with	O
the	O
maternal	O
lines	O
but	O
height	O
is	O
heritable	O
across	O
family	O
lines	O
in	O
the	O
Lifeways	O
Cross	O
-	O
Generation	O
Cohort	O
Study	O
Abstract	O
Objectives	O
Overweight	O
and	O
obesity	O
is	O
a	O
problem	O
in	O
children	O
in	O
particular	O
and	O
determining	O
pathways	O
of	O
transmission	O
is	O
important	O
in	O
prevention	O
.	O

This	O
process	O
has	O
been	O
called	O
nutritional	O
programming	O
(	O
Lucas	O
,	O
1991	O
;	O
Hales	O
and	O
Barker	O
,	O
2001	O
;	O
Gluckman	O
and	O
Hanson	O
,	O
2004	O
;	O
Barker	O
,	O
2007	O
;	O
Vaag	O
et	O
al	O
.,	O
2012	O
).	O

4	O
.	O

Since	O
Cesarean	O
delivery	O
results	O
in	O
differential	O
microbial	O
community	O
structure	O
of	O
the	O
infant	O
gut	O
[	O
24	O
],	O
and	O
the	O
gut	O
microbiome	O
is	O
a	O
complex	O
system	O
,	O
such	O
differences	O
are	O
plausible	O
;	O
experimental	O
studies	O
will	O
be	O
required	O
to	O
confirm	O
this	O
observation	O
.	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
captures	O
the	O
effect	O
of	O
multiple	O
vitamin	O
D	O
input	O
sources	O
(	O
supplement	O
,	O
sun	O
,	O
and	O
food	O
)	O
and	O
makes	O
provision	O
for	O
inter	O
-	O
individual	O
variability	O
in	O
dose	O
response	O
[	O
11	O
].	O

For	O
diagnosis	O
,	O
a	O
diary	O
of	O
allergy	O
symptoms	O
and	O
avoidance	O
of	O
specific	O
allergens	O
accompanied	O
by	O
monitoring	O
of	O
changes	O
of	O
allergic	O
symptoms	O
may	O
be	O
helpful	O
.	O

Genetic	O
constitution	O
is	O
important	O
[	O
4	O
],	O
but	O
environmental	O
factors	O
like	O
an	O
unhealthy	O
lifestyle	O
with	O
a	O
poor	O
diet	O
may	O
be	O
involved	O
[	O
5	O
,	O
6	O
].	O

The	O
most	O
commonly	O
used	O
herbs	O
were	O
ginger	O
and	O
peppermint	O
.	O

The	O
relatively	O
high	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
may	O
have	O
important	O
health	O
implications	O
for	O
Thai	O
people	O
as	O
the	O
science	O
of	O
vitamin	O
D	O
continues	O
to	O
be	O
unraveled	O
.	O

A	O
strong	O
relationship	O
was	O
found	O
between	O
maternal	O
serum	O
visfatin	O
and	O
neonatal	O
anthropometric	O
indicators	O
in	O
groups	O
A	O
and	O
B	O
,	O
with	O
a	O
possible	O
mechanism	O
of	O
maternal	O
visfatin	O
entering	O
the	O
fetal	O
blood	O
circulation	O
through	O
the	O
placenta	O
as	O
a	O
result	O
of	O
endocrine	O
changes	O
.	O

Bile	O
salts	O
are	O
amphipathic	O
compounds	O
that	O
act	O
as	O
biological	O
detergents	O
,	O
converting	O
dietary	O
fats	O
into	O
mixed	O
micelles	O
of	O
bile	O
salts	O
and	O
TGs	O
[	O
109	O
].	O

Handwashing	O
station	O
placement	O
was	O
guided	O
by	O
the	O
mother	O
and	O
other	O
relatives	O
such	O
that	O
the	O
mother	O
would	O
have	O
access	O
to	O
soap	O
and	O
water	O
in	O
the	O
key	O
locations	O
where	O
she	O
expected	O
to	O
spend	O
time	O
with	O
the	O
neonate	O
.	O

The	O
CB1	O
receptor	O
inverse	O
agonist	O
AM251	O
was	O
able	O
to	O
decrease	O
the	O
motivation	O
to	O
obtain	O
highly	O
palatable	O
food	O
in	O
a	O
free	O
choice	O
test	O
(	O
Mathes	O
et	O
al	O
.,	O
2008	O
;	O
Droste	O
et	O
al	O
.,	O
2010	O
;	O
Deshmukh	O
and	O
Sharma	O
,	O
2012	O
).	O

The	O
investigators	O
will	O
have	O
information	O
on	O
the	O
women	O
’	O
s	O
environmental	O
exposures	O
and	O
their	O
body	O
burden	O
of	O
metals	O
,	O
so	O
they	O
can	O
start	O
to	O
zero	O
in	O
on	O
how	B
arsenic	O
and	O
uranium	O
exposures	O
affect	O
protein	O
function	O
and	O
whether	O
zinc	O
supplementation	O
provides	O
any	O
protection	O
.	O

Methods	O
Study	O
design	O
and	O
setting	O
This	O
is	O
a	O
secondary	O
data	O
analysis	O
of	O
334	O
pregnant	O
women	O
enrolled	O
in	O
the	O
ROLO	O
(	O
Randomised	O
cOntrol	O
trial	O
of	O
a	O
LOw	O
glycaemic	O
index	O
diet	O
in	O
pregnancy	O
to	O
prevent	O
macrosomia	O
)	O
study	O
between	O
2007	O
and	O
2011	O
at	O
The	O
National	O
Maternity	O
Hospital	O
,	O
Dublin	O
,	O
Ireland	O
.	O

Infant	O
allergy	O
assessment	O
A	O
medical	O
doctor	O
assesses	O
the	O
allergy	O
phenotype	O
and	O
sensitisation	O
of	O
infants	O
with	O
the	O
Childhood	O
Allergy	O
and	O
Immunology	O
Research	O
(	O
CAIR	O
)	O
questionnaire	O
and	O
skin	O
prick	O
tests	O
at	O
phases	O
7	O
and	O
8	O
postnatally	O
.	O

The	O
limited	O
number	O
and	O
effectiveness	O
of	O
available	O
interventions	O
for	O
preterm	O
prevention	O
further	O
underscores	O
this	O
critical	O
major	O
knowledge	O
gap	O
,	O
and	O
makes	O
the	O
case	O
for	O
a	O
strategic	O
and	O
coordinated	O
research	O
effort	O
to	O
advance	O
understanding	O
of	O
causes	O
and	O
mechanisms	O
of	O
preterm	O
birth	O
and	O
identification	O
of	O
innovative	O
solutions	O
.	O

Main	O
outcome	O
measures	O
Maternal	O
,	O
pregnancy	O
,	O
delivery	O
and	O
neonatal	O
outcomes	O
.	O

Examining	O
large	O
groups	O
of	O
VD	O
-	O
deficient	O
patients	O
should	O
not	O
be	O
a	O
problem	O
—	O
most	O
societies	O
are	O
VD	O
-	O
deficient	O
either	O
way	O
.	O

Attendance	O
at	O
the	O
first	O
antenatal	O
visit	O
during	O
extended	O
winter	O
was	O
associated	O
with	O
reduced	O
intake	O
of	O
energy	O
(	O
kcal	O
)	O
(	O
winter	O
vs	O
.	O
summer	O
;	O
1795	O
.	O
2	O
±	O
412	O
.	O
0	O
vs	O
.	O
1904	O
.	O
7	O
±	O
418	O
.	O
2	O
,	O
P	O
=	O
0	O
.	O
031	O
),	O
protein	O
(	O
g	O
)	O
(	O
winter	O
vs	O
.	O
summer	O
;	O
74	O
.	O
4	O
±	O
17	O
.	O
4	O
vs	O
79	O
.	O
7	O
±	O
20	O
.	O
7	O
,	O
P	O
=	O
0	O
.	O
023	O
)	O
and	O
fat	O
(	O
g	O
)	O
(	O
winter	O
vs	O
.	O
summer	O
;	O
69	O
.	O
9	O
±	O
19	O
.	O
7	O
vs	O
77	O
.	O
2	O
±	O
22	O
.	O
8	O
,	O
P	O
=	O
0	O
.	O
005	O
).	O

Because	O
women	O
are	O
more	O
motivated	O
to	O
change	O
behaviors	O
during	O
pregnancy	O
and	O
immediately	O
postpartum	O
,	O
these	O
intervals	O
can	O
be	O
targeted	O
to	O
shape	O
eating	O
patterns	O
of	O
both	O
mother	O
and	O
child	O
.	O

Multivitamins	O
were	O
used	O
by	O
68	O
%	O
of	O
the	O
women	O
in	O
our	O
study	O
,	O
comparable	O
with	O
the	O
60	O
%	O
reported	O
by	O
the	O
IOMC	O
study	O
[	O
14	O
].	O

Shown	O
as	O
β	O
and	O
95	O
%	O
CI	O
.	O

Where	O
dietary	O
measures	O
are	O
inadequate	O
to	O
achieve	O
glycemic	O
targets	O
,	O
insulin	O
should	O
be	O
introduced	O
.	O

(	O
A	O
)	O
female	O
offspring	O
of	O
all	O
groups	O
fed	O
a	O
chow	O
diet	O
;	O
(	O
B	O
,	O
C	O
,	O
D	O
)	O
female	O
offspring	O
fed	O
a	O
postnatal	O
high	O
-	O
fat	O
diet	O
.	O

Some	O
studies	O
investigated	O
the	O
effect	O
of	O
reduced	O
exposure	O
of	O
infants	O
to	O
allergen	O
-	O
provoking	O
food	O
.	O

These	O
include	O
ethnicity	O
,	O
extent	O
of	O
skin	O
covering	O
,	O
liberal	O
use	O
of	O
sun	O
protection	O
,	O
adiposity	O
,	O
and	O
age	O
.	O

Previous	O
studies	O
have	O
shown	O
an	O
increased	O
blood	O
level	O
of	O
serotonin	O
in	O
individuals	O
affected	O
with	O
autism	O
spectrum	O
disorder	O
,	O
warranting	O
the	O
exploration	O
of	O
a	O
possible	O
association	O
[	O
65	O
].	O

In	O
contrast	O
,	O
the	O
RC	O
males	O
presented	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Napepld	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
whereas	O
RC	O
females	O
showed	O
lower	O
levels	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Faah	O
,	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Napepld	O
in	O
PAT	O
,	O
compared	O
to	O
those	O
of	O
their	O
respective	O
CC	O
offspring	O
(	O
Figures4B	O
,	O
C	O
).	O

Pregnant	O
women	O
who	O
fulfilled	O
the	O
inclusion	O
criteria	O
(	O
pregnant	O
women	O
presenting	O
for	O
the	O
second	O
or	O
subsequent	O
visit	O
)	O
and	O
consented	O
to	O
participate	O
in	O
the	O
study	O
were	O
enrolled	O
into	O
the	O
study	O
.	O

With	O
evidence	O
of	O
the	O
program	O
'	O
s	O
positive	O
impact	O
on	O
women	O
'	O
s	O
iron	O
status	O
the	O
weekly	O
supplement	O
program	O
with	O
twice	O
-	O
yearly	O
de	O
-	O
worming	O
was	O
scaled	O
up	O
to	O
province	O
level	O
(	O
with	O
an	O
estimated	O
target	O
group	O
of	O
250	O
,	O
000	O
women	O
of	O
reproductive	O
age	O
)	O
commencing	O
March	O
2008	O
.	O

In	O
addition	O
,	O
a	O
recent	O
meta	O
-	O
analysis	O
found	O
a	O
strong	O
association	O
between	O
receipt	O
of	O
influenza	O
vaccination	O
and	O
reduced	O
likelihood	O
of	O
PTB	O
and	O
LBW	O
,	O
and	O
the	O
magnitude	O
of	O
the	O
association	O
that	O
Nunes	O
et	O
al	O
.	O

The	O
potential	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
to	O
influence	O
inception	O
of	O
offspring	O
allergic	O
airways	O
disease	O
through	O
this	O
mechanism	O
was	O
recently	O
confirmed	O
in	O
a	O
mouse	O
model	O
[	O
42	O
].	O

Issued	O
by	O
the	O
March	O
of	O
Dimes	O
every	O
year	O
since	O
2008	O
,	O
the	O
Report	O
Cards	O
assign	O
a	O
letter	O
grade	O
to	O
the	O
United	O
States	O
and	O
to	O
each	O
of	O
50	O
state	O
governments	O
.	O

Interventions	O
such	O
as	O
family	O
planning	O
;	O
prevention	O
and	O
management	O
of	O
sexually	O
transmitted	O
infections	O
(	O
STIs	O
);	O
use	O
of	O
insecticide	O
-	O
treated	O
bednets	O
and	O
intermittent	O
preventive	O
treatment	O
for	O
malaria	O
;	O
identification	O
and	O
treatment	O
of	O
pre	O
-	O
eclampsia	O
,	O
and	O
reduction	O
of	O
physical	O
workload	O
are	O
examples	O
of	O
strategies	O
that	O
could	O
improve	O
birth	O
outcomes	O
in	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
settings	O
.	O

Male	O
offspring	O
from	O
the	O
HV	O
dams	O
weaned	O
to	O
the	O
RV	O
diet	O
had	O
5	O
%	O
higher	O
72	O
h	O
food	O
intake	O
(	O
Diet	O
:	O
P	O
=	O
0	O
.	O
03	O
,	O
Time	O
:	O
P	O
<	O
0	O
.	O
0001	O
,	O
Diet	O
*	O
Time	O
Interaction	O
:	O
P	O
=	O
0	O
.	O
4	O
),	O
8	O
%	O
higher	O
weight	O
gain	O
(	O
Diet	O
:	O
P	O
=	O
0	O
.	O
0006	O
,	O
Time	O
:	O
P	O
<	O
0	O
.	O
0001	O
,	O
Diet	O
*	O
Time	O
Interaction	O
:	O
P	O
=	O
0	O
.	O
3	O
)	O
and	O
36	O
%	O
higher	O
glucose	O
response	O
to	O
glucose	O
gavage	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
compared	O
to	O
those	O
from	O
the	O
RV	O
dams	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
(	O
Figure	O
2	O
,	O
3	O
,	O
4	O
).	O

However	O
,	O
at	O
6	O
month	O
of	O
age	O
,	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
,	O
the	O
VitD	O
-	O
mice	O
had	O
significantly	O
higher	O
values	O
of	O
renin	O
expression	O
than	O
the	O
SC	O
mice	O
(	O
P	O
=	O
0	O
.	O
001	O
).	O

Most	O
subject	O
characteristics	O
and	O
maternal	O
dietary	O
factors	O
were	O
not	O
different	O
between	O
delivery	O
mode	O
groups	O
(	O
Table	O
1	O
).	O

At	O
this	O
time	O
point	O
the	O
fetuses	O
were	O
subjected	O
to	O
a	O
serious	O
nutritional	O
deficiency	O
that	O
requires	O
an	O
acute	O
transcriptomic	O
response	O
.	O

Analysis	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
The	O
levels	O
of	O
25	O
(	O
OH	O
)	O
D	O
were	O
determined	O
by	O
an	O
automated	O
electrochemiluminescence	O
immunoassay	O
(	O
Roche	O
Diagnostics	O
,	O
Mannheim	O
,	O
Germany	O
)	O
in	O
the	O
core	O
lab	O
at	O
Chang	O
Gung	O
Memorial	O
Hospital	O
,	O
which	O
is	O
accredited	O
by	O
the	O
College	O
of	O
American	O
Pathologists	O
.	O

In	O
the	O
present	O
study	O
,	O
adiposity	O
was	O
not	O
the	O
focus	O
.	O

In	O
contrast	O
to	O
MHF	O
and	O
PLHF	O
offspring	O
,	O
those	O
born	O
to	O
dams	O
that	O
were	O
undernourished	O
during	O
pregnancy	O
showed	O
lower	O
adult	O
circulating	O
progesterone	O
concentrations	O
.	O

The	O
behavior	O
change	O
communication	O
strategy	O
was	O
based	O
on	O
a	O
theoretical	O
model	O
constructed	O
a	O
priori	O
that	O
included	O
concepts	O
of	O
the	O
Health	O
Belief	O
Model	O
and	O
the	O
heuristic	O
model	O
for	O
teachable	O
moments	O
,	O
described	O
by	O
McBride	O
and	O
colleagues	O
[	O
13	O
,	O
15	O
,	O
18	O
].	O

Female	O
rat	O
pups	O
born	O
to	O
and	O
suckled	O
by	O
fat	O
-	O
fed	O
mothers	O
have	O
high	O
blood	O
pressure	O
,	O
even	O
after	O
being	O
placed	O
on	O
a	O
balanced	O
diet	O
after	O
weaning	O
.	O

have	O
recently	O
shown	O
that	O
infants	O
with	O
low	O
cord	O
serum	O
vitamin	O
D	O
levels	O
have	O
a	O
higher	O
risk	O
of	O
childhood	O
wheezing	O
[	O
7	O
,	O
11	O
].	O

While	O
this	O
small	O
body	O
of	O
evidence	O
is	O
largely	O
composed	O
of	O
exploratory	O
in	O
vivo	O
high	O
-	O
dose	O
range	O
studies	O
,	O
it	O
does	O
set	O
a	O
precedent	O
for	O
the	O
existence	O
of	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
.	O

In	O
addition	O
,	O
the	O
type	O
and	O
amounts	O
of	O
fish	O
consumed	O
differed	O
across	O
study	O
locations	O
.	O

The	O
mean	O
total	O
number	O
of	O
combined	O
visits	O
was	O
9	O
.	O
58	O
±	O
4	O
.	O
88	O
:	O
18	O
%	O
of	O
participants	O
made	O
≤	O
4	O
visits	O
,	O
28	O
.	O
5	O
%	O
made	O
between	O
5	O
–	O
9	O
visits	O
and	O
53	O
.	O
3	O
%	O
had	O
≥	O
10	O
visits	O
.	O

One	O
possible	O
interpretation	O
for	O
our	O
present	O
data	O
is	O
that	O
a	O
vagal	O
withdrawal	O
,	O
rather	O
than	O
a	O
sympathetic	O
overactivity	O
,	O
could	O
precede	O
the	O
development	O
of	O
hypertension	O
and	O
other	O
cardiometabolic	O
diseases	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

These	O
findings	O
indicate	O
that	O
serotonin	O
homeostasis	O
is	O
necessary	O
for	O
proper	O
brain	O
maturation	O
and	O
fetal	O
development	O
.	O

For	O
example	O
,	O
robust	O
epigenetic	O
changes	O
induced	O
by	O
environmental	O
exposures	O
in	O
the	O
absence	O
of	O
a	O
phenotypic	O
consequence	O
essentially	O
become	O
the	O
‘	O
new	O
normal	O
’	O
epigenome	O
,	O
which	O
could	O
have	O
greater	O
susceptibility	O
to	O
disease	O
development	O
and	O
/	O
or	O
future	O
exposures	O
(	O
as	O
demonstrated	O
in	O
two	O
in	O
vivo	O
rat	O
models	O
(	O
Greathouse	O
et	O
al	O
.	O
2012	O
;	O
Wong	O
et	O
al	O
.	O
2015	O
)).	O

Further	O
adjustments	O
were	O
made	O
for	O
physical	O
activity	O
and	O
social	O
-	O
economic	O
levels	O
in	O
model	O
2	O
,	O
and	O
additionally	O
adjustment	O
for	O
delivery	O
status	O
,	O
IUGR	O
,	O
preterm	O
delivery	O
,	O
history	O
of	O
abortion	O
,	O
and	O
stillbirth	O
were	O
made	O
in	O
model	O
3	O
.	O

1	O
).	O

At	O
six	O
months	O
,	O
this	O
improvement	O
was	O
only	O
significant	O
for	O
children	O
of	O
women	O
in	O
the	O
highest	O
quintile	O
of	O
fish	O
consumption	O
,	O
suggesting	O
that	O
age	O
of	O
testing	O
may	O
be	O
relevant	O
[	O
22	O
].	O

We	O
computed	O
the	O
alternative	O
Mediterranean	O
diet	O
(	O
aMED	O
)	O
score	O
based	O
on	O
FFQ	O
-	O
derived	O
measures	O
of	O
daily	O
food	O
intake	O
,	O
following	O
the	O
method	O
of	O
Tobias	O
et	O
al	O
.	O

Test	O
of	O
feeding	O
response	O
to	O
AM251	O
To	O
evaluate	O
the	O
implication	O
of	O
the	O
cannabinoid	O
CB1	O
receptors	O
in	O
the	O
differential	O
response	O
on	O
caloric	O
intake	O
and	O
chocolate	O
preference	O
,	O
adult	O
rats	O
(	O
postnatal	O
weeks	O
13	O
–	O
14	O
)	O
were	O
firstly	O
treated	O
with	O
a	O
dose	O
of	O
the	O
CB1	O
receptor	O
inverse	O
agonist	O
AM251	O
(	O
3	O
mg	O
/	O
kg	O
)	O
and	O
then	O
exposed	O
to	O
a	O
free	O
choice	O
between	O
a	O
mixture	O
of	O
chocolates	O
and	O
a	O
standard	O
chow	O
.	O

Data	O
on	O
education	O
level	O
(≤	O
primary	O
level	O
,	O
secondary	O
level	O
or	O
university	O
level	O
)	O
and	O
origin	O
(	O
continent	O
of	O
birth	O
:	O
Northern	O
Europe	O
,	O
Continental	O
Europe	O
,	O
America	O
,	O
Asia	O
,	O
Africa	O
)	O
were	O
collected	O
from	O
study	O
questionnaires	O
.	O

A	O
recent	O
study	O
conducted	O
in	O
Sweden	O
by	O
Rai	O
et	O
al	O
.	O

However	O
,	O
the	O
highest	O
impact	O
interventions	O
,	O
notably	O
access	O
to	O
quality	O
intrapartum	O
care	O
and	O
emergency	O
obstetric	O
and	O
newborn	O
care	O
[	O
19	O
],	O
require	O
facility	O
-	O
based	O
services	O
.	O

However	O
,	O
it	O
is	O
likely	O
that	O
by	O
three	O
months	O
of	O
age	O
,	O
vitamin	O
D	O
has	O
a	O
key	O
role	O
in	O
calcium	O
absorption	O
,	O
especially	O
in	O
breast	O
-	O
fed	O
infants	O
with	O
a	O
relatively	O
low	O
calcium	O
intake	O
compared	O
to	O
formula	O
-	O
fed	O
infants	O
.	O

It	O
therefore	O
seems	O
likely	O
that	O
the	O
decreased	O
mortality	O
rate	O
was	O
at	O
least	O
in	O
part	O
a	O
consequence	O
of	O
treatment	O
of	O
GDM	O
,	O
rather	O
than	O
only	O
to	O
other	O
improvements	O
in	O
obstetric	O
outcome	O
.	O

In	O
addition	O
to	O
the	O
most	O
common	O
factors	O
the	O
sedentary	O
lifestyle	O
may	O
also	O
be	O
a	O
risk	O
factor	O
for	O
GDM	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Experimental	O
design	O
.	O

However	O
,	O
getting	O
25	O
(	O
OH	O
)	O
D	O
levels	O
consistently	O
above	O
75	O
nmol	O
/	O
L	O
(	O
30	O
ng	O
/	O
mL	O
)	O
may	O
require	O
at	O
least	O
1500	O
-	O
2000	O
IU	O
/	O
day	O
of	O
vitamin	O
D	O
.	O
If	O
a	O
mother	O
is	O
vitamin	O
D	O
deficient	O
,	O
breast	O
milk	O
is	O
not	O
a	O
good	O
source	O
of	O
vitamin	O
D	O
,	O
so	O
infants	O
need	O
to	O
be	O
given	O
vitamin	O
D	O
supplementation	O
until	O
they	O
are	O
weaned	O
.	O

The	O
nutrients	O
most	O
studied	O
during	O
pregnancy	O
include	O
B	O
-	O
vitamins	O
(	O
particularly	O
folic	O
acid	O
),	O
vitamin	O
D	O
,	O
iron	O
,	O
long	O
-	O
chain	O
polyunsaturated	O
fatty	O
acids	O
(	O
particularly	O
n	O
-	O
3	O
fatty	O
acids	O
)	O
and	O
iodine	O
[	O
8	O
,	O
10	O
].	O

In	O
vivo	O
and	O
in	O
vitro	O
models	O
have	O
shown	O
that	O
such	O
transfer	O
may	O
lead	O
to	O
reduced	O
neonatal	O
immunity	O
.	O

Cut	O
-	O
off	O
points	O
with	O
values	O
more	O
than	O
9	O
,	O
12	O
,	O
13	O
,	O
and	O
14	O
were	O
used	O
in	O
different	O
studies	O
to	O
determine	O
perinatal	O
depression	O
[	O
37	O
,	O
43	O
,	O
44	O
].	O

Regarding	O
the	O
time	O
exposure	O
to	O
diet	O
,	O
Palou	O
et	O
al	O
.	O

The	O
HV	O
pup	O
diet	O
brought	O
BDNF	O
expression	O
to	O
control	O
levels	O
but	O
the	O
HFol	O
pup	O
diet	O
only	O
attenuated	O
the	O
decrease	O
in	O
expression	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
(	O
Figure	O
5a	O
).	O

Results	O
3	O
.	O
1	O
.	O

The	O
text4baby	O
program	O
also	O
offers	O
an	O
example	O
of	O
using	O
behavioral	O
theory	O
to	O
the	O
design	O
mHealth	O
interventions	O
[	O
1	O
].	O

Both	O
hyperplasia	O
and	O
hypertrophy	O
are	O
involved	O
in	O
IMF	O
deposition	O
(	O
Figure	O
1	O
).	O

These	O
first	O
-	O
ever	O
country	O
estimates	O
of	O
preterm	O
birth	O
leave	O
us	O
without	O
the	O
excuse	O
of	O
ignorance	O
[	O
3	O
].	O

The	O
study	O
had	O
significant	O
selection	O
and	O
recall	O
biases	O
.	O

Total	O
GWG	O
was	O
computed	O
based	O
on	O
pregravid	O
weight	O
and	O
weight	O
at	O
the	O
last	O
clinic	O
visit	O
prior	O
to	O
delivery	O
.	O

Moreover	O
,	O
we	O
observed	O
a	O
sex	O
effect	O
on	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perigonadal	O
fat	O
relative	O
to	O
body	O
weight	O
.	O

Participants	O
took	O
a	O
survey	O
about	O
their	O
Vitamin	O
D	O
supplement	O
intake	O
history	O
,	O
including	O
brand	O
,	O
gestational	O
week	O
when	O
starting	O
the	O
intake	O
,	O
frequency	O
and	O
dose	O
,	O
and	O
calculation	O
of	O
non	O
-	O
dietary	O
Vitamin	O
D	O
daily	O
intake	O
.	O

For	O
the	O
microarray	O
experiments	O
individual	O
biotin	O
-	O
labeled	O
cRNA	O
was	O
synthesised	O
by	O
the	O
Gene	O
Chip	O
3	O
'	O
Express	O
Kit	O
(	O
Affymetrix	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
).	O

We	O
decided	O
not	O
to	O
include	O
dietary	O
Vitamin	O
D	O
estimates	O
in	O
the	O
final	O
multivariate	O
models	O
as	O
fish	O
is	O
a	O
rich	O
source	O
of	O
vitamin	O
D	O
and	O
could	O
account	O
for	O
some	O
of	O
the	O
effect	O
of	O
fish	O
on	O
our	O
outcome	O
.	O

Detectable	O
differences	O
would	O
range	O
from	O
6	O
.	O
2	O
%	O
(	O
with	O
follow	O
-	O
up	O
of	O
80	O
%	O
of	O
children	O
),	O
to	O
6	O
.	O
7	O
%	O
(	O
with	O
follow	O
-	O
up	O
of	O
70	O
%	O
of	O
children	O
;	O
alpha	O
0	O
.	O
05	O
;	O
power	O
80	O
%).	O

During	O
rapid	O
assessments	O
conducted	O
on	O
postnatal	O
days	O
4	O
-	O
5	O
,	O
the	O
proportion	O
of	O
households	O
observed	O
to	O
have	O
soap	O
and	O
water	O
at	O
a	O
handwashing	O
place	O
was	O
77	O
%	O
in	O
the	O
intervention	O
arm	O
and	O
27	O
%	O
in	O
the	O
control	O
arm	O
(	O
RR	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
2	O
.	O
11	O
–	O
4	O
.	O
15	O
,	O
p	O
<	O
.	O
0001	O
)	O
(	O
Figure	O
3	O
).	O

As	O
a	O
result	O
,	O
breastfeeding	O
studies	O
may	O
not	O
pass	O
muster	O
with	O
funding	O
committees	O
,	O
says	O
Raju	O
.	O

Behrman	O
,	O
Alderman	O
and	O
Hoddinott	O
,	O
2004	O
[	O
23	O
],	O
cite	O
estimates	O
for	O
Nepal	O
of	O
$	O
13	O
.	O
14	O
per	O
pregnancy	O
(	O
based	O
on	O
program	O
estimates	O
extrapolated	O
from	O
a	O
research	O
study	O
).	O

As	O
part	O
of	O
a	O
series	O
entitled	O
"	O
Born	O
Too	O
Soon	O
"	O
drawing	O
from	O
the	O
report	O
,	O
this	O
final	O
paper	O
summarises	O
the	O
problem	O
,	O
underlining	O
the	O
need	O
for	O
concerted	O
action	O
on	O
both	O
the	O
prevention	O
of	O
preterm	O
birth	O
and	O
care	O
of	O
the	O
premature	O
baby	O
,	O
to	O
ensure	O
every	O
mother	O
and	O
every	O
baby	O
survives	O
[	O
2	O
-	O
6	O
].	O

Additional	O
dietary	O
measures	O
are	O
usually	O
based	O
upon	O
the	O
general	O
recommendations	O
for	O
diabetes	O
mellitus	O
.	O

Respiratory	O
rate	O
and	O
anthropomorphic	O
data	O
were	O
collected	O
twice	O
and	O
we	O
used	O
the	O
mean	O
values	O
in	O
our	O
analysis	O
.	O

Previous	O
evidence	O
on	O
the	O
longer	O
-	O
term	O
effects	O
of	O
antenatal	O
dietary	O
and	O
lifestyle	O
interventions	O
is	O
limited	O
.	O

Second	O
,	O
it	O
provides	O
one	O
of	O
the	O
most	O
comprehensive	O
studies	O
to	O
date	O
evaluating	O
the	O
effect	O
of	O
mHealth	O
on	O
the	O
health	O
of	O
pregnant	O
military	O
female	O
soldiers	O
and	O
family	O
members	O
.	O

For	O
example	O
,	O
a	O
meta	O
-	O
analysis	O
by	O
Govarts	O
et	O
al	O
.	O

Cesarean	O
sections	O
are	O
also	O
more	O
common	O
,	O
and	O
GDM	O
is	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
pre	O
-	O
eclampsia	O
.	O
9	O
–	O
11	O
Exposure	O
of	O
the	O
fetus	O
to	O
hyperglycemia	O
may	O
also	O
predispose	O
the	O
child	O
to	O
a	O
diabetes	O
phenotype	O
in	O
later	O
life	O
.	O

Four	O
weeks	O
later	O
,	O
once	O
she	O
was	O
well	O
into	O
the	O
second	O
trimester	O
of	O
her	O
pregnancy	O
,	O
a	O
shave	O
removal	O
with	O
electrodessication	O
of	O
the	O
base	O
was	O
performed	O
after	O
reflecting	O
the	O
nail	O
plate	O
proximally	O
to	O
expose	O
the	O
lesion	O
.	O

A	O
total	O
of	O
169	O
participants	O
were	O
assigned	O
to	O
the	O
two	O
groups	O
of	O
placebo	O
and	O
vitamin	O
D	O
through	O
block	O
randomization	O
design	O
.	O

3	O
.	O
2	O
.	O

As	O
has	O
been	O
pointed	O
out	O
,	O
119the	O
relationship	O
between	O
the	O
MGM	O
in	O
particular	O
,	O
her	O
daughter	O
and	O
grandchild	O
represents	O
a	O
100	O
years	O
of	O
nutritional	O
flow	O
,	O
including	O
intrauterine	O
,	O
genetic	O
,	O
mitochondrial	O
and	O
environmental	O
nutritional	O
pathways	O
and	O
these	O
data	O
illustrate	O
this	O
effect	O
.	O

In	O
a	O
study	O
by	O
Mozaffari	O
-	O
Khosravi	O
et	O
al	O
.,	O
high	O
doses	O
of	O
vitamin	O
D	O
have	O
been	O
effective	O
in	O
men	O
and	O
women	O
who	O
were	O
depressed	O
[	O
30	O
].	O

The	O
quantity	O
μβis	O
the	O
average	O
association	O
between	O
all	O
regression	O
coefficients	O
and	O
the	O
outcome	O
,	O
whereas	O
σβcaptures	O
the	O
heterogeneity	O
of	O
effects	O
.	O

In	O
contrast	O
,	O
in	O
the	O
Faroe	O
Islands	O
study	O
researchers	O
found	O
that	O
exposure	O
to	O
PFASs	O
was	O
associated	O
with	O
shorter	O
breastfeeding	O
duration	O
among	O
both	O
primiparous	O
and	O
multiparous	O
mothers	O
.	O

The	O
recommendations	O
for	O
medical	O
treatment	O
have	O
been	O
summarized	O
by	O
a	O
Working	O
Group	O
of	O
the	O
National	O
Asthma	O
Education	O
and	O
Prevention	O
Program	O
in	O
a	O
report	O
on	O
managing	O
asthma	O
during	O
pregnancy	O
[	O
21	O
].	O

The	O
sum	O
of	O
the	O
total	O
deposits	O
of	O
perirenal	O
and	O
perigonadal	O
fat	O
determines	O
the	O
amount	O
of	O
abdominal	O
fat	O
.	O

Therefore	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
carry	O
out	O
the	O
first	O
national	O
representative	O
random	O
sample	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
in	O
a	O
European	O
country	O
and	O
to	O
assess	O
the	O
determinants	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
first	O
and	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Hypothalamic	O
Gene	O
Expression	O
Each	O
dissected	O
hypothalamus	O
was	O
homogenized	O
using	O
a	O
tissue	O
ruptor	O
homogenizer	O
(	O
Qiagen	O
Tech	O
.,	O
Mississauga	O
,	O
ON	O
,	O
Canada	O
).	O

Yearling	O
Brangus	O
×	O
Hereford	O
×	O
Angus	O
steers	O
fed	O
a	O
high	O
grain	O
diet	O
(	O
79	O
%	O
corn	O
)	O
had	O
more	O
growth	O
performance	O
,	O
greater	O
MS	O
,	O
and	O
higher	O
grade	O
meat	O
than	O
did	O
steers	O
fed	O
a	O
forage	O
diet	O
(	O
winter	O
wheat	O
pasture	O
with	O
sorghum	O
-	O
Sudan	O
and	O
Bermuda	O
grass	O
pasture	O
)	O
[	O
117	O
].	O

The	O
present	O
knowledge	O
on	O
the	O
impact	O
of	O
the	O
main	O
batokines	O
,	O
as	O
well	O
as	O
of	O
the	O
principal	O
other	O
UCP1	O
modulators	O
on	O
peripheral	O
metabolism	O
is	O
schematized	O
by	O
Figure1	O
.	O

We	O
identified	O
the	O
week	O
of	O
pregnancy	O
in	O
which	O
participants	O
enrolled	O
using	O
the	O
assumption	O
of	O
a	O
40	O
-	O
week	O
gestation	O
period	O
and	O
subtracting	O
the	O
total	O
number	O
of	O
days	O
between	O
the	O
participant	O
’	O
s	O
date	O
of	O
enrollment	O
and	O
due	O
date	O
recorded	O
by	O
the	O
study	O
site	O
.	O

Likewise	O
,	O
pharmaceutical	O
drug	O
-	O
induced	O
epigenetic	O
toxicity	O
in	O
human	O
cohorts	O
and	O
rodent	O
models	O
has	O
also	O
been	O
reported	O
.	O

In	O
both	O
models	O
,	O
some	O
variables	O
were	O
excluded	O
when	O
there	O
was	O
evidence	O
of	O
multi	O
-	O
colinearity	O
.	O

Nevertheless	O
,	O
the	O
findings	O
are	O
in	O
contrast	O
to	O
a	O
previously	O
published	O
study	O
which	O
found	O
that	O
in	O
utero	O
exposure	O
to	O
SGAs	O
was	O
associated	O
with	O
a	O
significantly	O
elevated	O
risk	O
of	O
small	O
for	O
gestational	O
age	O
births	O
.	O
16However	O
,	O
it	O
is	O
possible	O
that	O
this	O
difference	O
may	O
be	O
due	O
to	O
the	O
lack	O
of	O
control	O
of	O
potential	O
confounders	O
,	O
such	O
as	O
maternal	O
indication	O
for	O
smoking	O
or	O
substance	O
use	O
during	O
pregnancy	O
.	O

When	O
a	O
woman	O
struggles	O
,	O
Stuebe	O
says	O
,	O
“	O
she	O
is	O
often	O
told	O
to	O
try	O
harder	O
.”	O
Early	O
Environmental	O
Clues	O
In	O
1949	O
Morton	O
Biskind	O
,	O
a	O
Connecticut	O
physician	O
,	O
treated	O
a	O
pregnant	O
patient	O
with	O
acute	O
DDT	O
poisoning	O
.	O

When	O
considering	O
class	O
-	O
specific	O
relationships	O
,	O
a	O
positive	O
association	O
was	O
noted	O
between	O
AluYb8	O
methylation	O
and	O
methylation	O
of	O
CpGs	O
encompassing	O
the	O
low	O
to	O
intermediately	O
methylated	O
class	O
9	O
(	O
Figure	O
1	O
).	O

Experts	O
have	O
decried	O
the	O
lack	O
of	O
trustworthy	O
statistics	O
on	O
the	O
sources	O
and	O
extent	O
of	O
pollution	O
and	O
the	O
number	O
of	O
remediation	O
facilities	O
.	O

In	O
serum	O
,	O
vitamin	O
D	O
is	O
transported	O
by	O
vitamin	O
D	O
-	O
binding	O
protein	O
(	O
VDBP	O
)	O
to	O
the	O
liver	O
and	O
metabolized	O
to	O
an	O
active	O
form	O
of	O
25	O
-	O
hydroxycalciferol	O
(	O
25	O
[	O
OH	O
]	O
D	O
)	O
[	O
9	O
].	O

These	O
animals	O
were	O
from	O
four	O
separate	O
litters	O
per	O
experimental	O
group	O
.	O

The	O
relationship	O
between	O
visfatin	O
level	O
and	O
infant	O
’	O
s	O
anthropometric	O
indicators	O
The	O
mean	O
duration	O
of	O
neonatal	O
follow	O
-	O
up	O
was	O
10	O
.	O
19	O
±	O
2	O
.	O
83	O
months	O
.	O

Potentially	O
the	O
most	O
significant	O
nutritional	O
intervention	O
has	O
been	O
the	O
prenatal	O
supplementation	O
of	O
folate	O
,	O
which	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
incidence	O
of	O
neural	O
tube	O
defects	O
[	O
3	O
],	O
limb	O
malformations	O
,	O
urogenital	O
abnormalities	O
,	O
cardiovascular	O
malformations	O
[	O
4	O
],	O
and	O
cleft	O
lip	O
or	O
palate	O
[	O
5	O
].	O

p	O
Values	O
are	O
denoted	O
by	O
p	O
,	O
and	O
p	O
values	O
less	O
than	O
0	O
.	O
05	O
are	O
regarded	O
as	O
statistically	O
significant	O
.	O

One	O
explanation	O
is	O
that	O
PFAS	O
interact	O
with	O
estrogen	O
receptors	O
and	O
disrupt	O
hormonal	O
balances	O
[	O
20	O
].	O

The	O
PCR	O
conditions	O
used	O
were	O
40	O
cycles	O
of	O
98	O
°	O
C	O
for	O
5	O
sec	O
,	O
annealing	O
at	O
50	O
°	O
C	O
for	O
5	O
sec	O
,	O
and	O
elongation	O
at	O
72	O
°	O
C	O
for	O
15	O
sec	O
.	O

PubMed	O
Central	O
:	O

According	O
to	O
the	O
inclusion	O
criteria	O
,	O
the	O
mothers	O
were	O
of	O
Caucasian	O
origin	O
without	O
regular	O
medication	O
and	O
with	O
singleton	O
pregnancy	O
.	O

IFA	O
supplements	O
have	O
also	O
been	O
found	O
to	O
reduce	O
the	O
preterm	O
delivery	O
rate	O
and	O
neonatal	O
mortality	O
attributable	O
to	O
prematurity	O
and	O
birth	O
asphyxia	O
.	O

There	O
is	O
no	O
consensus	O
about	O
the	O
optimal	O
25	O
(	O
OH	O
)	O
D	O
level	O
,	O
but	O
many	O
experts	O
accept	O
a	O
range	O
75nmol	O
/	O
L	O
(≥	O
30	O
ng	O
/	O
mL	O
)	O
as	O
optimal	O
.	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
when	O
compared	O
to	O
the	O
women	O
recruited	O
in	O
Auckland	O
and	O
remained	O
lower	O
after	O
adjusting	O
for	O
covariates	O
including	O
maternal	O
body	O
mass	O
index	O
and	O
socioeconomic	O
index	O
(	O
Adelaide	O
:	O
58	O
.	O
4	O
±	O
50	O
.	O
3	O
vs	O
.	O
Auckland	O
:	O
70	O
.	O
2	O
±	O
54	O
.	O
5	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Such	O
a	O
change	O
results	O
in	O
the	O
inhibition	O
of	O
PTH	O
secretion	O
from	O
parathyroid	O
cells	O
.	O
27	O
The	O
increase	O
of	O
serum	O
calcium	O
in	O
the	O
IG	O
in	O
the	O
present	O
study	O
is	O
similar	O
to	O
that	O
reported	O
in	O
the	O
other	O
studies	O
.	O
15	O
,	O
17	O
-	O
20	O
,	O
22	O
-	O
25	O
,	O
27	O
,	O
28The	O
mechanism	O
of	O
increasing	O
serum	O
calcium	O
by	O
vitamin	O
D	O
is	O
that	O
vitamin	O
D	O
attaches	O
optionally	O
to	O
receptors	O
X	O
of	O
retinoic	O
acid	O
(	O
RXR	O
),	O
and	O
composes	O
a	O
heteromeric	O
complex	O
with	O
a	O
certain	O
sequence	O
on	O
the	O
DNA	O
,	O
known	O
as	O
reacting	O
elements	O
to	O
vitamin	O
D	O
.	O
This	O
leads	O
to	O
the	O
transcription	O
of	O
a	O
special	O
mRNA	O
,	O
which	O
results	O
in	O
the	O
translation	O
of	O
several	O
proteins	O
such	O
as	O
epithelial	O
calcium	O
channels	O
and	O
the	O
proteins	O
attached	O
to	O
calcium	O
.	O

Some	O
ncRNAs	O
can	O
also	O
promote	O
changes	O
in	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
,	O
and	O
/	O
or	O
the	O
expression	O
of	O
other	O
ncRNAs	O
.	O

Fatty	O
acids	O
of	O
dietary	O
origin	O
are	O
obtained	O
from	O
transporta	O
tion	O
of	O
TG	O
lipoprotein	O
and	O
subsequent	O
uptake	O
after	O
lipoprotein	O
lipase	O
hydrolysis	O
into	O
tissues	O
from	O
the	O
circulation	O
[	O
92	O
,	O
93	O
].	O

Measurement	O
of	O
metabolites	O
,	O
hepatic	O
enzymes	O
,	O
and	O
leptin	O
in	O
plasma	O
The	O
following	O
plasma	O
metabolites	O
and	O
enzymes	O
were	O
measured	O
:	O
basal	O
glucose	O
,	O
triglycerides	O
,	O
total	O
cholesterol	O
,	O
high	O
-	O
density	O
lipoprotein	O
(	O
HDL	O
),	O
urea	O
,	O
bilirubin	O
,	O
alkaline	O
phosphatase	O
(	O
ALKP	O
),	O
and	O
the	O
hepatic	O
enzymes	O
alanine	O
aminotransferase	O
(	O
ALT	O
),	O
aspartate	O
aminotransferase	O
(	O
AST	O
),	O
and	O
gamma	O
-	O
glutamyl	O
transpeptidase	O
(	O
γGT	O
).	O

Table	O
1describes	O
the	O
baseline	O
characteristics	O
of	O
the	O
subset	O
of	O
eligible	O
maternal	O
participants	O
,	O
and	O
are	O
similar	O
to	O
the	O
entire	O
randomised	O
cohort	O
(	O
data	O
not	O
shown	O
)	O
[	O
22	O
].	O

The	O
GEE	O
models	O
to	O
estimate	O
treatment	O
effects	O
on	O
measured	O
outcomes	O
did	O
not	O
demonstrate	O
any	O
significant	O
postpartum	O
text4baby	O
participation	O
effects	O
on	O
health	O
-	O
promoting	O
behaviors	O
.	O

A	O
research	O
pipeline	O
to	O
address	O
preterm	O
birth	O
Greater	O
investment	O
in	O
research	O
and	O
,	O
in	O
particular	O
,	O
into	O
discovery	O
of	O
the	O
many	O
complex	O
and	O
interrelated	O
factors	O
causing	O
preterm	O
birth	O
is	O
needed	O
to	O
strengthen	O
prevention	O
and	O
offers	O
a	O
potential	O
over	O
the	O
longer	O
term	O
for	O
significant	O
reductions	O
in	O
mortality	O
,	O
childhood	O
disability	O
and	O
healthcare	O
expenditure	O
.	O

Grain	O
type	O
and	O
processing	O
affect	O
IMF	O
content	O
[	O
115	O
]:	O
maize	O
is	O
more	O
effective	O
at	O
increasing	O
IMF	O
content	O
than	O
is	O
barley	O
,	O
followed	O
by	O
sorghum	O
.	O

Nonetheless	O
,	O
analyses	O
using	O
the	O
2009	O
criteria	O
confirmed	O
the	O
current	O
study	O
'	O
s	O
findings	O
(	O
data	O
not	O
shown	O
).	O

Previous	O
studies	O
have	O
shown	O
a	O
positive	O
association	O
between	O
socioeconomic	O
status	O
and	O
vitamin	O
D	O
in	O
both	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
[	O
36	O
,	O
37	O
].	O

Sample	O
size	O
of	O
the	O
random	O
sample	O
,	O
per	O
group	O
,	O
was	O
calculated	O
using	O
the	O
formula	O
to	O
estimate	O
a	O
proportion	O
assuming	O
that	O
90	O
%	O
of	O
those	O
who	O
self	O
-	O
reported	O
being	O
vaccinated	O
or	O
unvaccinated	O
status	O
were	O
truly	O
vaccinated	O
or	O
unvaccinated	O
,	O
respectively	O
[	O
37	O
].	O

Access	O
to	O
IFA	O
supplements	O
is	O
through	O
antenatal	O
care	O
,	O
however	O
,	O
in	O
rural	O
Bangladesh	O
,	O
the	O
median	O
gestation	O
that	O
women	O
commence	O
antenatal	O
care	O
is	O
5	O
.	O
2	O
months	O
,	O
and	O
44	O
%	O
of	O
women	O
report	O
no	O
use	O
of	O
antenatal	O
care	O
[	O
5	O
].	O

Furthermore	O
,	O
genes	O
involved	O
in	O
'	O
actin	O
cytoskeleton	O
signaling	O
',	O
'	O
RhoA	O
signaling	O
',	O
'	O
Rac	O
signaling	O
'	O
and	O
'	O
complement	O
system	O
'	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
.	O

Prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
were	O
tested	O
with	O
Fisher	O
’	O
s	O
Exact	O
test	O
.	O

In	O
a	O
recently	O
published	O
meta	O
-	O
analysis	O
,[	O
12	O
]	O
6	O
cohort	O
studies	O
evaluating	O
the	O
relationship	O
between	O
first	O
trimester	O
maternal	O
use	O
of	O
oral	O
corticosteroids	O
and	O
congenital	O
malformations	O
did	O
not	O
show	O
an	O
increased	O
risk	O
of	O
congenital	O
malformations	O
(	O
summary	O
odds	O
ratio	O
,	O
1	O
.	O
45	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
08	O
-	O
2	O
.	O
60	O
).	O

In	O
the	O
fetal	O
stage	O
,	O
the	O
main	O
process	O
is	O
increasing	O
the	O
number	O
of	O
adipocytes	O
(	O
hyperplasia	O
)	O
derived	O
from	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
[	O
21	O
].	O

Blood	O
pressure	O
increased	O
continually	O
from	O
3	O
to	O
6	O
months	O
of	O
age	O
in	O
both	O
groups	O
.	O

Introduction	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
,	O
and	O
it	O
is	O
related	O
to	O
excess	O
vasopressinase	O
activity	O
.	O

